gene_variant,total_occurrences,not_perturbed_count,inconclusive_count,perturbed_count,not_perturbed_percentage,inconclusive_percentage,perturbed_percentage,no_perturbed_percentage,no_perturbed_count,edge_x_pt_perc,ppi_assayed,symbol,ensembl_gene_id,orf_id,mut_id,ccsb_mutation_id,ccsb_allele_id,spdi,nt_change,aa_change,collection,entry_plate_orig,entry_well_orig,entry_plate_conso,entry_well_conso,entry_seq_pool,db_plate,db_well,n2h_plate,n2h_well,dualip_plate,dualip_well,mislocalization_plate,mislocalization_well,entry_sequenced,entry_sequence_confirmation_class,db_sequenced,db_sequence_confirmation_class,n2h_sequenced,n2h_sequence_confirmation_class,n2h_ref_sequence_confirmation_class,dualip_sequenced,dualip_sequence_confirmation_class,dualip_ref_sequence_confirmation_class,mislocalization_sequenced,mislocalization_sequence_confirmation_class,mislocalization_ref_sequence_confirmation_class,chr_num,nuc_loc,ref_allele,alt_allele,Chrom,entry_seq_final,db_seq_final,n2h_seq_final,dualip_seq_final,mislocalization_seq_final,varid,#AlleleID,Type,Name,GeneID,GeneSymbol,HGNC_ID,ClinicalSignificance,ClinSigSimple,LastEvaluated,RS# (dbSNP),nsv/esv (dbVar),RCVaccession,PhenotypeIDS,PhenotypeList,Origin,OriginSimple,Assembly,ChromosomeAccession,Chromosome,Start,Stop,Cytogenetic,ReviewStatus,NumberSubmitters,Guidelines,TestedInGTR,OtherIDs,SubmitterCategories,VariationID,PositionVCF,ReferenceAlleleVCF,AlternateAlleleVCF,SomaticClinicalImpact,SomaticClinicalImpactLastEvaluated,ReviewStatusClinicalImpact,Oncogenicity,OncogenicityLastEvaluated,ReviewStatusOncogenicity,SCVsForAggregateGermlineClassification,SCVsForAggregateSomaticClinicalImpact,SCVsForAggregateOncogenicityClassification,clinvar_nt_change,clinvar_aa_change,RefSeq_mRNA,StarStatus,clinvar_clnsig_clean,gnomad_af,clinvar_id,#chr,pos(1-based),ref,alt,aaref,aaalt,rs_dbSNP,hg19_chr,hg19_pos(1-based),hg18_chr,hg18_pos(1-based),aapos,genename,Ensembl_geneid,Ensembl_transcriptid,Ensembl_proteinid,Uniprot_acc,Uniprot_entry,HGVSc_snpEff,HGVSp_snpEff,HGVSc_VEP,HGVSp_VEP,APPRIS,GENCODE_basic,TSL,VEP_canonical,MANE,cds_strand,refcodon,codonpos,codon_degeneracy,Ancestral_allele,AltaiNeandertal,Denisova,VindijiaNeandertal,ChagyrskayaNeandertal,SIFT_score,SIFT_converted_rankscore,SIFT_pred,SIFT4G_score,SIFT4G_converted_rankscore,SIFT4G_pred,Polyphen2_HDIV_score,Polyphen2_HDIV_rankscore,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_rankscore,Polyphen2_HVAR_pred,MutationTaster_score,MutationTaster_converted_rankscore,MutationTaster_pred,MutationTaster_model,MutationTaster_trees_benign,MutationTaster_trees_deleterious,MutationAssessor_score,MutationAssessor_rankscore,MutationAssessor_pred,PROVEAN_score,PROVEAN_converted_rankscore,PROVEAN_pred,VEST4_score,VEST4_rankscore,MetaSVM_score,MetaSVM_rankscore,MetaSVM_pred,MetaLR_score,MetaLR_rankscore,MetaLR_pred,Reliability_index,MetaRNN_score,MetaRNN_rankscore,MetaRNN_pred,M-CAP_score,M-CAP_rankscore,M-CAP_pred,REVEL_score,REVEL_rankscore,MutPred_score,MutPred_rankscore,MutPred_protID,MutPred_AAchange,MutPred_Top5features,MVP_score,MVP_rankscore,gMVP_score,gMVP_rankscore,MPC_score,MPC_rankscore,PrimateAI_score,PrimateAI_rankscore,PrimateAI_pred,DEOGEN2_score,DEOGEN2_rankscore,DEOGEN2_pred,BayesDel_addAF_score,BayesDel_addAF_rankscore,BayesDel_addAF_pred,BayesDel_noAF_score,BayesDel_noAF_rankscore,BayesDel_noAF_pred,ClinPred_score,ClinPred_rankscore,ClinPred_pred,LIST-S2_score,LIST-S2_rankscore,LIST-S2_pred,VARITY_R_score,VARITY_R_rankscore,VARITY_ER_score,VARITY_ER_rankscore,VARITY_R_LOO_score,VARITY_R_LOO_rankscore,VARITY_ER_LOO_score,VARITY_ER_LOO_rankscore,ESM1b_score,ESM1b_rankscore,ESM1b_pred,AlphaMissense_score,AlphaMissense_rankscore,AlphaMissense_pred,PHACTboost_score,PHACTboost_rankscore,MutFormer_score,MutFormer_rankscore,MutScore_score,MutScore_rankscore,Aloft_Fraction_transcripts_affected,Aloft_prob_Tolerant,Aloft_prob_Recessive,Aloft_prob_Dominant,Aloft_pred,Aloft_Confidence,CADD_raw,CADD_raw_rankscore,CADD_phred,DANN_score,DANN_rankscore,fathmm-XF_coding_score,fathmm-XF_coding_rankscore,fathmm-XF_coding_pred,Eigen-raw_coding,Eigen-raw_coding_rankscore,Eigen-phred_coding,Eigen-PC-raw_coding,Eigen-PC-raw_coding_rankscore,Eigen-PC-phred_coding,GERP++_NR,GERP++_RS,GERP++_RS_rankscore,GERP_91_mammals,GERP_91_mammals_rankscore,phyloP100way_vertebrate,phyloP100way_vertebrate_rankscore,phyloP470way_mammalian,phyloP470way_mammalian_rankscore,phyloP17way_primate,phyloP17way_primate_rankscore,phastCons100way_vertebrate,phastCons100way_vertebrate_rankscore,phastCons470way_mammalian,phastCons470way_mammalian_rankscore,phastCons17way_primate,phastCons17way_primate_rankscore,bStatistic,bStatistic_converted_rankscore,1000Gp3_AC,1000Gp3_AF,1000Gp3_AFR_AC,1000Gp3_AFR_AF,1000Gp3_EUR_AC,1000Gp3_EUR_AF,1000Gp3_AMR_AC,1000Gp3_AMR_AF,1000Gp3_EAS_AC,1000Gp3_EAS_AF,1000Gp3_SAS_AC,1000Gp3_SAS_AF,TOPMed_frz8_AC,TOPMed_frz8_AN,TOPMed_frz8_AF,gnomAD2.1.1_exomes_flag,gnomAD2.1.1_exomes_controls_AC,gnomAD2.1.1_exomes_controls_AN,gnomAD2.1.1_exomes_controls_AF,gnomAD2.1.1_exomes_controls_nhomalt,gnomAD2.1.1_exomes_non_neuro_AC,gnomAD2.1.1_exomes_non_neuro_AN,gnomAD2.1.1_exomes_non_neuro_AF,gnomAD2.1.1_exomes_non_neuro_nhomalt,gnomAD2.1.1_exomes_non_cancer_AC,gnomAD2.1.1_exomes_non_cancer_AN,gnomAD2.1.1_exomes_non_cancer_AF,gnomAD2.1.1_exomes_non_cancer_nhomalt,gnomAD2.1.1_exomes_controls_AFR_AC,gnomAD2.1.1_exomes_controls_AFR_AN,gnomAD2.1.1_exomes_controls_AFR_AF,gnomAD2.1.1_exomes_controls_AFR_nhomalt,gnomAD2.1.1_exomes_controls_AMR_AC,gnomAD2.1.1_exomes_controls_AMR_AN,gnomAD2.1.1_exomes_controls_AMR_AF,gnomAD2.1.1_exomes_controls_AMR_nhomalt,gnomAD2.1.1_exomes_controls_ASJ_AC,gnomAD2.1.1_exomes_controls_ASJ_AN,gnomAD2.1.1_exomes_controls_ASJ_AF,gnomAD2.1.1_exomes_controls_ASJ_nhomalt,gnomAD2.1.1_exomes_controls_EAS_AC,gnomAD2.1.1_exomes_controls_EAS_AN,gnomAD2.1.1_exomes_controls_EAS_AF,gnomAD2.1.1_exomes_controls_EAS_nhomalt,gnomAD2.1.1_exomes_controls_FIN_AC,gnomAD2.1.1_exomes_controls_FIN_AN,gnomAD2.1.1_exomes_controls_FIN_AF,gnomAD2.1.1_exomes_controls_FIN_nhomalt,gnomAD2.1.1_exomes_controls_NFE_AC,gnomAD2.1.1_exomes_controls_NFE_AN,gnomAD2.1.1_exomes_controls_NFE_AF,gnomAD2.1.1_exomes_controls_NFE_nhomalt,gnomAD2.1.1_exomes_controls_SAS_AC,gnomAD2.1.1_exomes_controls_SAS_AN,gnomAD2.1.1_exomes_controls_SAS_AF,gnomAD2.1.1_exomes_controls_SAS_nhomalt,gnomAD2.1.1_exomes_controls_POPMAX_AC,gnomAD2.1.1_exomes_controls_POPMAX_AN,gnomAD2.1.1_exomes_controls_POPMAX_AF,gnomAD2.1.1_exomes_controls_POPMAX_nhomalt,gnomAD2.1.1_exomes_non_neuro_AFR_AC,gnomAD2.1.1_exomes_non_neuro_AFR_AN,gnomAD2.1.1_exomes_non_neuro_AFR_AF,gnomAD2.1.1_exomes_non_neuro_AFR_nhomalt,gnomAD2.1.1_exomes_non_neuro_AMR_AC,gnomAD2.1.1_exomes_non_neuro_AMR_AN,gnomAD2.1.1_exomes_non_neuro_AMR_AF,gnomAD2.1.1_exomes_non_neuro_AMR_nhomalt,gnomAD2.1.1_exomes_non_neuro_ASJ_AC,gnomAD2.1.1_exomes_non_neuro_ASJ_AN,gnomAD2.1.1_exomes_non_neuro_ASJ_AF,gnomAD2.1.1_exomes_non_neuro_ASJ_nhomalt,gnomAD2.1.1_exomes_non_neuro_EAS_AC,gnomAD2.1.1_exomes_non_neuro_EAS_AN,gnomAD2.1.1_exomes_non_neuro_EAS_AF,gnomAD2.1.1_exomes_non_neuro_EAS_nhomalt,gnomAD2.1.1_exomes_non_neuro_FIN_AC,gnomAD2.1.1_exomes_non_neuro_FIN_AN,gnomAD2.1.1_exomes_non_neuro_FIN_AF,gnomAD2.1.1_exomes_non_neuro_FIN_nhomalt,gnomAD2.1.1_exomes_non_neuro_NFE_AC,gnomAD2.1.1_exomes_non_neuro_NFE_AN,gnomAD2.1.1_exomes_non_neuro_NFE_AF,gnomAD2.1.1_exomes_non_neuro_NFE_nhomalt,gnomAD2.1.1_exomes_non_neuro_SAS_AC,gnomAD2.1.1_exomes_non_neuro_SAS_AN,gnomAD2.1.1_exomes_non_neuro_SAS_AF,gnomAD2.1.1_exomes_non_neuro_SAS_nhomalt,gnomAD2.1.1_exomes_non_neuro_POPMAX_AC,gnomAD2.1.1_exomes_non_neuro_POPMAX_AN,gnomAD2.1.1_exomes_non_neuro_POPMAX_AF,gnomAD2.1.1_exomes_non_neuro_POPMAX_nhomalt,gnomAD2.1.1_exomes_non_cancer_AFR_AC,gnomAD2.1.1_exomes_non_cancer_AFR_AN,gnomAD2.1.1_exomes_non_cancer_AFR_AF,gnomAD2.1.1_exomes_non_cancer_AFR_nhomalt,gnomAD2.1.1_exomes_non_cancer_AMR_AC,gnomAD2.1.1_exomes_non_cancer_AMR_AN,gnomAD2.1.1_exomes_non_cancer_AMR_AF,gnomAD2.1.1_exomes_non_cancer_AMR_nhomalt,gnomAD2.1.1_exomes_non_cancer_ASJ_AC,gnomAD2.1.1_exomes_non_cancer_ASJ_AN,gnomAD2.1.1_exomes_non_cancer_ASJ_AF,gnomAD2.1.1_exomes_non_cancer_ASJ_nhomalt,gnomAD2.1.1_exomes_non_cancer_EAS_AC,gnomAD2.1.1_exomes_non_cancer_EAS_AN,gnomAD2.1.1_exomes_non_cancer_EAS_AF,gnomAD2.1.1_exomes_non_cancer_EAS_nhomalt,gnomAD2.1.1_exomes_non_cancer_FIN_AC,gnomAD2.1.1_exomes_non_cancer_FIN_AN,gnomAD2.1.1_exomes_non_cancer_FIN_AF,gnomAD2.1.1_exomes_non_cancer_FIN_nhomalt,gnomAD2.1.1_exomes_non_cancer_NFE_AC,gnomAD2.1.1_exomes_non_cancer_NFE_AN,gnomAD2.1.1_exomes_non_cancer_NFE_AF,gnomAD2.1.1_exomes_non_cancer_NFE_nhomalt,gnomAD2.1.1_exomes_non_cancer_SAS_AC,gnomAD2.1.1_exomes_non_cancer_SAS_AN,gnomAD2.1.1_exomes_non_cancer_SAS_AF,gnomAD2.1.1_exomes_non_cancer_SAS_nhomalt,gnomAD2.1.1_exomes_non_cancer_POPMAX_AC,gnomAD2.1.1_exomes_non_cancer_POPMAX_AN,gnomAD2.1.1_exomes_non_cancer_POPMAX_AF,gnomAD2.1.1_exomes_non_cancer_POPMAX_nhomalt,gnomAD4.1_joint_flag,gnomAD4.1_joint_AC,gnomAD4.1_joint_AN,gnomAD4.1_joint_AF,gnomAD4.1_joint_nhomalt,gnomAD4.1_joint_POPMAX_AC,gnomAD4.1_joint_POPMAX_AN,gnomAD4.1_joint_POPMAX_AF,gnomAD4.1_joint_POPMAX_nhomalt,gnomAD4.1_joint_AFR_AC,gnomAD4.1_joint_AFR_AN,gnomAD4.1_joint_AFR_AF,gnomAD4.1_joint_AFR_nhomalt,gnomAD4.1_joint_AMI_AC,gnomAD4.1_joint_AMI_AN,gnomAD4.1_joint_AMI_AF,gnomAD4.1_joint_AMI_nhomalt,gnomAD4.1_joint_AMR_AC,gnomAD4.1_joint_AMR_AN,gnomAD4.1_joint_AMR_AF,gnomAD4.1_joint_AMR_nhomalt,gnomAD4.1_joint_ASJ_AC,gnomAD4.1_joint_ASJ_AN,gnomAD4.1_joint_ASJ_AF,gnomAD4.1_joint_ASJ_nhomalt,gnomAD4.1_joint_EAS_AC,gnomAD4.1_joint_EAS_AN,gnomAD4.1_joint_EAS_AF,gnomAD4.1_joint_EAS_nhomalt,gnomAD4.1_joint_FIN_AC,gnomAD4.1_joint_FIN_AN,gnomAD4.1_joint_FIN_AF,gnomAD4.1_joint_FIN_nhomalt,gnomAD4.1_joint_MID_AC,gnomAD4.1_joint_MID_AN,gnomAD4.1_joint_MID_AF,gnomAD4.1_joint_MID_nhomalt,gnomAD4.1_joint_NFE_AC,gnomAD4.1_joint_NFE_AN,gnomAD4.1_joint_NFE_AF,gnomAD4.1_joint_NFE_nhomalt,gnomAD4.1_joint_SAS_AC,gnomAD4.1_joint_SAS_AN,gnomAD4.1_joint_SAS_AF,gnomAD4.1_joint_SAS_nhomalt,ALFA_European_AC,ALFA_European_AN,ALFA_European_AF,ALFA_African_Others_AC,ALFA_African_Others_AN,ALFA_African_Others_AF,ALFA_East_Asian_AC,ALFA_East_Asian_AN,ALFA_East_Asian_AF,ALFA_African_American_AC,ALFA_African_American_AN,ALFA_African_American_AF,ALFA_Latin_American_1_AC,ALFA_Latin_American_1_AN,ALFA_Latin_American_1_AF,ALFA_Latin_American_2_AC,ALFA_Latin_American_2_AN,ALFA_Latin_American_2_AF,ALFA_Other_Asian_AC,ALFA_Other_Asian_AN,ALFA_Other_Asian_AF,ALFA_South_Asian_AC,ALFA_South_Asian_AN,ALFA_South_Asian_AF,ALFA_Other_AC,ALFA_Other_AN,ALFA_Other_AF,ALFA_African_AC,ALFA_African_AN,ALFA_African_AF,ALFA_Asian_AC,ALFA_Asian_AN,ALFA_Asian_AF,ALFA_Total_AC,ALFA_Total_AN,ALFA_Total_AF,clinvar_clnsig,clinvar_trait,clinvar_review,clinvar_hgvs,clinvar_var_source,clinvar_MedGen_id,clinvar_OMIM_id,clinvar_Orphanet_id,Interpro_domain,aaref_3,aaalt_3,#AlleleID_dbnsfp,Type_dbnsfp,Name_dbnsfp,GeneID_dbnsfp,GeneSymbol_dbnsfp,HGNC_ID_dbnsfp,ClinicalSignificance_dbnsfp,ClinSigSimple_dbnsfp,LastEvaluated_dbnsfp,RS# (dbSNP)_dbnsfp,nsv/esv (dbVar)_dbnsfp,RCVaccession_dbnsfp,PhenotypeIDS_dbnsfp,PhenotypeList_dbnsfp,Origin_dbnsfp,OriginSimple_dbnsfp,Assembly_dbnsfp,ChromosomeAccession_dbnsfp,Chromosome_dbnsfp,Start_dbnsfp,Stop_dbnsfp,Cytogenetic_dbnsfp,ReviewStatus_dbnsfp,NumberSubmitters_dbnsfp,Guidelines_dbnsfp,TestedInGTR_dbnsfp,OtherIDs_dbnsfp,SubmitterCategories_dbnsfp,VariationID_dbnsfp,PositionVCF_dbnsfp,ReferenceAlleleVCF_dbnsfp,AlternateAlleleVCF_dbnsfp,SomaticClinicalImpact_dbnsfp,SomaticClinicalImpactLastEvaluated_dbnsfp,ReviewStatusClinicalImpact_dbnsfp,Oncogenicity_dbnsfp,OncogenicityLastEvaluated_dbnsfp,ReviewStatusOncogenicity_dbnsfp,SCVsForAggregateGermlineClassification_dbnsfp,SCVsForAggregateSomaticClinicalImpact_dbnsfp,SCVsForAggregateOncogenicityClassification_dbnsfp,clinvar_nt_change_dbnsfp,clinvar_aa_change_dbnsfp,RefSeq_mRNA_dbnsfp,StarStatus_dbnsfp,clinvar_clnsig_clean_dbnsfp,plddt,rsa,OMIM_IDs,inheritance_pattern,disease_modules,disease_module_count,OMIM_disease_names,protein_AA,protein_Accessible surface area (Å²)*,protein_AlphaFold confidence (pLDDT),protein_Amino acid properties,protein_Amino acid residues,protein_Chain (UniProt),protein_Domain (UniProt),protein_Druggability score (fpocket)*,protein_Hydropathy,protein_Inter-chain Hydrogen bond (PDB),protein_Inter-chain Non-bonded interaction (PDB),protein_Intra-chain Hydrogen bond (AlphaFold2),protein_Intra-chain Hydrogen bond (PDB),protein_Intra-chain Non-bonded interaction (AlphaFold2),protein_Intra-chain Non-bonded interaction (PDB),protein_Intra-chain Salt bridge (AlphaFold2),protein_Intra-chain Salt bridge (PDB),protein_Molar mass (g/mol),protein_Mutagenesis (UniProt),protein_Phi angle (degrees)*,protein_Phosphorylation,protein_Pocket number (fpocket)*,protein_Psi angle (degrees)*,protein_Region (UniProt),protein_SNP-associated PTMs,protein_Secondary structure (DSSP 3-state)*,protein_Secondary structure (DSSP 9-state)*,protein_Secondary structure (PDBe/SIFTS),protein_Sequence conflict (UniProt),protein_Zinc finger (UniProt),protein_00000108-a-1 avg,protein_00000108-a-1 outliers⁺⁺,protein_00000108-a-2 avg,protein_00000108-a-2 outliers⁺⁺,protein_00000108-a-3 avg,protein_00000108-a-3 outliers⁺⁺,protein_00000096-a-1 avg,protein_00000096-a-1 outliers⁺⁺,protein_00000096-b-1 avg,protein_00000096-b-1 outliers⁺⁺,protein_00000001-d-2 avg,seq_confirmed_wt_ppi,seq_confirmed_allele_ppi,seq_confirmed_final,ppi_perturbed_manual,ppi_perturbed_llr,ID,Dataset,Gene,HGNC_id,STRAND,hg38_start,hg38_end,auth_transcript_id,transcript_pos,transcript_ref,transcript_alt,aa_pos,aa_ref,aa_alt,hgvs_c,hgvs_p,consequence,simplified_consequence,auth_reported_score,auth_reported_func_class,splice_measure,gnomad_MAF,clinvar_sig,clinvar_star,clinvar_date_last_reviewed,nucleotide_or_aa,MaveDB URN (score set),Ensembl_transcript_ID,Ref_seq_transcript_ID,Model_system,Assay Type ontology term,Phenotype Measured ontology term,Molecular or Biological Process Investigated (GO term),IGVF_produced,Interval 1 name,Interval 1 range,Interval 1 MaveDB class,Interval 2 name,Interval 2 range,Interval 2 MaveDB class,Interval 3 name,Interval 3 range,Interval 3 MaveDB class,Flag,REVEL,AM_score,AM_class,ClinVar Variation Id_ClinGen_repo,Allele Registry Id_ClinGen_repo,Disease_ClinGen_repo,Mondo Id_ClinGen_repo,Mode of Inheritance_ClinGen_repo,Assertion_ClinGen_repo,Applied Evidence Codes (Met)_ClinGen_repo,Applied Evidence Codes (Not Met)_ClinGen_repo,Summary of interpretation_ClinGen_repo,Expert Panel_ClinGen_repo,Guideline_ClinGen_repo,Approval Date_ClinGen_repo,Published Date_ClinGen_repo,Retracted_ClinGen_repo,Evidence Repo Link_ClinGen_repo,Uuid_ClinGen_repo,Updated_Classification_ClinGen_repo,Updated_Evidence Codes_ClinGen_repo,gene_variant_pp,pillar_tested,aa_change_pp
CTCF_Arg342Cys,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,CTCF,,6173,,CCSBVarC010851,,NC_000016.10:67616816:C:T,1024C>T,Arg342Cys,,,,,,,,,,,,,,,,,,,,,,,,,,,,16,67616816,C,T,16,,,,,,16-67616816-C-T,422102.0,single nucleotide variant,NM_006565.4(CTCF):c.1024C>T (p.Arg342Cys),10664.0,CTCF,HGNC:13723,Pathogenic/Likely pathogenic,1.0,"Aug 31, 2022",1131691283.0,-,RCV000494182|RCV001253429|RCV004535549,"MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|",not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|CTCF-related disorder,de novo;germline,germline,GRCh38,NC_000016.10,16,67616816.0,67616816.0,16q22.1,"criteria provided, multiple submitters, no conflicts",5.0,-,N,ClinGen:CA396312251,2.0,429261.0,67616816.0,C,T,-,-,-,-,-,-,SCV000581783|SCV001429134|SCV001449853|SCV004117060,-,-,1024C>T ,Arg342Cys,NM_006565.4,2.0,1_Pathogenic,,429261.0,16,67616816.0,C,T,R,C,rs1131691283,16,67650719,16,66208220,342.0,CTCF,ENSG00000102974,ENST00000642819,ENSP00000494408,P49711,CTCF_HUMAN,c.1024C>T,p.Arg342Cys,c.1024C>T,p.Arg342Cys,principal4,Y,.,.,.,+,CGT,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.996,0.84488,D,.,0.91795,.,.,.,.,2.925,0.84244,M,.,0.94690,.,.,0.66102,-0.5414,0.66965,T,0.2195,0.58068,T,10,0.90816814,0.90073,D,0.072612,0.71478,D,.,0.81796,0.799,0.91830,P49711,R342C,Loss of MoRF binding (P = 0.0286)| Loss of disorder (P = 0.0417)| Gain of methylation at K344 (P = 0.0462)| Loss of loop (P = 0.0804)| Loss of solvent accessibility (P = 0.1077),.,0.78989,.,0.92611,.,0.99749,0.963747024536,0.99943,D,0.874794,0.97303,D,0.243152,0.77795,D,0.111494,0.77506,D,0.998596012592316,0.94546,D,.,0.91755,.,0.8758145,0.89177,0.75798017,0.85523,0.79036707,0.83088,0.75543875,0.85370,-13.341,0.91976,D,0.9958,0.95928,LP,0.999472519562105,0.96705,0.95648080,0.93745,0.846,0.91546,.,.,.,.,.,.,5.456603,0.91125,32.0,0.99912080062961595,0.98096,0.927208,0.90917,D,0.872885598481848,0.90318,10.37319,0.805277495105465,0.90104,10.28159,4.89,4.89,0.63341,.,.,7.701,0.83585,7.609000,0.61899,0.599,0.40292,1.0,0.71675,1.0,0.68239,0.995,0.73271,55,0.97558,.,.,.,.,.,.,.,.,.,.,.,.,1,264690,3.7780044E-6,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1614136,6.195260e-07,0,1,1180010,8.474500e-07,0,0,75034,0.000000e+00,0,0,912,0.000000e+00,0,0,60000,0.000000e+00,0,0,29608,0.000000e+00,0,0,44890,0.000000e+00,0,0,64030,0.000000e+00,0,0,6062,0.000000e+00,0,1,1180010,8.474500e-07,0,0,91086,0.000000e+00,0,0,6962,0,0,84,0,0,84,0,0,2210,0,0,146,0,0,610,0,0,24,0,0,94,0,0,466,0,0,2294,0,0,108,0,0,10680,0,Conflicting_classifications_of_pathogenicity,not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder,"criteria_provided,_conflicting_classifications",NC_000016.10:g.67616816C>T,ClinGen:CA396312251,C3661900|C3809686,615502,363611,.,Arg,Cys,422102.0,single nucleotide variant,NM_006565.4(CTCF):c.1024C>T (p.Arg342Cys),10664.0,CTCF,HGNC:13723,Pathogenic/Likely pathogenic,1.0,"Aug 31, 2022",1131691283.0,-,RCV000494182|RCV001253429|RCV004535549,"MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|",not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|CTCF-related disorder,de novo;germline,germline,GRCh38,NC_000016.10,16,67616816.0,67616816.0,16q22.1,"criteria provided, multiple submitters, no conflicts",5.0,-,N,ClinGen:CA396312251,2.0,429261.0,67616816.0,C,T,-,-,-,-,-,-,SCV000581783|SCV001429134|SCV001449853|SCV004117060,-,-,1024C>T ,Arg342Cys,NM_006565.4,2.0,1_Pathogenic,86.65,0.407258064516129,['615502'],,,0,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21",R,101,86.65,Positively-charged,Arginine,Transcriptional repressor CTCF,,,-4.5,,,R342-V338; PAE: 1.0,9 interactions,"R342-H347, R342-E348, R342-V338, R342-T346; PAE: 3.0, 4.5, 1.0, 3.0",12 interactions,,,175,,-65.5,,,-35.5,,dbSNP: -; Variant type: US; AA change: Arg342His; PTM type: Phosphorylation; PTM morphology: VRHRR*yKHtHE; Var class: II&-,H (helix),H (α-helix),Helix,,C2H2-type 3,,,,,,,,,,,,,,,false,false,CTCF_unpublished_var157389,CTCF_unpublished,CTCF,13723,1.0,67616816.0,67616816.0,,1024,C,T,342.0,R,C,c.1024C>T,p.Arg342Cys,missense_variant,missense_variant,0.0968285,functionally_normal,Yes,6.195264835181174e-7,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Aug 31, 2022",nucleotide,,ENST00000264010.10,NM_006565.4,immortalized human cells,,,"molecular function (GO:0003674)
",Yes,,,,,,,,,,,0.559,0.9956,likely_pathogenic,,,,,,,,,,,,,,,,,,,CTCF_Arg342Cys,true,Arg342Cys
CTCF_His455Gln,2,2,0,0,100.0,0.0,0.0,100.0,2,0.0,true,CTCF,,6173,,CCSBVarC010858,,NC_000016.10:67626562:C:G,1365C>G,His455Gln,,,,,,,,,,,,,,,,,,,,,,,,,,,,16,67626562,C,G,16,,,,,,16-67626562-C-G,799962.0,single nucleotide variant,NM_006565.4(CTCF):c.1365C>G (p.His455Gln),10664.0,CTCF,HGNC:13723,Likely pathogenic,1.0,"Jun 10, 2019",1597725291.0,-,RCV001002552,"MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611",Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome,germline,germline,GRCh38,NC_000016.10,16,67626562.0,67626562.0,16q22.1,"criteria provided, single submitter",1.0,-,N,ClinGen:CA396317165,2.0,812003.0,67626562.0,C,G,-,-,-,-,-,-,SCV001160523,-,-,1365C>G ,His455Gln,NM_006565.4,1.0,1_Pathogenic,,812003.0,16,67626562.0,C,G,H,Q,rs1597725291,16,67660465,16,66217966,455.0,CTCF,ENSG00000102974,ENST00000264010,ENSP00000264010,P49711,CTCF_HUMAN,c.1365C>G,p.His455Gln,c.1365C>G,p.His455Gln,principal4,Y,1,YES,Select,+,CAC,3.0,2.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.0,0.92967,D,0.997,0.70687,D,0.992,0.80453,D,0.82,0.88440,A,simple_aae,18.0,82.0,4.485,0.98910,H,-7.51,0.95091,D,0.92,0.92320,-0.2605,0.75966,T,0.3925,0.74513,T,10,0.8887602,0.88083,D,0.149609,0.83093,D,0.579,0.82939,0.748,0.87844,P49711,H455Q,Gain of MoRF binding (P = 0.0878)| Loss of helix (P = 0.1706)| Gain of disorder (P = 0.19)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2629),0.949006423897,0.94804,.,0.97634,3.03790854674,0.99266,0.889497578144,0.95192,D,0.917886,0.98488,D,0.309664,0.83603,D,0.207035,0.83391,D,0.989961684048839,0.80030,D,.,0.80399,.,0.969477,0.98182,0.83204865,0.90192,0.969477,0.98182,0.83204865,0.90192,-13.14,0.89952,D,.,0.99795,.,0.99981684735099,0.98120,0.98982334,0.96704,0.864,0.92591,.,.,.,.,.,.,3.86468,0.56146,23.7,0.99143631297156454,0.53677,0.530946,0.54986,D,0.449511622968474,0.63986,4.666273,0.33042528030055,0.57107,3.898847,5.48,1.99,0.25354,2.62,0.47948,2.183,0.42298,0.800000,0.21732,-0.182,0.10118,1.0,0.71675,0.999,0.35501,0.99,0.65338,53,0.97599,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic,Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome,"criteria_provided,_single_submitter",NC_000016.10:g.67626562C>G,.,C3809686,615502,363611,.,His,Gln,799962.0,single nucleotide variant,NM_006565.4(CTCF):c.1365C>G (p.His455Gln),10664.0,CTCF,HGNC:13723,Likely pathogenic,1.0,"Jun 10, 2019",1597725291.0,-,RCV001002552,"MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611",Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome,germline,germline,GRCh38,NC_000016.10,16,67626562.0,67626562.0,16q22.1,"criteria provided, single submitter",1.0,-,N,ClinGen:CA396317165,2.0,812003.0,67626562.0,C,G,-,-,-,-,-,-,SCV001160523,-,-,1365C>G ,His455Gln,NM_006565.4,1.0,1_Pathogenic,85.99,0.1684782608695652,['615502'],,,0,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21",H,31,85.99,Positively-charged,Histidine,Transcriptional repressor CTCF,,,-3.2,,,"H455-Q459, H455-H460, H455-D451, H455-C442, H455-C439; PAE: 1.0, 2.0, 1.0, 2.5, 2.0",19 interactions,"H455-H460, H455-D451, H455-Q459; PAE: 2.0, 1.0, 1.0",20 interactions,,,155,,-63.8,,,-53.6,,,H (helix),H (α-helix),Helix,,C2H2-type 7,,,,,,,,,,,,,,,false,false,CTCF_unpublished_var159071,CTCF_unpublished,CTCF,13723,1.0,67626562.0,67626562.0,,1365,C,G,455.0,H,Q,c.1365C>G,p.His455Gln,missense_variant,missense_variant,-0.295056,functionally_abnormal,Yes,,Likely pathogenic,"criteria provided, single submitter","Jun 10, 2019",nucleotide,,ENST00000264010.10,NM_006565.4,immortalized human cells,,,"molecular function (GO:0003674)
",Yes,,,,,,,,,,,0.579,0.9999,likely_pathogenic,,,,,,,,,,,,,,,,,,,CTCF_His455Gln,true,His455Gln
CTCF_Tyr407Cys,2,2,0,0,100.0,0.0,0.0,100.0,2,0.0,true,CTCF,,6173,,CCSBVarC010870,,NC_000016.10:67621454:A:G,1220A>G,Tyr407Cys,,,,,,,,,,,,,,,,,,,,,,,,,,,,16,67621454,A,G,16,,,,,,16-67621454-A-G,260121.0,single nucleotide variant,NM_006565.4(CTCF):c.1220A>G (p.Tyr407Cys),10664.0,CTCF,HGNC:13723,Likely pathogenic,1.0,"Jan 06, 2025",886039600.0,-,RCV000255519,MedGen:C3661900,not provided,germline,germline,GRCh38,NC_000016.10,16,67621454.0,67621454.0,16q22.1,"criteria provided, single submitter",1.0,-,N,ClinGen:CA10588621,2.0,265526.0,67621454.0,A,G,-,-,-,-,-,-,SCV000322502,-,-,1220A>G ,Tyr407Cys,NM_006565.4,1.0,1_Pathogenic,,265526.0,16,67621454.0,A,G,Y,C,rs886039600,16,67655357,16,66212858,407.0,CTCF,ENSG00000102974,ENST00000644753,ENSP00000493495,P49711,CTCF_HUMAN,c.1220A>G,p.Tyr407Cys,c.1220A>G,p.Tyr407Cys,principal4,Y,.,.,.,+,TAT,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.78662,.,.,0.92967,.,0.914,0.50540,P,0.665,0.52957,P,.,0.86984,.,.,.,.,3.095,0.87372,M,.,0.96158,.,.,0.77038,-0.7497,0.57774,T,0.1518,0.47848,T,10,0.84561706,0.83554,D,0.084978,0.74353,D,.,0.78861,0.615,0.74786,P49711,Y407C,Loss of phosphorylation at Y407 (P = 0.0811)| Gain of ubiquitination at K405 (P = 0.1079)| Gain of disorder (P = 0.1124)| Gain of glycosylation at K405 (P = 0.1594)| Loss of MoRF binding (P = 0.1621),.,0.78538,.,0.94871,.,0.99706,0.954362869263,0.99834,D,0.875329,0.97318,D,0.258403,0.79229,D,0.133401,0.78960,D,0.997824430465698,0.92450,D,.,0.93500,.,0.8909639,0.90456,0.6975476,0.81981,0.8259339,0.85435,0.7453358,0.84765,-16.773,0.98709,D,.,0.96717,.,0.999749203930458,0.97751,0.97100700,0.94734,0.889,0.94066,.,.,.,.,.,.,5.434312,0.90871,32.0,0.99770787246477033,0.85930,0.932506,0.92271,D,0.717981494107391,0.80704,7.377784,0.688130749716732,0.81373,7.535864,5.83,4.72,0.59198,4.73,0.87084,9.325,0.96016,11.234000,0.90219,0.756,0.943,1.0,0.71675,1.0,0.68239,0.998,0.85369,54,0.97580,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic,not_provided,"criteria_provided,_single_submitter",NC_000016.10:g.67621454A>G,ClinGen:CA10588621,CN517202,.,.,.,Tyr,Cys,260121.0,single nucleotide variant,NM_006565.4(CTCF):c.1220A>G (p.Tyr407Cys),10664.0,CTCF,HGNC:13723,Likely pathogenic,1.0,"Jan 06, 2025",886039600.0,-,RCV000255519,MedGen:C3661900,not provided,germline,germline,GRCh38,NC_000016.10,16,67621454.0,67621454.0,16q22.1,"criteria provided, single submitter",1.0,-,N,ClinGen:CA10588621,2.0,265526.0,67621454.0,A,G,-,-,-,-,-,-,SCV000322502,-,-,1220A>G ,Tyr407Cys,NM_006565.4,1.0,1_Pathogenic,85.11,0.3333333333333333,,,,0,,Y,74,85.11,Aromatic,Tyrosine,Transcriptional repressor CTCF,,0.2481,-1.3,,,Y407-F416; PAE: 2.0,15 interactions,"Y407-Q418, Y407-S419, Y407-F416; PAE: 2.0, 2.5, 2.0",19 interactions,,,181,,-113.7,Morphology: tHsGEKPyECyICHA,"Pocket 2: Mean pLDDT: 83.64, Volume: 523.05 Å³, Druggability score: 0.25",108.8,,,B (undefined),E (parallel sheets),Beta strand,,C2H2-type 6,,,,,,,,,,,,,,,false,false,CTCF_unpublished_var158526,CTCF_unpublished,CTCF,13723,1.0,67621454.0,67621454.0,,1220,A,G,407.0,Y,C,c.1220A>G,p.Tyr407Cys,missense_variant,missense_variant,0.00170449,functionally_normal,Yes,,Likely pathogenic,"criteria provided, single submitter","Jan 12, 2016",nucleotide,,ENST00000264010.10,NM_006565.4,immortalized human cells,,,"molecular function (GO:0003674)
",Yes,,,,,,,,,,,0.51,0.9971,likely_pathogenic,,,,,,,,,,,,,,,,,,,CTCF_Tyr407Cys,true,Tyr407Cys
GCK_Ala387Glu,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214861,CCSBVarC006699,ALE00006697,NC_000007.14:44145590:G:T,1160C>A,Ala387Glu,CEGS2,CegsMutGDEh1043,B11,GDEhDisVCh_40037,F01,1.0,CegsMutGDDh1043,B11,VUSN2Hmut_GDN2h_09,H03,VUSMutpDEST2_03,B10,VUSmut_GDEh09,H03,1.0,1.0,1.0,1.0,1.0,5.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,7,44145590,G,T,7,Y,Y,N,Y,Y,7-44145590-G-T,44845.0,single nucleotide variant,NM_000162.5(GCK):c.1160C>A (p.Ala387Glu),2645.0,GCK,HGNC:4195,Likely pathogenic,1.0,"Feb 28, 2024",193921338.0,-,RCV000029844|RCV003883122,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Maturity-onset diabetes of the young type 2|Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44145590.0,44145590.0,7p13,reviewed by expert panel,2.0,-,N,ClinGen:CA213725,2.0,36181.0,44145590.0,G,T,-,-,-,-,-,-,SCV004697906,-,-,1160C>A ,Ala387Glu,NM_000162.5,3.0,1_Pathogenic,6.8858e-7,36181.0,7,44145590.0,G,T,A,E,rs193921338,7,44185189,7,44151714,387.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.1160C>A,p.Ala387Glu,c.1160C>A,p.Ala387Glu,principal1,Y,1,YES,Select,-,GCG,2.0,0.0,G,G/G,G/G,G/G,G/G,0.0,0.91343,D,0.002,0.79703,D,1.0,0.90580,D,0.999,0.92348,D,1.0,0.99291,A,simple_aae,0.0,100.0,3.375,0.91274,M,-4.12,0.76771,D,0.844,0.83943,1.0862,0.99092,D,0.9717,0.99109,D,10,0.99201083,0.99734,D,0.870064,0.99003,D,0.958,0.99315,0.935,0.99041,P35557,A387E,Gain of disorder (P = 0.0374)| Loss of MoRF binding (P = 0.059)| Loss of catalytic residue at A387 (P = 0.1806)| Gain of helix (P = 0.2294)| Loss of methylation at R392 (P = 0.4738),0.987331409019,0.98705,.,0.99984,.,0.96565,0.811778783798,0.83736,D,0.947901,0.99219,D,0.560597,0.96212,D,0.567482,0.96152,D,0.997854888439178,0.92528,D,0.964304,0.88661,D,0.98488784,0.99450,0.9533024,0.98573,0.9799398,0.99090,0.97126704,0.99511,-13.645,0.91965,D,0.9824,0.93458,P,0.999603109944392,0.97154,0.99983466,0.99778,0.978,0.99209,.,.,.,.,.,.,5.614955,0.9257,32.0,0.99531726386056985,0.69939,0.974355,0.99552,D,1.03310609236388,0.96655,14.9943,0.958102556661233,0.97626,16.48479,5.46,5.46,0.79994,3.81,0.70705,9.901,0.98627,11.604000,0.93507,0.672,0.70176,1.0,0.71675,1.000000,0.68239,0.969,0.5403,716,0.55914,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,99980,0.000000e+00,0,1,191874,5.211750e-06,0,1,218022,4.586690e-06,0,0,6062,0.000000e+00,0,0,16398,0.000000e+00,0,0,2158,0.000000e+00,0,0,8222,0.000000e+00,0,0,10776,0.000000e+00,0,0,39570,0.000000e+00,0,0,15040,0.000000e+00,0,.,.,.,.,0,14210,0.000000e+00,0,1,29300,3.412970e-05,0,0,5846,0.000000e+00,0,0,12418,0.000000e+00,0,0,13834,0.000000e+00,0,0,82322,0.000000e+00,0,0,29408,0.000000e+00,0,1,29300,3.412970e-05,0,0,13174,0.000000e+00,0,1,33064,3.024440e-05,0,0,9234,0.000000e+00,0,0,16688,0.000000e+00,0,0,17606,0.000000e+00,0,0,93648,0.000000e+00,0,0,29338,0.000000e+00,0,1,33064,3.024440e-05,0,.,1,1604628,6.231970e-07,0,1,59324,1.685660e-05,0,0,74932,0.000000e+00,0,0,912,0.000000e+00,0,1,59324,1.685660e-05,0,0,29448,0.000000e+00,0,0,44558,0.000000e+00,0,0,59780,0.000000e+00,0,0,6032,0.000000e+00,0,0,1177334,0.000000e+00,0,0,90186,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic,Monogenic_diabetes|Maturity-onset_diabetes_of_the_young_type_2,reviewed_by_expert_panel,NC_000007.14:g.44145590G>T,ClinGen:CA213725,C3888631|C0342277,125851,183625|552,"Hexokinase, C-terminal",Ala,Glu,44845.0,single nucleotide variant,NM_000162.5(GCK):c.1160C>A (p.Ala387Glu),2645.0,GCK,HGNC:4195,Likely pathogenic,1.0,"Feb 28, 2024",193921338.0,-,RCV000029844|RCV003883122,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Maturity-onset diabetes of the young type 2|Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44145590.0,44145590.0,7p13,reviewed by expert panel,2.0,-,N,ClinGen:CA213725,2.0,36181.0,44145590.0,G,T,-,-,-,-,-,-,SCV004697906,-,-,1160C>A ,Ala387Glu,NM_000162.5,3.0,1_Pathogenic,98.76,0.0,['125851'],autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2",A,0,98.76,Aliphatic,Alanine,Hexokinase-4,Hexokinase,,1.8,,,"A387-N391, A387-S383; PAE: 1.0, 1.0",23 interactions,"A387-N391, A387-S383; PAE: 1.0, 1.0",23 interactions,,,89,,-60.0,,,-35.7,Hexokinase large subdomain,,H (helix),H (α-helix),Helix,,,,,,,,,0.171,,0.088,"4 mutation(s) (Ala387Tyr: -0.950, Ala387Pro: -0.600, Ala387His: -0.482, Ala387Trp: -0.435)",,,,,false,false,GCK_Gersing_2023_complementation_var268313,GCK_Gersing_2023_complementation,GCK,4195,-1.0,44145590.0,44145590.0,,1160,C,A,387.0,A,E,c.1160C>A,p.Ala387Glu,missense_variant,missense_variant,0.0350375557645431,,No,6.231974015161147e-7,Likely pathogenic,reviewed by expert panel,"Feb 28, 2024",aa,urn:mavedb:00000096-a-1,ENST00000403799.8,NM_000162.5,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",voltage dependence of activation (ICEPO:0000006),"catalytic activity (GO:0003824), gluconokinase activity (GO:0046316)",No,Decreased activity,"(-Inf, 0.66)",Abnormal,Hyperactive,"(1.18, Inf)",Not specified,Synonymous,"(0.66,1.18)",Normal,,0.958,0.9824,likely_pathogenic,36181.0,CA213725,monogenic diabetes,MONDO:0015967,Semidominant inheritance,Likely Pathogenic,"PM2_Supporting,PM5_Strong,PP2,PP3,PP4","PS4,PM1","The c.1160C>A variant in the glucokinase gene, GCK, causes an amino acid change of alanine to glutamic acid at codon 387 (p. (Ala387Glu)) of NM_000162.5.  This variant has an incomputable gnomAD v2.1.1  Grpmax filtering allele frequency due to one copy in the European non-Finnish subpopulation and no copies in any other subpopulation, thereby meeting the ClinGen MDEP threshold criteria for PM2_Supporting (ENF Popmax FAF <= 0.000003 and <= 2 copies in ENF and <=1 copy in any other subpopulation) (PM2_Supporting).  GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2).  This variant is located in the larger hexokinase domain of the GCK gene (PMID: 31638168) but this variant does not reside in an amino acid that directly binds glucose or ATP, which is defined as critical for the protein’s function by the ClinGen MDEP, so it does not meet PM1.  This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.958 which is greater than the MDEP VCEP threshold of 0.70 (PP3). Two other missense variants, c.1159G>A p.(Ala387Thr) and c.1160C>T p.(Ala387Val) have been interpreted as pathogenic by the ClinGen MDEP (PM5_Strong). This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4; internal lab contributors).  In summary, c.1160C>A meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP VCEP (VCEP specifications version v1.3.0; approved 8/11/2023): PP2, PP3, PM2_Supporting, PP4, PM5_Strong. ",Monogenic Diabetes VCEP,https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50016,2/28/24,2/28/24,false,https://erepo.genome.network/evrepo/ui/classification/6d8941fd-d5e3-465b-9e80-eceefd70894e,6d8941fd-d5e3-465b-9e80-eceefd70894e,VUS,"PM2_Supporting,PM5_Strong,PP2",GCK_Ala387Glu,true,Ala387Glu
GCK_Ala387Glu,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214861,CCSBVarC006699,ALE00006697,NC_000007.14:44145590:G:T,1160C>A,Ala387Glu,CEGS2,CegsMutGDEh1043,B11,GDEhDisVCh_40037,F01,1.0,CegsMutGDDh1043,B11,VUSN2Hmut_GDN2h_09,H03,VUSMutpDEST2_03,B10,VUSmut_GDEh09,H03,1.0,1.0,1.0,1.0,1.0,5.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,7,44145590,G,T,7,Y,Y,N,Y,Y,7-44145590-G-T,44845.0,single nucleotide variant,NM_000162.5(GCK):c.1160C>A (p.Ala387Glu),2645.0,GCK,HGNC:4195,Likely pathogenic,1.0,"Feb 28, 2024",193921338.0,-,RCV000029844|RCV003883122,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Maturity-onset diabetes of the young type 2|Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44145590.0,44145590.0,7p13,reviewed by expert panel,2.0,-,N,ClinGen:CA213725,2.0,36181.0,44145590.0,G,T,-,-,-,-,-,-,SCV004697906,-,-,1160C>A ,Ala387Glu,NM_000162.5,3.0,1_Pathogenic,6.8858e-7,36181.0,7,44145590.0,G,T,A,E,rs193921338,7,44185189,7,44151714,387.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.1160C>A,p.Ala387Glu,c.1160C>A,p.Ala387Glu,principal1,Y,1,YES,Select,-,GCG,2.0,0.0,G,G/G,G/G,G/G,G/G,0.0,0.91343,D,0.002,0.79703,D,1.0,0.90580,D,0.999,0.92348,D,1.0,0.99291,A,simple_aae,0.0,100.0,3.375,0.91274,M,-4.12,0.76771,D,0.844,0.83943,1.0862,0.99092,D,0.9717,0.99109,D,10,0.99201083,0.99734,D,0.870064,0.99003,D,0.958,0.99315,0.935,0.99041,P35557,A387E,Gain of disorder (P = 0.0374)| Loss of MoRF binding (P = 0.059)| Loss of catalytic residue at A387 (P = 0.1806)| Gain of helix (P = 0.2294)| Loss of methylation at R392 (P = 0.4738),0.987331409019,0.98705,.,0.99984,.,0.96565,0.811778783798,0.83736,D,0.947901,0.99219,D,0.560597,0.96212,D,0.567482,0.96152,D,0.997854888439178,0.92528,D,0.964304,0.88661,D,0.98488784,0.99450,0.9533024,0.98573,0.9799398,0.99090,0.97126704,0.99511,-13.645,0.91965,D,0.9824,0.93458,P,0.999603109944392,0.97154,0.99983466,0.99778,0.978,0.99209,.,.,.,.,.,.,5.614955,0.9257,32.0,0.99531726386056985,0.69939,0.974355,0.99552,D,1.03310609236388,0.96655,14.9943,0.958102556661233,0.97626,16.48479,5.46,5.46,0.79994,3.81,0.70705,9.901,0.98627,11.604000,0.93507,0.672,0.70176,1.0,0.71675,1.000000,0.68239,0.969,0.5403,716,0.55914,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,99980,0.000000e+00,0,1,191874,5.211750e-06,0,1,218022,4.586690e-06,0,0,6062,0.000000e+00,0,0,16398,0.000000e+00,0,0,2158,0.000000e+00,0,0,8222,0.000000e+00,0,0,10776,0.000000e+00,0,0,39570,0.000000e+00,0,0,15040,0.000000e+00,0,.,.,.,.,0,14210,0.000000e+00,0,1,29300,3.412970e-05,0,0,5846,0.000000e+00,0,0,12418,0.000000e+00,0,0,13834,0.000000e+00,0,0,82322,0.000000e+00,0,0,29408,0.000000e+00,0,1,29300,3.412970e-05,0,0,13174,0.000000e+00,0,1,33064,3.024440e-05,0,0,9234,0.000000e+00,0,0,16688,0.000000e+00,0,0,17606,0.000000e+00,0,0,93648,0.000000e+00,0,0,29338,0.000000e+00,0,1,33064,3.024440e-05,0,.,1,1604628,6.231970e-07,0,1,59324,1.685660e-05,0,0,74932,0.000000e+00,0,0,912,0.000000e+00,0,1,59324,1.685660e-05,0,0,29448,0.000000e+00,0,0,44558,0.000000e+00,0,0,59780,0.000000e+00,0,0,6032,0.000000e+00,0,0,1177334,0.000000e+00,0,0,90186,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic,Monogenic_diabetes|Maturity-onset_diabetes_of_the_young_type_2,reviewed_by_expert_panel,NC_000007.14:g.44145590G>T,ClinGen:CA213725,C3888631|C0342277,125851,183625|552,"Hexokinase, C-terminal",Ala,Glu,44845.0,single nucleotide variant,NM_000162.5(GCK):c.1160C>A (p.Ala387Glu),2645.0,GCK,HGNC:4195,Likely pathogenic,1.0,"Feb 28, 2024",193921338.0,-,RCV000029844|RCV003883122,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Maturity-onset diabetes of the young type 2|Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44145590.0,44145590.0,7p13,reviewed by expert panel,2.0,-,N,ClinGen:CA213725,2.0,36181.0,44145590.0,G,T,-,-,-,-,-,-,SCV004697906,-,-,1160C>A ,Ala387Glu,NM_000162.5,3.0,1_Pathogenic,98.76,0.0,['125851'],autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2",A,0,98.76,Aliphatic,Alanine,Hexokinase-4,Hexokinase,,1.8,,,"A387-N391, A387-S383; PAE: 1.0, 1.0",23 interactions,"A387-N391, A387-S383; PAE: 1.0, 1.0",23 interactions,,,89,,-60.0,,,-35.7,Hexokinase large subdomain,,H (helix),H (α-helix),Helix,,,,,,,,,0.171,,0.088,"4 mutation(s) (Ala387Tyr: -0.950, Ala387Pro: -0.600, Ala387His: -0.482, Ala387Trp: -0.435)",,,,,false,false,GCK_Gersing_2024_abundance_var322374,GCK_Gersing_2024_abundance,GCK,4195,-1.0,44145590.0,44145590.0,ENST00000403799.8,1160,C,A,387.0,A,E,c.1160C>A,p.Ala387Glu,missense_variant,missense_variant,-0.106697788432006,,No,6.231974015161147e-7,Likely pathogenic,reviewed by expert panel,"Feb 28, 2024",aa,urn:mavedb:00000096-b-1,ENST00000403799.8,NM_000162.5,yeast,protein stability assay (BAO_0002804),fluorescence intensity (BAO_0000363),regulation of protein stability (GO:0031647),No,Low abundance,"(-Inf, 0.58)",Abnormal,,,,,,,,0.958,0.9824,likely_pathogenic,36181.0,CA213725,monogenic diabetes,MONDO:0015967,Semidominant inheritance,Likely Pathogenic,"PM2_Supporting,PM5_Strong,PP2,PP3,PP4","PS4,PM1","The c.1160C>A variant in the glucokinase gene, GCK, causes an amino acid change of alanine to glutamic acid at codon 387 (p. (Ala387Glu)) of NM_000162.5.  This variant has an incomputable gnomAD v2.1.1  Grpmax filtering allele frequency due to one copy in the European non-Finnish subpopulation and no copies in any other subpopulation, thereby meeting the ClinGen MDEP threshold criteria for PM2_Supporting (ENF Popmax FAF <= 0.000003 and <= 2 copies in ENF and <=1 copy in any other subpopulation) (PM2_Supporting).  GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2).  This variant is located in the larger hexokinase domain of the GCK gene (PMID: 31638168) but this variant does not reside in an amino acid that directly binds glucose or ATP, which is defined as critical for the protein’s function by the ClinGen MDEP, so it does not meet PM1.  This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.958 which is greater than the MDEP VCEP threshold of 0.70 (PP3). Two other missense variants, c.1159G>A p.(Ala387Thr) and c.1160C>T p.(Ala387Val) have been interpreted as pathogenic by the ClinGen MDEP (PM5_Strong). This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4; internal lab contributors).  In summary, c.1160C>A meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP VCEP (VCEP specifications version v1.3.0; approved 8/11/2023): PP2, PP3, PM2_Supporting, PP4, PM5_Strong. ",Monogenic Diabetes VCEP,https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50016,2/28/24,2/28/24,false,https://erepo.genome.network/evrepo/ui/classification/6d8941fd-d5e3-465b-9e80-eceefd70894e,6d8941fd-d5e3-465b-9e80-eceefd70894e,VUS,"PM2_Supporting,PM5_Strong,PP2",GCK_Ala387Glu,true,Ala387Glu
GCK_Arg303Trp,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214847,CCSBVarC006693,ALE00006691,NC_000007.14:44146575:G:A,907C>T,Arg303Trp,CEGS2,CegsMutGDEh1045,B08,GDEhDisVCh_40037,C05,1.0,CegsMutGDDh1045,B08,VUSN2Hmut_GDN2h_09,E10,VUSMutpDEST2_03,D09,VUSmut_GDEh09,E10,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,6.0,1.0,1.0,1.0,1.0,7,44146575,G,A,7,Y,Y,Y,N,Y,7-44146575-G-A,44928.0,single nucleotide variant,NM_000162.5(GCK):c.907C>T (p.Arg303Trp),2645.0,GCK,HGNC:4195,Likely pathogenic,1.0,"Oct 20, 2023",193922336.0,-,RCV000029927|RCV000711788|RCV002371788,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552",Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young,germline,germline,GRCh38,NC_000007.14,7,44146575.0,44146575.0,7p13,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA213862,2.0,36264.0,44146575.0,G,A,-,-,-,-,-,-,SCV000052582|SCV000842185|SCV002688544|SCV004295150,-,-,907C>T ,Arg303Trp,NM_000162.5,2.0,1_Pathogenic,6.84923e-7,36264.0,7,44146575.0,G,A,R,W,rs193922336,7,44186174,7,44152699,303.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.907C>T,p.Arg303Trp,c.907C>T,p.Arg303Trp,principal1,Y,1,YES,Select,-,CGG,1.0,2.0,G,G/G,G/G,G/G,G/G,0.0,0.91343,D,0.0,0.92967,D,1.0,0.90580,D,0.996,0.97365,D,1.0,0.99291,A,simple_aae,0.0,100.0,3.91,0.96121,H,-7.43,0.95620,D,0.984,0.99346,1.0240,0.97601,D,0.9827,0.99470,D,10,0.9946202,0.99953,D,0.874274,0.99037,D,0.971,0.99671,0.983,0.99835,P35557,R303W,Gain of catalytic residue at L301 (P = 0.0054)| Loss of MoRF binding (P = 0.2334)| Loss of methylation at R303 (P = 0.529)| Loss of helix (P = 0.5596)| Loss of disorder (P = 0.704),0.990771566325,0.99056,.,0.99530,.,0.96238,0.825230181217,0.85806,D,0.963923,0.99552,D,0.535654,0.95277,D,0.531653,0.95208,D,0.999597728252411,0.98050,D,0.99598,0.98629,D,0.9196614,0.93114,0.86529386,0.92441,0.9396137,0.95135,0.86898375,0.92699,-14.04,0.93199,D,0.9475,0.89484,P,0.999429393664456,0.96550,0.99983537,0.99792,0.981,0.99334,.,.,.,.,.,.,5.83412,0.9376,33.0,0.999174190492922,0.98519,0.892615,0.82911,D,0.801043153705935,0.86095,8.800712,0.663109094355815,0.79479,7.114674,4.77,3.78,0.42561,1.37,0.32764,3.129,0.5029,3.042000,0.36167,0.618,0.50684,1.0,0.71675,1.000000,0.68239,0.956,0.50825,712,0.56407,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1612312,6.202270e-07,0,1,62198,1.607770e-05,0,0,75046,0.000000e+00,0,0,912,0.000000e+00,0,0,60032,0.000000e+00,0,0,29602,0.000000e+00,0,0,44862,0.000000e+00,0,1,62198,1.607770e-05,0,0,6062,0.000000e+00,0,0,1180014,0.000000e+00,0,0,91086,0.000000e+00,0,0,7040,0,0,84,0,0,118,0,0,2642,0,0,146,0,0,610,0,0,24,0,0,100,0,0,574,0,0,2726,0,0,142,0,0,11338,0,Likely_pathogenic,not_provided|Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000007.14:g.44146575G>A,ClinGen:CA213862,C3661900|C0342277|C0342276,125851|606391,552|552,"Hexokinase, C-terminal",Arg,Trp,44928.0,single nucleotide variant,NM_000162.5(GCK):c.907C>T (p.Arg303Trp),2645.0,GCK,HGNC:4195,Likely pathogenic,1.0,"Oct 20, 2023",193922336.0,-,RCV000029927|RCV000711788|RCV002371788,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552",Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young,germline,germline,GRCh38,NC_000007.14,7,44146575.0,44146575.0,7p13,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA213862,2.0,36264.0,44146575.0,G,A,-,-,-,-,-,-,SCV000052582|SCV000842185|SCV002688544|SCV004295150,-,-,907C>T ,Arg303Trp,NM_000162.5,2.0,1_Pathogenic,98.7,0.0564516129032258,"['125851', '606391']",autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG",R,14,98.7,Positively-charged,Arginine,Hexokinase-4,Hexokinase,,-4.5,,,"R303-L324, R303-L307, R303-G299; PAE: 1.0, 1.0, 1.0",25 interactions,"R303-L307, R303-G328, R303-G299; PAE: 1.0, 1.0, 1.0",23 interactions,R303-E300; PAE: 1.0,21 interactions,175,,-54.0,,,-46.0,Hexokinase large subdomain,,H (helix),H (α-helix),Helix,,,,,,,,,0.151,,0.152,,,,,,false,false,GCK_Gersing_2023_complementation_var268632,GCK_Gersing_2023_complementation,GCK,4195,-1.0,44146575.0,44146575.0,,907,C,T,303.0,R,W,c.907C>T,p.Arg303Trp,missense_variant,missense_variant,0.145534620576282,,No,6.202273505376131e-7,Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Oct 20, 2023",aa,urn:mavedb:00000096-a-1,ENST00000403799.8,NM_000162.5,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",voltage dependence of activation (ICEPO:0000006),"catalytic activity (GO:0003824), gluconokinase activity (GO:0046316)",No,Decreased activity,"(-Inf, 0.66)",Abnormal,Hyperactive,"(1.18, Inf)",Not specified,Synonymous,"(0.66,1.18)",Normal,updated,0.971,0.9475,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Arg303Trp,true,Arg303Trp
GCK_Arg303Trp,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214847,CCSBVarC006693,ALE00006691,NC_000007.14:44146575:G:A,907C>T,Arg303Trp,CEGS2,CegsMutGDEh1045,B08,GDEhDisVCh_40037,C05,1.0,CegsMutGDDh1045,B08,VUSN2Hmut_GDN2h_09,E10,VUSMutpDEST2_03,D09,VUSmut_GDEh09,E10,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,6.0,1.0,1.0,1.0,1.0,7,44146575,G,A,7,Y,Y,Y,N,Y,7-44146575-G-A,44928.0,single nucleotide variant,NM_000162.5(GCK):c.907C>T (p.Arg303Trp),2645.0,GCK,HGNC:4195,Likely pathogenic,1.0,"Oct 20, 2023",193922336.0,-,RCV000029927|RCV000711788|RCV002371788,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552",Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young,germline,germline,GRCh38,NC_000007.14,7,44146575.0,44146575.0,7p13,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA213862,2.0,36264.0,44146575.0,G,A,-,-,-,-,-,-,SCV000052582|SCV000842185|SCV002688544|SCV004295150,-,-,907C>T ,Arg303Trp,NM_000162.5,2.0,1_Pathogenic,6.84923e-7,36264.0,7,44146575.0,G,A,R,W,rs193922336,7,44186174,7,44152699,303.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.907C>T,p.Arg303Trp,c.907C>T,p.Arg303Trp,principal1,Y,1,YES,Select,-,CGG,1.0,2.0,G,G/G,G/G,G/G,G/G,0.0,0.91343,D,0.0,0.92967,D,1.0,0.90580,D,0.996,0.97365,D,1.0,0.99291,A,simple_aae,0.0,100.0,3.91,0.96121,H,-7.43,0.95620,D,0.984,0.99346,1.0240,0.97601,D,0.9827,0.99470,D,10,0.9946202,0.99953,D,0.874274,0.99037,D,0.971,0.99671,0.983,0.99835,P35557,R303W,Gain of catalytic residue at L301 (P = 0.0054)| Loss of MoRF binding (P = 0.2334)| Loss of methylation at R303 (P = 0.529)| Loss of helix (P = 0.5596)| Loss of disorder (P = 0.704),0.990771566325,0.99056,.,0.99530,.,0.96238,0.825230181217,0.85806,D,0.963923,0.99552,D,0.535654,0.95277,D,0.531653,0.95208,D,0.999597728252411,0.98050,D,0.99598,0.98629,D,0.9196614,0.93114,0.86529386,0.92441,0.9396137,0.95135,0.86898375,0.92699,-14.04,0.93199,D,0.9475,0.89484,P,0.999429393664456,0.96550,0.99983537,0.99792,0.981,0.99334,.,.,.,.,.,.,5.83412,0.9376,33.0,0.999174190492922,0.98519,0.892615,0.82911,D,0.801043153705935,0.86095,8.800712,0.663109094355815,0.79479,7.114674,4.77,3.78,0.42561,1.37,0.32764,3.129,0.5029,3.042000,0.36167,0.618,0.50684,1.0,0.71675,1.000000,0.68239,0.956,0.50825,712,0.56407,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1612312,6.202270e-07,0,1,62198,1.607770e-05,0,0,75046,0.000000e+00,0,0,912,0.000000e+00,0,0,60032,0.000000e+00,0,0,29602,0.000000e+00,0,0,44862,0.000000e+00,0,1,62198,1.607770e-05,0,0,6062,0.000000e+00,0,0,1180014,0.000000e+00,0,0,91086,0.000000e+00,0,0,7040,0,0,84,0,0,118,0,0,2642,0,0,146,0,0,610,0,0,24,0,0,100,0,0,574,0,0,2726,0,0,142,0,0,11338,0,Likely_pathogenic,not_provided|Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000007.14:g.44146575G>A,ClinGen:CA213862,C3661900|C0342277|C0342276,125851|606391,552|552,"Hexokinase, C-terminal",Arg,Trp,44928.0,single nucleotide variant,NM_000162.5(GCK):c.907C>T (p.Arg303Trp),2645.0,GCK,HGNC:4195,Likely pathogenic,1.0,"Oct 20, 2023",193922336.0,-,RCV000029927|RCV000711788|RCV002371788,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552",Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young,germline,germline,GRCh38,NC_000007.14,7,44146575.0,44146575.0,7p13,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA213862,2.0,36264.0,44146575.0,G,A,-,-,-,-,-,-,SCV000052582|SCV000842185|SCV002688544|SCV004295150,-,-,907C>T ,Arg303Trp,NM_000162.5,2.0,1_Pathogenic,98.7,0.0564516129032258,"['125851', '606391']",autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG",R,14,98.7,Positively-charged,Arginine,Hexokinase-4,Hexokinase,,-4.5,,,"R303-L324, R303-L307, R303-G299; PAE: 1.0, 1.0, 1.0",25 interactions,"R303-L307, R303-G328, R303-G299; PAE: 1.0, 1.0, 1.0",23 interactions,R303-E300; PAE: 1.0,21 interactions,175,,-54.0,,,-46.0,Hexokinase large subdomain,,H (helix),H (α-helix),Helix,,,,,,,,,0.151,,0.152,,,,,,false,false,GCK_Gersing_2024_abundance_var322688,GCK_Gersing_2024_abundance,GCK,4195,-1.0,44146575.0,44146575.0,ENST00000403799.8,907,C,T,303.0,R,W,c.907C>T,p.Arg303Trp,missense_variant,missense_variant,0.0228417097677071,,No,6.202273505376131e-7,Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Oct 20, 2023",aa,urn:mavedb:00000096-b-1,ENST00000403799.8,NM_000162.5,yeast,protein stability assay (BAO_0002804),fluorescence intensity (BAO_0000363),regulation of protein stability (GO:0031647),No,Low abundance,"(-Inf, 0.58)",Abnormal,,,,,,,updated,0.971,0.9475,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Arg303Trp,true,Arg303Trp
GCK_Glu221Lys,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214835,CCSBVarC006689,ALE00006687,NC_000007.14:44149778:C:T,661G>A,Glu221Lys,CEGS2,CegsMutGDEh1046,B11,GDEhDisVCh_40037,B08,1.0,CegsMutGDDh1046,B11,VUSN2Hmut_GDN2h_10,E03,VUSMutpDEST2_03,H08,VUSmut_GDEh10,E03,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,7,44149778,C,T,7,Y,Y,Y,Y,Y,7-44149778-C-T,44905.0,single nucleotide variant,NM_000162.5(GCK):c.661G>A (p.Glu221Lys),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"Feb 28, 2024",193922317.0,-,RCV000029904|RCV000711781|RCV002371787|RCV003155041,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young|Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44149778.0,44149778.0,7p13,reviewed by expert panel,6.0,-,N,"ClinGen:CA213824,UniProtKB:P35557#VAR_003702",2.0,36241.0,44149778.0,C,T,-,-,-,-,-,-,SCV004697921,-,-,661G>A ,Glu221Lys,NM_000162.5,3.0,1_Pathogenic,2.73639e-6,36241.0,7,44149778.0,C,T,E,K,rs193922317,7,44189377,7,44155902,221.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.661G>A,p.Glu221Lys,c.661G>A,p.Glu221Lys,principal1,Y,1,YES,Select,-,GAG,1.0,0.0,C,C/C,C/C,C/C,C/C,0.113,0.28905,T,0.204,0.27537,T,1.0,0.90580,D,0.998,0.88579,D,0.98,0.97016,A,simple_aae,2.0,98.0,1.21,0.30316,L,-3.61,0.69513,D,0.933,0.94561,0.8006,0.94399,D,0.8954,0.96523,D,10,0.9329977,0.92552,D,0.108562,0.78449,D,0.789,0.93005,0.834,0.94200,P35557,E221K,Gain of methylation at E221 (P = 0.0028)| Gain of ubiquitination at E221 (P = 0.0267)| Gain of relative solvent accessibility (P = 0.2629)| Gain of solvent accessibility (P = 0.2987)| Loss of sheet (P = 0.302),0.983011969047,0.98265,.,0.99768,.,0.96833,0.733988523483,0.72041,T,0.750067,0.93081,D,0.47959,0.93637,D,0.451121,0.93558,D,0.995560765266418,0.87555,D,0.987968,0.95957,D,0.8720905,0.88876,0.77897,0.86803,0.8974364,0.91030,0.6910655,0.81612,-10.642,0.77732,D,0.7102,0.81122,P,0.99866779060353,0.94835,0.99977785,0.99714,0.832,0.90743,.,.,.,.,.,.,6.105187,0.94579,34.0,0.99921364031156767,0.98788,0.959188,0.97930,D,0.666727412039614,0.77334,6.67797,0.740520883425636,0.85365,8.583408,6.17,6.17,0.99707,3.81,0.70705,7.905,0.86513,7.614000,0.62087,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.982,0.59239,671,0.60828,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,4,1614066,2.478210e-06,0,3,1179996,2.542380e-06,0,0,75030,0.000000e+00,0,0,912,0.000000e+00,0,0,60020,0.000000e+00,0,0,29604,0.000000e+00,0,0,44870,0.000000e+00,0,0,63988,0.000000e+00,0,0,6062,0.000000e+00,0,3,1179996,2.542380e-06,0,0,91078,0.000000e+00,0,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young|Monogenic_diabetes|not_provided,reviewed_by_expert_panel,NC_000007.14:g.44149778C>T,ClinGen:CA213824|UniProtKB:P35557#VAR_003702,C0342277|C0342276|C3888631|C3661900,125851|606391,552|552|183625,.,Glu,Lys,44905.0,single nucleotide variant,NM_000162.5(GCK):c.661G>A (p.Glu221Lys),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"Feb 28, 2024",193922317.0,-,RCV000029904|RCV000711781|RCV002371787|RCV003155041,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young|Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44149778.0,44149778.0,7p13,reviewed by expert panel,6.0,-,N,"ClinGen:CA213824,UniProtKB:P35557#VAR_003702",2.0,36241.0,44149778.0,C,T,-,-,-,-,-,-,SCV004697921,-,-,661G>A ,Glu221Lys,NM_000162.5,3.0,1_Pathogenic,96.16,0.1030927835051546,"['125851', '606391']",autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG",E,20,96.16,Negatively-charged,Glutamic Acid,Hexokinase-4,Hexokinase,,-3.5,,,"E221-R397, E221-T405, E221-M235, E221-R250; PAE: 2.0, 1.0, 1.0, 2.0",24 interactions,E221-M235; PAE: 1.0,21 interactions,"E221-R397, E221-R250; PAE: 2.0, 2.0",22 interactions,146,,-113.5,,,10.8,Hexokinase large subdomain,,B (undefined),E (parallel sheets),Beta strand,,,,,,,,,1.212,,0.624,,,,,,false,false,GCK_Gersing_2024_abundance_var324693,GCK_Gersing_2024_abundance,GCK,4195,-1.0,44149778.0,44149778.0,ENST00000403799.8,661,G,A,221.0,E,K,c.661G>A,p.Glu221Lys,missense_variant,missense_variant,0.498750935733332,,No,2.4782134063e-6,Pathogenic,reviewed by expert panel,"Feb 28, 2024",aa,urn:mavedb:00000096-b-1,ENST00000403799.8,NM_000162.5,yeast,protein stability assay (BAO_0002804),fluorescence intensity (BAO_0000363),regulation of protein stability (GO:0031647),No,Low abundance,"(-Inf, 0.58)",Abnormal,,,,,,,updated,0.789,0.7102,likely_pathogenic,36241.0,CA213824,monogenic diabetes,MONDO:0015967,Semidominant inheritance,Pathogenic,"PP4_Moderate,PP1_Strong,PM2_Supporting,PS4,PP2,PP3","PS3,PM1","The c.661A>G variant in the glucokinase gene, GCK, causes an amino acid change of glutamic acid to lysine at codon 221 (p.(Glu221Lys)) of NM_000162.5.  GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2).  This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.789, which is greater than the MDEP VCEP threshold of 0.70 (PP3).  This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant is located in the larger hexokinase domain of the GCK gene (PMID: 31638168) but this variant does not reside in an amino acid that directly binds glucose or ATP, which is defined as critical for the protein’s function by the ClinGen MDEP.  This variant was identified in 4 unelated individuals with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6% and negative antibodies or 2 hour OGTT glucose increment < 3 mmol/L) (PP4_Moderate; PMID: 23295292, internal lab contributors). This variant has been identified in 25 unrelated individuals with hyperglycemia and segregated with the phenotype, with 17 informative meioses in at least 7 families (PS4, PP1_Strong; PMIDs: 10694920, 12955723, 31658956, 34462253, 35592779, 35733065, 23295292, and 30592380).  A relative activity index (RAI) was calculated for this variant but the wild type parameters are outside of MDEP's recommendations; therefore, this data cannot be used towards PS3 (PMID: 30592380).  In summary, c.661A>G meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3, approved 8/11/2023): PS4, PP1_Strong, PP4_Moderate, PP2, PP3, PM2_Supporting.        ",Monogenic Diabetes VCEP,https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50016,2/28/24,2/28/24,false,https://erepo.genome.network/evrepo/ui/classification/bcac1d6c-8f3c-4870-ae6e-44213e7b972a,bcac1d6c-8f3c-4870-ae6e-44213e7b972a,Pathogenic,"PP1_Strong,PM2_Supporting,PS4,PP2",GCK_Glu221Lys,true,Glu221Lys
GCK_Glu221Lys,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214835,CCSBVarC006689,ALE00006687,NC_000007.14:44149778:C:T,661G>A,Glu221Lys,CEGS2,CegsMutGDEh1046,B11,GDEhDisVCh_40037,B08,1.0,CegsMutGDDh1046,B11,VUSN2Hmut_GDN2h_10,E03,VUSMutpDEST2_03,H08,VUSmut_GDEh10,E03,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,7,44149778,C,T,7,Y,Y,Y,Y,Y,7-44149778-C-T,44905.0,single nucleotide variant,NM_000162.5(GCK):c.661G>A (p.Glu221Lys),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"Feb 28, 2024",193922317.0,-,RCV000029904|RCV000711781|RCV002371787|RCV003155041,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young|Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44149778.0,44149778.0,7p13,reviewed by expert panel,6.0,-,N,"ClinGen:CA213824,UniProtKB:P35557#VAR_003702",2.0,36241.0,44149778.0,C,T,-,-,-,-,-,-,SCV004697921,-,-,661G>A ,Glu221Lys,NM_000162.5,3.0,1_Pathogenic,2.73639e-6,36241.0,7,44149778.0,C,T,E,K,rs193922317,7,44189377,7,44155902,221.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.661G>A,p.Glu221Lys,c.661G>A,p.Glu221Lys,principal1,Y,1,YES,Select,-,GAG,1.0,0.0,C,C/C,C/C,C/C,C/C,0.113,0.28905,T,0.204,0.27537,T,1.0,0.90580,D,0.998,0.88579,D,0.98,0.97016,A,simple_aae,2.0,98.0,1.21,0.30316,L,-3.61,0.69513,D,0.933,0.94561,0.8006,0.94399,D,0.8954,0.96523,D,10,0.9329977,0.92552,D,0.108562,0.78449,D,0.789,0.93005,0.834,0.94200,P35557,E221K,Gain of methylation at E221 (P = 0.0028)| Gain of ubiquitination at E221 (P = 0.0267)| Gain of relative solvent accessibility (P = 0.2629)| Gain of solvent accessibility (P = 0.2987)| Loss of sheet (P = 0.302),0.983011969047,0.98265,.,0.99768,.,0.96833,0.733988523483,0.72041,T,0.750067,0.93081,D,0.47959,0.93637,D,0.451121,0.93558,D,0.995560765266418,0.87555,D,0.987968,0.95957,D,0.8720905,0.88876,0.77897,0.86803,0.8974364,0.91030,0.6910655,0.81612,-10.642,0.77732,D,0.7102,0.81122,P,0.99866779060353,0.94835,0.99977785,0.99714,0.832,0.90743,.,.,.,.,.,.,6.105187,0.94579,34.0,0.99921364031156767,0.98788,0.959188,0.97930,D,0.666727412039614,0.77334,6.67797,0.740520883425636,0.85365,8.583408,6.17,6.17,0.99707,3.81,0.70705,7.905,0.86513,7.614000,0.62087,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.982,0.59239,671,0.60828,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,4,1614066,2.478210e-06,0,3,1179996,2.542380e-06,0,0,75030,0.000000e+00,0,0,912,0.000000e+00,0,0,60020,0.000000e+00,0,0,29604,0.000000e+00,0,0,44870,0.000000e+00,0,0,63988,0.000000e+00,0,0,6062,0.000000e+00,0,3,1179996,2.542380e-06,0,0,91078,0.000000e+00,0,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young|Monogenic_diabetes|not_provided,reviewed_by_expert_panel,NC_000007.14:g.44149778C>T,ClinGen:CA213824|UniProtKB:P35557#VAR_003702,C0342277|C0342276|C3888631|C3661900,125851|606391,552|552|183625,.,Glu,Lys,44905.0,single nucleotide variant,NM_000162.5(GCK):c.661G>A (p.Glu221Lys),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"Feb 28, 2024",193922317.0,-,RCV000029904|RCV000711781|RCV002371787|RCV003155041,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young|Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44149778.0,44149778.0,7p13,reviewed by expert panel,6.0,-,N,"ClinGen:CA213824,UniProtKB:P35557#VAR_003702",2.0,36241.0,44149778.0,C,T,-,-,-,-,-,-,SCV004697921,-,-,661G>A ,Glu221Lys,NM_000162.5,3.0,1_Pathogenic,96.16,0.1030927835051546,"['125851', '606391']",autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG",E,20,96.16,Negatively-charged,Glutamic Acid,Hexokinase-4,Hexokinase,,-3.5,,,"E221-R397, E221-T405, E221-M235, E221-R250; PAE: 2.0, 1.0, 1.0, 2.0",24 interactions,E221-M235; PAE: 1.0,21 interactions,"E221-R397, E221-R250; PAE: 2.0, 2.0",22 interactions,146,,-113.5,,,10.8,Hexokinase large subdomain,,B (undefined),E (parallel sheets),Beta strand,,,,,,,,,1.212,,0.624,,,,,,false,false,GCK_Gersing_2023_complementation_var270691,GCK_Gersing_2023_complementation,GCK,4195,-1.0,44149778.0,44149778.0,,661,G,A,221.0,E,K,c.661G>A,p.Glu221Lys,missense_variant,missense_variant,1.12695012650976,,No,2.4782134063e-6,Pathogenic,reviewed by expert panel,"Feb 28, 2024",aa,urn:mavedb:00000096-a-1,ENST00000403799.8,NM_000162.5,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",voltage dependence of activation (ICEPO:0000006),"catalytic activity (GO:0003824), gluconokinase activity (GO:0046316)",No,Decreased activity,"(-Inf, 0.66)",Abnormal,Hyperactive,"(1.18, Inf)",Not specified,Synonymous,"(0.66,1.18)",Normal,updated,0.789,0.7102,likely_pathogenic,36241.0,CA213824,monogenic diabetes,MONDO:0015967,Semidominant inheritance,Pathogenic,"PP4_Moderate,PP1_Strong,PM2_Supporting,PS4,PP2,PP3","PS3,PM1","The c.661A>G variant in the glucokinase gene, GCK, causes an amino acid change of glutamic acid to lysine at codon 221 (p.(Glu221Lys)) of NM_000162.5.  GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2).  This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.789, which is greater than the MDEP VCEP threshold of 0.70 (PP3).  This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant is located in the larger hexokinase domain of the GCK gene (PMID: 31638168) but this variant does not reside in an amino acid that directly binds glucose or ATP, which is defined as critical for the protein’s function by the ClinGen MDEP.  This variant was identified in 4 unelated individuals with a clinical history highly specific for GCK-hyperglycemia (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6% and negative antibodies or 2 hour OGTT glucose increment < 3 mmol/L) (PP4_Moderate; PMID: 23295292, internal lab contributors). This variant has been identified in 25 unrelated individuals with hyperglycemia and segregated with the phenotype, with 17 informative meioses in at least 7 families (PS4, PP1_Strong; PMIDs: 10694920, 12955723, 31658956, 34462253, 35592779, 35733065, 23295292, and 30592380).  A relative activity index (RAI) was calculated for this variant but the wild type parameters are outside of MDEP's recommendations; therefore, this data cannot be used towards PS3 (PMID: 30592380).  In summary, c.661A>G meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3, approved 8/11/2023): PS4, PP1_Strong, PP4_Moderate, PP2, PP3, PM2_Supporting.        ",Monogenic Diabetes VCEP,https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50016,2/28/24,2/28/24,false,https://erepo.genome.network/evrepo/ui/classification/bcac1d6c-8f3c-4870-ae6e-44213e7b972a,bcac1d6c-8f3c-4870-ae6e-44213e7b972a,Pathogenic,"PP1_Strong,PM2_Supporting,PS4,PP2",GCK_Glu221Lys,true,Glu221Lys
GCK_Gly175Arg,2,1,1,0,50.0,50.0,0.0,100.0,2,0.0,true,GCK,ENSG00000106633,3689,214825,CCSBVarC006688,ALE00006686,NC_000007.14:44150025:C:G,523G>C,Gly175Arg,CEGS2,CegsMutGDEh1046,E05,GDEhDisVCh_40037,A07,1.0,CegsMutGDDh1046,E05,VUSN2Hmut_GDN2h_10,G01,VUSMutpDEST2_03,G08,VUSmut_GDEh10,G01,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,5.0,1.0,1.0,1.0,1.0,7,44150025,C,G,7,Y,Y,Y,N,Y,7-44150025-C-G,3184695.0,single nucleotide variant,NM_000162.5(GCK):c.523G>C (p.Gly175Arg),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"Feb 23, 2024",-1.0,-,RCV003883459,"MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44150025.0,44150025.0,7p13,reviewed by expert panel,1.0,-,N,ClinGen:CA367401686,2.0,3024423.0,44150025.0,C,G,-,-,-,-,-,-,SCV004697926,-,-,523G>C ,Gly175Arg,NM_000162.5,3.0,1_Pathogenic,,3024423.0,7,44150025.0,C,G,G,R,.,7,44189624,7,44156149,175.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.523G>C,p.Gly175Arg,c.523G>C,p.Gly175Arg,principal1,Y,1,YES,Select,-,GGA,1.0,0.0,C,C/C,C/C,C/C,C/C,0.001,0.78662,D,0.002,0.79703,D,1.0,0.90580,D,1.0,0.97365,D,1.0,0.99291,D,simple_aae,0.0,100.0,3.12,0.87775,M,-4.9,0.82724,D,0.986,0.99555,1.0855,0.99065,D,0.9786,0.99336,D,10,0.9885726,0.99275,D,0.644074,0.96968,D,0.965,0.99518,0.931,0.98924,P35557,G175R,Gain of solvent accessibility (P = 0.0042)| Gain of MoRF binding (P = 0.0243)| Loss of ubiquitination at K172 (P = 0.0303)| Loss of catalytic residue at G175 (P = 0.0658)| Gain of relative solvent accessibility (P = 0.09),0.980989907939,0.98059,.,0.97734,.,0.97218,0.894961953163,0.95857,D,0.965681,0.99586,D,0.537165,0.95302,D,0.533824,0.95233,D,0.998664021492004,0.94753,D,0.976102,0.91686,D,0.8858796,0.90018,0.8613234,0.92165,0.89920586,0.91188,0.87691617,0.93257,-11.47,0.82228,D,0.8182,0.84062,P,0.996650295463753,0.92339,0.99983668,0.99792,0.977,0.99166,.,.,.,.,.,.,5.143258,0.86143,28.8,0.99941511458053944,0.99797,0.960488,0.98125,D,0.923742279552392,0.92833,11.68111,0.882600563202776,0.94739,13.02673,5.69,5.69,0.88329,3.87,0.72853,6.164,0.71785,7.609000,0.61899,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.994,0.71086,667,0.61202,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,Monogenic_diabetes,reviewed_by_expert_panel,NC_000007.14:g.44150025C>G,.,C3888631,.,183625,"Hexokinase, N-terminal",Gly,Arg,3184695.0,single nucleotide variant,NM_000162.5(GCK):c.523G>C (p.Gly175Arg),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"Feb 23, 2024",-1.0,-,RCV003883459,"MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44150025.0,44150025.0,7p13,reviewed by expert panel,1.0,-,N,ClinGen:CA367401686,2.0,3024423.0,44150025.0,C,G,-,-,-,-,-,-,SCV004697926,-,-,523G>C ,Gly175Arg,NM_000162.5,3.0,1_Pathogenic,95.88,0.6190476190476191,,,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,,G,52,95.88,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,Hexokinase-4,Hexokinase,,-0.4,,,,14 interactions,G175-N179; PAE: 1.0,16 interactions,,,75,,82.3,,,0.3,Hexokinase small subdomain,dbSNP: rs587780344; Variant type: LP/P; AA change: Gly175Arg; PTM type: Ubiquitylation; PTM morphology: WTkGFkASG*AE; Var class: II,C (loop/coil),T (turn),,,,,,,,,,-0.031,1 mutation(s) (Gly175Trp: -0.565),0.805,,,,,,false,false,GCK_Gersing_2023_complementation_var271555,GCK_Gersing_2023_complementation,GCK,4195,-1.0,44150025.0,44150025.0,,523,G,C,175.0,G,R,c.523G>C,p.Gly175Arg,missense_variant,missense_variant,-0.0344324432362774,,No,,Pathogenic,reviewed by expert panel,"Feb 23, 2024",aa,urn:mavedb:00000096-a-1,ENST00000403799.8,NM_000162.5,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",voltage dependence of activation (ICEPO:0000006),"catalytic activity (GO:0003824), gluconokinase activity (GO:0046316)",No,Decreased activity,"(-Inf, 0.66)",Abnormal,Hyperactive,"(1.18, Inf)",Not specified,Synonymous,"(0.66,1.18)",Normal,updated,0.965,0.8182,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Gly175Arg,true,Gly175Arg
GCK_Gly175Arg,2,1,1,0,50.0,50.0,0.0,100.0,2,0.0,true,GCK,ENSG00000106633,3689,214825,CCSBVarC006688,ALE00006686,NC_000007.14:44150025:C:G,523G>C,Gly175Arg,CEGS2,CegsMutGDEh1046,E05,GDEhDisVCh_40037,A07,1.0,CegsMutGDDh1046,E05,VUSN2Hmut_GDN2h_10,G01,VUSMutpDEST2_03,G08,VUSmut_GDEh10,G01,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,5.0,1.0,1.0,1.0,1.0,7,44150025,C,G,7,Y,Y,Y,N,Y,7-44150025-C-G,3184695.0,single nucleotide variant,NM_000162.5(GCK):c.523G>C (p.Gly175Arg),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"Feb 23, 2024",-1.0,-,RCV003883459,"MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44150025.0,44150025.0,7p13,reviewed by expert panel,1.0,-,N,ClinGen:CA367401686,2.0,3024423.0,44150025.0,C,G,-,-,-,-,-,-,SCV004697926,-,-,523G>C ,Gly175Arg,NM_000162.5,3.0,1_Pathogenic,,3024423.0,7,44150025.0,C,G,G,R,.,7,44189624,7,44156149,175.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.523G>C,p.Gly175Arg,c.523G>C,p.Gly175Arg,principal1,Y,1,YES,Select,-,GGA,1.0,0.0,C,C/C,C/C,C/C,C/C,0.001,0.78662,D,0.002,0.79703,D,1.0,0.90580,D,1.0,0.97365,D,1.0,0.99291,D,simple_aae,0.0,100.0,3.12,0.87775,M,-4.9,0.82724,D,0.986,0.99555,1.0855,0.99065,D,0.9786,0.99336,D,10,0.9885726,0.99275,D,0.644074,0.96968,D,0.965,0.99518,0.931,0.98924,P35557,G175R,Gain of solvent accessibility (P = 0.0042)| Gain of MoRF binding (P = 0.0243)| Loss of ubiquitination at K172 (P = 0.0303)| Loss of catalytic residue at G175 (P = 0.0658)| Gain of relative solvent accessibility (P = 0.09),0.980989907939,0.98059,.,0.97734,.,0.97218,0.894961953163,0.95857,D,0.965681,0.99586,D,0.537165,0.95302,D,0.533824,0.95233,D,0.998664021492004,0.94753,D,0.976102,0.91686,D,0.8858796,0.90018,0.8613234,0.92165,0.89920586,0.91188,0.87691617,0.93257,-11.47,0.82228,D,0.8182,0.84062,P,0.996650295463753,0.92339,0.99983668,0.99792,0.977,0.99166,.,.,.,.,.,.,5.143258,0.86143,28.8,0.99941511458053944,0.99797,0.960488,0.98125,D,0.923742279552392,0.92833,11.68111,0.882600563202776,0.94739,13.02673,5.69,5.69,0.88329,3.87,0.72853,6.164,0.71785,7.609000,0.61899,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.994,0.71086,667,0.61202,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,Monogenic_diabetes,reviewed_by_expert_panel,NC_000007.14:g.44150025C>G,.,C3888631,.,183625,"Hexokinase, N-terminal",Gly,Arg,3184695.0,single nucleotide variant,NM_000162.5(GCK):c.523G>C (p.Gly175Arg),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"Feb 23, 2024",-1.0,-,RCV003883459,"MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625",Monogenic diabetes,germline,germline,GRCh38,NC_000007.14,7,44150025.0,44150025.0,7p13,reviewed by expert panel,1.0,-,N,ClinGen:CA367401686,2.0,3024423.0,44150025.0,C,G,-,-,-,-,-,-,SCV004697926,-,-,523G>C ,Gly175Arg,NM_000162.5,3.0,1_Pathogenic,95.88,0.6190476190476191,,,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,,G,52,95.88,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,Hexokinase-4,Hexokinase,,-0.4,,,,14 interactions,G175-N179; PAE: 1.0,16 interactions,,,75,,82.3,,,0.3,Hexokinase small subdomain,dbSNP: rs587780344; Variant type: LP/P; AA change: Gly175Arg; PTM type: Ubiquitylation; PTM morphology: WTkGFkASG*AE; Var class: II,C (loop/coil),T (turn),,,,,,,,,,-0.031,1 mutation(s) (Gly175Trp: -0.565),0.805,,,,,,false,false,GCK_Gersing_2024_abundance_var325556,GCK_Gersing_2024_abundance,GCK,4195,-1.0,44150025.0,44150025.0,ENST00000403799.8,523,G,C,175.0,G,R,c.523G>C,p.Gly175Arg,missense_variant,missense_variant,0.91063171913998,,No,,Pathogenic,reviewed by expert panel,"Feb 23, 2024",aa,urn:mavedb:00000096-b-1,ENST00000403799.8,NM_000162.5,yeast,protein stability assay (BAO_0002804),fluorescence intensity (BAO_0000363),regulation of protein stability (GO:0031647),No,Low abundance,"(-Inf, 0.58)",Abnormal,,,,,,,updated,0.965,0.8182,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Gly175Arg,true,Gly175Arg
GCK_Gly178Arg,2,1,1,0,50.0,50.0,0.0,100.0,2,0.0,true,GCK,ENSG00000106633,3689,214822,CCSBVarC006687,ALE00006685,NC_000007.14:44150016:C:G,532G>C,Gly178Arg,CEGS2,CegsMutGDEh1046,E03,GDEhDisVCh_40037,E06,1.0,CegsMutGDDh1046,E03,VUSN2Hmut_GDN2h_10,B01,VUSMutpDEST2_03,F08,VUSmut_GDEh10,B01,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,6.0,1.0,7,44150016,C,G,7,Y,Y,Y,Y,N,7-44150016-C-G,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5_Others,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,,G,55,96.55,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,Hexokinase-4,Hexokinase,,-0.4,,,G178-L164; PAE: 1.0,16 interactions,G178-L164; PAE: 1.0,16 interactions,,,75,,73.8,,,0.8,Hexokinase small subdomain,,C (loop/coil),T (turn),,,,,,,,,,0.08,,0.974,,,,,,false,false,GCK_Gersing_2024_abundance_var325577,GCK_Gersing_2024_abundance,GCK,4195,-1.0,44150016.0,44150016.0,ENST00000403799.8,532,G,C,178.0,G,R,c.532G>C,p.Gly178Arg,missense_variant,missense_variant,0.962922199382195,,No,,,,,aa,urn:mavedb:00000096-b-1,ENST00000403799.8,NM_000162.5,yeast,protein stability assay (BAO_0002804),fluorescence intensity (BAO_0000363),regulation of protein stability (GO:0031647),No,Low abundance,"(-Inf, 0.58)",Abnormal,,,,,,,updated,0.979,0.8524,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Gly178Arg,true,Gly178Arg
GCK_Gly178Arg,2,1,1,0,50.0,50.0,0.0,100.0,2,0.0,true,GCK,ENSG00000106633,3689,214822,CCSBVarC006687,ALE00006685,NC_000007.14:44150016:C:G,532G>C,Gly178Arg,CEGS2,CegsMutGDEh1046,E03,GDEhDisVCh_40037,E06,1.0,CegsMutGDDh1046,E03,VUSN2Hmut_GDN2h_10,B01,VUSMutpDEST2_03,F08,VUSmut_GDEh10,B01,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,6.0,1.0,7,44150016,C,G,7,Y,Y,Y,Y,N,7-44150016-C-G,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5_Others,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,,G,55,96.55,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,Hexokinase-4,Hexokinase,,-0.4,,,G178-L164; PAE: 1.0,16 interactions,G178-L164; PAE: 1.0,16 interactions,,,75,,73.8,,,0.8,Hexokinase small subdomain,,C (loop/coil),T (turn),,,,,,,,,,0.08,,0.974,,,,,,false,false,GCK_Gersing_2023_complementation_var271576,GCK_Gersing_2023_complementation,GCK,4195,-1.0,44150016.0,44150016.0,,532,G,C,178.0,G,R,c.532G>C,p.Gly178Arg,missense_variant,missense_variant,-0.383399292283869,,No,,,,,aa,urn:mavedb:00000096-a-1,ENST00000403799.8,NM_000162.5,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",voltage dependence of activation (ICEPO:0000006),"catalytic activity (GO:0003824), gluconokinase activity (GO:0046316)",No,Decreased activity,"(-Inf, 0.66)",Abnormal,Hyperactive,"(1.18, Inf)",Not specified,Synonymous,"(0.66,1.18)",Normal,updated,0.979,0.8524,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Gly178Arg,true,Gly178Arg
GCK_Gly299Arg,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214851,CCSBVarC006694,ALE00006692,NC_000007.14:44146587:C:G,895G>C,Gly299Arg,CEGS2,CegsMutGDEh1045,E10,GDEhDisVCh_40037,G05,1.0,CegsMutGDDh1045,E10,VUSN2Hmut_GDN2h_09,B11,VUSMutpDEST2_03,E09,VUSmut_GDEh09,B11,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,7.0,1.0,7,44146587,C,G,7,Y,Y,Y,Y,Y,7-44146587-C-G,31175.0,single nucleotide variant,NM_000162.5(GCK):c.895G>C (p.Gly299Arg),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"May 18, 2024",104894009.0,-,RCV000017516|RCV001288185,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900",Maturity-onset diabetes of the young type 2|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,44146587.0,44146587.0,7p13,"criteria provided, multiple submitters, no conflicts",3.0,-,N,"ClinGen:CA126212,UniProtKB:P35557#VAR_003710,OMIM:138079.0005",3.0,16136.0,44146587.0,C,G,-,-,-,-,-,-,SCV001475132|SCV005835277,-,-,895G>C ,Gly299Arg,NM_000162.5,2.0,1_Pathogenic,,16136.0,7,44146587.0,C,G,G,R,rs104894009,7,44186186,7,44152711,299.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.895G>C,p.Gly299Arg,c.895G>C,p.Gly299Arg,principal1,Y,1,YES,Select,-,GGC,1.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.001,0.83643,D,0.999,0.77914,D,0.967,0.80453,D,1.0,0.99291,A,simple_aae,0.0,100.0,3.615,0.93786,H,-7.4,0.95559,D,0.991,0.99781,0.9545,0.96452,D,0.9917,0.99792,D,9,0.9954407,0.99985,D,0.958393,0.99723,D,0.985,0.99930,0.997,0.99969,P35557,G299R,Gain of MoRF binding (P = 0.0095)| Gain of methylation at K296 (P = 0.1057)| Loss of ubiquitination at K296 (P = 0.152)| Gain of glycosylation at K296 (P = 0.1608)| Gain of helix (P = 0.1736),0.992121500454,0.99194,.,0.99891,.,0.97104,0.775753200054,0.78249,T,0.968658,0.99642,D,0.564186,0.96283,D,0.572637,0.96224,D,0.999379277229309,0.97130,D,0.999394,0.99805,D,0.9890143,0.99706,0.96495694,0.99216,0.9860968,0.99530,0.960452,0.98980,-13.277,0.90754,D,0.9967,0.96856,P,0.999827466907589,0.98179,0.99984097,0.99792,0.997,0.99892,.,.,.,.,.,.,5.624991,0.92642,32.0,0.9993193236961907,0.99439,0.967442,0.98988,D,0.926695616404469,0.92965,11.76197,0.826377040188961,0.91519,10.9513,4.77,4.77,0.60376,.,.,7.766,0.84189,7.538000,0.60097,0.549,0.27038,1.0,0.71675,1.000000,0.68239,0.995,0.73271,712,0.56407,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,not_provided|Maturity-onset_diabetes_of_the_young_type_2,"criteria_provided,_single_submitter",NC_000007.14:g.44146587C>G,ClinGen:CA126212|OMIM:138079.0005|UniProtKB:P35557#VAR_003710,C3661900|C0342277,125851,552,"Hexokinase, C-terminal",Gly,Arg,31175.0,single nucleotide variant,NM_000162.5(GCK):c.895G>C (p.Gly299Arg),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"May 18, 2024",104894009.0,-,RCV000017516|RCV001288185,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900",Maturity-onset diabetes of the young type 2|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,44146587.0,44146587.0,7p13,"criteria provided, multiple submitters, no conflicts",3.0,-,N,"ClinGen:CA126212,UniProtKB:P35557#VAR_003710,OMIM:138079.0005",3.0,16136.0,44146587.0,C,G,-,-,-,-,-,-,SCV001475132|SCV005835277,-,-,895G>C ,Gly299Arg,NM_000162.5,2.0,1_Pathogenic,98.36,0.0119047619047619,['125851'],autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2",G,1,98.36,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,Hexokinase-4,Hexokinase,,-0.4,,,"G299-R303, G299-T332; PAE: 1.0, 1.0",23 interactions,"G299-R303, G299-T332; PAE: 1.0, 1.0",23 interactions,,,75,,-63.2,,,-39.2,Hexokinase large subdomain,dbSNP: rs104894009; Variant type: LP/P; AA change: Gly299Arg; PTM type: Acetylation; PTM morphology: KLIGGkYMG*EL; Var class: II,H (helix),H (α-helix),Helix,,,,,,,,,0.238,,0.224,,,,,,false,false,GCK_Gersing_2024_abundance_var325853,GCK_Gersing_2024_abundance,GCK,4195,-1.0,44146587.0,44146587.0,ENST00000403799.8,895,G,C,299.0,G,R,c.895G>C,p.Gly299Arg,missense_variant,missense_variant,-0.120920502144243,,No,,Pathogenic,"criteria provided, single submitter","Nov 27, 2019",aa,urn:mavedb:00000096-b-1,ENST00000403799.8,NM_000162.5,yeast,protein stability assay (BAO_0002804),fluorescence intensity (BAO_0000363),regulation of protein stability (GO:0031647),No,Low abundance,"(-Inf, 0.58)",Abnormal,,,,,,,updated,0.985,0.9967,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Gly299Arg,true,Gly299Arg
GCK_Gly299Arg,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214851,CCSBVarC006694,ALE00006692,NC_000007.14:44146587:C:G,895G>C,Gly299Arg,CEGS2,CegsMutGDEh1045,E10,GDEhDisVCh_40037,G05,1.0,CegsMutGDDh1045,E10,VUSN2Hmut_GDN2h_09,B11,VUSMutpDEST2_03,E09,VUSmut_GDEh09,B11,1.0,1.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,7.0,1.0,7,44146587,C,G,7,Y,Y,Y,Y,Y,7-44146587-C-G,31175.0,single nucleotide variant,NM_000162.5(GCK):c.895G>C (p.Gly299Arg),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"May 18, 2024",104894009.0,-,RCV000017516|RCV001288185,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900",Maturity-onset diabetes of the young type 2|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,44146587.0,44146587.0,7p13,"criteria provided, multiple submitters, no conflicts",3.0,-,N,"ClinGen:CA126212,UniProtKB:P35557#VAR_003710,OMIM:138079.0005",3.0,16136.0,44146587.0,C,G,-,-,-,-,-,-,SCV001475132|SCV005835277,-,-,895G>C ,Gly299Arg,NM_000162.5,2.0,1_Pathogenic,,16136.0,7,44146587.0,C,G,G,R,rs104894009,7,44186186,7,44152711,299.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.895G>C,p.Gly299Arg,c.895G>C,p.Gly299Arg,principal1,Y,1,YES,Select,-,GGC,1.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.001,0.83643,D,0.999,0.77914,D,0.967,0.80453,D,1.0,0.99291,A,simple_aae,0.0,100.0,3.615,0.93786,H,-7.4,0.95559,D,0.991,0.99781,0.9545,0.96452,D,0.9917,0.99792,D,9,0.9954407,0.99985,D,0.958393,0.99723,D,0.985,0.99930,0.997,0.99969,P35557,G299R,Gain of MoRF binding (P = 0.0095)| Gain of methylation at K296 (P = 0.1057)| Loss of ubiquitination at K296 (P = 0.152)| Gain of glycosylation at K296 (P = 0.1608)| Gain of helix (P = 0.1736),0.992121500454,0.99194,.,0.99891,.,0.97104,0.775753200054,0.78249,T,0.968658,0.99642,D,0.564186,0.96283,D,0.572637,0.96224,D,0.999379277229309,0.97130,D,0.999394,0.99805,D,0.9890143,0.99706,0.96495694,0.99216,0.9860968,0.99530,0.960452,0.98980,-13.277,0.90754,D,0.9967,0.96856,P,0.999827466907589,0.98179,0.99984097,0.99792,0.997,0.99892,.,.,.,.,.,.,5.624991,0.92642,32.0,0.9993193236961907,0.99439,0.967442,0.98988,D,0.926695616404469,0.92965,11.76197,0.826377040188961,0.91519,10.9513,4.77,4.77,0.60376,.,.,7.766,0.84189,7.538000,0.60097,0.549,0.27038,1.0,0.71675,1.000000,0.68239,0.995,0.73271,712,0.56407,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,not_provided|Maturity-onset_diabetes_of_the_young_type_2,"criteria_provided,_single_submitter",NC_000007.14:g.44146587C>G,ClinGen:CA126212|OMIM:138079.0005|UniProtKB:P35557#VAR_003710,C3661900|C0342277,125851,552,"Hexokinase, C-terminal",Gly,Arg,31175.0,single nucleotide variant,NM_000162.5(GCK):c.895G>C (p.Gly299Arg),2645.0,GCK,HGNC:4195,Pathogenic,1.0,"May 18, 2024",104894009.0,-,RCV000017516|RCV001288185,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900",Maturity-onset diabetes of the young type 2|not provided,germline;unknown,germline,GRCh38,NC_000007.14,7,44146587.0,44146587.0,7p13,"criteria provided, multiple submitters, no conflicts",3.0,-,N,"ClinGen:CA126212,UniProtKB:P35557#VAR_003710,OMIM:138079.0005",3.0,16136.0,44146587.0,C,G,-,-,-,-,-,-,SCV001475132|SCV005835277,-,-,895G>C ,Gly299Arg,NM_000162.5,2.0,1_Pathogenic,98.36,0.0119047619047619,['125851'],autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2",G,1,98.36,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,Hexokinase-4,Hexokinase,,-0.4,,,"G299-R303, G299-T332; PAE: 1.0, 1.0",23 interactions,"G299-R303, G299-T332; PAE: 1.0, 1.0",23 interactions,,,75,,-63.2,,,-39.2,Hexokinase large subdomain,dbSNP: rs104894009; Variant type: LP/P; AA change: Gly299Arg; PTM type: Acetylation; PTM morphology: KLIGGkYMG*EL; Var class: II,H (helix),H (α-helix),Helix,,,,,,,,,0.238,,0.224,,,,,,false,false,GCK_Gersing_2023_complementation_var271860,GCK_Gersing_2023_complementation,GCK,4195,-1.0,44146587.0,44146587.0,,895,G,C,299.0,G,R,c.895G>C,p.Gly299Arg,missense_variant,missense_variant,0.11620176837648,,No,,Pathogenic,"criteria provided, single submitter","Nov 27, 2019",aa,urn:mavedb:00000096-a-1,ENST00000403799.8,NM_000162.5,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",voltage dependence of activation (ICEPO:0000006),"catalytic activity (GO:0003824), gluconokinase activity (GO:0046316)",No,Decreased activity,"(-Inf, 0.66)",Abnormal,Hyperactive,"(1.18, Inf)",Not specified,Synonymous,"(0.66,1.18)",Normal,updated,0.985,0.9967,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Gly299Arg,true,Gly299Arg
GCK_Gly385Arg,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214859,CCSBVarC006697,ALE00006695,NC_000007.14:44145597:C:T,1153G>A,Gly385Arg,CEGS2,CegsMutGDEh1044,F08,GDEhDisVCh_40037,B03,1.0,CegsMutGDDh1044,F08,VUSN2Hmut_GDN2h_09,G06,VUSMutpDEST2_03,H09,VUSmut_GDEh09,G06,1.0,6.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,7,44145597,C,T,7,N,Y,Y,Y,Y,7-44145597-C-T,44843.0,single nucleotide variant,NM_000162.5(GCK):c.1153G>A (p.Gly385Arg),2645.0,GCK,HGNC:4195,Likely pathogenic/Likely risk allele,1.0,"Aug 18, 2011",193922267.0,-,RCV000029842|RCV002463594,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552",Maturity-onset diabetes of the young type 2|Maturity onset diabetes mellitus in young,germline;unknown,germline,GRCh38,NC_000007.14,7,44145597.0,44145597.0,7p13,"criteria provided, multiple submitters, no conflicts",2.0,-,N,ClinGen:CA213721,2.0,36179.0,44145597.0,C,T,-,-,-,-,-,-,SCV000052497|SCV002605086,-,-,1153G>A ,Gly385Arg,NM_000162.5,2.0,1_Pathogenic,0.0,36179.0,7,44145597.0,C,T,G,R,rs193922267,7,44185196,7,44151721,385.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.1153G>A,p.Gly385Arg,c.1153G>A,p.Gly385Arg,principal1,Y,1,YES,Select,-,GGG,1.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.001,0.83643,D,1.0,0.90580,D,1.0,0.97365,D,1.0,0.99291,A,simple_aae,0.0,100.0,3.8,0.95330,H,-5.13,0.87940,D,0.966,0.97658,1.0885,0.99178,D,0.9687,0.99007,D,10,0.99321365,0.99853,D,0.81417,0.98549,D,0.962,0.99434,0.976,0.99775,P35557,G385R,Gain of methylation at G385 (P = 0.0071)| Gain of MoRF binding (P = 0.0093)| Loss of catalytic residue at A384 (P = 0.0427)| Gain of disorder (P = 0.0551)| Loss of stability (P = 0.4192),0.976041132959,0.97555,.,0.99910,.,0.97218,0.899795651436,0.96414,D,0.939492,0.99028,D,0.540798,0.95432,D,0.539042,0.95364,D,0.998842716217041,0.95303,D,0.963704,0.86505,D,0.9927741,0.99889,0.9464729,0.98155,0.9899593,0.99758,0.96298075,0.99116,-13.091,0.90510,D,0.9931,0.95140,P,0.99887997863384,0.95226,0.99983823,0.99792,0.984,0.99450,.,.,.,.,.,.,5.272541,0.88551,29.6,0.99894492961875325,0.96745,0.866045,0.78455,D,0.878649383831347,0.90623,10.51293,0.786564022153535,0.88782,9.73724,5.46,5.46,0.79994,3.81,0.70705,4.064,0.57311,7.531000,0.59982,0.596,0.33565,0.997,0.40243,1.000000,0.68239,0.958,0.51242,716,0.55914,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic/Likely_risk_allele,Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000007.14:g.44145597C>T,ClinGen:CA213721,C0342277|C0342276,125851|606391,552|552,"Hexokinase, C-terminal",Gly,Arg,44843.0,single nucleotide variant,NM_000162.5(GCK):c.1153G>A (p.Gly385Arg),2645.0,GCK,HGNC:4195,Likely pathogenic/Likely risk allele,1.0,"Aug 18, 2011",193922267.0,-,RCV000029842|RCV002463594,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552",Maturity-onset diabetes of the young type 2|Maturity onset diabetes mellitus in young,germline;unknown,germline,GRCh38,NC_000007.14,7,44145597.0,44145597.0,7p13,"criteria provided, multiple submitters, no conflicts",2.0,-,N,ClinGen:CA213721,2.0,36179.0,44145597.0,C,T,-,-,-,-,-,-,SCV000052497|SCV002605086,-,-,1153G>A ,Gly385Arg,NM_000162.5,2.0,1_Pathogenic,98.76,0.0,"['125851', '606391']",autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG",G,0,98.76,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,Hexokinase-4,Hexokinase,,-0.4,,,"G385-M381, G385-Y289, G385-V389; PAE: 1.0, 1.0, 1.0",21 interactions,"G385-M381, G385-V389; PAE: 1.0, 1.0",23 interactions,,,75,,-61.8,,,-51.9,Hexokinase large subdomain,dbSNP: -; Variant type: LP/P; AA change: Gly385Val; PTM type: Phosphorylation; PTM morphology: AAHMCsAG*LAG; Var class: II,H (helix),H (α-helix),Helix,,,,,,,,,-0.031,1 mutation(s) (Gly385Phe: -0.644),0.564,1 mutation(s) (Gly385Lys: -0.492),,,,,false,false,GCK_Gersing_2024_abundance_var325953,GCK_Gersing_2024_abundance,GCK,4195,-1.0,44145597.0,44145597.0,ENST00000403799.8,1153,G,A,385.0,G,R,c.1153G>A,p.Gly385Arg,missense_variant,missense_variant,0.404077587078468,,No,,Likely pathogenic/Likely risk allele,"criteria provided, multiple submitters, no conflicts","Aug 18, 2011",aa,urn:mavedb:00000096-b-1,ENST00000403799.8,NM_000162.5,yeast,protein stability assay (BAO_0002804),fluorescence intensity (BAO_0000363),regulation of protein stability (GO:0031647),No,Low abundance,"(-Inf, 0.58)",Abnormal,,,,,,,updated,0.962,0.9931,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Gly385Arg,true,Gly385Arg
GCK_Gly385Arg,2,1,0,1,50.0,0.0,50.0,50.0,1,1.0,true,GCK,ENSG00000106633,3689,214859,CCSBVarC006697,ALE00006695,NC_000007.14:44145597:C:T,1153G>A,Gly385Arg,CEGS2,CegsMutGDEh1044,F08,GDEhDisVCh_40037,B03,1.0,CegsMutGDDh1044,F08,VUSN2Hmut_GDN2h_09,G06,VUSMutpDEST2_03,H09,VUSmut_GDEh09,G06,1.0,6.0,1.0,1.0,1.0,1.0,7.0,1.0,1.0,1.0,1.0,1.0,1.0,7,44145597,C,T,7,N,Y,Y,Y,Y,7-44145597-C-T,44843.0,single nucleotide variant,NM_000162.5(GCK):c.1153G>A (p.Gly385Arg),2645.0,GCK,HGNC:4195,Likely pathogenic/Likely risk allele,1.0,"Aug 18, 2011",193922267.0,-,RCV000029842|RCV002463594,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552",Maturity-onset diabetes of the young type 2|Maturity onset diabetes mellitus in young,germline;unknown,germline,GRCh38,NC_000007.14,7,44145597.0,44145597.0,7p13,"criteria provided, multiple submitters, no conflicts",2.0,-,N,ClinGen:CA213721,2.0,36179.0,44145597.0,C,T,-,-,-,-,-,-,SCV000052497|SCV002605086,-,-,1153G>A ,Gly385Arg,NM_000162.5,2.0,1_Pathogenic,0.0,36179.0,7,44145597.0,C,T,G,R,rs193922267,7,44185196,7,44151721,385.0,GCK,ENSG00000106633,ENST00000403799,ENSP00000384247,P35557,HXK4_HUMAN,c.1153G>A,p.Gly385Arg,c.1153G>A,p.Gly385Arg,principal1,Y,1,YES,Select,-,GGG,1.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.001,0.83643,D,1.0,0.90580,D,1.0,0.97365,D,1.0,0.99291,A,simple_aae,0.0,100.0,3.8,0.95330,H,-5.13,0.87940,D,0.966,0.97658,1.0885,0.99178,D,0.9687,0.99007,D,10,0.99321365,0.99853,D,0.81417,0.98549,D,0.962,0.99434,0.976,0.99775,P35557,G385R,Gain of methylation at G385 (P = 0.0071)| Gain of MoRF binding (P = 0.0093)| Loss of catalytic residue at A384 (P = 0.0427)| Gain of disorder (P = 0.0551)| Loss of stability (P = 0.4192),0.976041132959,0.97555,.,0.99910,.,0.97218,0.899795651436,0.96414,D,0.939492,0.99028,D,0.540798,0.95432,D,0.539042,0.95364,D,0.998842716217041,0.95303,D,0.963704,0.86505,D,0.9927741,0.99889,0.9464729,0.98155,0.9899593,0.99758,0.96298075,0.99116,-13.091,0.90510,D,0.9931,0.95140,P,0.99887997863384,0.95226,0.99983823,0.99792,0.984,0.99450,.,.,.,.,.,.,5.272541,0.88551,29.6,0.99894492961875325,0.96745,0.866045,0.78455,D,0.878649383831347,0.90623,10.51293,0.786564022153535,0.88782,9.73724,5.46,5.46,0.79994,3.81,0.70705,4.064,0.57311,7.531000,0.59982,0.596,0.33565,0.997,0.40243,1.000000,0.68239,0.958,0.51242,716,0.55914,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic/Likely_risk_allele,Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000007.14:g.44145597C>T,ClinGen:CA213721,C0342277|C0342276,125851|606391,552|552,"Hexokinase, C-terminal",Gly,Arg,44843.0,single nucleotide variant,NM_000162.5(GCK):c.1153G>A (p.Gly385Arg),2645.0,GCK,HGNC:4195,Likely pathogenic/Likely risk allele,1.0,"Aug 18, 2011",193922267.0,-,RCV000029842|RCV002463594,"MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552",Maturity-onset diabetes of the young type 2|Maturity onset diabetes mellitus in young,germline;unknown,germline,GRCh38,NC_000007.14,7,44145597.0,44145597.0,7p13,"criteria provided, multiple submitters, no conflicts",2.0,-,N,ClinGen:CA213721,2.0,36179.0,44145597.0,C,T,-,-,-,-,-,-,SCV000052497|SCV002605086,-,-,1153G>A ,Gly385Arg,NM_000162.5,2.0,1_Pathogenic,98.76,0.0,"['125851', '606391']",autosomal dominant,Rare genetic developmental defect during embryogenesis; Rare genetic endocrine disease; Rare inborn errors of metabolism,3,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MATURITY-ONSET DIABETES OF THE YOUNG",G,0,98.76,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,Hexokinase-4,Hexokinase,,-0.4,,,"G385-M381, G385-Y289, G385-V389; PAE: 1.0, 1.0, 1.0",21 interactions,"G385-M381, G385-V389; PAE: 1.0, 1.0",23 interactions,,,75,,-61.8,,,-51.9,Hexokinase large subdomain,dbSNP: -; Variant type: LP/P; AA change: Gly385Val; PTM type: Phosphorylation; PTM morphology: AAHMCsAG*LAG; Var class: II,H (helix),H (α-helix),Helix,,,,,,,,,-0.031,1 mutation(s) (Gly385Phe: -0.644),0.564,1 mutation(s) (Gly385Lys: -0.492),,,,,false,false,GCK_Gersing_2023_complementation_var271965,GCK_Gersing_2023_complementation,GCK,4195,-1.0,44145597.0,44145597.0,,1153,G,A,385.0,G,R,c.1153G>A,p.Gly385Arg,missense_variant,missense_variant,-0.103305588410467,,No,,Likely pathogenic/Likely risk allele,"criteria provided, multiple submitters, no conflicts","Aug 18, 2011",aa,urn:mavedb:00000096-a-1,ENST00000403799.8,NM_000162.5,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",voltage dependence of activation (ICEPO:0000006),"catalytic activity (GO:0003824), gluconokinase activity (GO:0046316)",No,Decreased activity,"(-Inf, 0.66)",Abnormal,Hyperactive,"(1.18, Inf)",Not specified,Synonymous,"(0.66,1.18)",Normal,updated,0.962,0.9931,likely_pathogenic,,,,,,,,,,,,,,,,,,,GCK_Gly385Arg,true,Gly385Arg
HMBS_Ala252Val,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200942,CCSBVarC005176,ALE00005176,NC_000011.10:119092507:C:T,755C>T,Ala252Val,CEGS2,CegsMutGDEh1042,E04,GDEhDisVCh_40054,D07,2.0,CegsMutGDDh1042,E04,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092507,C,T,11,Y,Y,N,N,N,11-119092507-C-T,16512.0,single nucleotide variant,NM_000190.4(HMBS):c.755C>T (p.Ala252Val),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204114.0,-,RCV000001538,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092507.0,119092507.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033",1.0,1473.0,119092507.0,C,T,-,-,-,-,-,-,SCV000021693,-,-,755C>T ,Ala252Val,NM_000190.4,,1_Pathogenic,,1473.0,11,119092507.0,C,T,A,V,rs118204114,11,118963217,11,118468427,252.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.755C>T,p.Ala252Val,c.755C>T,p.Ala252Val,principal2,Y,.,YES,Select,+,GCC,2.0,0.0,C,C/C,C/C,C/C,C/C,.,0.72322,.,.,0.55281,.,0.107,0.26097,B,0.097,0.30392,B,.,0.97926,.,.,.,.,2.76,0.80456,M,.,0.62039,.,.,0.82201,0.9737,0.96750,D,0.9316,0.97739,D,9,.,0.96984,.,0.3086,0.91093,D,.,0.94374,0.935,0.99041,P08397,A252V,Loss of catalytic residue at A252 (P = 0.0344)| Loss of methylation at R255 (P = 0.4078)| Gain of MoRF binding (P = 0.564)| Loss of helix (P = 0.6555)| Loss of disorder (P = 0.6714),.,0.97885,0.8369897311874793,0.83559,.,.,0.632630169392,0.57453,T,0.971703,0.99696,D,0.545865,0.95596,D,0.546321,0.95531,D,0.962264060974121,0.66102,D,0.987901,0.95926,D,0.88892263,0.90279,0.81493074,0.89076,0.91241264,0.92412,0.8381258,0.90593,-8.484,0.64399,D,0.7104,0.74340,P,0.996622567730506,0.92311,0.23534976,0.74589,0.955,0.98022,.,.,.,.,.,.,4.679191,0.74916,26.2,0.9983030953696117,0.91205,0.964820,0.98698,D,0.315479336033447,0.56722,3.859968,0.448529610016467,0.64429,4.721709,5.24,5.24,0.72825,5.83,0.96354,7.693,0.83514,7.655000,0.63966,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.999,0.91597,228,0.91137,1,1.9968051118210862E-4,0,0.0,1,9.940357852882703E-4,0,0.0,0,0.0,0,0.0,.,.,.,.,1,109394,9.141270e-06,0,1,208108,4.805200e-06,0,1,236842,4.222220e-06,0,0,7162,0.000000e+00,0,0,17112,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13384,0.000000e+00,0,1,42768,2.338200e-05,0,0,15688,0.000000e+00,0,1,42768,2.338200e-05,0,0,16214,0.000000e+00,0,0,30524,0.000000e+00,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16724,0.000000e+00,0,1,89548,1.116720e-05,0,0,30606,0.000000e+00,0,1,89548,1.116720e-05,0,0,14900,0.000000e+00,0,0,34258,0.000000e+00,0,0,9568,0.000000e+00,0,0,17692,0.000000e+00,0,0,21620,0.000000e+00,0,1,102660,9.740890e-06,0,0,30524,0.000000e+00,0,1,102660,9.740890e-06,0,.,1,1614164,6.195160e-07,0,1,1180028,8.474380e-07,0,0,75030,0.000000e+00,0,0,912,0.000000e+00,0,0,60028,0.000000e+00,0,0,29606,0.000000e+00,0,0,44888,0.000000e+00,0,0,64018,0.000000e+00,0,0,6062,0.000000e+00,0,1,1180028,8.474380e-07,0,0,91082,0.000000e+00,0,0,76,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,106,0,0,434,0,0,34,0,0,656,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092507C>T,ClinGen:CA251834|OMIM:609806.0033|UniProtKB:P08397#VAR_003668,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",Ala,Val,16512.0,single nucleotide variant,NM_000190.4(HMBS):c.755C>T (p.Ala252Val),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204114.0,-,RCV000001538,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092507.0,119092507.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033",1.0,1473.0,119092507.0,C,T,-,-,-,-,-,-,SCV000021693,-,-,755C>T ,Ala252Val,NM_000190.4,,1_Pathogenic,98.39,0.0283018867924528,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",A,3,98.39,Aliphatic,Alanine,Porphobilinogen deaminase,,,1.8,,,"A252-H256, A252-I248; PAE: 1.0, 1.0",9 interactions,"A252-H256, A252-I248; PAE: 1.0, 1.0",9 interactions,,,89,,-64.4,,,-44.8,,,H (helix),H (α-helix),Helix,,,0.255,,0.281,,0.349,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_combined_var219066,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119092507.0,119092507.0,,755,C,T,252.0,A,V,c.755C>T,p.Ala252Val,missense_variant,missense_variant,1.217938992,,No,6.195157369387497e-7,Pathogenic,no assertion criteria provided,"Dec 01, 1993",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.824,0.7104,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Ala252Val,true,Ala252Val
HMBS_Ala252Val,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200942,CCSBVarC005176,ALE00005176,NC_000011.10:119092507:C:T,755C>T,Ala252Val,CEGS2,CegsMutGDEh1042,E04,GDEhDisVCh_40054,D07,2.0,CegsMutGDDh1042,E04,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092507,C,T,11,Y,Y,N,N,N,11-119092507-C-T,16512.0,single nucleotide variant,NM_000190.4(HMBS):c.755C>T (p.Ala252Val),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204114.0,-,RCV000001538,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092507.0,119092507.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033",1.0,1473.0,119092507.0,C,T,-,-,-,-,-,-,SCV000021693,-,-,755C>T ,Ala252Val,NM_000190.4,,1_Pathogenic,,1473.0,11,119092507.0,C,T,A,V,rs118204114,11,118963217,11,118468427,252.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.755C>T,p.Ala252Val,c.755C>T,p.Ala252Val,principal2,Y,.,YES,Select,+,GCC,2.0,0.0,C,C/C,C/C,C/C,C/C,.,0.72322,.,.,0.55281,.,0.107,0.26097,B,0.097,0.30392,B,.,0.97926,.,.,.,.,2.76,0.80456,M,.,0.62039,.,.,0.82201,0.9737,0.96750,D,0.9316,0.97739,D,9,.,0.96984,.,0.3086,0.91093,D,.,0.94374,0.935,0.99041,P08397,A252V,Loss of catalytic residue at A252 (P = 0.0344)| Loss of methylation at R255 (P = 0.4078)| Gain of MoRF binding (P = 0.564)| Loss of helix (P = 0.6555)| Loss of disorder (P = 0.6714),.,0.97885,0.8369897311874793,0.83559,.,.,0.632630169392,0.57453,T,0.971703,0.99696,D,0.545865,0.95596,D,0.546321,0.95531,D,0.962264060974121,0.66102,D,0.987901,0.95926,D,0.88892263,0.90279,0.81493074,0.89076,0.91241264,0.92412,0.8381258,0.90593,-8.484,0.64399,D,0.7104,0.74340,P,0.996622567730506,0.92311,0.23534976,0.74589,0.955,0.98022,.,.,.,.,.,.,4.679191,0.74916,26.2,0.9983030953696117,0.91205,0.964820,0.98698,D,0.315479336033447,0.56722,3.859968,0.448529610016467,0.64429,4.721709,5.24,5.24,0.72825,5.83,0.96354,7.693,0.83514,7.655000,0.63966,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.999,0.91597,228,0.91137,1,1.9968051118210862E-4,0,0.0,1,9.940357852882703E-4,0,0.0,0,0.0,0,0.0,.,.,.,.,1,109394,9.141270e-06,0,1,208108,4.805200e-06,0,1,236842,4.222220e-06,0,0,7162,0.000000e+00,0,0,17112,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13384,0.000000e+00,0,1,42768,2.338200e-05,0,0,15688,0.000000e+00,0,1,42768,2.338200e-05,0,0,16214,0.000000e+00,0,0,30524,0.000000e+00,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16724,0.000000e+00,0,1,89548,1.116720e-05,0,0,30606,0.000000e+00,0,1,89548,1.116720e-05,0,0,14900,0.000000e+00,0,0,34258,0.000000e+00,0,0,9568,0.000000e+00,0,0,17692,0.000000e+00,0,0,21620,0.000000e+00,0,1,102660,9.740890e-06,0,0,30524,0.000000e+00,0,1,102660,9.740890e-06,0,.,1,1614164,6.195160e-07,0,1,1180028,8.474380e-07,0,0,75030,0.000000e+00,0,0,912,0.000000e+00,0,0,60028,0.000000e+00,0,0,29606,0.000000e+00,0,0,44888,0.000000e+00,0,0,64018,0.000000e+00,0,0,6062,0.000000e+00,0,1,1180028,8.474380e-07,0,0,91082,0.000000e+00,0,0,76,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,106,0,0,434,0,0,34,0,0,656,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092507C>T,ClinGen:CA251834|OMIM:609806.0033|UniProtKB:P08397#VAR_003668,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",Ala,Val,16512.0,single nucleotide variant,NM_000190.4(HMBS):c.755C>T (p.Ala252Val),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204114.0,-,RCV000001538,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092507.0,119092507.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033",1.0,1473.0,119092507.0,C,T,-,-,-,-,-,-,SCV000021693,-,-,755C>T ,Ala252Val,NM_000190.4,,1_Pathogenic,98.39,0.0283018867924528,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",A,3,98.39,Aliphatic,Alanine,Porphobilinogen deaminase,,,1.8,,,"A252-H256, A252-I248; PAE: 1.0, 1.0",9 interactions,"A252-H256, A252-I248; PAE: 1.0, 1.0",9 interactions,,,89,,-64.4,,,-44.8,,,H (helix),H (α-helix),Helix,,,0.255,,0.281,,0.349,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_erythroid_var212489,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119092507.0,119092507.0,,755,C,T,252.0,A,V,c.755C>T,p.Ala252Val,missense_variant,missense_variant,1.234009103,,No,6.195157369387497e-7,Pathogenic,no assertion criteria provided,"Dec 01, 1993",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.824,0.7104,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Ala252Val,true,Ala252Val
HMBS_Ala252Val,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200942,CCSBVarC005176,ALE00005176,NC_000011.10:119092507:C:T,755C>T,Ala252Val,CEGS2,CegsMutGDEh1042,E04,GDEhDisVCh_40054,D07,2.0,CegsMutGDDh1042,E04,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092507,C,T,11,Y,Y,N,N,N,11-119092507-C-T,16512.0,single nucleotide variant,NM_000190.4(HMBS):c.755C>T (p.Ala252Val),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204114.0,-,RCV000001538,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092507.0,119092507.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033",1.0,1473.0,119092507.0,C,T,-,-,-,-,-,-,SCV000021693,-,-,755C>T ,Ala252Val,NM_000190.4,,1_Pathogenic,,1473.0,11,119092507.0,C,T,A,V,rs118204114,11,118963217,11,118468427,252.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.755C>T,p.Ala252Val,c.755C>T,p.Ala252Val,principal2,Y,.,YES,Select,+,GCC,2.0,0.0,C,C/C,C/C,C/C,C/C,.,0.72322,.,.,0.55281,.,0.107,0.26097,B,0.097,0.30392,B,.,0.97926,.,.,.,.,2.76,0.80456,M,.,0.62039,.,.,0.82201,0.9737,0.96750,D,0.9316,0.97739,D,9,.,0.96984,.,0.3086,0.91093,D,.,0.94374,0.935,0.99041,P08397,A252V,Loss of catalytic residue at A252 (P = 0.0344)| Loss of methylation at R255 (P = 0.4078)| Gain of MoRF binding (P = 0.564)| Loss of helix (P = 0.6555)| Loss of disorder (P = 0.6714),.,0.97885,0.8369897311874793,0.83559,.,.,0.632630169392,0.57453,T,0.971703,0.99696,D,0.545865,0.95596,D,0.546321,0.95531,D,0.962264060974121,0.66102,D,0.987901,0.95926,D,0.88892263,0.90279,0.81493074,0.89076,0.91241264,0.92412,0.8381258,0.90593,-8.484,0.64399,D,0.7104,0.74340,P,0.996622567730506,0.92311,0.23534976,0.74589,0.955,0.98022,.,.,.,.,.,.,4.679191,0.74916,26.2,0.9983030953696117,0.91205,0.964820,0.98698,D,0.315479336033447,0.56722,3.859968,0.448529610016467,0.64429,4.721709,5.24,5.24,0.72825,5.83,0.96354,7.693,0.83514,7.655000,0.63966,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.999,0.91597,228,0.91137,1,1.9968051118210862E-4,0,0.0,1,9.940357852882703E-4,0,0.0,0,0.0,0,0.0,.,.,.,.,1,109394,9.141270e-06,0,1,208108,4.805200e-06,0,1,236842,4.222220e-06,0,0,7162,0.000000e+00,0,0,17112,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13384,0.000000e+00,0,1,42768,2.338200e-05,0,0,15688,0.000000e+00,0,1,42768,2.338200e-05,0,0,16214,0.000000e+00,0,0,30524,0.000000e+00,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16724,0.000000e+00,0,1,89548,1.116720e-05,0,0,30606,0.000000e+00,0,1,89548,1.116720e-05,0,0,14900,0.000000e+00,0,0,34258,0.000000e+00,0,0,9568,0.000000e+00,0,0,17692,0.000000e+00,0,0,21620,0.000000e+00,0,1,102660,9.740890e-06,0,0,30524,0.000000e+00,0,1,102660,9.740890e-06,0,.,1,1614164,6.195160e-07,0,1,1180028,8.474380e-07,0,0,75030,0.000000e+00,0,0,912,0.000000e+00,0,0,60028,0.000000e+00,0,0,29606,0.000000e+00,0,0,44888,0.000000e+00,0,0,64018,0.000000e+00,0,0,6062,0.000000e+00,0,1,1180028,8.474380e-07,0,0,91082,0.000000e+00,0,0,76,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,106,0,0,434,0,0,34,0,0,656,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092507C>T,ClinGen:CA251834|OMIM:609806.0033|UniProtKB:P08397#VAR_003668,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",Ala,Val,16512.0,single nucleotide variant,NM_000190.4(HMBS):c.755C>T (p.Ala252Val),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204114.0,-,RCV000001538,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092507.0,119092507.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033",1.0,1473.0,119092507.0,C,T,-,-,-,-,-,-,SCV000021693,-,-,755C>T ,Ala252Val,NM_000190.4,,1_Pathogenic,98.39,0.0283018867924528,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",A,3,98.39,Aliphatic,Alanine,Porphobilinogen deaminase,,,1.8,,,"A252-H256, A252-I248; PAE: 1.0, 1.0",9 interactions,"A252-H256, A252-I248; PAE: 1.0, 1.0",9 interactions,,,89,,-64.4,,,-44.8,,,H (helix),H (α-helix),Helix,,,0.255,,0.281,,0.349,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_ubquitous_var205952,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119092507.0,119092507.0,,755,C,T,252.0,A,V,c.755C>T,p.Ala252Val,missense_variant,missense_variant,1.20549556,,No,6.195157369387497e-7,Pathogenic,no assertion criteria provided,"Dec 01, 1993",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.824,0.7104,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Ala252Val,true,Ala252Val
HMBS_Arg149Gln,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200930,CCSBVarC005163,ALE00005163,NC_000011.10:119090213:G:A,446G>A,Arg149Gln,CEGS2,CegsMutGDEh1037,B04,GDEhDisVCh_40054,E03,2.0,CegsMutGDDh1037,B04,,,,,,,1.0,1.0,1.0,2.0,0.0,,,0.0,,,0.0,,,11,119090213,G,A,11,Y,Y,N,N,N,11-119090213-G-A,16488.0,single nucleotide variant,NM_000190.4(HMBS):c.446G>A (p.Arg149Gln),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 08, 1999",118204098.0,-,RCV000001514,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119090213.0,119090213.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251802,UniProtKB:P08397#VAR_003650,OMIM:609806.0008",1.0,1449.0,119090213.0,G,A,-,-,-,-,-,-,SCV000021669,-,-,446G>A ,Arg149Gln,NM_000190.4,,1_Pathogenic,,1449.0,11,119090213.0,G,A,R,Q,rs118204098,11,118960923,11,118466133,149.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.446G>A,p.Arg149Gln,c.446G>A,p.Arg149Gln,principal2,Y,.,YES,Select,+,CGA,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.999,0.92348,D,.,0.97926,.,.,.,.,4.125,0.97400,H,.,0.71557,.,.,0.99617,0.9258,0.96030,D,0.9979,0.99947,D,9,.,0.99875,.,0.665105,0.97189,D,.,0.99285,0.987,0.99867,P08397,R149Q,Loss of MoRF binding (P = 0.0216)| Loss of methylation at R149 (P = 0.0499)| Loss of phosphorylation at S147 (P = 0.0769)| Loss of catalytic residue at R149 (P = 0.0953)| Loss of helix (P = 0.1299),.,0.98849,0.9004548517599092,0.89954,.,.,0.620476007462,0.55731,T,0.996618,0.99995,D,0.592801,0.97349,D,0.613741,0.97307,D,0.999856233596802,0.99358,D,0.999654,0.99880,D,0.9785351,0.98978,0.9302809,0.97072,0.98125356,0.99190,0.94504,0.98064,-15.339,0.96604,D,0.9908,0.93839,P,0.999550081799675,0.96973,0.39844300,0.79549,0.995,0.99826,.,.,.,.,.,.,5.851943,0.93829,33.0,0.99954113174828796,0.99963,0.953544,0.96982,D,1.19462742128387,0.99497,23.23098,1.09238016298993,0.99747,26.2228,6.11,6.11,0.99131,6.13,0.98113,9.647,0.97855,11.799000,0.96601,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.84,0.39676,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119090213G>A,ClinGen:CA251802|OMIM:609806.0008|UniProtKB:P08397#VAR_003650,C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,16488.0,single nucleotide variant,NM_000190.4(HMBS):c.446G>A (p.Arg149Gln),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 08, 1999",118204098.0,-,RCV000001514,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119090213.0,119090213.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251802,UniProtKB:P08397#VAR_003650,OMIM:609806.0008",1.0,1449.0,119090213.0,G,A,-,-,-,-,-,-,SCV000021669,-,-,446G>A ,Arg149Gln,NM_000190.4,,1_Pathogenic,96.65,0.0524193548387096,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,13,96.65,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,"R149-M212, R149-Q153, R149-D121; PAE: 1.0, 1.0, 1.0",10 interactions,"R149-Q153, R149-A214; PAE: 1.0, 1.0",9 interactions,,7 interactions,175,,-51.7,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",-47.9,,dbSNP: -; Variant type: LP/P; AA change: Arg149Leu; PTM type: Phosphorylation; PTM morphology: VVGTSsLR*RAA; Var class: II&rs118204098,H (helix),H (α-helix),Helix,,,0.06,,0.072,,0.136,1 mutation(s) (Arg149Gly: 0.000),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var205663,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119090213.0,119090213.0,,446,G,A,149.0,R,Q,c.446G>A,p.Arg149Gln,missense_variant,missense_variant,0.005231198,,No,,Pathogenic,no assertion criteria provided,"Oct 08, 1999",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.957,0.9908,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg149Gln,true,Arg149Gln
HMBS_Arg149Gln,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200930,CCSBVarC005163,ALE00005163,NC_000011.10:119090213:G:A,446G>A,Arg149Gln,CEGS2,CegsMutGDEh1037,B04,GDEhDisVCh_40054,E03,2.0,CegsMutGDDh1037,B04,,,,,,,1.0,1.0,1.0,2.0,0.0,,,0.0,,,0.0,,,11,119090213,G,A,11,Y,Y,N,N,N,11-119090213-G-A,16488.0,single nucleotide variant,NM_000190.4(HMBS):c.446G>A (p.Arg149Gln),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 08, 1999",118204098.0,-,RCV000001514,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119090213.0,119090213.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251802,UniProtKB:P08397#VAR_003650,OMIM:609806.0008",1.0,1449.0,119090213.0,G,A,-,-,-,-,-,-,SCV000021669,-,-,446G>A ,Arg149Gln,NM_000190.4,,1_Pathogenic,,1449.0,11,119090213.0,G,A,R,Q,rs118204098,11,118960923,11,118466133,149.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.446G>A,p.Arg149Gln,c.446G>A,p.Arg149Gln,principal2,Y,.,YES,Select,+,CGA,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.999,0.92348,D,.,0.97926,.,.,.,.,4.125,0.97400,H,.,0.71557,.,.,0.99617,0.9258,0.96030,D,0.9979,0.99947,D,9,.,0.99875,.,0.665105,0.97189,D,.,0.99285,0.987,0.99867,P08397,R149Q,Loss of MoRF binding (P = 0.0216)| Loss of methylation at R149 (P = 0.0499)| Loss of phosphorylation at S147 (P = 0.0769)| Loss of catalytic residue at R149 (P = 0.0953)| Loss of helix (P = 0.1299),.,0.98849,0.9004548517599092,0.89954,.,.,0.620476007462,0.55731,T,0.996618,0.99995,D,0.592801,0.97349,D,0.613741,0.97307,D,0.999856233596802,0.99358,D,0.999654,0.99880,D,0.9785351,0.98978,0.9302809,0.97072,0.98125356,0.99190,0.94504,0.98064,-15.339,0.96604,D,0.9908,0.93839,P,0.999550081799675,0.96973,0.39844300,0.79549,0.995,0.99826,.,.,.,.,.,.,5.851943,0.93829,33.0,0.99954113174828796,0.99963,0.953544,0.96982,D,1.19462742128387,0.99497,23.23098,1.09238016298993,0.99747,26.2228,6.11,6.11,0.99131,6.13,0.98113,9.647,0.97855,11.799000,0.96601,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.84,0.39676,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119090213G>A,ClinGen:CA251802|OMIM:609806.0008|UniProtKB:P08397#VAR_003650,C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,16488.0,single nucleotide variant,NM_000190.4(HMBS):c.446G>A (p.Arg149Gln),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 08, 1999",118204098.0,-,RCV000001514,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119090213.0,119090213.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251802,UniProtKB:P08397#VAR_003650,OMIM:609806.0008",1.0,1449.0,119090213.0,G,A,-,-,-,-,-,-,SCV000021669,-,-,446G>A ,Arg149Gln,NM_000190.4,,1_Pathogenic,96.65,0.0524193548387096,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,13,96.65,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,"R149-M212, R149-Q153, R149-D121; PAE: 1.0, 1.0, 1.0",10 interactions,"R149-Q153, R149-A214; PAE: 1.0, 1.0",9 interactions,,7 interactions,175,,-51.7,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",-47.9,,dbSNP: -; Variant type: LP/P; AA change: Arg149Leu; PTM type: Phosphorylation; PTM morphology: VVGTSsLR*RAA; Var class: II&rs118204098,H (helix),H (α-helix),Helix,,,0.06,,0.072,,0.136,1 mutation(s) (Arg149Gly: 0.000),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var212040,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119090213.0,119090213.0,,446,G,A,149.0,R,Q,c.446G>A,p.Arg149Gln,missense_variant,missense_variant,0.0016450579999999,,No,,Pathogenic,no assertion criteria provided,"Oct 08, 1999",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.957,0.9908,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg149Gln,true,Arg149Gln
HMBS_Arg149Gln,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200930,CCSBVarC005163,ALE00005163,NC_000011.10:119090213:G:A,446G>A,Arg149Gln,CEGS2,CegsMutGDEh1037,B04,GDEhDisVCh_40054,E03,2.0,CegsMutGDDh1037,B04,,,,,,,1.0,1.0,1.0,2.0,0.0,,,0.0,,,0.0,,,11,119090213,G,A,11,Y,Y,N,N,N,11-119090213-G-A,16488.0,single nucleotide variant,NM_000190.4(HMBS):c.446G>A (p.Arg149Gln),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 08, 1999",118204098.0,-,RCV000001514,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119090213.0,119090213.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251802,UniProtKB:P08397#VAR_003650,OMIM:609806.0008",1.0,1449.0,119090213.0,G,A,-,-,-,-,-,-,SCV000021669,-,-,446G>A ,Arg149Gln,NM_000190.4,,1_Pathogenic,,1449.0,11,119090213.0,G,A,R,Q,rs118204098,11,118960923,11,118466133,149.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.446G>A,p.Arg149Gln,c.446G>A,p.Arg149Gln,principal2,Y,.,YES,Select,+,CGA,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.999,0.92348,D,.,0.97926,.,.,.,.,4.125,0.97400,H,.,0.71557,.,.,0.99617,0.9258,0.96030,D,0.9979,0.99947,D,9,.,0.99875,.,0.665105,0.97189,D,.,0.99285,0.987,0.99867,P08397,R149Q,Loss of MoRF binding (P = 0.0216)| Loss of methylation at R149 (P = 0.0499)| Loss of phosphorylation at S147 (P = 0.0769)| Loss of catalytic residue at R149 (P = 0.0953)| Loss of helix (P = 0.1299),.,0.98849,0.9004548517599092,0.89954,.,.,0.620476007462,0.55731,T,0.996618,0.99995,D,0.592801,0.97349,D,0.613741,0.97307,D,0.999856233596802,0.99358,D,0.999654,0.99880,D,0.9785351,0.98978,0.9302809,0.97072,0.98125356,0.99190,0.94504,0.98064,-15.339,0.96604,D,0.9908,0.93839,P,0.999550081799675,0.96973,0.39844300,0.79549,0.995,0.99826,.,.,.,.,.,.,5.851943,0.93829,33.0,0.99954113174828796,0.99963,0.953544,0.96982,D,1.19462742128387,0.99497,23.23098,1.09238016298993,0.99747,26.2228,6.11,6.11,0.99131,6.13,0.98113,9.647,0.97855,11.799000,0.96601,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.84,0.39676,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119090213G>A,ClinGen:CA251802|OMIM:609806.0008|UniProtKB:P08397#VAR_003650,C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,16488.0,single nucleotide variant,NM_000190.4(HMBS):c.446G>A (p.Arg149Gln),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 08, 1999",118204098.0,-,RCV000001514,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119090213.0,119090213.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251802,UniProtKB:P08397#VAR_003650,OMIM:609806.0008",1.0,1449.0,119090213.0,G,A,-,-,-,-,-,-,SCV000021669,-,-,446G>A ,Arg149Gln,NM_000190.4,,1_Pathogenic,96.65,0.0524193548387096,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,13,96.65,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,"R149-M212, R149-Q153, R149-D121; PAE: 1.0, 1.0, 1.0",10 interactions,"R149-Q153, R149-A214; PAE: 1.0, 1.0",9 interactions,,7 interactions,175,,-51.7,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",-47.9,,dbSNP: -; Variant type: LP/P; AA change: Arg149Leu; PTM type: Phosphorylation; PTM morphology: VVGTSsLR*RAA; Var class: II&rs118204098,H (helix),H (α-helix),Helix,,,0.06,,0.072,,0.136,1 mutation(s) (Arg149Gly: 0.000),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var218566,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119090213.0,119090213.0,,446,G,A,149.0,R,Q,c.446G>A,p.Arg149Gln,missense_variant,missense_variant,0.003824012,,No,,Pathogenic,no assertion criteria provided,"Oct 08, 1999",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.957,0.9908,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg149Gln,true,Arg149Gln
HMBS_Arg167Gln,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200931,CCSBVarC005165,ALE00005165,NC_000011.10:119091414:G:A,500G>A,Arg167Gln,CEGS2,CegsMutGDEh1037,B10,GDEhDisVCh_40054,F03,2.0,CegsMutGDDh1037,B10,,,,,,,1.0,6.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091414,G,A,11,N,Y,N,N,N,11-119091414-G-A,16485.0,single nucleotide variant,NM_000190.4(HMBS):c.500G>A (p.Arg167Gln),3145.0,HMBS,HGNC:4982,Pathogenic/Likely pathogenic,1.0,"Dec 26, 2024",118204095.0,-,RCV000001511|RCV000520560|RCV003764510|RCV003764509,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related",germline;not applicable;unknown,germline,GRCh38,NC_000011.10,11,119091414.0,119091414.0,11q23.3,"criteria provided, multiple submitters, no conflicts",9.0,-,N,"ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005",3.0,1446.0,119091414.0,G,A,-,-,-,-,-,-,SCV000616739|SCV001132052|SCV001220631|SCV002059538|SCV004099797|SCV004226624,-,-,500G>A ,Arg167Gln,NM_000190.4,2.0,1_Pathogenic,0.0000714944,1446.0,11,119091414.0,G,A,R,Q,rs118204095,11,118962124,11,118467334,167.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.500G>A,p.Arg167Gln,c.500G>A,p.Arg167Gln,principal2,Y,.,YES,Select,+,CGG,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.999,0.92348,D,.,0.97926,.,.,.,.,4.47,0.98862,H,.,0.73719,.,.,0.99270,0.9015,0.95680,D,0.9974,0.99936,D,9,.,0.90053,.,0.570538,0.96108,D,.,0.98488,.,.,.,.,.,.,0.98037,0.9226281451906604,0.92190,.,.,0.690265059471,0.65687,T,0.997348,0.99997,D,0.422159,0.91068,D,0.605294,0.97266,D,0.998139619827271,0.93265,D,0.993042,0.97822,D,0.9738522,0.98584,0.9580932,0.98851,0.9606895,0.97307,0.9386867,0.97647,-13.053,0.89603,D,0.9858,0.92409,P,0.99957541651783,0.97044,0.39117932,0.79368,0.997,0.99892,.,.,.,.,.,.,8.637649,0.97824,38.0,0.99943123104295695,0.99848,0.962367,0.98389,D,1.166860771854,0.99181,21.11462,1.05940119228111,0.99479,23.07704,5.59,5.59,0.84656,5.91,0.96850,9.934,0.98847,11.823000,0.97301,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,20,264690,7.556009E-5,.,3,65048,4.611980e-05,0,7,132592,5.279350e-05,0,5,151816,3.293460e-05,0,0,2860,0.000000e+00,0,1,12384,8.074940e-05,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,0,11472,0.000000e+00,0,1,19468,5.136630e-05,0,0,11442,0.000000e+00,0,1,12384,8.074940e-05,0,1,8700,1.149430e-04,0,1,20684,4.834650e-05,0,0,4756,0.000000e+00,0,0,8792,0.000000e+00,0,0,13488,0.000000e+00,0,4,49812,8.030190e-05,0,0,22780,0.000000e+00,0,1,8700,1.149430e-04,0,1,8160,1.225490e-04,0,1,24652,4.056470e-05,0,0,8326,0.000000e+00,0,0,11040,0.000000e+00,0,0,15362,0.000000e+00,0,2,57210,3.495890e-05,0,0,22768,0.000000e+00,0,1,8160,1.225490e-04,0,.,109,1550946,7.027970e-05,0,99,1146426,8.635530e-05,0,6,73048,8.213780e-05,0,0,910,0.000000e+00,0,2,50986,3.922650e-05,0,0,28652,0.000000e+00,0,1,40942,2.442480e-05,0,0,59880,0.000000e+00,0,0,6008,0.000000e+00,0,99,1146426,8.635530e-05,0,0,84054,0.000000e+00,0,9,25918,3.4724901612778763E-4,0,298,0,0,86,0,0,7864,0,0,146,0,0,610,0,0,26,0,0,98,0,0,2232,0,0,8162,0,0,112,0,9,37278,2.4142926122646064E-4,Pathogenic/Likely_pathogenic,"Encephalopathy,_porphyria-related|Leukoencephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119091414G>A,ClinGen:CA251795|OMIM:609806.0005|UniProtKB:P08397#VAR_003651,CN376852|CN376853|C0162565|C3661900,620704|620711|176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,16485.0,single nucleotide variant,NM_000190.4(HMBS):c.500G>A (p.Arg167Gln),3145.0,HMBS,HGNC:4982,Pathogenic/Likely pathogenic,1.0,"Dec 26, 2024",118204095.0,-,RCV000001511|RCV000520560|RCV003764510|RCV003764509,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related",germline;not applicable;unknown,germline,GRCh38,NC_000011.10,11,119091414.0,119091414.0,11q23.3,"criteria provided, multiple submitters, no conflicts",9.0,-,N,"ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005",3.0,1446.0,119091414.0,G,A,-,-,-,-,-,-,SCV000616739|SCV001132052|SCV001220631|SCV002059538|SCV004099797|SCV004226624,-,-,500G>A ,Arg167Gln,NM_000190.4,2.0,1_Pathogenic,86.83,0.1411290322580645,"['176000', '620711', '620704']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; LEUKOENCEPHALOPATHY, PORPHYRIA-RELATED; ENCEPHALOPATHY, PORPHYRIA-RELATED",R,35,86.83,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,R167-K176; PAE: 1.5,7 interactions,R167-L64; PAE: 8.5,3 interactions,,,175,,-108.5,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",156.7,,,C (loop/coil),C (loop/coil),,,,0.52,,0.546,,0.547,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var212429,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119091414.0,119091414.0,,500,G,A,167.0,R,Q,c.500G>A,p.Arg167Gln,"missense_variant,splice_region_variant",missense_variant,0.72629094,,No,0.000070279687365,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Jun 13, 2024",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.934,0.9858,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg167Gln,true,Arg167Gln
HMBS_Arg167Gln,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200931,CCSBVarC005165,ALE00005165,NC_000011.10:119091414:G:A,500G>A,Arg167Gln,CEGS2,CegsMutGDEh1037,B10,GDEhDisVCh_40054,F03,2.0,CegsMutGDDh1037,B10,,,,,,,1.0,6.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091414,G,A,11,N,Y,N,N,N,11-119091414-G-A,16485.0,single nucleotide variant,NM_000190.4(HMBS):c.500G>A (p.Arg167Gln),3145.0,HMBS,HGNC:4982,Pathogenic/Likely pathogenic,1.0,"Dec 26, 2024",118204095.0,-,RCV000001511|RCV000520560|RCV003764510|RCV003764509,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related",germline;not applicable;unknown,germline,GRCh38,NC_000011.10,11,119091414.0,119091414.0,11q23.3,"criteria provided, multiple submitters, no conflicts",9.0,-,N,"ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005",3.0,1446.0,119091414.0,G,A,-,-,-,-,-,-,SCV000616739|SCV001132052|SCV001220631|SCV002059538|SCV004099797|SCV004226624,-,-,500G>A ,Arg167Gln,NM_000190.4,2.0,1_Pathogenic,0.0000714944,1446.0,11,119091414.0,G,A,R,Q,rs118204095,11,118962124,11,118467334,167.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.500G>A,p.Arg167Gln,c.500G>A,p.Arg167Gln,principal2,Y,.,YES,Select,+,CGG,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.999,0.92348,D,.,0.97926,.,.,.,.,4.47,0.98862,H,.,0.73719,.,.,0.99270,0.9015,0.95680,D,0.9974,0.99936,D,9,.,0.90053,.,0.570538,0.96108,D,.,0.98488,.,.,.,.,.,.,0.98037,0.9226281451906604,0.92190,.,.,0.690265059471,0.65687,T,0.997348,0.99997,D,0.422159,0.91068,D,0.605294,0.97266,D,0.998139619827271,0.93265,D,0.993042,0.97822,D,0.9738522,0.98584,0.9580932,0.98851,0.9606895,0.97307,0.9386867,0.97647,-13.053,0.89603,D,0.9858,0.92409,P,0.99957541651783,0.97044,0.39117932,0.79368,0.997,0.99892,.,.,.,.,.,.,8.637649,0.97824,38.0,0.99943123104295695,0.99848,0.962367,0.98389,D,1.166860771854,0.99181,21.11462,1.05940119228111,0.99479,23.07704,5.59,5.59,0.84656,5.91,0.96850,9.934,0.98847,11.823000,0.97301,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,20,264690,7.556009E-5,.,3,65048,4.611980e-05,0,7,132592,5.279350e-05,0,5,151816,3.293460e-05,0,0,2860,0.000000e+00,0,1,12384,8.074940e-05,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,0,11472,0.000000e+00,0,1,19468,5.136630e-05,0,0,11442,0.000000e+00,0,1,12384,8.074940e-05,0,1,8700,1.149430e-04,0,1,20684,4.834650e-05,0,0,4756,0.000000e+00,0,0,8792,0.000000e+00,0,0,13488,0.000000e+00,0,4,49812,8.030190e-05,0,0,22780,0.000000e+00,0,1,8700,1.149430e-04,0,1,8160,1.225490e-04,0,1,24652,4.056470e-05,0,0,8326,0.000000e+00,0,0,11040,0.000000e+00,0,0,15362,0.000000e+00,0,2,57210,3.495890e-05,0,0,22768,0.000000e+00,0,1,8160,1.225490e-04,0,.,109,1550946,7.027970e-05,0,99,1146426,8.635530e-05,0,6,73048,8.213780e-05,0,0,910,0.000000e+00,0,2,50986,3.922650e-05,0,0,28652,0.000000e+00,0,1,40942,2.442480e-05,0,0,59880,0.000000e+00,0,0,6008,0.000000e+00,0,99,1146426,8.635530e-05,0,0,84054,0.000000e+00,0,9,25918,3.4724901612778763E-4,0,298,0,0,86,0,0,7864,0,0,146,0,0,610,0,0,26,0,0,98,0,0,2232,0,0,8162,0,0,112,0,9,37278,2.4142926122646064E-4,Pathogenic/Likely_pathogenic,"Encephalopathy,_porphyria-related|Leukoencephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119091414G>A,ClinGen:CA251795|OMIM:609806.0005|UniProtKB:P08397#VAR_003651,CN376852|CN376853|C0162565|C3661900,620704|620711|176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,16485.0,single nucleotide variant,NM_000190.4(HMBS):c.500G>A (p.Arg167Gln),3145.0,HMBS,HGNC:4982,Pathogenic/Likely pathogenic,1.0,"Dec 26, 2024",118204095.0,-,RCV000001511|RCV000520560|RCV003764510|RCV003764509,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related",germline;not applicable;unknown,germline,GRCh38,NC_000011.10,11,119091414.0,119091414.0,11q23.3,"criteria provided, multiple submitters, no conflicts",9.0,-,N,"ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005",3.0,1446.0,119091414.0,G,A,-,-,-,-,-,-,SCV000616739|SCV001132052|SCV001220631|SCV002059538|SCV004099797|SCV004226624,-,-,500G>A ,Arg167Gln,NM_000190.4,2.0,1_Pathogenic,86.83,0.1411290322580645,"['176000', '620711', '620704']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; LEUKOENCEPHALOPATHY, PORPHYRIA-RELATED; ENCEPHALOPATHY, PORPHYRIA-RELATED",R,35,86.83,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,R167-K176; PAE: 1.5,7 interactions,R167-L64; PAE: 8.5,3 interactions,,,175,,-108.5,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",156.7,,,C (loop/coil),C (loop/coil),,,,0.52,,0.546,,0.547,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var205507,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119091414.0,119091414.0,,500,G,A,167.0,R,Q,c.500G>A,p.Arg167Gln,"missense_variant,splice_region_variant",missense_variant,0.7501873659999999,,No,0.000070279687365,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Jun 13, 2024",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.934,0.9858,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg167Gln,true,Arg167Gln
HMBS_Arg167Gln,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200931,CCSBVarC005165,ALE00005165,NC_000011.10:119091414:G:A,500G>A,Arg167Gln,CEGS2,CegsMutGDEh1037,B10,GDEhDisVCh_40054,F03,2.0,CegsMutGDDh1037,B10,,,,,,,1.0,6.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091414,G,A,11,N,Y,N,N,N,11-119091414-G-A,16485.0,single nucleotide variant,NM_000190.4(HMBS):c.500G>A (p.Arg167Gln),3145.0,HMBS,HGNC:4982,Pathogenic/Likely pathogenic,1.0,"Dec 26, 2024",118204095.0,-,RCV000001511|RCV000520560|RCV003764510|RCV003764509,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related",germline;not applicable;unknown,germline,GRCh38,NC_000011.10,11,119091414.0,119091414.0,11q23.3,"criteria provided, multiple submitters, no conflicts",9.0,-,N,"ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005",3.0,1446.0,119091414.0,G,A,-,-,-,-,-,-,SCV000616739|SCV001132052|SCV001220631|SCV002059538|SCV004099797|SCV004226624,-,-,500G>A ,Arg167Gln,NM_000190.4,2.0,1_Pathogenic,0.0000714944,1446.0,11,119091414.0,G,A,R,Q,rs118204095,11,118962124,11,118467334,167.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.500G>A,p.Arg167Gln,c.500G>A,p.Arg167Gln,principal2,Y,.,YES,Select,+,CGG,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.999,0.92348,D,.,0.97926,.,.,.,.,4.47,0.98862,H,.,0.73719,.,.,0.99270,0.9015,0.95680,D,0.9974,0.99936,D,9,.,0.90053,.,0.570538,0.96108,D,.,0.98488,.,.,.,.,.,.,0.98037,0.9226281451906604,0.92190,.,.,0.690265059471,0.65687,T,0.997348,0.99997,D,0.422159,0.91068,D,0.605294,0.97266,D,0.998139619827271,0.93265,D,0.993042,0.97822,D,0.9738522,0.98584,0.9580932,0.98851,0.9606895,0.97307,0.9386867,0.97647,-13.053,0.89603,D,0.9858,0.92409,P,0.99957541651783,0.97044,0.39117932,0.79368,0.997,0.99892,.,.,.,.,.,.,8.637649,0.97824,38.0,0.99943123104295695,0.99848,0.962367,0.98389,D,1.166860771854,0.99181,21.11462,1.05940119228111,0.99479,23.07704,5.59,5.59,0.84656,5.91,0.96850,9.934,0.98847,11.823000,0.97301,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,20,264690,7.556009E-5,.,3,65048,4.611980e-05,0,7,132592,5.279350e-05,0,5,151816,3.293460e-05,0,0,2860,0.000000e+00,0,1,12384,8.074940e-05,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,0,11472,0.000000e+00,0,1,19468,5.136630e-05,0,0,11442,0.000000e+00,0,1,12384,8.074940e-05,0,1,8700,1.149430e-04,0,1,20684,4.834650e-05,0,0,4756,0.000000e+00,0,0,8792,0.000000e+00,0,0,13488,0.000000e+00,0,4,49812,8.030190e-05,0,0,22780,0.000000e+00,0,1,8700,1.149430e-04,0,1,8160,1.225490e-04,0,1,24652,4.056470e-05,0,0,8326,0.000000e+00,0,0,11040,0.000000e+00,0,0,15362,0.000000e+00,0,2,57210,3.495890e-05,0,0,22768,0.000000e+00,0,1,8160,1.225490e-04,0,.,109,1550946,7.027970e-05,0,99,1146426,8.635530e-05,0,6,73048,8.213780e-05,0,0,910,0.000000e+00,0,2,50986,3.922650e-05,0,0,28652,0.000000e+00,0,1,40942,2.442480e-05,0,0,59880,0.000000e+00,0,0,6008,0.000000e+00,0,99,1146426,8.635530e-05,0,0,84054,0.000000e+00,0,9,25918,3.4724901612778763E-4,0,298,0,0,86,0,0,7864,0,0,146,0,0,610,0,0,26,0,0,98,0,0,2232,0,0,8162,0,0,112,0,9,37278,2.4142926122646064E-4,Pathogenic/Likely_pathogenic,"Encephalopathy,_porphyria-related|Leukoencephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119091414G>A,ClinGen:CA251795|OMIM:609806.0005|UniProtKB:P08397#VAR_003651,CN376852|CN376853|C0162565|C3661900,620704|620711|176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,16485.0,single nucleotide variant,NM_000190.4(HMBS):c.500G>A (p.Arg167Gln),3145.0,HMBS,HGNC:4982,Pathogenic/Likely pathogenic,1.0,"Dec 26, 2024",118204095.0,-,RCV000001511|RCV000520560|RCV003764510|RCV003764509,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related",germline;not applicable;unknown,germline,GRCh38,NC_000011.10,11,119091414.0,119091414.0,11q23.3,"criteria provided, multiple submitters, no conflicts",9.0,-,N,"ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005",3.0,1446.0,119091414.0,G,A,-,-,-,-,-,-,SCV000616739|SCV001132052|SCV001220631|SCV002059538|SCV004099797|SCV004226624,-,-,500G>A ,Arg167Gln,NM_000190.4,2.0,1_Pathogenic,86.83,0.1411290322580645,"['176000', '620711', '620704']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; LEUKOENCEPHALOPATHY, PORPHYRIA-RELATED; ENCEPHALOPATHY, PORPHYRIA-RELATED",R,35,86.83,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,R167-K176; PAE: 1.5,7 interactions,R167-L64; PAE: 8.5,3 interactions,,,175,,-108.5,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",156.7,,,C (loop/coil),C (loop/coil),,,,0.52,,0.546,,0.547,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var218541,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119091414.0,119091414.0,,500,G,A,167.0,R,Q,c.500G>A,p.Arg167Gln,"missense_variant,splice_region_variant",missense_variant,0.7325651559999999,,No,0.000070279687365,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Jun 13, 2024",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.934,0.9858,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg167Gln,true,Arg167Gln
HMBS_Arg167Trp,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200933,CCSBVarC005164,ALE00005164,NC_000011.10:119091413:C:T,499C>T,Arg167Trp,CEGS2,CegsMutGDEh1040,B05,GDEhDisVCh_40054,E05,2.0,CegsMutGDDh1040,B05,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091413,C,T,11,Y,Y,N,N,N,11-119091413-C-T,16495.0,single nucleotide variant,NM_000190.4(HMBS):c.499C>T (p.Arg167Trp),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 23, 2024",118204101.0,-,RCV000001521|RCV000489906|RCV003764512,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119091413.0,119091413.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,"ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013",3.0,1456.0,119091413.0,C,T,-,-,-,-,-,-,SCV000577609|SCV000944323|SCV003822772,-,-,499C>T ,Arg167Trp,NM_000190.4,2.0,1_Pathogenic,0.0000178827,1456.0,11,119091413.0,C,T,R,W,rs118204101,11,118962123,11,118467333,167.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.499C>T,p.Arg167Trp,c.499C>T,p.Arg167Trp,principal2,Y,.,YES,Select,+,CGG,1.0,2.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.99291,.,.,.,.,4.47,0.98862,H,.,0.95993,.,.,0.99781,0.9220,0.95974,D,0.9969,0.99925,D,8,.,0.99183,.,0.63732,0.96895,D,.,0.98815,0.935,0.99041,P08397,R167W,Loss of disorder (P = 0.005)| Loss of phosphorylation at S165 (P = 0.0626)| Loss of catalytic residue at R167 (P = 0.0698)| Loss of methylation at R167 (P = 0.0968)| Loss of MoRF binding (P = 0.1082),.,0.98805,0.9452538033324966,0.94473,.,.,0.799257516861,0.81818,T,0.996766,0.99996,D,0.466542,0.93148,D,0.554924,0.95729,D,0.9987753033638,0.95085,D,0.968103,0.88633,D,0.95707107,0.96936,0.9364312,0.97495,0.9548803,0.96710,0.9486082,0.98289,-14.152,0.93771,D,0.9678,0.89069,P,0.999562839962743,0.97008,0.36574966,0.78714,0.997,0.99892,.,.,.,.,.,.,5.272347,0.88542,29.6,0.99915589236646773,0.98380,0.850988,0.76698,D,0.730269790374957,0.81518,7.564326,0.566952235508211,0.72434,5.833057,5.59,2.46,0.28956,3.52,0.63825,2.499,0.45133,0.815000,0.21873,0.599,0.40292,1.0,0.71675,0.999000,0.35501,0.991,0.66489,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,3,264690,1.1334013E-5,.,3,65048,4.611980e-05,0,6,132592,4.525160e-05,0,6,151818,3.952100e-05,0,0,2858,0.000000e+00,0,1,12384,8.074940e-05,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,2,11472,1.743380e-04,0,0,19468,0.000000e+00,0,0,11444,0.000000e+00,0,1,12384,8.074940e-05,0,0,8702,0.000000e+00,0,1,20684,4.834650e-05,0,0,4758,0.000000e+00,0,0,8792,0.000000e+00,0,3,13484,2.224860e-04,0,2,49808,4.015420e-05,0,0,22782,0.000000e+00,0,1,20684,4.834650e-05,0,0,8160,0.000000e+00,0,1,24652,4.056470e-05,0,0,8322,0.000000e+00,0,0,11040,0.000000e+00,0,3,15358,1.953380e-04,0,2,57218,3.495400e-05,0,0,22770,0.000000e+00,0,1,24652,4.056470e-05,0,.,25,1550366,1.612520e-05,0,6,59884,1.001940e-04,0,0,73154,0.000000e+00,0,0,912,0.000000e+00,0,1,51008,1.960480e-05,0,0,28650,0.000000e+00,0,0,40920,0.000000e+00,0,6,59884,1.001940e-04,0,0,5990,0.000000e+00,0,14,1145742,1.221920e-05,0,0,84046,0.000000e+00,0,1,15830,6.317119393556538E-5,0,122,0,0,146,0,0,3804,0,0,146,0,0,610,0,0,56,0,0,104,0,1,2880,3.4722222222222224E-4,0,3926,0,0,202,0,2,23698,8.439530762089628E-5,Pathogenic,"Encephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119091413C>T,ClinGen:CA251813|OMIM:609806.0013|UniProtKB:P08397#VAR_003652,CN376852|C0162565|C3661900,620704|176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Trp,16495.0,single nucleotide variant,NM_000190.4(HMBS):c.499C>T (p.Arg167Trp),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 23, 2024",118204101.0,-,RCV000001521|RCV000489906|RCV003764512,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119091413.0,119091413.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,"ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013",3.0,1456.0,119091413.0,C,T,-,-,-,-,-,-,SCV000577609|SCV000944323|SCV003822772,-,-,499C>T ,Arg167Trp,NM_000190.4,2.0,1_Pathogenic,86.83,0.1411290322580645,"['176000', '620704']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; ENCEPHALOPATHY, PORPHYRIA-RELATED",R,35,86.83,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,R167-K176; PAE: 1.5,7 interactions,R167-L64; PAE: 8.5,3 interactions,,,175,,-108.5,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",156.7,,,C (loop/coil),C (loop/coil),,,,0.52,,0.546,,0.547,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var212416,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119091413.0,119091413.0,,499,C,T,167.0,R,W,c.499C>T,p.Arg167Trp,"missense_variant,splice_region_variant",missense_variant,0.519182568,,No,0.0000161252246243,Pathogenic,"criteria provided, multiple submitters, no conflicts","Oct 06, 2023",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.943,0.9678,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg167Trp,true,Arg167Trp
HMBS_Arg167Trp,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200933,CCSBVarC005164,ALE00005164,NC_000011.10:119091413:C:T,499C>T,Arg167Trp,CEGS2,CegsMutGDEh1040,B05,GDEhDisVCh_40054,E05,2.0,CegsMutGDDh1040,B05,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091413,C,T,11,Y,Y,N,N,N,11-119091413-C-T,16495.0,single nucleotide variant,NM_000190.4(HMBS):c.499C>T (p.Arg167Trp),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 23, 2024",118204101.0,-,RCV000001521|RCV000489906|RCV003764512,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119091413.0,119091413.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,"ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013",3.0,1456.0,119091413.0,C,T,-,-,-,-,-,-,SCV000577609|SCV000944323|SCV003822772,-,-,499C>T ,Arg167Trp,NM_000190.4,2.0,1_Pathogenic,0.0000178827,1456.0,11,119091413.0,C,T,R,W,rs118204101,11,118962123,11,118467333,167.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.499C>T,p.Arg167Trp,c.499C>T,p.Arg167Trp,principal2,Y,.,YES,Select,+,CGG,1.0,2.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.99291,.,.,.,.,4.47,0.98862,H,.,0.95993,.,.,0.99781,0.9220,0.95974,D,0.9969,0.99925,D,8,.,0.99183,.,0.63732,0.96895,D,.,0.98815,0.935,0.99041,P08397,R167W,Loss of disorder (P = 0.005)| Loss of phosphorylation at S165 (P = 0.0626)| Loss of catalytic residue at R167 (P = 0.0698)| Loss of methylation at R167 (P = 0.0968)| Loss of MoRF binding (P = 0.1082),.,0.98805,0.9452538033324966,0.94473,.,.,0.799257516861,0.81818,T,0.996766,0.99996,D,0.466542,0.93148,D,0.554924,0.95729,D,0.9987753033638,0.95085,D,0.968103,0.88633,D,0.95707107,0.96936,0.9364312,0.97495,0.9548803,0.96710,0.9486082,0.98289,-14.152,0.93771,D,0.9678,0.89069,P,0.999562839962743,0.97008,0.36574966,0.78714,0.997,0.99892,.,.,.,.,.,.,5.272347,0.88542,29.6,0.99915589236646773,0.98380,0.850988,0.76698,D,0.730269790374957,0.81518,7.564326,0.566952235508211,0.72434,5.833057,5.59,2.46,0.28956,3.52,0.63825,2.499,0.45133,0.815000,0.21873,0.599,0.40292,1.0,0.71675,0.999000,0.35501,0.991,0.66489,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,3,264690,1.1334013E-5,.,3,65048,4.611980e-05,0,6,132592,4.525160e-05,0,6,151818,3.952100e-05,0,0,2858,0.000000e+00,0,1,12384,8.074940e-05,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,2,11472,1.743380e-04,0,0,19468,0.000000e+00,0,0,11444,0.000000e+00,0,1,12384,8.074940e-05,0,0,8702,0.000000e+00,0,1,20684,4.834650e-05,0,0,4758,0.000000e+00,0,0,8792,0.000000e+00,0,3,13484,2.224860e-04,0,2,49808,4.015420e-05,0,0,22782,0.000000e+00,0,1,20684,4.834650e-05,0,0,8160,0.000000e+00,0,1,24652,4.056470e-05,0,0,8322,0.000000e+00,0,0,11040,0.000000e+00,0,3,15358,1.953380e-04,0,2,57218,3.495400e-05,0,0,22770,0.000000e+00,0,1,24652,4.056470e-05,0,.,25,1550366,1.612520e-05,0,6,59884,1.001940e-04,0,0,73154,0.000000e+00,0,0,912,0.000000e+00,0,1,51008,1.960480e-05,0,0,28650,0.000000e+00,0,0,40920,0.000000e+00,0,6,59884,1.001940e-04,0,0,5990,0.000000e+00,0,14,1145742,1.221920e-05,0,0,84046,0.000000e+00,0,1,15830,6.317119393556538E-5,0,122,0,0,146,0,0,3804,0,0,146,0,0,610,0,0,56,0,0,104,0,1,2880,3.4722222222222224E-4,0,3926,0,0,202,0,2,23698,8.439530762089628E-5,Pathogenic,"Encephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119091413C>T,ClinGen:CA251813|OMIM:609806.0013|UniProtKB:P08397#VAR_003652,CN376852|C0162565|C3661900,620704|176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Trp,16495.0,single nucleotide variant,NM_000190.4(HMBS):c.499C>T (p.Arg167Trp),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 23, 2024",118204101.0,-,RCV000001521|RCV000489906|RCV003764512,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119091413.0,119091413.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,"ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013",3.0,1456.0,119091413.0,C,T,-,-,-,-,-,-,SCV000577609|SCV000944323|SCV003822772,-,-,499C>T ,Arg167Trp,NM_000190.4,2.0,1_Pathogenic,86.83,0.1411290322580645,"['176000', '620704']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; ENCEPHALOPATHY, PORPHYRIA-RELATED",R,35,86.83,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,R167-K176; PAE: 1.5,7 interactions,R167-L64; PAE: 8.5,3 interactions,,,175,,-108.5,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",156.7,,,C (loop/coil),C (loop/coil),,,,0.52,,0.546,,0.547,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var205494,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119091413.0,119091413.0,,499,C,T,167.0,R,W,c.499C>T,p.Arg167Trp,"missense_variant,splice_region_variant",missense_variant,0.575834133,,No,0.0000161252246243,Pathogenic,"criteria provided, multiple submitters, no conflicts","Oct 06, 2023",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.943,0.9678,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg167Trp,true,Arg167Trp
HMBS_Arg167Trp,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200933,CCSBVarC005164,ALE00005164,NC_000011.10:119091413:C:T,499C>T,Arg167Trp,CEGS2,CegsMutGDEh1040,B05,GDEhDisVCh_40054,E05,2.0,CegsMutGDDh1040,B05,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091413,C,T,11,Y,Y,N,N,N,11-119091413-C-T,16495.0,single nucleotide variant,NM_000190.4(HMBS):c.499C>T (p.Arg167Trp),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 23, 2024",118204101.0,-,RCV000001521|RCV000489906|RCV003764512,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119091413.0,119091413.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,"ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013",3.0,1456.0,119091413.0,C,T,-,-,-,-,-,-,SCV000577609|SCV000944323|SCV003822772,-,-,499C>T ,Arg167Trp,NM_000190.4,2.0,1_Pathogenic,0.0000178827,1456.0,11,119091413.0,C,T,R,W,rs118204101,11,118962123,11,118467333,167.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.499C>T,p.Arg167Trp,c.499C>T,p.Arg167Trp,principal2,Y,.,YES,Select,+,CGG,1.0,2.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.99291,.,.,.,.,4.47,0.98862,H,.,0.95993,.,.,0.99781,0.9220,0.95974,D,0.9969,0.99925,D,8,.,0.99183,.,0.63732,0.96895,D,.,0.98815,0.935,0.99041,P08397,R167W,Loss of disorder (P = 0.005)| Loss of phosphorylation at S165 (P = 0.0626)| Loss of catalytic residue at R167 (P = 0.0698)| Loss of methylation at R167 (P = 0.0968)| Loss of MoRF binding (P = 0.1082),.,0.98805,0.9452538033324966,0.94473,.,.,0.799257516861,0.81818,T,0.996766,0.99996,D,0.466542,0.93148,D,0.554924,0.95729,D,0.9987753033638,0.95085,D,0.968103,0.88633,D,0.95707107,0.96936,0.9364312,0.97495,0.9548803,0.96710,0.9486082,0.98289,-14.152,0.93771,D,0.9678,0.89069,P,0.999562839962743,0.97008,0.36574966,0.78714,0.997,0.99892,.,.,.,.,.,.,5.272347,0.88542,29.6,0.99915589236646773,0.98380,0.850988,0.76698,D,0.730269790374957,0.81518,7.564326,0.566952235508211,0.72434,5.833057,5.59,2.46,0.28956,3.52,0.63825,2.499,0.45133,0.815000,0.21873,0.599,0.40292,1.0,0.71675,0.999000,0.35501,0.991,0.66489,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,3,264690,1.1334013E-5,.,3,65048,4.611980e-05,0,6,132592,4.525160e-05,0,6,151818,3.952100e-05,0,0,2858,0.000000e+00,0,1,12384,8.074940e-05,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,2,11472,1.743380e-04,0,0,19468,0.000000e+00,0,0,11444,0.000000e+00,0,1,12384,8.074940e-05,0,0,8702,0.000000e+00,0,1,20684,4.834650e-05,0,0,4758,0.000000e+00,0,0,8792,0.000000e+00,0,3,13484,2.224860e-04,0,2,49808,4.015420e-05,0,0,22782,0.000000e+00,0,1,20684,4.834650e-05,0,0,8160,0.000000e+00,0,1,24652,4.056470e-05,0,0,8322,0.000000e+00,0,0,11040,0.000000e+00,0,3,15358,1.953380e-04,0,2,57218,3.495400e-05,0,0,22770,0.000000e+00,0,1,24652,4.056470e-05,0,.,25,1550366,1.612520e-05,0,6,59884,1.001940e-04,0,0,73154,0.000000e+00,0,0,912,0.000000e+00,0,1,51008,1.960480e-05,0,0,28650,0.000000e+00,0,0,40920,0.000000e+00,0,6,59884,1.001940e-04,0,0,5990,0.000000e+00,0,14,1145742,1.221920e-05,0,0,84046,0.000000e+00,0,1,15830,6.317119393556538E-5,0,122,0,0,146,0,0,3804,0,0,146,0,0,610,0,0,56,0,0,104,0,1,2880,3.4722222222222224E-4,0,3926,0,0,202,0,2,23698,8.439530762089628E-5,Pathogenic,"Encephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119091413C>T,ClinGen:CA251813|OMIM:609806.0013|UniProtKB:P08397#VAR_003652,CN376852|C0162565|C3661900,620704|176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Trp,16495.0,single nucleotide variant,NM_000190.4(HMBS):c.499C>T (p.Arg167Trp),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 23, 2024",118204101.0,-,RCV000001521|RCV000489906|RCV003764512,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119091413.0,119091413.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,"ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013",3.0,1456.0,119091413.0,C,T,-,-,-,-,-,-,SCV000577609|SCV000944323|SCV003822772,-,-,499C>T ,Arg167Trp,NM_000190.4,2.0,1_Pathogenic,86.83,0.1411290322580645,"['176000', '620704']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; ENCEPHALOPATHY, PORPHYRIA-RELATED",R,35,86.83,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,R167-K176; PAE: 1.5,7 interactions,R167-L64; PAE: 8.5,3 interactions,,,175,,-108.5,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",156.7,,,C (loop/coil),C (loop/coil),,,,0.52,,0.546,,0.547,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var218528,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119091413.0,119091413.0,,499,C,T,167.0,R,W,c.499C>T,p.Arg167Trp,"missense_variant,splice_region_variant",missense_variant,0.522313858,,No,0.0000161252246243,Pathogenic,"criteria provided, multiple submitters, no conflicts","Oct 06, 2023",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.943,0.9678,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg167Trp,true,Arg167Trp
HMBS_Arg195Cys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200936,CCSBVarC005168,ALE00005168,NC_000011.10:119091497:C:T,583C>T,Arg195Cys,CEGS2,CegsMutGDEh1045,E06,GDEhDisVCh_40054,E08,2.0,CegsMutGDDh1045,E06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091497,C,T,11,Y,Y,N,N,N,11-119091497-C-T,171129.0,single nucleotide variant,NM_000190.4(HMBS):c.583C>T (p.Arg195Cys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 30, 2024",34413634.0,-,RCV000148509|RCV001041963,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091497.0,119091497.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"ClinGen:CA272877,UniProtKB:P08397#VAR_003656",2.0,161251.0,119091497.0,C,T,-,-,-,-,-,-,SCV001205617,-,-,583C>T ,Arg195Cys,NM_000190.4,1.0,1_Pathogenic,4.2883e-6,161251.0,11,119091497.0,C,T,R,C,rs34413634,11,118962207,11,118467417,195.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.583C>T,p.Arg195Cys,c.583C>T,p.Arg195Cys,principal2,Y,.,YES,Select,+,CGC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.97926,.,.,.,.,4.465,0.98846,H,.,0.96074,.,.,0.96886,0.9224,0.95980,D,0.9971,0.99930,D,10,.,0.95335,.,0.611225,0.96601,D,.,0.97318,.,.,.,.,.,.,0.98045,0.9703382934487912,0.97005,.,.,0.672052979469,0.63070,T,0.99727,0.99997,D,0.550346,0.95766,D,0.552757,0.95703,D,0.9998539686203,0.99358,D,0.999706,0.99911,D,0.98425967,0.99407,0.93367016,0.97307,0.9818209,0.99233,0.9470098,0.98190,-11.377,0.81998,D,0.9561,0.92535,P,0.999529425028906,0.96869,0.47329053,0.81303,0.992,0.99727,.,.,.,.,.,.,5.776933,0.93514,33.0,0.99929786013626687,0.99279,0.821829,0.74135,D,1.00511884949098,0.95876,14.08343,0.900425950493327,0.95567,13.76994,5.96,5.96,0.96689,.,.,2.357,0.43881,7.650000,0.63706,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,2,264690,7.5560088E-6,.,0,65032,0.000000e+00,0,1,132486,7.547970e-06,0,0,151810,0.000000e+00,0,0,2852,0.000000e+00,0,0,12384,0.000000e+00,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,0,11468,0.000000e+00,0,0,19462,0.000000e+00,0,0,11444,0.000000e+00,0,.,.,.,.,0,8682,0.000000e+00,0,0,20684,0.000000e+00,0,0,4754,0.000000e+00,0,0,8792,0.000000e+00,0,0,13480,0.000000e+00,0,1,49728,2.010940e-05,0,0,22782,0.000000e+00,0,1,49728,2.010940e-05,0,0,8152,0.000000e+00,0,0,24654,0.000000e+00,0,0,8328,0.000000e+00,0,0,11040,0.000000e+00,0,0,15350,0.000000e+00,0,0,57216,0.000000e+00,0,0,22772,0.000000e+00,0,.,.,.,.,.,7,1551406,4.512040e-06,0,7,1146816,6.103860e-06,0,0,73056,0.000000e+00,0,0,912,0.000000e+00,0,0,50992,0.000000e+00,0,0,28652,0.000000e+00,0,0,40940,0.000000e+00,0,0,59870,0.000000e+00,0,0,6014,0.000000e+00,0,7,1146816,6.103860e-06,0,0,84070,0.000000e+00,0,1,37010,2.7019724398811132E-5,0,150,0,0,352,0,1,3854,2.594706798131811E-4,0,852,0,0,820,0,0,60,0,0,142,0,0,4746,0,1,4004,2.4975024975024975E-4,0,412,0,2,47986,4.167882299003876E-5,Pathogenic,not_provided|Acute_intermittent_porphyria,"criteria_provided,_single_submitter",NC_000011.10:g.119091497C>T,ClinGen:CA272877|UniProtKB:P08397#VAR_003656,C3661900|C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Cys,171129.0,single nucleotide variant,NM_000190.4(HMBS):c.583C>T (p.Arg195Cys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 30, 2024",34413634.0,-,RCV000148509|RCV001041963,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091497.0,119091497.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"ClinGen:CA272877,UniProtKB:P08397#VAR_003656",2.0,161251.0,119091497.0,C,T,-,-,-,-,-,-,SCV001205617,-,-,583C>T ,Arg195Cys,NM_000190.4,1.0,1_Pathogenic,97.47,0.1330645161290322,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,33,97.47,Positively-charged,Arginine,Porphobilinogen deaminase,,,-4.5,,1 interaction,"R195-G218, R195-E117, R195-A191; PAE: 1.0, 1.5, 1.0",9 interactions,"R195-Q34, R195-A191; PAE: 1.0, 1.0",9 interactions,,4 interactions,175,Mutation: R -> A. Loss of hydroxymethylbilane synthase activity.,-57.2,,,-37.5,,,H (helix),H (α-helix),Helix,,,0.246,,0.275,,0.302,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var205883,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119091497.0,119091497.0,,583,C,T,195.0,R,C,c.583C>T,p.Arg195Cys,missense_variant,missense_variant,0.536989523,,No,4.5120361787e-6,Pathogenic,"criteria provided, single submitter","Feb 03, 2023",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.903,0.9561,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg195Cys,true,Arg195Cys
HMBS_Arg195Cys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200936,CCSBVarC005168,ALE00005168,NC_000011.10:119091497:C:T,583C>T,Arg195Cys,CEGS2,CegsMutGDEh1045,E06,GDEhDisVCh_40054,E08,2.0,CegsMutGDDh1045,E06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091497,C,T,11,Y,Y,N,N,N,11-119091497-C-T,171129.0,single nucleotide variant,NM_000190.4(HMBS):c.583C>T (p.Arg195Cys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 30, 2024",34413634.0,-,RCV000148509|RCV001041963,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091497.0,119091497.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"ClinGen:CA272877,UniProtKB:P08397#VAR_003656",2.0,161251.0,119091497.0,C,T,-,-,-,-,-,-,SCV001205617,-,-,583C>T ,Arg195Cys,NM_000190.4,1.0,1_Pathogenic,4.2883e-6,161251.0,11,119091497.0,C,T,R,C,rs34413634,11,118962207,11,118467417,195.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.583C>T,p.Arg195Cys,c.583C>T,p.Arg195Cys,principal2,Y,.,YES,Select,+,CGC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.97926,.,.,.,.,4.465,0.98846,H,.,0.96074,.,.,0.96886,0.9224,0.95980,D,0.9971,0.99930,D,10,.,0.95335,.,0.611225,0.96601,D,.,0.97318,.,.,.,.,.,.,0.98045,0.9703382934487912,0.97005,.,.,0.672052979469,0.63070,T,0.99727,0.99997,D,0.550346,0.95766,D,0.552757,0.95703,D,0.9998539686203,0.99358,D,0.999706,0.99911,D,0.98425967,0.99407,0.93367016,0.97307,0.9818209,0.99233,0.9470098,0.98190,-11.377,0.81998,D,0.9561,0.92535,P,0.999529425028906,0.96869,0.47329053,0.81303,0.992,0.99727,.,.,.,.,.,.,5.776933,0.93514,33.0,0.99929786013626687,0.99279,0.821829,0.74135,D,1.00511884949098,0.95876,14.08343,0.900425950493327,0.95567,13.76994,5.96,5.96,0.96689,.,.,2.357,0.43881,7.650000,0.63706,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,2,264690,7.5560088E-6,.,0,65032,0.000000e+00,0,1,132486,7.547970e-06,0,0,151810,0.000000e+00,0,0,2852,0.000000e+00,0,0,12384,0.000000e+00,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,0,11468,0.000000e+00,0,0,19462,0.000000e+00,0,0,11444,0.000000e+00,0,.,.,.,.,0,8682,0.000000e+00,0,0,20684,0.000000e+00,0,0,4754,0.000000e+00,0,0,8792,0.000000e+00,0,0,13480,0.000000e+00,0,1,49728,2.010940e-05,0,0,22782,0.000000e+00,0,1,49728,2.010940e-05,0,0,8152,0.000000e+00,0,0,24654,0.000000e+00,0,0,8328,0.000000e+00,0,0,11040,0.000000e+00,0,0,15350,0.000000e+00,0,0,57216,0.000000e+00,0,0,22772,0.000000e+00,0,.,.,.,.,.,7,1551406,4.512040e-06,0,7,1146816,6.103860e-06,0,0,73056,0.000000e+00,0,0,912,0.000000e+00,0,0,50992,0.000000e+00,0,0,28652,0.000000e+00,0,0,40940,0.000000e+00,0,0,59870,0.000000e+00,0,0,6014,0.000000e+00,0,7,1146816,6.103860e-06,0,0,84070,0.000000e+00,0,1,37010,2.7019724398811132E-5,0,150,0,0,352,0,1,3854,2.594706798131811E-4,0,852,0,0,820,0,0,60,0,0,142,0,0,4746,0,1,4004,2.4975024975024975E-4,0,412,0,2,47986,4.167882299003876E-5,Pathogenic,not_provided|Acute_intermittent_porphyria,"criteria_provided,_single_submitter",NC_000011.10:g.119091497C>T,ClinGen:CA272877|UniProtKB:P08397#VAR_003656,C3661900|C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Cys,171129.0,single nucleotide variant,NM_000190.4(HMBS):c.583C>T (p.Arg195Cys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 30, 2024",34413634.0,-,RCV000148509|RCV001041963,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091497.0,119091497.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"ClinGen:CA272877,UniProtKB:P08397#VAR_003656",2.0,161251.0,119091497.0,C,T,-,-,-,-,-,-,SCV001205617,-,-,583C>T ,Arg195Cys,NM_000190.4,1.0,1_Pathogenic,97.47,0.1330645161290322,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,33,97.47,Positively-charged,Arginine,Porphobilinogen deaminase,,,-4.5,,1 interaction,"R195-G218, R195-E117, R195-A191; PAE: 1.0, 1.5, 1.0",9 interactions,"R195-Q34, R195-A191; PAE: 1.0, 1.0",9 interactions,,4 interactions,175,Mutation: R -> A. Loss of hydroxymethylbilane synthase activity.,-57.2,,,-37.5,,,H (helix),H (α-helix),Helix,,,0.246,,0.275,,0.302,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var211935,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119091497.0,119091497.0,,583,C,T,195.0,R,C,c.583C>T,p.Arg195Cys,missense_variant,missense_variant,0.148733865,,No,4.5120361787e-6,Pathogenic,"criteria provided, single submitter","Feb 03, 2023",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.903,0.9561,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg195Cys,true,Arg195Cys
HMBS_Arg195Cys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200936,CCSBVarC005168,ALE00005168,NC_000011.10:119091497:C:T,583C>T,Arg195Cys,CEGS2,CegsMutGDEh1045,E06,GDEhDisVCh_40054,E08,2.0,CegsMutGDDh1045,E06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119091497,C,T,11,Y,Y,N,N,N,11-119091497-C-T,171129.0,single nucleotide variant,NM_000190.4(HMBS):c.583C>T (p.Arg195Cys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 30, 2024",34413634.0,-,RCV000148509|RCV001041963,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091497.0,119091497.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"ClinGen:CA272877,UniProtKB:P08397#VAR_003656",2.0,161251.0,119091497.0,C,T,-,-,-,-,-,-,SCV001205617,-,-,583C>T ,Arg195Cys,NM_000190.4,1.0,1_Pathogenic,4.2883e-6,161251.0,11,119091497.0,C,T,R,C,rs34413634,11,118962207,11,118467417,195.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.583C>T,p.Arg195Cys,c.583C>T,p.Arg195Cys,principal2,Y,.,YES,Select,+,CGC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.97926,.,.,.,.,4.465,0.98846,H,.,0.96074,.,.,0.96886,0.9224,0.95980,D,0.9971,0.99930,D,10,.,0.95335,.,0.611225,0.96601,D,.,0.97318,.,.,.,.,.,.,0.98045,0.9703382934487912,0.97005,.,.,0.672052979469,0.63070,T,0.99727,0.99997,D,0.550346,0.95766,D,0.552757,0.95703,D,0.9998539686203,0.99358,D,0.999706,0.99911,D,0.98425967,0.99407,0.93367016,0.97307,0.9818209,0.99233,0.9470098,0.98190,-11.377,0.81998,D,0.9561,0.92535,P,0.999529425028906,0.96869,0.47329053,0.81303,0.992,0.99727,.,.,.,.,.,.,5.776933,0.93514,33.0,0.99929786013626687,0.99279,0.821829,0.74135,D,1.00511884949098,0.95876,14.08343,0.900425950493327,0.95567,13.76994,5.96,5.96,0.96689,.,.,2.357,0.43881,7.650000,0.63706,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,2,264690,7.5560088E-6,.,0,65032,0.000000e+00,0,1,132486,7.547970e-06,0,0,151810,0.000000e+00,0,0,2852,0.000000e+00,0,0,12384,0.000000e+00,0,0,1454,0.000000e+00,0,0,4604,0.000000e+00,0,0,11468,0.000000e+00,0,0,19462,0.000000e+00,0,0,11444,0.000000e+00,0,.,.,.,.,0,8682,0.000000e+00,0,0,20684,0.000000e+00,0,0,4754,0.000000e+00,0,0,8792,0.000000e+00,0,0,13480,0.000000e+00,0,1,49728,2.010940e-05,0,0,22782,0.000000e+00,0,1,49728,2.010940e-05,0,0,8152,0.000000e+00,0,0,24654,0.000000e+00,0,0,8328,0.000000e+00,0,0,11040,0.000000e+00,0,0,15350,0.000000e+00,0,0,57216,0.000000e+00,0,0,22772,0.000000e+00,0,.,.,.,.,.,7,1551406,4.512040e-06,0,7,1146816,6.103860e-06,0,0,73056,0.000000e+00,0,0,912,0.000000e+00,0,0,50992,0.000000e+00,0,0,28652,0.000000e+00,0,0,40940,0.000000e+00,0,0,59870,0.000000e+00,0,0,6014,0.000000e+00,0,7,1146816,6.103860e-06,0,0,84070,0.000000e+00,0,1,37010,2.7019724398811132E-5,0,150,0,0,352,0,1,3854,2.594706798131811E-4,0,852,0,0,820,0,0,60,0,0,142,0,0,4746,0,1,4004,2.4975024975024975E-4,0,412,0,2,47986,4.167882299003876E-5,Pathogenic,not_provided|Acute_intermittent_porphyria,"criteria_provided,_single_submitter",NC_000011.10:g.119091497C>T,ClinGen:CA272877|UniProtKB:P08397#VAR_003656,C3661900|C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,Cys,171129.0,single nucleotide variant,NM_000190.4(HMBS):c.583C>T (p.Arg195Cys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Oct 30, 2024",34413634.0,-,RCV000148509|RCV001041963,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119091497.0,119091497.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"ClinGen:CA272877,UniProtKB:P08397#VAR_003656",2.0,161251.0,119091497.0,C,T,-,-,-,-,-,-,SCV001205617,-,-,583C>T ,Arg195Cys,NM_000190.4,1.0,1_Pathogenic,97.47,0.1330645161290322,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,33,97.47,Positively-charged,Arginine,Porphobilinogen deaminase,,,-4.5,,1 interaction,"R195-G218, R195-E117, R195-A191; PAE: 1.0, 1.5, 1.0",9 interactions,"R195-Q34, R195-A191; PAE: 1.0, 1.0",9 interactions,,4 interactions,175,Mutation: R -> A. Loss of hydroxymethylbilane synthase activity.,-57.2,,,-37.5,,,H (helix),H (α-helix),Helix,,,0.246,,0.275,,0.302,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var218481,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119091497.0,119091497.0,,583,C,T,195.0,R,C,c.583C>T,p.Arg195Cys,missense_variant,missense_variant,0.247595886,,No,4.5120361787e-6,Pathogenic,"criteria provided, single submitter","Feb 03, 2023",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.903,0.9561,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg195Cys,true,Arg195Cys
HMBS_Arg225Gln,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200938,CCSBVarC005172,ALE00005172,NC_000011.10:119092426:G:A,674G>A,Arg225Gln,CEGS2,CegsMutGDEh1041,D06,GDEhDisVCh_40054,F06,2.0,CegsMutGDDh1041,D06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092426,G,A,11,Y,Y,N,N,N,11-119092426-G-A,171130.0,single nucleotide variant,NM_000190.4(HMBS):c.674G>A (p.Arg225Gln),3145.0,HMBS,HGNC:4982,Uncertain significance,1.0,"Jan 30, 2025",142459647.0,-,RCV000148511|RCV000498317|RCV003764896,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119092426.0,119092426.0,11q23.3,"criteria provided, multiple submitters, no conflicts",5.0,-,N,"ClinGen:CA272881,UniProtKB:P08397#VAR_025574,OMIM:609806.0047",3.0,161253.0,119092426.0,G,A,-,-,-,-,-,-,SCV000589335|SCV002212600|SCV005408173,-,-,674G>A ,Arg225Gln,NM_000190.4,2.0,4_VUS,0.00033931,161253.0,11,119092426.0,G,A,R,Q,rs142459647,11,118963136,11,118468346,225.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.674G>A,p.Arg225Gln,c.674G>A,p.Arg225Gln,principal2,Y,.,YES,Select,+,CGA,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.63383,.,.,0.69466,.,0.997,0.70687,D,0.857,0.61060,P,.,0.97926,.,.,.,.,3.715,0.94651,H,.,0.67273,.,.,0.96431,0.9771,0.96803,D,0.9924,0.99816,D,10,.,0.88113,.,0.706346,0.97600,D,.,0.97773,.,.,.,.,.,.,0.96866,0.9562318792121636,0.95582,.,.,0.571098089218,0.48768,T,0.995598,0.99992,D,0.3198,0.84348,D,0.566532,0.95991,D,0.808724462985992,0.46674,D,0.912409,0.83895,D,0.90877837,0.92067,0.72923934,0.83811,0.9131859,0.92486,0.76490796,0.85942,-11.326,0.81474,D,0.6058,0.69064,P,0.997202798579699,0.92882,0.32941398,0.77714,0.932,0.96656,.,.,.,.,.,.,5.715775,0.93205,33.0,0.9994771199218434,0.99923,0.958528,0.97829,D,1.0246033594676,0.96431,14.71205,0.953043659807544,0.97480,16.22598,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.991,0.66489,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,53,264690,2.0023424E-4,.,18,109348,1.646120e-04,0,38,208056,1.826430e-04,0,37,236886,1.561930e-04,0,0,7164,0.000000e+00,0,3,17112,1.753160e-04,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,3,13338,2.249210e-04,0,12,42768,2.805840e-04,0,0,15688,0.000000e+00,0,12,42768,2.805840e-04,0,1,16214,6.167510e-05,0,5,30524,1.638060e-04,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,3,16678,1.798780e-04,0,29,89542,3.238700e-04,0,0,30606,0.000000e+00,0,29,89542,3.238700e-04,0,1,14902,6.710510e-05,0,6,34258,1.751420e-04,0,0,9572,0.000000e+00,0,1,17692,5.652270e-05,0,3,21576,1.390430e-04,0,26,102744,2.530560e-04,0,0,30524,0.000000e+00,0,26,102744,2.530560e-04,0,.,528,1613954,3.271470e-04,1,499,1180022,4.228730e-04,1,10,74920,1.334760e-04,0,0,910,0.000000e+00,0,6,60000,1.000000e-04,0,0,29604,0.000000e+00,0,0,44894,0.000000e+00,0,5,63964,7.816900e-05,0,0,6082,0.000000e+00,0,499,1180022,4.228730e-04,1,3,91074,3.294020e-05,0,61,173884,3.508085850337006E-4,0,360,0,0,4502,0,2,9432,2.1204410517387616E-4,0,796,0,1,968,0.0010330578512396695,0,1848,0,0,280,0,7,17166,4.077828265175347E-4,2,9792,2.042483660130719E-4,0,6350,0,71,209236,3.3932975205031637E-4,Uncertain_significance,"not_provided|Acute_intermittent_porphyria|Leukoencephalopathy,_porphyria-related","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119092426G>A,ClinGen:CA272881|OMIM:609806.0047|UniProtKB:P08397#VAR_025574,C3661900|C0162565|CN376853,176000|620711,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,171130.0,single nucleotide variant,NM_000190.4(HMBS):c.674G>A (p.Arg225Gln),3145.0,HMBS,HGNC:4982,Uncertain significance,1.0,"Jan 30, 2025",142459647.0,-,RCV000148511|RCV000498317|RCV003764896,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119092426.0,119092426.0,11q23.3,"criteria provided, multiple submitters, no conflicts",5.0,-,N,"ClinGen:CA272881,UniProtKB:P08397#VAR_025574,OMIM:609806.0047",3.0,161253.0,119092426.0,G,A,-,-,-,-,-,-,SCV000589335|SCV002212600|SCV005408173,-,-,674G>A ,Arg225Gln,NM_000190.4,2.0,4_VUS,97.51,0.1169354838709677,"['176000', '620711']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; LEUKOENCEPHALOPATHY, PORPHYRIA-RELATED",R,29,97.51,Positively-charged,Arginine,Porphobilinogen deaminase,,0.0049,-4.5,,,"R225-V90, R225-L85; PAE: 1.0, 1.0",10 interactions,"R225-D91, R225-L85; PAE: 1.0, 1.0",9 interactions,R225-D228; PAE: 1.0,9 interactions,175,,-68.0,,"Pocket 2: Mean pLDDT: 93.7, Volume: 392.46 Å³, Druggability score: 0",127.8,,dbSNP: -; Variant type: LP/P; AA change: Arg225Gly; PTM type: Ubiquitylation; PTM morphology: VEVR*AkDQDIL; Var class: II&rs142459647,B (undefined),E (parallel sheets),Beta strand,,,0.465,,0.511,,0.473,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var218431,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119092426.0,119092426.0,,674,G,A,225.0,R,Q,c.674G>A,p.Arg225Gln,missense_variant,missense_variant,0.0,,No,0.0003271468703568,Uncertain significance,"criteria provided, multiple submitters, no conflicts","Dec 18, 2023",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.915,0.6058,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg225Gln,true,Arg225Gln
HMBS_Arg225Gln,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200938,CCSBVarC005172,ALE00005172,NC_000011.10:119092426:G:A,674G>A,Arg225Gln,CEGS2,CegsMutGDEh1041,D06,GDEhDisVCh_40054,F06,2.0,CegsMutGDDh1041,D06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092426,G,A,11,Y,Y,N,N,N,11-119092426-G-A,171130.0,single nucleotide variant,NM_000190.4(HMBS):c.674G>A (p.Arg225Gln),3145.0,HMBS,HGNC:4982,Uncertain significance,1.0,"Jan 30, 2025",142459647.0,-,RCV000148511|RCV000498317|RCV003764896,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119092426.0,119092426.0,11q23.3,"criteria provided, multiple submitters, no conflicts",5.0,-,N,"ClinGen:CA272881,UniProtKB:P08397#VAR_025574,OMIM:609806.0047",3.0,161253.0,119092426.0,G,A,-,-,-,-,-,-,SCV000589335|SCV002212600|SCV005408173,-,-,674G>A ,Arg225Gln,NM_000190.4,2.0,4_VUS,0.00033931,161253.0,11,119092426.0,G,A,R,Q,rs142459647,11,118963136,11,118468346,225.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.674G>A,p.Arg225Gln,c.674G>A,p.Arg225Gln,principal2,Y,.,YES,Select,+,CGA,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.63383,.,.,0.69466,.,0.997,0.70687,D,0.857,0.61060,P,.,0.97926,.,.,.,.,3.715,0.94651,H,.,0.67273,.,.,0.96431,0.9771,0.96803,D,0.9924,0.99816,D,10,.,0.88113,.,0.706346,0.97600,D,.,0.97773,.,.,.,.,.,.,0.96866,0.9562318792121636,0.95582,.,.,0.571098089218,0.48768,T,0.995598,0.99992,D,0.3198,0.84348,D,0.566532,0.95991,D,0.808724462985992,0.46674,D,0.912409,0.83895,D,0.90877837,0.92067,0.72923934,0.83811,0.9131859,0.92486,0.76490796,0.85942,-11.326,0.81474,D,0.6058,0.69064,P,0.997202798579699,0.92882,0.32941398,0.77714,0.932,0.96656,.,.,.,.,.,.,5.715775,0.93205,33.0,0.9994771199218434,0.99923,0.958528,0.97829,D,1.0246033594676,0.96431,14.71205,0.953043659807544,0.97480,16.22598,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.991,0.66489,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,53,264690,2.0023424E-4,.,18,109348,1.646120e-04,0,38,208056,1.826430e-04,0,37,236886,1.561930e-04,0,0,7164,0.000000e+00,0,3,17112,1.753160e-04,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,3,13338,2.249210e-04,0,12,42768,2.805840e-04,0,0,15688,0.000000e+00,0,12,42768,2.805840e-04,0,1,16214,6.167510e-05,0,5,30524,1.638060e-04,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,3,16678,1.798780e-04,0,29,89542,3.238700e-04,0,0,30606,0.000000e+00,0,29,89542,3.238700e-04,0,1,14902,6.710510e-05,0,6,34258,1.751420e-04,0,0,9572,0.000000e+00,0,1,17692,5.652270e-05,0,3,21576,1.390430e-04,0,26,102744,2.530560e-04,0,0,30524,0.000000e+00,0,26,102744,2.530560e-04,0,.,528,1613954,3.271470e-04,1,499,1180022,4.228730e-04,1,10,74920,1.334760e-04,0,0,910,0.000000e+00,0,6,60000,1.000000e-04,0,0,29604,0.000000e+00,0,0,44894,0.000000e+00,0,5,63964,7.816900e-05,0,0,6082,0.000000e+00,0,499,1180022,4.228730e-04,1,3,91074,3.294020e-05,0,61,173884,3.508085850337006E-4,0,360,0,0,4502,0,2,9432,2.1204410517387616E-4,0,796,0,1,968,0.0010330578512396695,0,1848,0,0,280,0,7,17166,4.077828265175347E-4,2,9792,2.042483660130719E-4,0,6350,0,71,209236,3.3932975205031637E-4,Uncertain_significance,"not_provided|Acute_intermittent_porphyria|Leukoencephalopathy,_porphyria-related","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119092426G>A,ClinGen:CA272881|OMIM:609806.0047|UniProtKB:P08397#VAR_025574,C3661900|C0162565|CN376853,176000|620711,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,171130.0,single nucleotide variant,NM_000190.4(HMBS):c.674G>A (p.Arg225Gln),3145.0,HMBS,HGNC:4982,Uncertain significance,1.0,"Jan 30, 2025",142459647.0,-,RCV000148511|RCV000498317|RCV003764896,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119092426.0,119092426.0,11q23.3,"criteria provided, multiple submitters, no conflicts",5.0,-,N,"ClinGen:CA272881,UniProtKB:P08397#VAR_025574,OMIM:609806.0047",3.0,161253.0,119092426.0,G,A,-,-,-,-,-,-,SCV000589335|SCV002212600|SCV005408173,-,-,674G>A ,Arg225Gln,NM_000190.4,2.0,4_VUS,97.51,0.1169354838709677,"['176000', '620711']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; LEUKOENCEPHALOPATHY, PORPHYRIA-RELATED",R,29,97.51,Positively-charged,Arginine,Porphobilinogen deaminase,,0.0049,-4.5,,,"R225-V90, R225-L85; PAE: 1.0, 1.0",10 interactions,"R225-D91, R225-L85; PAE: 1.0, 1.0",9 interactions,R225-D228; PAE: 1.0,9 interactions,175,,-68.0,,"Pocket 2: Mean pLDDT: 93.7, Volume: 392.46 Å³, Druggability score: 0",127.8,,dbSNP: -; Variant type: LP/P; AA change: Arg225Gly; PTM type: Ubiquitylation; PTM morphology: VEVR*AkDQDIL; Var class: II&rs142459647,B (undefined),E (parallel sheets),Beta strand,,,0.465,,0.511,,0.473,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var205447,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119092426.0,119092426.0,,674,G,A,225.0,R,Q,c.674G>A,p.Arg225Gln,missense_variant,missense_variant,-0.116476344,,No,0.0003271468703568,Uncertain significance,"criteria provided, multiple submitters, no conflicts","Dec 18, 2023",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.915,0.6058,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg225Gln,true,Arg225Gln
HMBS_Arg225Gln,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200938,CCSBVarC005172,ALE00005172,NC_000011.10:119092426:G:A,674G>A,Arg225Gln,CEGS2,CegsMutGDEh1041,D06,GDEhDisVCh_40054,F06,2.0,CegsMutGDDh1041,D06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092426,G,A,11,Y,Y,N,N,N,11-119092426-G-A,171130.0,single nucleotide variant,NM_000190.4(HMBS):c.674G>A (p.Arg225Gln),3145.0,HMBS,HGNC:4982,Uncertain significance,1.0,"Jan 30, 2025",142459647.0,-,RCV000148511|RCV000498317|RCV003764896,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119092426.0,119092426.0,11q23.3,"criteria provided, multiple submitters, no conflicts",5.0,-,N,"ClinGen:CA272881,UniProtKB:P08397#VAR_025574,OMIM:609806.0047",3.0,161253.0,119092426.0,G,A,-,-,-,-,-,-,SCV000589335|SCV002212600|SCV005408173,-,-,674G>A ,Arg225Gln,NM_000190.4,2.0,4_VUS,0.00033931,161253.0,11,119092426.0,G,A,R,Q,rs142459647,11,118963136,11,118468346,225.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.674G>A,p.Arg225Gln,c.674G>A,p.Arg225Gln,principal2,Y,.,YES,Select,+,CGA,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.63383,.,.,0.69466,.,0.997,0.70687,D,0.857,0.61060,P,.,0.97926,.,.,.,.,3.715,0.94651,H,.,0.67273,.,.,0.96431,0.9771,0.96803,D,0.9924,0.99816,D,10,.,0.88113,.,0.706346,0.97600,D,.,0.97773,.,.,.,.,.,.,0.96866,0.9562318792121636,0.95582,.,.,0.571098089218,0.48768,T,0.995598,0.99992,D,0.3198,0.84348,D,0.566532,0.95991,D,0.808724462985992,0.46674,D,0.912409,0.83895,D,0.90877837,0.92067,0.72923934,0.83811,0.9131859,0.92486,0.76490796,0.85942,-11.326,0.81474,D,0.6058,0.69064,P,0.997202798579699,0.92882,0.32941398,0.77714,0.932,0.96656,.,.,.,.,.,.,5.715775,0.93205,33.0,0.9994771199218434,0.99923,0.958528,0.97829,D,1.0246033594676,0.96431,14.71205,0.953043659807544,0.97480,16.22598,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.991,0.66489,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,53,264690,2.0023424E-4,.,18,109348,1.646120e-04,0,38,208056,1.826430e-04,0,37,236886,1.561930e-04,0,0,7164,0.000000e+00,0,3,17112,1.753160e-04,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,3,13338,2.249210e-04,0,12,42768,2.805840e-04,0,0,15688,0.000000e+00,0,12,42768,2.805840e-04,0,1,16214,6.167510e-05,0,5,30524,1.638060e-04,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,3,16678,1.798780e-04,0,29,89542,3.238700e-04,0,0,30606,0.000000e+00,0,29,89542,3.238700e-04,0,1,14902,6.710510e-05,0,6,34258,1.751420e-04,0,0,9572,0.000000e+00,0,1,17692,5.652270e-05,0,3,21576,1.390430e-04,0,26,102744,2.530560e-04,0,0,30524,0.000000e+00,0,26,102744,2.530560e-04,0,.,528,1613954,3.271470e-04,1,499,1180022,4.228730e-04,1,10,74920,1.334760e-04,0,0,910,0.000000e+00,0,6,60000,1.000000e-04,0,0,29604,0.000000e+00,0,0,44894,0.000000e+00,0,5,63964,7.816900e-05,0,0,6082,0.000000e+00,0,499,1180022,4.228730e-04,1,3,91074,3.294020e-05,0,61,173884,3.508085850337006E-4,0,360,0,0,4502,0,2,9432,2.1204410517387616E-4,0,796,0,1,968,0.0010330578512396695,0,1848,0,0,280,0,7,17166,4.077828265175347E-4,2,9792,2.042483660130719E-4,0,6350,0,71,209236,3.3932975205031637E-4,Uncertain_significance,"not_provided|Acute_intermittent_porphyria|Leukoencephalopathy,_porphyria-related","criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119092426G>A,ClinGen:CA272881|OMIM:609806.0047|UniProtKB:P08397#VAR_025574,C3661900|C0162565|CN376853,176000|620711,79276,"Porphobilinogen deaminase, N-terminal",Arg,Gln,171130.0,single nucleotide variant,NM_000190.4(HMBS):c.674G>A (p.Arg225Gln),3145.0,HMBS,HGNC:4982,Uncertain significance,1.0,"Jan 30, 2025",142459647.0,-,RCV000148511|RCV000498317|RCV003764896,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711","Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119092426.0,119092426.0,11q23.3,"criteria provided, multiple submitters, no conflicts",5.0,-,N,"ClinGen:CA272881,UniProtKB:P08397#VAR_025574,OMIM:609806.0047",3.0,161253.0,119092426.0,G,A,-,-,-,-,-,-,SCV000589335|SCV002212600|SCV005408173,-,-,674G>A ,Arg225Gln,NM_000190.4,2.0,4_VUS,97.51,0.1169354838709677,"['176000', '620711']",multiple,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT; LEUKOENCEPHALOPATHY, PORPHYRIA-RELATED",R,29,97.51,Positively-charged,Arginine,Porphobilinogen deaminase,,0.0049,-4.5,,,"R225-V90, R225-L85; PAE: 1.0, 1.0",10 interactions,"R225-D91, R225-L85; PAE: 1.0, 1.0",9 interactions,R225-D228; PAE: 1.0,9 interactions,175,,-68.0,,"Pocket 2: Mean pLDDT: 93.7, Volume: 392.46 Å³, Druggability score: 0",127.8,,dbSNP: -; Variant type: LP/P; AA change: Arg225Gly; PTM type: Ubiquitylation; PTM morphology: VEVR*AkDQDIL; Var class: II&rs142459647,B (undefined),E (parallel sheets),Beta strand,,,0.465,,0.511,,0.473,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var211871,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119092426.0,119092426.0,,674,G,A,225.0,R,Q,c.674G>A,p.Arg225Gln,missense_variant,missense_variant,0.54697015,,No,0.0003271468703568,Uncertain significance,"criteria provided, multiple submitters, no conflicts","Dec 18, 2023",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.915,0.6058,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg225Gln,true,Arg225Gln
HMBS_Arg26His,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200922,CCSBVarC005157,ALE00005157,NC_000011.10:119088298:G:A,77G>A,Arg26His,CEGS2,CegsMutGDEh1038,H11,GDEhDisVCh_40054,C04,2.0,CegsMutGDDh1038,H11,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119088298,G,A,11,Y,Y,N,N,N,11-119088298-G-A,16482.0,single nucleotide variant,NM_000190.4(HMBS):c.77G>A (p.Arg26His),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Nov 02, 2024",118204103.0,-,RCV000001508|RCV000798844,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119088298.0,119088298.0,11q23.3,"criteria provided, multiple submitters, no conflicts",3.0,-,N,"ClinGen:CA251791,UniProtKB:P08397#VAR_003639,OMIM:609806.0015",3.0,1443.0,119088298.0,G,A,-,-,-,-,-,-,SCV000938479|SCV005414015,-,-,77G>A ,Arg26His,NM_000190.4,2.0,1_Pathogenic,6.84103e-7,1443.0,11,119088298.0,G,A,R,H,rs118204103,11,118959008,11,118464218,26.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.77G>A,p.Arg26His,c.77G>A,p.Arg26His,principal2,Y,.,YES,Select,+,CGC,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.984,0.76117,D,.,0.97016,.,.,.,.,4.47,0.98862,H,.,0.79262,.,.,0.89342,0.9246,0.96012,D,0.9977,0.99943,D,9,.,0.99726,.,0.668687,0.97227,D,.,0.99647,0.991,0.99904,P08397,R26H,Loss of phosphorylation at T25 (P = 0.0975)| Loss of methylation at K27 (P = 0.1033)| Gain of catalytic residue at K27 (P = 0.1145)| Loss of disorder (P = 0.1319)| Loss of MoRF binding (P = 0.2161),.,0.98196,0.94187620925175,0.94133,.,.,0.715661764145,0.69362,T,0.997606,0.99998,D,0.590797,0.97339,D,0.610862,0.97297,D,0.999914169311523,0.99678,D,0.9954,0.98433,D,0.96320134,0.97562,0.8812829,0.93566,0.9360872,0.94771,0.8641442,0.92362,-14.194,0.93682,D,0.9974,0.96927,P,0.99739938518121,0.93089,0.40135920,0.79621,0.992,0.99727,.,.,.,.,.,.,6.147239,0.94675,34.0,0.99955459766990529,0.99975,0.913011,0.87396,D,1.14604209760668,0.98893,19.80175,1.03741763637192,0.99224,21.34227,5.52,5.52,0.82128,6.13,0.98113,7.968,0.87561,11.821000,0.97243,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.998,0.85369,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1614074,6.195500e-07,0,1,1179960,8.474860e-07,0,0,75044,0.000000e+00,0,0,910,0.000000e+00,0,0,60012,0.000000e+00,0,0,29608,0.000000e+00,0,0,44890,0.000000e+00,0,0,64034,0.000000e+00,0,0,6038,0.000000e+00,0,1,1179960,8.474860e-07,0,0,91080,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,not_provided|Acute_intermittent_porphyria,"criteria_provided,_single_submitter",NC_000011.10:g.119088298G>A,ClinGen:CA251791|OMIM:609806.0015|UniProtKB:P08397#VAR_003639,C3661900|C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,His,16482.0,single nucleotide variant,NM_000190.4(HMBS):c.77G>A (p.Arg26His),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Nov 02, 2024",118204103.0,-,RCV000001508|RCV000798844,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119088298.0,119088298.0,11q23.3,"criteria provided, multiple submitters, no conflicts",3.0,-,N,"ClinGen:CA251791,UniProtKB:P08397#VAR_003639,OMIM:609806.0015",3.0,1443.0,119088298.0,G,A,-,-,-,-,-,-,SCV000938479|SCV005414015,-,-,77G>A ,Arg26His,NM_000190.4,2.0,1_Pathogenic,91.49,0.1733870967741935,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,43,91.49,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,R26-D61; PAE: 6.5,3 interactions,R26-T58; PAE: 2.5,2 interactions,,2 interactions,175,Mutation: R -> A. Loss of hydroxymethylbilane synthase activity.,-74.6,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",149.3,,,B (undefined),E (parallel sheets),,,,,,-0.547,"5 mutation(s) (Arg26Met: -1.608, Arg26Glu: -1.575, Arg26Ile: -1.243, Arg26Thr: -1.137, Arg26Gln: -0.934)",0.049,1 mutation(s) (Arg26Val: 0.000),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var218249,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119088298.0,119088298.0,,77,G,A,26.0,R,H,c.77G>A,p.Arg26His,missense_variant,missense_variant,0.0,,No,6.195502808421423e-7,Pathogenic,"criteria provided, multiple submitters, no conflicts","Feb 02, 2024",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.97,0.9974,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg26His,true,Arg26His
HMBS_Arg26His,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200922,CCSBVarC005157,ALE00005157,NC_000011.10:119088298:G:A,77G>A,Arg26His,CEGS2,CegsMutGDEh1038,H11,GDEhDisVCh_40054,C04,2.0,CegsMutGDDh1038,H11,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119088298,G,A,11,Y,Y,N,N,N,11-119088298-G-A,16482.0,single nucleotide variant,NM_000190.4(HMBS):c.77G>A (p.Arg26His),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Nov 02, 2024",118204103.0,-,RCV000001508|RCV000798844,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119088298.0,119088298.0,11q23.3,"criteria provided, multiple submitters, no conflicts",3.0,-,N,"ClinGen:CA251791,UniProtKB:P08397#VAR_003639,OMIM:609806.0015",3.0,1443.0,119088298.0,G,A,-,-,-,-,-,-,SCV000938479|SCV005414015,-,-,77G>A ,Arg26His,NM_000190.4,2.0,1_Pathogenic,6.84103e-7,1443.0,11,119088298.0,G,A,R,H,rs118204103,11,118959008,11,118464218,26.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.77G>A,p.Arg26His,c.77G>A,p.Arg26His,principal2,Y,.,YES,Select,+,CGC,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.984,0.76117,D,.,0.97016,.,.,.,.,4.47,0.98862,H,.,0.79262,.,.,0.89342,0.9246,0.96012,D,0.9977,0.99943,D,9,.,0.99726,.,0.668687,0.97227,D,.,0.99647,0.991,0.99904,P08397,R26H,Loss of phosphorylation at T25 (P = 0.0975)| Loss of methylation at K27 (P = 0.1033)| Gain of catalytic residue at K27 (P = 0.1145)| Loss of disorder (P = 0.1319)| Loss of MoRF binding (P = 0.2161),.,0.98196,0.94187620925175,0.94133,.,.,0.715661764145,0.69362,T,0.997606,0.99998,D,0.590797,0.97339,D,0.610862,0.97297,D,0.999914169311523,0.99678,D,0.9954,0.98433,D,0.96320134,0.97562,0.8812829,0.93566,0.9360872,0.94771,0.8641442,0.92362,-14.194,0.93682,D,0.9974,0.96927,P,0.99739938518121,0.93089,0.40135920,0.79621,0.992,0.99727,.,.,.,.,.,.,6.147239,0.94675,34.0,0.99955459766990529,0.99975,0.913011,0.87396,D,1.14604209760668,0.98893,19.80175,1.03741763637192,0.99224,21.34227,5.52,5.52,0.82128,6.13,0.98113,7.968,0.87561,11.821000,0.97243,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.998,0.85369,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1614074,6.195500e-07,0,1,1179960,8.474860e-07,0,0,75044,0.000000e+00,0,0,910,0.000000e+00,0,0,60012,0.000000e+00,0,0,29608,0.000000e+00,0,0,44890,0.000000e+00,0,0,64034,0.000000e+00,0,0,6038,0.000000e+00,0,1,1179960,8.474860e-07,0,0,91080,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,not_provided|Acute_intermittent_porphyria,"criteria_provided,_single_submitter",NC_000011.10:g.119088298G>A,ClinGen:CA251791|OMIM:609806.0015|UniProtKB:P08397#VAR_003639,C3661900|C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Arg,His,16482.0,single nucleotide variant,NM_000190.4(HMBS):c.77G>A (p.Arg26His),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Nov 02, 2024",118204103.0,-,RCV000001508|RCV000798844,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119088298.0,119088298.0,11q23.3,"criteria provided, multiple submitters, no conflicts",3.0,-,N,"ClinGen:CA251791,UniProtKB:P08397#VAR_003639,OMIM:609806.0015",3.0,1443.0,119088298.0,G,A,-,-,-,-,-,-,SCV000938479|SCV005414015,-,-,77G>A ,Arg26His,NM_000190.4,2.0,1_Pathogenic,91.49,0.1733870967741935,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,43,91.49,Positively-charged,Arginine,Porphobilinogen deaminase,,0.7555,-4.5,,,R26-D61; PAE: 6.5,3 interactions,R26-T58; PAE: 2.5,2 interactions,,2 interactions,175,Mutation: R -> A. Loss of hydroxymethylbilane synthase activity.,-74.6,,"Pocket 1: Mean pLDDT: 74.72, Volume: 1967.64 Å³, Druggability score: 0.76",149.3,,,B (undefined),E (parallel sheets),,,,,,-0.547,"5 mutation(s) (Arg26Met: -1.608, Arg26Glu: -1.575, Arg26Ile: -1.243, Arg26Thr: -1.137, Arg26Gln: -0.934)",0.049,1 mutation(s) (Arg26Val: 0.000),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var211778,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119088298.0,119088298.0,,77,G,A,26.0,R,H,c.77G>A,p.Arg26His,missense_variant,missense_variant,-0.336043157999999,,No,6.195502808421423e-7,Pathogenic,"criteria provided, multiple submitters, no conflicts","Feb 02, 2024",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.97,0.9974,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Arg26His,true,Arg26His
HMBS_Arg321His,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200946,CCSBVarC005178,ALE00005178,NC_000011.10:119093159:G:A,962G>A,Arg321His,CEGS2,CegsMutGDEh1045,A10,GDEhDisVCh_40054,B09,2.0,CegsMutGDDh1045,A10,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119093159,G,A,11,Y,Y,N,N,N,11-119093159-G-A,171131.0,single nucleotide variant,NM_000190.4(HMBS):c.962G>A (p.Arg321His),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Feb 02, 2025",150428209.0,-,RCV000148508|RCV000730694,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;not applicable,germline,GRCh38,NC_000011.10,11,119093159.0,119093159.0,11q23.3,"criteria provided, conflicting classifications",8.0,-,N,ClinGen:CA272874,2.0,161250.0,119093159.0,G,A,-,-,-,-,-,-,SCV000367707|SCV000858452|SCV001051958|SCV001132051|SCV001764085,-,-,962G>A ,Arg321His,NM_000190.4,1.0,3_Conflicting,0.00128533,161250.0,11,119093159.0,G,A,R,H,rs150428209,11,118963869,11,118469079,321.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.962G>A,p.Arg321His,c.962G>A,p.Arg321His,principal2,Y,.,YES,Select,+,CGT,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.17221,.,.,0.31545,.,0.01,0.15546,B,0.007,0.12988,B,.,0.16373,.,.,.,.,1.01,0.25176,L,.,0.23101,.,.,0.72440,1.3840,0.99989,D,0.9535,0.98487,D,10,.,0.01961,.,0.746019,0.97967,D,.,0.82027,.,.,.,.,.,.,0.99428,0.32063829405747085,0.31776,.,.,0.245244860649,0.03286,T,0.377637,0.73904,T,-0.0929411,0.37234,T,0.0878623,0.75924,D,0.00434302333184015,0.00046,T,0.927007,0.74353,D,0.13126433,0.30337,0.045844223,0.06275,0.114731535,0.26841,0.044000093,0.05617,-4.069,0.29791,T,0.0852,0.23287,B,0.0862180440551417,0.41983,0.04845008,0.59156,0.053,0.14148,.,.,.,.,.,.,1.431216,0.18518,13.77,0.85070210413198144,0.15906,0.191087,0.31617,N,-0.909542547684793,0.10491,0.508263,-0.858022797407406,0.12868,0.6774282,5.35,-0.632,0.10914,-1.14,0.15097,-0.597,0.05819,0.128000,0.15073,0.674,0.70877,0.001,0.13799,0.000000,0.08389,0.988,0.63383,228,0.91137,2,3.9936102236421724E-4,0,0.0,0,0.0,0,0.0,0,0.0,2,0.002044989775051125,269,264690,0.0010162832,.,141,109408,1.288750e-03,1,230,208128,1.105090e-03,1,281,236952,1.185890e-03,1,2,7164,2.791740e-04,0,12,17112,7.012620e-04,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,14,13394,1.045240e-03,0,108,42768,2.525250e-03,1,5,15690,3.186740e-04,0,108,42768,2.525250e-03,1,3,16218,1.849800e-04,0,14,30522,4.586860e-04,0,0,6212,0.000000e+00,0,1,13416,7.453790e-05,0,16,16734,9.561370e-04,0,185,89552,2.065840e-03,1,9,30608,2.940410e-04,0,185,89552,2.065840e-03,1,3,14902,2.013150e-04,0,17,34258,4.962340e-04,0,0,9570,0.000000e+00,0,1,17692,5.652270e-05,0,22,21632,1.017010e-03,0,227,102752,2.209200e-03,1,9,30526,2.948310e-04,0,227,102752,2.209200e-03,1,.,2034,1614178,1.260080e-03,4,1813,1180004,1.536440e-03,2,7,75054,9.326620e-05,0,0,910,0.000000e+00,0,29,60028,4.831080e-04,0,0,29600,0.000000e+00,0,2,44886,4.455730e-05,0,73,64040,1.139910e-03,0,6,6062,9.897720e-04,0,1813,1180004,1.536440e-03,2,27,91088,2.964170e-04,0,284,174478,0.001627712376345442,0,176,0,0,4502,0,0,4798,0,0,796,0,1,964,0.001037344398340249,0,1848,0,0,280,0,19,16012,0.0011866100424681488,0,4974,0,0,6350,0,304,203854,0.0014912633551463301,Conflicting_classifications_of_pathogenicity,Acute_intermittent_porphyria|not_provided,"criteria_provided,_conflicting_classifications",NC_000011.10:g.119093159G>A,ClinGen:CA272874,C0162565|C3661900,176000,79276,.,Arg,His,171131.0,single nucleotide variant,NM_000190.4(HMBS):c.962G>A (p.Arg321His),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Feb 02, 2025",150428209.0,-,RCV000148508|RCV000730694,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;not applicable,germline,GRCh38,NC_000011.10,11,119093159.0,119093159.0,11q23.3,"criteria provided, conflicting classifications",8.0,-,N,ClinGen:CA272874,2.0,161250.0,119093159.0,G,A,-,-,-,-,-,-,SCV000367707|SCV000858452|SCV001051958|SCV001132051|SCV001764085,-,-,962G>A ,Arg321His,NM_000190.4,1.0,3_Conflicting,90.41,0.4153225806451613,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,103,90.41,Positively-charged,Arginine,Porphobilinogen deaminase,,0.0021,-4.5,,,R321-Q229; PAE: 2.5,8 interactions,,9 interactions,,,175,,-76.5,,"Pocket 5: Mean pLDDT: 92.37, Volume: 200.06 Å³, Druggability score: 0",-17.7,,,C (loop/coil),T (turn),,,,0.63,,0.623,,0.663,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_ubquitous_var205377,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119093159.0,119093159.0,,962,G,A,321.0,R,H,c.962G>A,p.Arg321His,missense_variant,missense_variant,0.863077075,,No,0.0012600840799465,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Jan 31, 2024",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.563,0.0852,likely_benign,,,,,,,,,,,,,,,,,,,HMBS_Arg321His,true,Arg321His
HMBS_Arg321His,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200946,CCSBVarC005178,ALE00005178,NC_000011.10:119093159:G:A,962G>A,Arg321His,CEGS2,CegsMutGDEh1045,A10,GDEhDisVCh_40054,B09,2.0,CegsMutGDDh1045,A10,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119093159,G,A,11,Y,Y,N,N,N,11-119093159-G-A,171131.0,single nucleotide variant,NM_000190.4(HMBS):c.962G>A (p.Arg321His),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Feb 02, 2025",150428209.0,-,RCV000148508|RCV000730694,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;not applicable,germline,GRCh38,NC_000011.10,11,119093159.0,119093159.0,11q23.3,"criteria provided, conflicting classifications",8.0,-,N,ClinGen:CA272874,2.0,161250.0,119093159.0,G,A,-,-,-,-,-,-,SCV000367707|SCV000858452|SCV001051958|SCV001132051|SCV001764085,-,-,962G>A ,Arg321His,NM_000190.4,1.0,3_Conflicting,0.00128533,161250.0,11,119093159.0,G,A,R,H,rs150428209,11,118963869,11,118469079,321.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.962G>A,p.Arg321His,c.962G>A,p.Arg321His,principal2,Y,.,YES,Select,+,CGT,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.17221,.,.,0.31545,.,0.01,0.15546,B,0.007,0.12988,B,.,0.16373,.,.,.,.,1.01,0.25176,L,.,0.23101,.,.,0.72440,1.3840,0.99989,D,0.9535,0.98487,D,10,.,0.01961,.,0.746019,0.97967,D,.,0.82027,.,.,.,.,.,.,0.99428,0.32063829405747085,0.31776,.,.,0.245244860649,0.03286,T,0.377637,0.73904,T,-0.0929411,0.37234,T,0.0878623,0.75924,D,0.00434302333184015,0.00046,T,0.927007,0.74353,D,0.13126433,0.30337,0.045844223,0.06275,0.114731535,0.26841,0.044000093,0.05617,-4.069,0.29791,T,0.0852,0.23287,B,0.0862180440551417,0.41983,0.04845008,0.59156,0.053,0.14148,.,.,.,.,.,.,1.431216,0.18518,13.77,0.85070210413198144,0.15906,0.191087,0.31617,N,-0.909542547684793,0.10491,0.508263,-0.858022797407406,0.12868,0.6774282,5.35,-0.632,0.10914,-1.14,0.15097,-0.597,0.05819,0.128000,0.15073,0.674,0.70877,0.001,0.13799,0.000000,0.08389,0.988,0.63383,228,0.91137,2,3.9936102236421724E-4,0,0.0,0,0.0,0,0.0,0,0.0,2,0.002044989775051125,269,264690,0.0010162832,.,141,109408,1.288750e-03,1,230,208128,1.105090e-03,1,281,236952,1.185890e-03,1,2,7164,2.791740e-04,0,12,17112,7.012620e-04,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,14,13394,1.045240e-03,0,108,42768,2.525250e-03,1,5,15690,3.186740e-04,0,108,42768,2.525250e-03,1,3,16218,1.849800e-04,0,14,30522,4.586860e-04,0,0,6212,0.000000e+00,0,1,13416,7.453790e-05,0,16,16734,9.561370e-04,0,185,89552,2.065840e-03,1,9,30608,2.940410e-04,0,185,89552,2.065840e-03,1,3,14902,2.013150e-04,0,17,34258,4.962340e-04,0,0,9570,0.000000e+00,0,1,17692,5.652270e-05,0,22,21632,1.017010e-03,0,227,102752,2.209200e-03,1,9,30526,2.948310e-04,0,227,102752,2.209200e-03,1,.,2034,1614178,1.260080e-03,4,1813,1180004,1.536440e-03,2,7,75054,9.326620e-05,0,0,910,0.000000e+00,0,29,60028,4.831080e-04,0,0,29600,0.000000e+00,0,2,44886,4.455730e-05,0,73,64040,1.139910e-03,0,6,6062,9.897720e-04,0,1813,1180004,1.536440e-03,2,27,91088,2.964170e-04,0,284,174478,0.001627712376345442,0,176,0,0,4502,0,0,4798,0,0,796,0,1,964,0.001037344398340249,0,1848,0,0,280,0,19,16012,0.0011866100424681488,0,4974,0,0,6350,0,304,203854,0.0014912633551463301,Conflicting_classifications_of_pathogenicity,Acute_intermittent_porphyria|not_provided,"criteria_provided,_conflicting_classifications",NC_000011.10:g.119093159G>A,ClinGen:CA272874,C0162565|C3661900,176000,79276,.,Arg,His,171131.0,single nucleotide variant,NM_000190.4(HMBS):c.962G>A (p.Arg321His),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Feb 02, 2025",150428209.0,-,RCV000148508|RCV000730694,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;not applicable,germline,GRCh38,NC_000011.10,11,119093159.0,119093159.0,11q23.3,"criteria provided, conflicting classifications",8.0,-,N,ClinGen:CA272874,2.0,161250.0,119093159.0,G,A,-,-,-,-,-,-,SCV000367707|SCV000858452|SCV001051958|SCV001132051|SCV001764085,-,-,962G>A ,Arg321His,NM_000190.4,1.0,3_Conflicting,90.41,0.4153225806451613,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",R,103,90.41,Positively-charged,Arginine,Porphobilinogen deaminase,,0.0021,-4.5,,,R321-Q229; PAE: 2.5,8 interactions,,9 interactions,,,175,,-76.5,,"Pocket 5: Mean pLDDT: 92.37, Volume: 200.06 Å³, Druggability score: 0",-17.7,,,C (loop/coil),T (turn),,,,0.63,,0.623,,0.663,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_combined_var218745,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119093159.0,119093159.0,,962,G,A,321.0,R,H,c.962G>A,p.Arg321His,missense_variant,missense_variant,0.863077075,,No,0.0012600840799465,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Jan 31, 2024",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.563,0.0852,likely_benign,,,,,,,,,,,,,,,,,,,HMBS_Arg321His,true,Arg321His
HMBS_Asp359Asn,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200947,CCSBVarC005179,ALE00005179,NC_000011.10:119093272:G:A,1075G>A,Asp359Asn,CEGS2,CegsMutGDEh1042,H08,GDEhDisVCh_40054,H07,2.0,CegsMutGDDh1042,H08,,,,,,,1.0,1.0,1.0,2.0,0.0,,,0.0,,,0.0,,,11,119093272,G,A,11,Y,Y,N,N,N,11-119093272-G-A,171132.0,single nucleotide variant,NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn),3145.0,HMBS,HGNC:4982,Benign/Likely benign,0.0,"Jan 01, 2025",144949995.0,-,RCV000148507|RCV001356682,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119093272.0,119093272.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA272871,2.0,161249.0,119093272.0,G,A,-,-,-,-,-,-,SCV001259472|SCV002447753,-,-,1075G>A ,Asp359Asn,NM_000190.4,2.0,2_Benign,0.0000649879,161249.0,11,119093272.0,G,A,D,N,rs144949995,11,118963982,11,118469192,359.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.1075G>A,p.Asp359Asn,c.1075G>A,p.Asp359Asn,principal2,Y,.,YES,Select,+,GAT,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.65576,.,.,0.57446,.,0.979,0.62341,D,0.527,0.50892,P,.,0.10877,.,.,.,.,2.14,0.59685,M,.,0.38141,.,.,0.77038,1.0459,0.98026,D,0.9846,0.99532,D,10,.,0.30896,.,0.746723,0.97973,D,.,0.87667,.,.,.,.,.,.,0.91579,0.39072444537365264,0.38784,.,.,0.512455224991,0.40508,T,0.432739,0.77879,T,-0.170586,0.24805,T,-0.0682527,0.65505,T,0.104062861534229,0.12635,T,0.910309,0.68120,D,0.3453892,0.56375,0.3170101,0.57454,0.37713367,0.58781,0.32851937,0.58510,-4.539,0.33492,T,0.1264,0.27406,B,0.948487344713086,0.80270,0.03907438,0.56847,0.765,0.86988,.,.,.,.,.,.,4.645467,0.74048,26.1,0.99903784978921351,0.97503,0.952613,0.96811,D,0.622631496984238,0.74470,6.161659,0.651979823880355,0.78641,6.941212,4.99,4.99,0.65898,.,.,9.075,0.93427,11.804000,0.96740,0.66,0.55068,1.0,0.71675,1.000000,0.68239,0.972,0.54981,228,0.91137,1,1.9968051118210862E-4,1,7.564296520423601E-4,0,0.0,0,0.0,0,0.0,0,0.0,113,264690,4.269145E-4,.,8,109344,7.316360e-05,0,24,207970,1.154010e-04,1,22,236602,9.298320e-05,1,8,7164,1.116690e-03,0,0,17102,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13358,0.000000e+00,0,0,42750,0.000000e+00,0,0,15690,0.000000e+00,0,8,7164,1.116690e-03,0,20,16212,1.233650e-03,0,0,30502,0.000000e+00,0,0,6212,0.000000e+00,0,0,13412,0.000000e+00,0,0,16696,0.000000e+00,0,1,89468,1.117720e-05,0,0,30604,0.000000e+00,0,20,16212,1.233650e-03,0,19,14900,1.275170e-03,0,0,34234,0.000000e+00,0,0,9564,0.000000e+00,0,0,17692,0.000000e+00,0,0,21582,0.000000e+00,0,1,102490,9.757050e-06,0,0,30522,0.000000e+00,0,19,14900,1.275170e-03,0,.,151,1614106,9.355020e-05,1,110,75040,1.465880e-03,0,110,75040,1.465880e-03,0,0,910,0.000000e+00,0,4,60026,6.663780e-05,0,0,29606,0.000000e+00,0,0,44870,0.000000e+00,0,0,64012,0.000000e+00,0,6,6036,9.940360e-04,1,20,1180020,1.694890e-05,0,0,91080,0.000000e+00,0,5,156854,3.1876777130325014E-5,0,352,0,0,2686,0,8,8770,9.122006841505131E-4,0,442,0,0,950,0,0,652,0,0,280,0,1,9042,1.1059500110595002E-4,8,9122,8.770006577504934E-4,0,3338,0,14,180028,7.776568089408314E-5,Benign/Likely_benign,Acute_intermittent_porphyria|not_provided,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119093272G>A,ClinGen:CA272871,C0162565|C3661900,176000,79276,.,Asp,Asn,171132.0,single nucleotide variant,NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn),3145.0,HMBS,HGNC:4982,Benign/Likely benign,0.0,"Jan 01, 2025",144949995.0,-,RCV000148507|RCV001356682,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119093272.0,119093272.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA272871,2.0,161249.0,119093272.0,G,A,-,-,-,-,-,-,SCV001259472|SCV002447753,-,-,1075G>A ,Asp359Asn,NM_000190.4,2.0,2_Benign,77.6,0.6932515337423313,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",D,113,77.6,Negatively-charged,Aspartic Acid,Porphobilinogen deaminase,,,-3.5,,,D359-R355; PAE: 2.0,1 interaction,D359-R355; PAE: 2.0,1 interaction,,,132,,-76.8,,,-26.5,,,H (helix),H (α-helix),,,,0.741,1 mutation(s) (Asp359Ala: 1.522),0.775,1 mutation(s) (Asp359Ala: 1.538),0.743,1 mutation(s) (Asp359Ala: 1.528),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var211121,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119093272.0,119093272.0,,1075,G,A,359.0,D,N,c.1075G>A,p.Asp359Asn,missense_variant,missense_variant,0.723369732,,No,0.0000935502377167,Benign/Likely benign,"criteria provided, multiple submitters, no conflicts","Dec 27, 2023",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.669,0.1264,likely_benign,,,,,,,,,,,,,,,,,,,HMBS_Asp359Asn,true,Asp359Asn
HMBS_Asp359Asn,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200947,CCSBVarC005179,ALE00005179,NC_000011.10:119093272:G:A,1075G>A,Asp359Asn,CEGS2,CegsMutGDEh1042,H08,GDEhDisVCh_40054,H07,2.0,CegsMutGDDh1042,H08,,,,,,,1.0,1.0,1.0,2.0,0.0,,,0.0,,,0.0,,,11,119093272,G,A,11,Y,Y,N,N,N,11-119093272-G-A,171132.0,single nucleotide variant,NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn),3145.0,HMBS,HGNC:4982,Benign/Likely benign,0.0,"Jan 01, 2025",144949995.0,-,RCV000148507|RCV001356682,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119093272.0,119093272.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA272871,2.0,161249.0,119093272.0,G,A,-,-,-,-,-,-,SCV001259472|SCV002447753,-,-,1075G>A ,Asp359Asn,NM_000190.4,2.0,2_Benign,0.0000649879,161249.0,11,119093272.0,G,A,D,N,rs144949995,11,118963982,11,118469192,359.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.1075G>A,p.Asp359Asn,c.1075G>A,p.Asp359Asn,principal2,Y,.,YES,Select,+,GAT,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.65576,.,.,0.57446,.,0.979,0.62341,D,0.527,0.50892,P,.,0.10877,.,.,.,.,2.14,0.59685,M,.,0.38141,.,.,0.77038,1.0459,0.98026,D,0.9846,0.99532,D,10,.,0.30896,.,0.746723,0.97973,D,.,0.87667,.,.,.,.,.,.,0.91579,0.39072444537365264,0.38784,.,.,0.512455224991,0.40508,T,0.432739,0.77879,T,-0.170586,0.24805,T,-0.0682527,0.65505,T,0.104062861534229,0.12635,T,0.910309,0.68120,D,0.3453892,0.56375,0.3170101,0.57454,0.37713367,0.58781,0.32851937,0.58510,-4.539,0.33492,T,0.1264,0.27406,B,0.948487344713086,0.80270,0.03907438,0.56847,0.765,0.86988,.,.,.,.,.,.,4.645467,0.74048,26.1,0.99903784978921351,0.97503,0.952613,0.96811,D,0.622631496984238,0.74470,6.161659,0.651979823880355,0.78641,6.941212,4.99,4.99,0.65898,.,.,9.075,0.93427,11.804000,0.96740,0.66,0.55068,1.0,0.71675,1.000000,0.68239,0.972,0.54981,228,0.91137,1,1.9968051118210862E-4,1,7.564296520423601E-4,0,0.0,0,0.0,0,0.0,0,0.0,113,264690,4.269145E-4,.,8,109344,7.316360e-05,0,24,207970,1.154010e-04,1,22,236602,9.298320e-05,1,8,7164,1.116690e-03,0,0,17102,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13358,0.000000e+00,0,0,42750,0.000000e+00,0,0,15690,0.000000e+00,0,8,7164,1.116690e-03,0,20,16212,1.233650e-03,0,0,30502,0.000000e+00,0,0,6212,0.000000e+00,0,0,13412,0.000000e+00,0,0,16696,0.000000e+00,0,1,89468,1.117720e-05,0,0,30604,0.000000e+00,0,20,16212,1.233650e-03,0,19,14900,1.275170e-03,0,0,34234,0.000000e+00,0,0,9564,0.000000e+00,0,0,17692,0.000000e+00,0,0,21582,0.000000e+00,0,1,102490,9.757050e-06,0,0,30522,0.000000e+00,0,19,14900,1.275170e-03,0,.,151,1614106,9.355020e-05,1,110,75040,1.465880e-03,0,110,75040,1.465880e-03,0,0,910,0.000000e+00,0,4,60026,6.663780e-05,0,0,29606,0.000000e+00,0,0,44870,0.000000e+00,0,0,64012,0.000000e+00,0,6,6036,9.940360e-04,1,20,1180020,1.694890e-05,0,0,91080,0.000000e+00,0,5,156854,3.1876777130325014E-5,0,352,0,0,2686,0,8,8770,9.122006841505131E-4,0,442,0,0,950,0,0,652,0,0,280,0,1,9042,1.1059500110595002E-4,8,9122,8.770006577504934E-4,0,3338,0,14,180028,7.776568089408314E-5,Benign/Likely_benign,Acute_intermittent_porphyria|not_provided,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119093272G>A,ClinGen:CA272871,C0162565|C3661900,176000,79276,.,Asp,Asn,171132.0,single nucleotide variant,NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn),3145.0,HMBS,HGNC:4982,Benign/Likely benign,0.0,"Jan 01, 2025",144949995.0,-,RCV000148507|RCV001356682,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119093272.0,119093272.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA272871,2.0,161249.0,119093272.0,G,A,-,-,-,-,-,-,SCV001259472|SCV002447753,-,-,1075G>A ,Asp359Asn,NM_000190.4,2.0,2_Benign,77.6,0.6932515337423313,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",D,113,77.6,Negatively-charged,Aspartic Acid,Porphobilinogen deaminase,,,-3.5,,,D359-R355; PAE: 2.0,1 interaction,D359-R355; PAE: 2.0,1 interaction,,,132,,-76.8,,,-26.5,,,H (helix),H (α-helix),,,,0.741,1 mutation(s) (Asp359Ala: 1.522),0.775,1 mutation(s) (Asp359Ala: 1.538),0.743,1 mutation(s) (Asp359Ala: 1.528),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var217919,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119093272.0,119093272.0,,1075,G,A,359.0,D,N,c.1075G>A,p.Asp359Asn,missense_variant,missense_variant,0.705900403,,No,0.0000935502377167,Benign/Likely benign,"criteria provided, multiple submitters, no conflicts","Dec 27, 2023",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.669,0.1264,likely_benign,,,,,,,,,,,,,,,,,,,HMBS_Asp359Asn,true,Asp359Asn
HMBS_Asp359Asn,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200947,CCSBVarC005179,ALE00005179,NC_000011.10:119093272:G:A,1075G>A,Asp359Asn,CEGS2,CegsMutGDEh1042,H08,GDEhDisVCh_40054,H07,2.0,CegsMutGDDh1042,H08,,,,,,,1.0,1.0,1.0,2.0,0.0,,,0.0,,,0.0,,,11,119093272,G,A,11,Y,Y,N,N,N,11-119093272-G-A,171132.0,single nucleotide variant,NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn),3145.0,HMBS,HGNC:4982,Benign/Likely benign,0.0,"Jan 01, 2025",144949995.0,-,RCV000148507|RCV001356682,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119093272.0,119093272.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA272871,2.0,161249.0,119093272.0,G,A,-,-,-,-,-,-,SCV001259472|SCV002447753,-,-,1075G>A ,Asp359Asn,NM_000190.4,2.0,2_Benign,0.0000649879,161249.0,11,119093272.0,G,A,D,N,rs144949995,11,118963982,11,118469192,359.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.1075G>A,p.Asp359Asn,c.1075G>A,p.Asp359Asn,principal2,Y,.,YES,Select,+,GAT,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.65576,.,.,0.57446,.,0.979,0.62341,D,0.527,0.50892,P,.,0.10877,.,.,.,.,2.14,0.59685,M,.,0.38141,.,.,0.77038,1.0459,0.98026,D,0.9846,0.99532,D,10,.,0.30896,.,0.746723,0.97973,D,.,0.87667,.,.,.,.,.,.,0.91579,0.39072444537365264,0.38784,.,.,0.512455224991,0.40508,T,0.432739,0.77879,T,-0.170586,0.24805,T,-0.0682527,0.65505,T,0.104062861534229,0.12635,T,0.910309,0.68120,D,0.3453892,0.56375,0.3170101,0.57454,0.37713367,0.58781,0.32851937,0.58510,-4.539,0.33492,T,0.1264,0.27406,B,0.948487344713086,0.80270,0.03907438,0.56847,0.765,0.86988,.,.,.,.,.,.,4.645467,0.74048,26.1,0.99903784978921351,0.97503,0.952613,0.96811,D,0.622631496984238,0.74470,6.161659,0.651979823880355,0.78641,6.941212,4.99,4.99,0.65898,.,.,9.075,0.93427,11.804000,0.96740,0.66,0.55068,1.0,0.71675,1.000000,0.68239,0.972,0.54981,228,0.91137,1,1.9968051118210862E-4,1,7.564296520423601E-4,0,0.0,0,0.0,0,0.0,0,0.0,113,264690,4.269145E-4,.,8,109344,7.316360e-05,0,24,207970,1.154010e-04,1,22,236602,9.298320e-05,1,8,7164,1.116690e-03,0,0,17102,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13358,0.000000e+00,0,0,42750,0.000000e+00,0,0,15690,0.000000e+00,0,8,7164,1.116690e-03,0,20,16212,1.233650e-03,0,0,30502,0.000000e+00,0,0,6212,0.000000e+00,0,0,13412,0.000000e+00,0,0,16696,0.000000e+00,0,1,89468,1.117720e-05,0,0,30604,0.000000e+00,0,20,16212,1.233650e-03,0,19,14900,1.275170e-03,0,0,34234,0.000000e+00,0,0,9564,0.000000e+00,0,0,17692,0.000000e+00,0,0,21582,0.000000e+00,0,1,102490,9.757050e-06,0,0,30522,0.000000e+00,0,19,14900,1.275170e-03,0,.,151,1614106,9.355020e-05,1,110,75040,1.465880e-03,0,110,75040,1.465880e-03,0,0,910,0.000000e+00,0,4,60026,6.663780e-05,0,0,29606,0.000000e+00,0,0,44870,0.000000e+00,0,0,64012,0.000000e+00,0,6,6036,9.940360e-04,1,20,1180020,1.694890e-05,0,0,91080,0.000000e+00,0,5,156854,3.1876777130325014E-5,0,352,0,0,2686,0,8,8770,9.122006841505131E-4,0,442,0,0,950,0,0,652,0,0,280,0,1,9042,1.1059500110595002E-4,8,9122,8.770006577504934E-4,0,3338,0,14,180028,7.776568089408314E-5,Benign/Likely_benign,Acute_intermittent_porphyria|not_provided,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000011.10:g.119093272G>A,ClinGen:CA272871,C0162565|C3661900,176000,79276,.,Asp,Asn,171132.0,single nucleotide variant,NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn),3145.0,HMBS,HGNC:4982,Benign/Likely benign,0.0,"Jan 01, 2025",144949995.0,-,RCV000148507|RCV001356682,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119093272.0,119093272.0,11q23.3,"criteria provided, multiple submitters, no conflicts",4.0,-,N,ClinGen:CA272871,2.0,161249.0,119093272.0,G,A,-,-,-,-,-,-,SCV001259472|SCV002447753,-,-,1075G>A ,Asp359Asn,NM_000190.4,2.0,2_Benign,77.6,0.6932515337423313,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",D,113,77.6,Negatively-charged,Aspartic Acid,Porphobilinogen deaminase,,,-3.5,,,D359-R355; PAE: 2.0,1 interaction,D359-R355; PAE: 2.0,1 interaction,,,132,,-76.8,,,-26.5,,,H (helix),H (α-helix),,,,0.741,1 mutation(s) (Asp359Ala: 1.522),0.775,1 mutation(s) (Asp359Ala: 1.538),0.743,1 mutation(s) (Asp359Ala: 1.528),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var204826,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119093272.0,119093272.0,,1075,G,A,359.0,D,N,c.1075G>A,p.Asp359Asn,missense_variant,missense_variant,0.6496385170000001,,No,0.0000935502377167,Benign/Likely benign,"criteria provided, multiple submitters, no conflicts","Dec 27, 2023",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.669,0.1264,likely_benign,,,,,,,,,,,,,,,,,,,HMBS_Asp359Asn,true,Asp359Asn
HMBS_Cys247Arg,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200941,CCSBVarC005173,ALE00005173,NC_000011.10:119092491:T:C,739T>C,Cys247Arg,CEGS2,CegsMutGDEh1038,E07,GDEhDisVCh_40054,A04,2.0,CegsMutGDDh1038,E07,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092491,T,C,11,Y,Y,N,N,N,11-119092491-T-C,16508.0,single nucleotide variant,NM_000190.4(HMBS):c.739T>C (p.Cys247Arg),3145.0,HMBS,HGNC:4982,Likely pathogenic,1.0,"Apr 27, 2022",118204111.0,-,RCV000001534|RCV002298429,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119092491.0,119092491.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"OMIM:609806.0029,ClinGen:CA251828,UniProtKB:P08397#VAR_003664",3.0,1469.0,119092491.0,T,C,-,-,-,-,-,-,SCV002588423,-,-,739T>C ,Cys247Arg,NM_000190.4,1.0,1_Pathogenic,,1469.0,11,119092491.0,T,C,C,R,rs118204111,11,118963201,11,118468411,247.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.739T>C,p.Cys247Arg,c.739T>C,p.Cys247Arg,principal2,Y,.,YES,Select,+,TGC,1.0,0.0,T,T/T,T/T,T/T,T/T,.,0.78662,.,.,0.79703,.,0.998,0.73231,D,0.971,0.72446,D,.,0.99291,.,.,.,.,3.925,0.96220,H,.,0.98155,.,.,0.99676,1.0903,0.99249,D,0.9702,0.99058,D,9,.,0.99822,.,0.647307,0.97002,D,.,0.99874,0.963,0.99626,P08397,C247R,Gain of MoRF binding (P = 0.0818)| Loss of stability (P = 0.1649)| Gain of phosphorylation at T243 (P = 0.1874)| Gain of loop (P = 0.2045)| Gain of disorder (P = 0.2752),.,0.97282,0.9822774360526177,0.98211,.,.,0.795790910721,0.81289,T,0.987516,0.99931,D,0.5811,0.96983,D,0.596934,0.96933,D,0.999698281288147,0.98518,D,0.981319,0.93978,D,0.9981772,0.99999,0.99488765,0.99998,0.9974032,0.99996,0.9917317,0.99988,-10.862,0.79915,D,0.9946,0.95323,P,0.99971834985505,0.97610,0.41990957,0.80070,0.992,0.99727,.,.,.,.,.,.,5.30356,0.89052,29.8,0.99728061688826253,0.82565,0.980876,0.99856,D,0.910860435130785,0.92239,11.33446,0.838709940678899,0.92296,11.37002,5.24,5.24,0.72825,.,.,7.802,0.84573,7.871000,0.72005,0.665,0.62996,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Likely_pathogenic,Acute_intermittent_porphyria|not_provided,"criteria_provided,_single_submitter",NC_000011.10:g.119092491T>C,ClinGen:CA251828|OMIM:609806.0029|UniProtKB:P08397#VAR_003664,C0162565|C3661900,176000,79276,"Porphobilinogen deaminase, C-terminal",Cys,Arg,16508.0,single nucleotide variant,NM_000190.4(HMBS):c.739T>C (p.Cys247Arg),3145.0,HMBS,HGNC:4982,Likely pathogenic,1.0,"Apr 27, 2022",118204111.0,-,RCV000001534|RCV002298429,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119092491.0,119092491.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"OMIM:609806.0029,ClinGen:CA251828,UniProtKB:P08397#VAR_003664",3.0,1469.0,119092491.0,T,C,-,-,-,-,-,-,SCV002588423,-,-,739T>C ,Cys247Arg,NM_000190.4,1.0,1_Pathogenic,98.65,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",C,0,98.65,"Special, a very reactive sulfhydryl group",Cysteine,Porphobilinogen deaminase,,,2.5,,,"C247-R251, C247-T243; PAE: 1.0, 1.0",9 interactions,"C247-R251, C247-T243; PAE: 1.0, 1.0",9 interactions,,,121,,-68.2,,,-32.6,,,H (helix),H (α-helix),Helix,,,0.369,1 mutation(s) (Cys247Ile: -1.123),0.265,1 mutation(s) (Cys247Ile: -1.145),0.414,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_erythroid_var210803,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119092491.0,119092491.0,,739,T,C,247.0,C,R,c.739T>C,p.Cys247Arg,missense_variant,missense_variant,-0.126983089,,No,,Likely pathogenic,"criteria provided, single submitter","Apr 27, 2022",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.981,0.9946,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Cys247Arg,true,Cys247Arg
HMBS_Cys247Arg,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200941,CCSBVarC005173,ALE00005173,NC_000011.10:119092491:T:C,739T>C,Cys247Arg,CEGS2,CegsMutGDEh1038,E07,GDEhDisVCh_40054,A04,2.0,CegsMutGDDh1038,E07,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092491,T,C,11,Y,Y,N,N,N,11-119092491-T-C,16508.0,single nucleotide variant,NM_000190.4(HMBS):c.739T>C (p.Cys247Arg),3145.0,HMBS,HGNC:4982,Likely pathogenic,1.0,"Apr 27, 2022",118204111.0,-,RCV000001534|RCV002298429,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119092491.0,119092491.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"OMIM:609806.0029,ClinGen:CA251828,UniProtKB:P08397#VAR_003664",3.0,1469.0,119092491.0,T,C,-,-,-,-,-,-,SCV002588423,-,-,739T>C ,Cys247Arg,NM_000190.4,1.0,1_Pathogenic,,1469.0,11,119092491.0,T,C,C,R,rs118204111,11,118963201,11,118468411,247.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.739T>C,p.Cys247Arg,c.739T>C,p.Cys247Arg,principal2,Y,.,YES,Select,+,TGC,1.0,0.0,T,T/T,T/T,T/T,T/T,.,0.78662,.,.,0.79703,.,0.998,0.73231,D,0.971,0.72446,D,.,0.99291,.,.,.,.,3.925,0.96220,H,.,0.98155,.,.,0.99676,1.0903,0.99249,D,0.9702,0.99058,D,9,.,0.99822,.,0.647307,0.97002,D,.,0.99874,0.963,0.99626,P08397,C247R,Gain of MoRF binding (P = 0.0818)| Loss of stability (P = 0.1649)| Gain of phosphorylation at T243 (P = 0.1874)| Gain of loop (P = 0.2045)| Gain of disorder (P = 0.2752),.,0.97282,0.9822774360526177,0.98211,.,.,0.795790910721,0.81289,T,0.987516,0.99931,D,0.5811,0.96983,D,0.596934,0.96933,D,0.999698281288147,0.98518,D,0.981319,0.93978,D,0.9981772,0.99999,0.99488765,0.99998,0.9974032,0.99996,0.9917317,0.99988,-10.862,0.79915,D,0.9946,0.95323,P,0.99971834985505,0.97610,0.41990957,0.80070,0.992,0.99727,.,.,.,.,.,.,5.30356,0.89052,29.8,0.99728061688826253,0.82565,0.980876,0.99856,D,0.910860435130785,0.92239,11.33446,0.838709940678899,0.92296,11.37002,5.24,5.24,0.72825,.,.,7.802,0.84573,7.871000,0.72005,0.665,0.62996,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Likely_pathogenic,Acute_intermittent_porphyria|not_provided,"criteria_provided,_single_submitter",NC_000011.10:g.119092491T>C,ClinGen:CA251828|OMIM:609806.0029|UniProtKB:P08397#VAR_003664,C0162565|C3661900,176000,79276,"Porphobilinogen deaminase, C-terminal",Cys,Arg,16508.0,single nucleotide variant,NM_000190.4(HMBS):c.739T>C (p.Cys247Arg),3145.0,HMBS,HGNC:4982,Likely pathogenic,1.0,"Apr 27, 2022",118204111.0,-,RCV000001534|RCV002298429,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119092491.0,119092491.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"OMIM:609806.0029,ClinGen:CA251828,UniProtKB:P08397#VAR_003664",3.0,1469.0,119092491.0,T,C,-,-,-,-,-,-,SCV002588423,-,-,739T>C ,Cys247Arg,NM_000190.4,1.0,1_Pathogenic,98.65,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",C,0,98.65,"Special, a very reactive sulfhydryl group",Cysteine,Porphobilinogen deaminase,,,2.5,,,"C247-R251, C247-T243; PAE: 1.0, 1.0",9 interactions,"C247-R251, C247-T243; PAE: 1.0, 1.0",9 interactions,,,121,,-68.2,,,-32.6,,,H (helix),H (α-helix),Helix,,,0.369,1 mutation(s) (Cys247Ile: -1.123),0.265,1 mutation(s) (Cys247Ile: -1.145),0.414,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_combined_var217636,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119092491.0,119092491.0,,739,T,C,247.0,C,R,c.739T>C,p.Cys247Arg,missense_variant,missense_variant,0.0,,No,,Likely pathogenic,"criteria provided, single submitter","Apr 27, 2022",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.981,0.9946,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Cys247Arg,true,Cys247Arg
HMBS_Cys247Arg,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200941,CCSBVarC005173,ALE00005173,NC_000011.10:119092491:T:C,739T>C,Cys247Arg,CEGS2,CegsMutGDEh1038,E07,GDEhDisVCh_40054,A04,2.0,CegsMutGDDh1038,E07,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092491,T,C,11,Y,Y,N,N,N,11-119092491-T-C,16508.0,single nucleotide variant,NM_000190.4(HMBS):c.739T>C (p.Cys247Arg),3145.0,HMBS,HGNC:4982,Likely pathogenic,1.0,"Apr 27, 2022",118204111.0,-,RCV000001534|RCV002298429,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119092491.0,119092491.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"OMIM:609806.0029,ClinGen:CA251828,UniProtKB:P08397#VAR_003664",3.0,1469.0,119092491.0,T,C,-,-,-,-,-,-,SCV002588423,-,-,739T>C ,Cys247Arg,NM_000190.4,1.0,1_Pathogenic,,1469.0,11,119092491.0,T,C,C,R,rs118204111,11,118963201,11,118468411,247.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.739T>C,p.Cys247Arg,c.739T>C,p.Cys247Arg,principal2,Y,.,YES,Select,+,TGC,1.0,0.0,T,T/T,T/T,T/T,T/T,.,0.78662,.,.,0.79703,.,0.998,0.73231,D,0.971,0.72446,D,.,0.99291,.,.,.,.,3.925,0.96220,H,.,0.98155,.,.,0.99676,1.0903,0.99249,D,0.9702,0.99058,D,9,.,0.99822,.,0.647307,0.97002,D,.,0.99874,0.963,0.99626,P08397,C247R,Gain of MoRF binding (P = 0.0818)| Loss of stability (P = 0.1649)| Gain of phosphorylation at T243 (P = 0.1874)| Gain of loop (P = 0.2045)| Gain of disorder (P = 0.2752),.,0.97282,0.9822774360526177,0.98211,.,.,0.795790910721,0.81289,T,0.987516,0.99931,D,0.5811,0.96983,D,0.596934,0.96933,D,0.999698281288147,0.98518,D,0.981319,0.93978,D,0.9981772,0.99999,0.99488765,0.99998,0.9974032,0.99996,0.9917317,0.99988,-10.862,0.79915,D,0.9946,0.95323,P,0.99971834985505,0.97610,0.41990957,0.80070,0.992,0.99727,.,.,.,.,.,.,5.30356,0.89052,29.8,0.99728061688826253,0.82565,0.980876,0.99856,D,0.910860435130785,0.92239,11.33446,0.838709940678899,0.92296,11.37002,5.24,5.24,0.72825,.,.,7.802,0.84573,7.871000,0.72005,0.665,0.62996,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Likely_pathogenic,Acute_intermittent_porphyria|not_provided,"criteria_provided,_single_submitter",NC_000011.10:g.119092491T>C,ClinGen:CA251828|OMIM:609806.0029|UniProtKB:P08397#VAR_003664,C0162565|C3661900,176000,79276,"Porphobilinogen deaminase, C-terminal",Cys,Arg,16508.0,single nucleotide variant,NM_000190.4(HMBS):c.739T>C (p.Cys247Arg),3145.0,HMBS,HGNC:4982,Likely pathogenic,1.0,"Apr 27, 2022",118204111.0,-,RCV000001534|RCV002298429,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline,germline,GRCh38,NC_000011.10,11,119092491.0,119092491.0,11q23.3,"criteria provided, single submitter",2.0,-,N,"OMIM:609806.0029,ClinGen:CA251828,UniProtKB:P08397#VAR_003664",3.0,1469.0,119092491.0,T,C,-,-,-,-,-,-,SCV002588423,-,-,739T>C ,Cys247Arg,NM_000190.4,1.0,1_Pathogenic,98.65,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",C,0,98.65,"Special, a very reactive sulfhydryl group",Cysteine,Porphobilinogen deaminase,,,2.5,,,"C247-R251, C247-T243; PAE: 1.0, 1.0",9 interactions,"C247-R251, C247-T243; PAE: 1.0, 1.0",9 interactions,,,121,,-68.2,,,-32.6,,,H (helix),H (α-helix),Helix,,,0.369,1 mutation(s) (Cys247Ile: -1.123),0.265,1 mutation(s) (Cys247Ile: -1.145),0.414,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_ubquitous_var204672,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119092491.0,119092491.0,,739,T,C,247.0,C,R,c.739T>C,p.Cys247Arg,missense_variant,missense_variant,0.067977338,,No,,Likely pathogenic,"criteria provided, single submitter","Apr 27, 2022",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.981,0.9946,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Cys247Arg,true,Cys247Arg
HMBS_Gln34Lys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200923,CCSBVarC005158,ALE00005158,NC_000011.10:119088647:C:A,100C>A,Gln34Lys,CEGS2,CegsMutGDEh1039,A04,GDEhDisVCh_40054,E04,2.0,CegsMutGDDh1039,A04,,,,,,,1.0,6.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119088647,C,A,11,N,Y,N,N,N,11-119088647-C-A,16494.0,single nucleotide variant,NM_000190.4(HMBS):c.100C>A (p.Gln34Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Sep 01, 1992",118204105.0,-,RCV000001520,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119088647.0,119088647.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251811,UniProtKB:P08397#VAR_003641,OMIM:609806.0017",1.0,1455.0,119088647.0,C,A,-,-,-,-,-,-,SCV000021675,-,-,100C>A ,Gln34Lys,NM_000190.4,,1_Pathogenic,,1455.0,11,119088647.0,C,A,Q,K,rs118204105,11,118959357,11,118464567,34.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.100C>A,p.Gln34Lys,c.100C>A,p.Gln34Lys,principal2,Y,.,YES,Select,+,CAG,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.998,0.88579,D,.,0.97016,.,.,.,.,4.47,0.98862,H,.,0.72746,.,.,0.99974,0.9038,0.95714,D,0.9962,0.99912,D,9,.,0.99628,.,0.666812,0.97207,D,.,0.99695,0.988,0.99876,P08397,Q34K,Gain of catalytic residue at Q34 (P = 0.0293)| Gain of MoRF binding (P = 0.0502)| Gain of phosphorylation at T35 (P = 0.1359)| Gain of disorder (P = 0.1863)| Gain of methylation at Q34 (P = 0.1955),.,0.98290,0.98746795927839,0.98736,.,.,0.668422341347,0.62552,T,0.996415,0.99995,D,0.580589,0.96975,D,0.5962,0.96926,D,0.999150395393372,0.96329,D,0.949805,0.88094,D,0.9930165,0.99899,0.9686536,0.99395,0.99230266,0.99870,0.9659788,0.99268,-18.924,0.99796,D,0.975,0.91467,P,0.999930232982536,0.98982,0.40520808,0.79716,1,0.99985,.,.,.,.,.,.,5.269885,0.88506,29.6,0.98478870246162831,0.42080,0.860229,0.77724,D,1.01097472279383,0.96050,14.27046,0.895296341151146,0.95337,13.55232,4.96,4.96,0.65108,.,.,6.969,0.75938,7.664000,0.64459,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.999,0.91597,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119088647C>A,ClinGen:CA251811|OMIM:609806.0017|UniProtKB:P08397#VAR_003641,C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Gln,Lys,16494.0,single nucleotide variant,NM_000190.4(HMBS):c.100C>A (p.Gln34Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Sep 01, 1992",118204105.0,-,RCV000001520,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119088647.0,119088647.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251811,UniProtKB:P08397#VAR_003641,OMIM:609806.0017",1.0,1455.0,119088647.0,C,A,-,-,-,-,-,-,SCV000021675,-,-,100C>A ,Gln34Lys,NM_000190.4,,1_Pathogenic,98.03,0.0353535353535353,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",Q,7,98.03,Polar/Neutral,Glutamine,Porphobilinogen deaminase,,,-3.5,,,"Q34-V38, Q34-L30, Q34-S96; PAE: 1.0, 1.0, 1.0",10 interactions,"Q34-V38, Q34-R195, Q34-L30; PAE: 1.0, 1.0, 1.0",10 interactions,,,146,Mutation: Q -> A. Loss of hydroxymethylbilane synthase activity.,-60.5,,,-47.2,,dbSNP: rs118204105; Variant type: LP/P; AA change: Gln34Lys; PTM type: Phosphorylation; PTM morphology: LARIQ*tDSVVA; Var class: II&-,H (helix),H (α-helix),Helix,,,,,0.199,,0.336,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var210660,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119088647.0,119088647.0,,100,C,A,34.0,Q,K,c.100C>A,p.Gln34Lys,missense_variant,missense_variant,-0.608830582,,No,,Pathogenic,no assertion criteria provided,"Sep 01, 1992",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.972,0.975,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Gln34Lys,true,Gln34Lys
HMBS_Gln34Lys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200923,CCSBVarC005158,ALE00005158,NC_000011.10:119088647:C:A,100C>A,Gln34Lys,CEGS2,CegsMutGDEh1039,A04,GDEhDisVCh_40054,E04,2.0,CegsMutGDDh1039,A04,,,,,,,1.0,6.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119088647,C,A,11,N,Y,N,N,N,11-119088647-C-A,16494.0,single nucleotide variant,NM_000190.4(HMBS):c.100C>A (p.Gln34Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Sep 01, 1992",118204105.0,-,RCV000001520,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119088647.0,119088647.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251811,UniProtKB:P08397#VAR_003641,OMIM:609806.0017",1.0,1455.0,119088647.0,C,A,-,-,-,-,-,-,SCV000021675,-,-,100C>A ,Gln34Lys,NM_000190.4,,1_Pathogenic,,1455.0,11,119088647.0,C,A,Q,K,rs118204105,11,118959357,11,118464567,34.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.100C>A,p.Gln34Lys,c.100C>A,p.Gln34Lys,principal2,Y,.,YES,Select,+,CAG,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,0.998,0.88579,D,.,0.97016,.,.,.,.,4.47,0.98862,H,.,0.72746,.,.,0.99974,0.9038,0.95714,D,0.9962,0.99912,D,9,.,0.99628,.,0.666812,0.97207,D,.,0.99695,0.988,0.99876,P08397,Q34K,Gain of catalytic residue at Q34 (P = 0.0293)| Gain of MoRF binding (P = 0.0502)| Gain of phosphorylation at T35 (P = 0.1359)| Gain of disorder (P = 0.1863)| Gain of methylation at Q34 (P = 0.1955),.,0.98290,0.98746795927839,0.98736,.,.,0.668422341347,0.62552,T,0.996415,0.99995,D,0.580589,0.96975,D,0.5962,0.96926,D,0.999150395393372,0.96329,D,0.949805,0.88094,D,0.9930165,0.99899,0.9686536,0.99395,0.99230266,0.99870,0.9659788,0.99268,-18.924,0.99796,D,0.975,0.91467,P,0.999930232982536,0.98982,0.40520808,0.79716,1,0.99985,.,.,.,.,.,.,5.269885,0.88506,29.6,0.98478870246162831,0.42080,0.860229,0.77724,D,1.01097472279383,0.96050,14.27046,0.895296341151146,0.95337,13.55232,4.96,4.96,0.65108,.,.,6.969,0.75938,7.664000,0.64459,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.999,0.91597,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119088647C>A,ClinGen:CA251811|OMIM:609806.0017|UniProtKB:P08397#VAR_003641,C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Gln,Lys,16494.0,single nucleotide variant,NM_000190.4(HMBS):c.100C>A (p.Gln34Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Sep 01, 1992",118204105.0,-,RCV000001520,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119088647.0,119088647.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251811,UniProtKB:P08397#VAR_003641,OMIM:609806.0017",1.0,1455.0,119088647.0,C,A,-,-,-,-,-,-,SCV000021675,-,-,100C>A ,Gln34Lys,NM_000190.4,,1_Pathogenic,98.03,0.0353535353535353,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",Q,7,98.03,Polar/Neutral,Glutamine,Porphobilinogen deaminase,,,-3.5,,,"Q34-V38, Q34-L30, Q34-S96; PAE: 1.0, 1.0, 1.0",10 interactions,"Q34-V38, Q34-R195, Q34-L30; PAE: 1.0, 1.0, 1.0",10 interactions,,,146,Mutation: Q -> A. Loss of hydroxymethylbilane synthase activity.,-60.5,,,-47.2,,dbSNP: rs118204105; Variant type: LP/P; AA change: Gln34Lys; PTM type: Phosphorylation; PTM morphology: LARIQ*tDSVVA; Var class: II&-,H (helix),H (α-helix),Helix,,,,,0.199,,0.336,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var217322,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119088647.0,119088647.0,,100,C,A,34.0,Q,K,c.100C>A,p.Gln34Lys,missense_variant,missense_variant,0.0,,No,,Pathogenic,no assertion criteria provided,"Sep 01, 1992",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.972,0.975,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Gln34Lys,true,Gln34Lys
HMBS_Glu223Lys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200944,CCSBVarC005171,ALE00005171,NC_000011.10:119092419:G:A,667G>A,Glu223Lys,CEGS2,CegsMutGDEh1037,G11,GDEhDisVCh_40054,H03,2.0,CegsMutGDDh1037,G11,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092419,G,A,11,Y,Y,N,N,N,11-119092419-G-A,16506.0,single nucleotide variant,NM_000190.4(HMBS):c.667G>A (p.Glu223Lys),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,1.0,"Aug 08, 2019",118204110.0,-,RCV000001532|RCV001209137,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119092419.0,119092419.0,11q23.3,"criteria provided, conflicting classifications",3.0,-,N,"ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027",3.0,1467.0,119092419.0,G,A,-,-,-,-,-,-,SCV000923439|SCV001380560,-,-,667G>A ,Glu223Lys,NM_000190.4,1.0,3_Conflicting,1.36818e-6,1467.0,11,119092419.0,G,A,E,K,rs118204110,11,118963129,11,118468339,223.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.667G>A,p.Glu223Lys,c.667G>A,p.Glu223Lys,principal2,Y,.,YES,Select,+,GAA,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.83643,.,0.984,0.60748,D,0.844,0.60367,P,.,0.97016,.,.,.,.,4.39,0.98587,H,.,0.70105,.,.,0.98575,0.9422,0.96268,D,0.9940,0.99862,D,9,.,0.99405,.,0.620418,0.96706,D,.,0.99491,0.958,0.99550,P08397,E223K,Gain of ubiquitination at E223 (P = 0.0247)| Gain of methylation at E223 (P = 0.2525)| Gain of catalytic residue at G218 (P = 0.2916)| Loss of sheet (P = 0.302)| Gain of MoRF binding (P = 0.3431),.,0.96597,0.9828188442725427,0.98266,.,.,0.804392039776,0.82601,D,0.993857,0.99983,D,0.578822,0.96948,D,0.593661,0.96898,D,0.999448597431183,0.97407,D,0.998339,0.99218,D,0.99575716,0.99977,0.9741762,0.99627,0.99394846,0.99931,0.9588173,0.98891,-12.917,0.89042,D,0.9885,0.93132,P,0.999885612956612,0.98571,0.39407990,0.79441,0.997,0.99892,.,.,.,.,.,.,5.893047,0.93979,33.0,0.99921160894565186,0.98788,0.960290,0.98095,D,1.07768468966601,0.97685,16.59439,0.984470716393643,0.98295,17.92141,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.989,0.64309,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,2,1614098,1.239080e-06,0,2,1180018,1.694890e-06,0,0,75058,0.000000e+00,0,0,912,0.000000e+00,0,0,60020,0.000000e+00,0,0,29606,0.000000e+00,0,0,44878,0.000000e+00,0,0,63952,0.000000e+00,0,0,6060,0.000000e+00,0,2,1180018,1.694890e-06,0,0,91086,0.000000e+00,0,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Conflicting_classifications_of_pathogenicity,Acute_intermittent_porphyria|not_provided,"criteria_provided,_conflicting_classifications",NC_000011.10:g.119092419G>A,ClinGen:CA251826|OMIM:609806.0027|UniProtKB:P08397#VAR_003659,C0162565|C3661900,176000,79276,"Porphobilinogen deaminase, N-terminal",Glu,Lys,16506.0,single nucleotide variant,NM_000190.4(HMBS):c.667G>A (p.Glu223Lys),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,1.0,"Aug 08, 2019",118204110.0,-,RCV000001532|RCV001209137,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119092419.0,119092419.0,11q23.3,"criteria provided, conflicting classifications",3.0,-,N,"ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027",3.0,1467.0,119092419.0,G,A,-,-,-,-,-,-,SCV000923439|SCV001380560,-,-,667G>A ,Glu223Lys,NM_000190.4,1.0,3_Conflicting,98.19,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,0,98.19,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,,-3.5,,,E223-V93; PAE: 1.0,8 interactions,E223-V93; PAE: 1.0,8 interactions,,,146,,-88.3,,,135.5,,dbSNP: rs118204110; Variant type: LP/P; AA change: Glu223Lys; PTM type: Ubiquitylation; PTM morphology: VE*VRAkDQDIL; Var class: II,B (undefined),E (parallel sheets),Beta strand,,,0.256,1 mutation(s) (Glu223Met: -0.962),0.163,1 mutation(s) (Glu223Met: -1.384),0.32,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var217523,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119092419.0,119092419.0,,667,G,A,223.0,E,K,c.667G>A,p.Glu223Lys,missense_variant,missense_variant,0.0,,No,1.2390821375e-6,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Aug 08, 2019",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.964,0.9885,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Glu223Lys,true,Glu223Lys
HMBS_Glu223Lys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200944,CCSBVarC005171,ALE00005171,NC_000011.10:119092419:G:A,667G>A,Glu223Lys,CEGS2,CegsMutGDEh1037,G11,GDEhDisVCh_40054,H03,2.0,CegsMutGDDh1037,G11,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092419,G,A,11,Y,Y,N,N,N,11-119092419-G-A,16506.0,single nucleotide variant,NM_000190.4(HMBS):c.667G>A (p.Glu223Lys),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,1.0,"Aug 08, 2019",118204110.0,-,RCV000001532|RCV001209137,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119092419.0,119092419.0,11q23.3,"criteria provided, conflicting classifications",3.0,-,N,"ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027",3.0,1467.0,119092419.0,G,A,-,-,-,-,-,-,SCV000923439|SCV001380560,-,-,667G>A ,Glu223Lys,NM_000190.4,1.0,3_Conflicting,1.36818e-6,1467.0,11,119092419.0,G,A,E,K,rs118204110,11,118963129,11,118468339,223.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.667G>A,p.Glu223Lys,c.667G>A,p.Glu223Lys,principal2,Y,.,YES,Select,+,GAA,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.83643,.,0.984,0.60748,D,0.844,0.60367,P,.,0.97016,.,.,.,.,4.39,0.98587,H,.,0.70105,.,.,0.98575,0.9422,0.96268,D,0.9940,0.99862,D,9,.,0.99405,.,0.620418,0.96706,D,.,0.99491,0.958,0.99550,P08397,E223K,Gain of ubiquitination at E223 (P = 0.0247)| Gain of methylation at E223 (P = 0.2525)| Gain of catalytic residue at G218 (P = 0.2916)| Loss of sheet (P = 0.302)| Gain of MoRF binding (P = 0.3431),.,0.96597,0.9828188442725427,0.98266,.,.,0.804392039776,0.82601,D,0.993857,0.99983,D,0.578822,0.96948,D,0.593661,0.96898,D,0.999448597431183,0.97407,D,0.998339,0.99218,D,0.99575716,0.99977,0.9741762,0.99627,0.99394846,0.99931,0.9588173,0.98891,-12.917,0.89042,D,0.9885,0.93132,P,0.999885612956612,0.98571,0.39407990,0.79441,0.997,0.99892,.,.,.,.,.,.,5.893047,0.93979,33.0,0.99921160894565186,0.98788,0.960290,0.98095,D,1.07768468966601,0.97685,16.59439,0.984470716393643,0.98295,17.92141,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.989,0.64309,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,2,1614098,1.239080e-06,0,2,1180018,1.694890e-06,0,0,75058,0.000000e+00,0,0,912,0.000000e+00,0,0,60020,0.000000e+00,0,0,29606,0.000000e+00,0,0,44878,0.000000e+00,0,0,63952,0.000000e+00,0,0,6060,0.000000e+00,0,2,1180018,1.694890e-06,0,0,91086,0.000000e+00,0,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Conflicting_classifications_of_pathogenicity,Acute_intermittent_porphyria|not_provided,"criteria_provided,_conflicting_classifications",NC_000011.10:g.119092419G>A,ClinGen:CA251826|OMIM:609806.0027|UniProtKB:P08397#VAR_003659,C0162565|C3661900,176000,79276,"Porphobilinogen deaminase, N-terminal",Glu,Lys,16506.0,single nucleotide variant,NM_000190.4(HMBS):c.667G>A (p.Glu223Lys),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,1.0,"Aug 08, 2019",118204110.0,-,RCV000001532|RCV001209137,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119092419.0,119092419.0,11q23.3,"criteria provided, conflicting classifications",3.0,-,N,"ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027",3.0,1467.0,119092419.0,G,A,-,-,-,-,-,-,SCV000923439|SCV001380560,-,-,667G>A ,Glu223Lys,NM_000190.4,1.0,3_Conflicting,98.19,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,0,98.19,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,,-3.5,,,E223-V93; PAE: 1.0,8 interactions,E223-V93; PAE: 1.0,8 interactions,,,146,,-88.3,,,135.5,,dbSNP: rs118204110; Variant type: LP/P; AA change: Glu223Lys; PTM type: Ubiquitylation; PTM morphology: VE*VRAkDQDIL; Var class: II,B (undefined),E (parallel sheets),Beta strand,,,0.256,1 mutation(s) (Glu223Met: -0.962),0.163,1 mutation(s) (Glu223Met: -1.384),0.32,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var204348,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119092419.0,119092419.0,,667,G,A,223.0,E,K,c.667G>A,p.Glu223Lys,missense_variant,missense_variant,-0.013029526,,No,1.2390821375e-6,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Aug 08, 2019",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.964,0.9885,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Glu223Lys,true,Glu223Lys
HMBS_Glu223Lys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200944,CCSBVarC005171,ALE00005171,NC_000011.10:119092419:G:A,667G>A,Glu223Lys,CEGS2,CegsMutGDEh1037,G11,GDEhDisVCh_40054,H03,2.0,CegsMutGDDh1037,G11,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092419,G,A,11,Y,Y,N,N,N,11-119092419-G-A,16506.0,single nucleotide variant,NM_000190.4(HMBS):c.667G>A (p.Glu223Lys),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,1.0,"Aug 08, 2019",118204110.0,-,RCV000001532|RCV001209137,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119092419.0,119092419.0,11q23.3,"criteria provided, conflicting classifications",3.0,-,N,"ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027",3.0,1467.0,119092419.0,G,A,-,-,-,-,-,-,SCV000923439|SCV001380560,-,-,667G>A ,Glu223Lys,NM_000190.4,1.0,3_Conflicting,1.36818e-6,1467.0,11,119092419.0,G,A,E,K,rs118204110,11,118963129,11,118468339,223.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.667G>A,p.Glu223Lys,c.667G>A,p.Glu223Lys,principal2,Y,.,YES,Select,+,GAA,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.83643,.,0.984,0.60748,D,0.844,0.60367,P,.,0.97016,.,.,.,.,4.39,0.98587,H,.,0.70105,.,.,0.98575,0.9422,0.96268,D,0.9940,0.99862,D,9,.,0.99405,.,0.620418,0.96706,D,.,0.99491,0.958,0.99550,P08397,E223K,Gain of ubiquitination at E223 (P = 0.0247)| Gain of methylation at E223 (P = 0.2525)| Gain of catalytic residue at G218 (P = 0.2916)| Loss of sheet (P = 0.302)| Gain of MoRF binding (P = 0.3431),.,0.96597,0.9828188442725427,0.98266,.,.,0.804392039776,0.82601,D,0.993857,0.99983,D,0.578822,0.96948,D,0.593661,0.96898,D,0.999448597431183,0.97407,D,0.998339,0.99218,D,0.99575716,0.99977,0.9741762,0.99627,0.99394846,0.99931,0.9588173,0.98891,-12.917,0.89042,D,0.9885,0.93132,P,0.999885612956612,0.98571,0.39407990,0.79441,0.997,0.99892,.,.,.,.,.,.,5.893047,0.93979,33.0,0.99921160894565186,0.98788,0.960290,0.98095,D,1.07768468966601,0.97685,16.59439,0.984470716393643,0.98295,17.92141,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.989,0.64309,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,2,1614098,1.239080e-06,0,2,1180018,1.694890e-06,0,0,75058,0.000000e+00,0,0,912,0.000000e+00,0,0,60020,0.000000e+00,0,0,29606,0.000000e+00,0,0,44878,0.000000e+00,0,0,63952,0.000000e+00,0,0,6060,0.000000e+00,0,2,1180018,1.694890e-06,0,0,91086,0.000000e+00,0,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Conflicting_classifications_of_pathogenicity,Acute_intermittent_porphyria|not_provided,"criteria_provided,_conflicting_classifications",NC_000011.10:g.119092419G>A,ClinGen:CA251826|OMIM:609806.0027|UniProtKB:P08397#VAR_003659,C0162565|C3661900,176000,79276,"Porphobilinogen deaminase, N-terminal",Glu,Lys,16506.0,single nucleotide variant,NM_000190.4(HMBS):c.667G>A (p.Glu223Lys),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,1.0,"Aug 08, 2019",118204110.0,-,RCV000001532|RCV001209137,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900",Acute intermittent porphyria|not provided,germline;unknown,germline,GRCh38,NC_000011.10,11,119092419.0,119092419.0,11q23.3,"criteria provided, conflicting classifications",3.0,-,N,"ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027",3.0,1467.0,119092419.0,G,A,-,-,-,-,-,-,SCV000923439|SCV001380560,-,-,667G>A ,Glu223Lys,NM_000190.4,1.0,3_Conflicting,98.19,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,0,98.19,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,,-3.5,,,E223-V93; PAE: 1.0,8 interactions,E223-V93; PAE: 1.0,8 interactions,,,146,,-88.3,,,135.5,,dbSNP: rs118204110; Variant type: LP/P; AA change: Glu223Lys; PTM type: Ubiquitylation; PTM morphology: VE*VRAkDQDIL; Var class: II,B (undefined),E (parallel sheets),Beta strand,,,0.256,1 mutation(s) (Glu223Met: -0.962),0.163,1 mutation(s) (Glu223Met: -1.384),0.32,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var210370,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119092419.0,119092419.0,,667,G,A,223.0,E,K,c.667G>A,p.Glu223Lys,missense_variant,missense_variant,-0.298472164,,No,1.2390821375e-6,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Aug 08, 2019",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.964,0.9885,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Glu223Lys,true,Glu223Lys
HMBS_Glu250Lys,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200945,CCSBVarC005174,ALE00005174,NC_000011.10:119092500:G:A,748G>A,Glu250Lys,CEGS2,CegsMutGDEh1041,D10,GDEhDisVCh_40054,H06,2.0,CegsMutGDDh1041,D10,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092500,G,A,11,Y,Y,N,N,N,11-119092500-G-A,16510.0,single nucleotide variant,NM_000190.4(HMBS):c.748G>A (p.Glu250Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 1994",118204112.0,-,RCV000001536,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092500.0,119092500.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031",1.0,1471.0,119092500.0,G,A,-,-,-,-,-,-,SCV000021691,-,-,748G>A ,Glu250Lys,NM_000190.4,,1_Pathogenic,,1471.0,11,119092500.0,G,A,E,K,rs118204112,11,118963210,11,118468420,250.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.748G>A,p.Glu250Lys,c.748G>A,p.Glu250Lys,principal2,Y,.,YES,Select,+,GAA,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.83643,.,0.992,0.64752,D,0.914,0.64978,D,.,0.97926,.,.,.,.,4.825,0.99678,H,.,0.69751,.,.,0.99617,0.9146,0.95868,D,0.9975,0.99938,D,9,.,0.99558,.,0.738524,0.97899,D,.,0.99491,0.987,0.99867,P08397,E250K,Gain of ubiquitination at E250 (P = 0.0428)| Gain of MoRF binding (P = 0.0511)| Loss of stability (P = 0.133)| Gain of catalytic residue at E250 (P = 0.1966)| Gain of methylation at R255 (P = 0.391),.,0.98017,0.989704692009024,0.98962,.,.,0.765738248825,0.76745,T,0.992676,0.99976,D,0.587906,0.97317,D,0.60671,0.97274,D,0.998330771923065,0.93808,D,0.999644,0.99872,D,0.9871062,0.99593,0.9669672,0.99316,0.98515564,0.99468,0.9623646,0.99083,-12.947,0.90370,D,0.9963,0.96212,P,0.999883168686179,0.98571,0.39991770,0.79586,0.997,0.99892,.,.,.,.,.,.,6.168285,0.9472,34.0,0.99931779663292331,0.99388,0.964492,0.98659,D,1.08555498492097,0.97845,16.9058,0.995398746587554,0.98528,18.56252,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092500G>A,ClinGen:CA251830|OMIM:609806.0031|UniProtKB:P08397#VAR_003666,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",Glu,Lys,16510.0,single nucleotide variant,NM_000190.4(HMBS):c.748G>A (p.Glu250Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 1994",118204112.0,-,RCV000001536,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092500.0,119092500.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031",1.0,1471.0,119092500.0,G,A,-,-,-,-,-,-,SCV000021691,-,-,748G>A ,Glu250Lys,NM_000190.4,,1_Pathogenic,98.78,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,0,98.78,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,,-3.5,,,"E250-L254, E250-R116, E250-T269, E250-G216, E250-R246; PAE: 1.0, 1.5, 1.0, 1.0, 1.0",12 interactions,"E250-L254, E250-T269, E250-R246; PAE: 1.0, 1.0, 1.0",10 interactions,,7 interactions,146,,-61.4,,,-44.6,,,H (helix),H (α-helix),Helix,,,-0.004,,0.057,1 mutation(s) (Glu250Asp: 1.509),0.173,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_ubquitous_var204309,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119092500.0,119092500.0,,748,G,A,250.0,E,K,c.748G>A,p.Glu250Lys,missense_variant,missense_variant,0.10360063,,No,,Pathogenic,no assertion criteria provided,"Jan 01, 1994",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.964,0.9963,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Glu250Lys,true,Glu250Lys
HMBS_Glu250Lys,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200945,CCSBVarC005174,ALE00005174,NC_000011.10:119092500:G:A,748G>A,Glu250Lys,CEGS2,CegsMutGDEh1041,D10,GDEhDisVCh_40054,H06,2.0,CegsMutGDDh1041,D10,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092500,G,A,11,Y,Y,N,N,N,11-119092500-G-A,16510.0,single nucleotide variant,NM_000190.4(HMBS):c.748G>A (p.Glu250Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 1994",118204112.0,-,RCV000001536,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092500.0,119092500.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031",1.0,1471.0,119092500.0,G,A,-,-,-,-,-,-,SCV000021691,-,-,748G>A ,Glu250Lys,NM_000190.4,,1_Pathogenic,,1471.0,11,119092500.0,G,A,E,K,rs118204112,11,118963210,11,118468420,250.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.748G>A,p.Glu250Lys,c.748G>A,p.Glu250Lys,principal2,Y,.,YES,Select,+,GAA,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.83643,.,0.992,0.64752,D,0.914,0.64978,D,.,0.97926,.,.,.,.,4.825,0.99678,H,.,0.69751,.,.,0.99617,0.9146,0.95868,D,0.9975,0.99938,D,9,.,0.99558,.,0.738524,0.97899,D,.,0.99491,0.987,0.99867,P08397,E250K,Gain of ubiquitination at E250 (P = 0.0428)| Gain of MoRF binding (P = 0.0511)| Loss of stability (P = 0.133)| Gain of catalytic residue at E250 (P = 0.1966)| Gain of methylation at R255 (P = 0.391),.,0.98017,0.989704692009024,0.98962,.,.,0.765738248825,0.76745,T,0.992676,0.99976,D,0.587906,0.97317,D,0.60671,0.97274,D,0.998330771923065,0.93808,D,0.999644,0.99872,D,0.9871062,0.99593,0.9669672,0.99316,0.98515564,0.99468,0.9623646,0.99083,-12.947,0.90370,D,0.9963,0.96212,P,0.999883168686179,0.98571,0.39991770,0.79586,0.997,0.99892,.,.,.,.,.,.,6.168285,0.9472,34.0,0.99931779663292331,0.99388,0.964492,0.98659,D,1.08555498492097,0.97845,16.9058,0.995398746587554,0.98528,18.56252,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092500G>A,ClinGen:CA251830|OMIM:609806.0031|UniProtKB:P08397#VAR_003666,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",Glu,Lys,16510.0,single nucleotide variant,NM_000190.4(HMBS):c.748G>A (p.Glu250Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 1994",118204112.0,-,RCV000001536,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092500.0,119092500.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031",1.0,1471.0,119092500.0,G,A,-,-,-,-,-,-,SCV000021691,-,-,748G>A ,Glu250Lys,NM_000190.4,,1_Pathogenic,98.78,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,0,98.78,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,,-3.5,,,"E250-L254, E250-R116, E250-T269, E250-G216, E250-R246; PAE: 1.0, 1.5, 1.0, 1.0, 1.0",12 interactions,"E250-L254, E250-T269, E250-R246; PAE: 1.0, 1.0, 1.0",10 interactions,,7 interactions,146,,-61.4,,,-44.6,,,H (helix),H (α-helix),Helix,,,-0.004,,0.057,1 mutation(s) (Glu250Asp: 1.509),0.173,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_erythroid_var210963,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119092500.0,119092500.0,,748,G,A,250.0,E,K,c.748G>A,p.Glu250Lys,missense_variant,missense_variant,-0.169740986999999,,No,,Pathogenic,no assertion criteria provided,"Jan 01, 1994",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.964,0.9963,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Glu250Lys,true,Glu250Lys
HMBS_Glu250Lys,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,HMBS,ENSG00000256269,2803,200945,CCSBVarC005174,ALE00005174,NC_000011.10:119092500:G:A,748G>A,Glu250Lys,CEGS2,CegsMutGDEh1041,D10,GDEhDisVCh_40054,H06,2.0,CegsMutGDDh1041,D10,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092500,G,A,11,Y,Y,N,N,N,11-119092500-G-A,16510.0,single nucleotide variant,NM_000190.4(HMBS):c.748G>A (p.Glu250Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 1994",118204112.0,-,RCV000001536,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092500.0,119092500.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031",1.0,1471.0,119092500.0,G,A,-,-,-,-,-,-,SCV000021691,-,-,748G>A ,Glu250Lys,NM_000190.4,,1_Pathogenic,,1471.0,11,119092500.0,G,A,E,K,rs118204112,11,118963210,11,118468420,250.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.748G>A,p.Glu250Lys,c.748G>A,p.Glu250Lys,principal2,Y,.,YES,Select,+,GAA,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.91343,.,.,0.83643,.,0.992,0.64752,D,0.914,0.64978,D,.,0.97926,.,.,.,.,4.825,0.99678,H,.,0.69751,.,.,0.99617,0.9146,0.95868,D,0.9975,0.99938,D,9,.,0.99558,.,0.738524,0.97899,D,.,0.99491,0.987,0.99867,P08397,E250K,Gain of ubiquitination at E250 (P = 0.0428)| Gain of MoRF binding (P = 0.0511)| Loss of stability (P = 0.133)| Gain of catalytic residue at E250 (P = 0.1966)| Gain of methylation at R255 (P = 0.391),.,0.98017,0.989704692009024,0.98962,.,.,0.765738248825,0.76745,T,0.992676,0.99976,D,0.587906,0.97317,D,0.60671,0.97274,D,0.998330771923065,0.93808,D,0.999644,0.99872,D,0.9871062,0.99593,0.9669672,0.99316,0.98515564,0.99468,0.9623646,0.99083,-12.947,0.90370,D,0.9963,0.96212,P,0.999883168686179,0.98571,0.39991770,0.79586,0.997,0.99892,.,.,.,.,.,.,6.168285,0.9472,34.0,0.99931779663292331,0.99388,0.964492,0.98659,D,1.08555498492097,0.97845,16.9058,0.995398746587554,0.98528,18.56252,5.24,5.24,0.72825,.,.,9.732,0.98033,11.804000,0.96740,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092500G>A,ClinGen:CA251830|OMIM:609806.0031|UniProtKB:P08397#VAR_003666,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",Glu,Lys,16510.0,single nucleotide variant,NM_000190.4(HMBS):c.748G>A (p.Glu250Lys),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 1994",118204112.0,-,RCV000001536,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092500.0,119092500.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031",1.0,1471.0,119092500.0,G,A,-,-,-,-,-,-,SCV000021691,-,-,748G>A ,Glu250Lys,NM_000190.4,,1_Pathogenic,98.78,0.0,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,0,98.78,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,,-3.5,,,"E250-L254, E250-R116, E250-T269, E250-G216, E250-R246; PAE: 1.0, 1.5, 1.0, 1.0, 1.0",12 interactions,"E250-L254, E250-T269, E250-R246; PAE: 1.0, 1.0, 1.0",10 interactions,,7 interactions,146,,-61.4,,,-44.6,,,H (helix),H (α-helix),Helix,,,-0.004,,0.057,1 mutation(s) (Glu250Asp: 1.509),0.173,,,,,,,,,,true,true,HMBS_van_Loggerenberg_2023_combined_var216902,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119092500.0,119092500.0,,748,G,A,250.0,E,K,c.748G>A,p.Glu250Lys,missense_variant,missense_variant,0.018138794,,No,,Pathogenic,no assertion criteria provided,"Jan 01, 1994",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.964,0.9963,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Glu250Lys,true,Glu250Lys
HMBS_Glu86Val,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200926,CCSBVarC005160,ALE00005160,NC_000011.10:119089263:A:T,257A>T,Glu86Val,CEGS2,CegsMutGDEh1037,D01,GDEhDisVCh_40054,D03,2.0,CegsMutGDDh1037,D01,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119089263,A,T,11,Y,Y,N,N,N,11-119089263-A-T,171128.0,single nucleotide variant,NM_000190.4(HMBS):c.257A>T (p.Glu86Val),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Jan 24, 2025",150763621.0,-,RCV000148510|RCV001514054|RCV003927449,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|",Acute intermittent porphyria|not provided|HMBS-related disorder,germline,germline,GRCh38,NC_000011.10,11,119089263.0,119089263.0,11q23.3,"criteria provided, conflicting classifications",7.0,-,N,"ClinGen:CA272879,UniProtKB:P08397#VAR_025564",2.0,161252.0,119089263.0,A,T,-,-,-,-,-,-,SCV001167212|SCV001261488|SCV001721801|SCV001822907|SCV002541174,-,-,257A>T ,Glu86Val,NM_000190.4,1.0,3_Conflicting,0.000441296,161252.0,11,119089263.0,A,T,E,V,rs150763621,11,118959973,11,118465183,86.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.257A>T,p.Glu86Val,c.257A>T,p.Glu86Val,principal2,Y,.,YES,Select,+,GAG,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.21176,.,.,0.35789,.,0.996,0.77914,D,0.952,0.69100,D,.,0.13669,.,.,.,.,1.09,0.27188,L,.,0.62887,.,.,0.79136,1.0972,0.99541,D,0.9735,0.99169,D,10,.,0.00319,.,0.419506,0.93751,D,.,0.97167,.,.,.,.,.,.,0.93792,0.6347533317158794,0.63238,.,.,0.638639688492,0.58306,T,0.783028,0.94240,D,0.305539,0.83282,D,0.493258,0.94422,D,0.0607448145747185,0.07204,T,0.978852,0.92661,D,0.54433566,0.69341,0.3582298,0.61063,0.45547208,0.64071,0.31428748,0.57197,-6.406,0.51861,T,0.4027,0.59683,A,0.97727566799837,0.84692,0.19951561,0.73062,0.868,0.92825,.,.,.,.,.,.,4.992618,0.8281,27.9,0.99206915280202579,0.55544,0.945445,0.95360,D,0.607929687953653,0.73534,6.005115,0.678876757756973,0.80671,7.37513,5.96,5.96,0.96689,5.21,0.92006,8.683,0.90982,6.865000,0.56840,0.756,0.943,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,125,264690,4.7225057E-4,.,49,109408,4.478650e-04,0,141,208136,6.774420e-04,1,198,236958,8.355910e-04,1,0,7164,0.000000e+00,0,1,17112,5.843850e-05,0,39,2320,1.681030e-02,0,0,9046,0.000000e+00,0,0,13394,0.000000e+00,0,7,42768,1.636740e-04,0,0,15690,0.000000e+00,0,7,42768,1.636740e-04,0,2,16218,1.233200e-04,0,1,30524,3.276110e-05,0,109,6212,1.754670e-02,1,0,13416,0.000000e+00,0,0,16734,0.000000e+00,0,22,89558,2.456510e-04,0,0,30608,0.000000e+00,0,22,89558,2.456510e-04,0,2,14902,1.342100e-04,0,1,34260,2.918860e-05,0,164,9572,1.713330e-02,1,0,17692,0.000000e+00,0,0,21632,0.000000e+00,0,23,102754,2.238360e-04,0,0,30526,0.000000e+00,0,23,102754,2.238360e-04,0,.,716,1613784,4.436780e-04,4,499,29608,1.685360e-02,4,5,74906,6.675030e-05,0,0,912,0.000000e+00,0,2,60000,3.333330e-05,0,499,29608,1.685360e-02,4,0,44890,0.000000e+00,0,0,64026,0.000000e+00,0,0,5920,0.000000e+00,0,128,1179982,1.084760e-04,0,0,91074,0.000000e+00,0,143,96962,0.0014748045626121573,0,174,0,0,2670,0,4,4198,9.528346831824678E-4,0,790,0,0,946,0,0,656,0,0,274,0,27,8054,0.0033523714924261236,4,4372,9.149130832570906E-4,0,3326,0,174,114724,0.0015166835187057635,Conflicting_classifications_of_pathogenicity,not_provided|Acute_intermittent_porphyria|HMBS-related_disorder,"criteria_provided,_conflicting_classifications",NC_000011.10:g.119089263A>T,ClinGen:CA272879|UniProtKB:P08397#VAR_025564,C3661900|C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Glu,Val,171128.0,single nucleotide variant,NM_000190.4(HMBS):c.257A>T (p.Glu86Val),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Jan 24, 2025",150763621.0,-,RCV000148510|RCV001514054|RCV003927449,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|",Acute intermittent porphyria|not provided|HMBS-related disorder,germline,germline,GRCh38,NC_000011.10,11,119089263.0,119089263.0,11q23.3,"criteria provided, conflicting classifications",7.0,-,N,"ClinGen:CA272879,UniProtKB:P08397#VAR_025564",2.0,161252.0,119089263.0,A,T,-,-,-,-,-,-,SCV001167212|SCV001261488|SCV001721801|SCV001822907|SCV002541174,-,-,257A>T ,Glu86Val,NM_000190.4,1.0,3_Conflicting,95.84,0.6649484536082474,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,129,95.84,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,0.0049,-3.5,,,E86-E82; PAE: 1.0,8 interactions,E86-E82; PAE: 1.0,8 interactions,,,146,,-58.5,,"Pocket 2: Mean pLDDT: 93.7, Volume: 392.46 Å³, Druggability score: 0",-44.9,,dbSNP: rs150763621; Variant type: LP/P; AA change: Glu86Val; PTM type: Acetylation; PTM morphology: EHALE*kNEVDL; Var class: II,H (helix),H (α-helix),Helix,,,0.797,1 mutation(s) (Glu86Tyr: 1.545),0.817,1 mutation(s) (Glu86Tyr: 1.545),0.817,1 mutation(s) (Glu86Tyr: 1.545),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var210328,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119089263.0,119089263.0,,257,A,T,86.0,E,V,c.257A>T,p.Glu86Val,missense_variant,missense_variant,0.736515357,,No,0.0004436777164725,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Feb 01, 2024",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.899,0.4027,ambiguous,,,,,,,,,,,,,,,,,,,HMBS_Glu86Val,true,Glu86Val
HMBS_Glu86Val,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200926,CCSBVarC005160,ALE00005160,NC_000011.10:119089263:A:T,257A>T,Glu86Val,CEGS2,CegsMutGDEh1037,D01,GDEhDisVCh_40054,D03,2.0,CegsMutGDDh1037,D01,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119089263,A,T,11,Y,Y,N,N,N,11-119089263-A-T,171128.0,single nucleotide variant,NM_000190.4(HMBS):c.257A>T (p.Glu86Val),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Jan 24, 2025",150763621.0,-,RCV000148510|RCV001514054|RCV003927449,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|",Acute intermittent porphyria|not provided|HMBS-related disorder,germline,germline,GRCh38,NC_000011.10,11,119089263.0,119089263.0,11q23.3,"criteria provided, conflicting classifications",7.0,-,N,"ClinGen:CA272879,UniProtKB:P08397#VAR_025564",2.0,161252.0,119089263.0,A,T,-,-,-,-,-,-,SCV001167212|SCV001261488|SCV001721801|SCV001822907|SCV002541174,-,-,257A>T ,Glu86Val,NM_000190.4,1.0,3_Conflicting,0.000441296,161252.0,11,119089263.0,A,T,E,V,rs150763621,11,118959973,11,118465183,86.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.257A>T,p.Glu86Val,c.257A>T,p.Glu86Val,principal2,Y,.,YES,Select,+,GAG,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.21176,.,.,0.35789,.,0.996,0.77914,D,0.952,0.69100,D,.,0.13669,.,.,.,.,1.09,0.27188,L,.,0.62887,.,.,0.79136,1.0972,0.99541,D,0.9735,0.99169,D,10,.,0.00319,.,0.419506,0.93751,D,.,0.97167,.,.,.,.,.,.,0.93792,0.6347533317158794,0.63238,.,.,0.638639688492,0.58306,T,0.783028,0.94240,D,0.305539,0.83282,D,0.493258,0.94422,D,0.0607448145747185,0.07204,T,0.978852,0.92661,D,0.54433566,0.69341,0.3582298,0.61063,0.45547208,0.64071,0.31428748,0.57197,-6.406,0.51861,T,0.4027,0.59683,A,0.97727566799837,0.84692,0.19951561,0.73062,0.868,0.92825,.,.,.,.,.,.,4.992618,0.8281,27.9,0.99206915280202579,0.55544,0.945445,0.95360,D,0.607929687953653,0.73534,6.005115,0.678876757756973,0.80671,7.37513,5.96,5.96,0.96689,5.21,0.92006,8.683,0.90982,6.865000,0.56840,0.756,0.943,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,125,264690,4.7225057E-4,.,49,109408,4.478650e-04,0,141,208136,6.774420e-04,1,198,236958,8.355910e-04,1,0,7164,0.000000e+00,0,1,17112,5.843850e-05,0,39,2320,1.681030e-02,0,0,9046,0.000000e+00,0,0,13394,0.000000e+00,0,7,42768,1.636740e-04,0,0,15690,0.000000e+00,0,7,42768,1.636740e-04,0,2,16218,1.233200e-04,0,1,30524,3.276110e-05,0,109,6212,1.754670e-02,1,0,13416,0.000000e+00,0,0,16734,0.000000e+00,0,22,89558,2.456510e-04,0,0,30608,0.000000e+00,0,22,89558,2.456510e-04,0,2,14902,1.342100e-04,0,1,34260,2.918860e-05,0,164,9572,1.713330e-02,1,0,17692,0.000000e+00,0,0,21632,0.000000e+00,0,23,102754,2.238360e-04,0,0,30526,0.000000e+00,0,23,102754,2.238360e-04,0,.,716,1613784,4.436780e-04,4,499,29608,1.685360e-02,4,5,74906,6.675030e-05,0,0,912,0.000000e+00,0,2,60000,3.333330e-05,0,499,29608,1.685360e-02,4,0,44890,0.000000e+00,0,0,64026,0.000000e+00,0,0,5920,0.000000e+00,0,128,1179982,1.084760e-04,0,0,91074,0.000000e+00,0,143,96962,0.0014748045626121573,0,174,0,0,2670,0,4,4198,9.528346831824678E-4,0,790,0,0,946,0,0,656,0,0,274,0,27,8054,0.0033523714924261236,4,4372,9.149130832570906E-4,0,3326,0,174,114724,0.0015166835187057635,Conflicting_classifications_of_pathogenicity,not_provided|Acute_intermittent_porphyria|HMBS-related_disorder,"criteria_provided,_conflicting_classifications",NC_000011.10:g.119089263A>T,ClinGen:CA272879|UniProtKB:P08397#VAR_025564,C3661900|C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Glu,Val,171128.0,single nucleotide variant,NM_000190.4(HMBS):c.257A>T (p.Glu86Val),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Jan 24, 2025",150763621.0,-,RCV000148510|RCV001514054|RCV003927449,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|",Acute intermittent porphyria|not provided|HMBS-related disorder,germline,germline,GRCh38,NC_000011.10,11,119089263.0,119089263.0,11q23.3,"criteria provided, conflicting classifications",7.0,-,N,"ClinGen:CA272879,UniProtKB:P08397#VAR_025564",2.0,161252.0,119089263.0,A,T,-,-,-,-,-,-,SCV001167212|SCV001261488|SCV001721801|SCV001822907|SCV002541174,-,-,257A>T ,Glu86Val,NM_000190.4,1.0,3_Conflicting,95.84,0.6649484536082474,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,129,95.84,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,0.0049,-3.5,,,E86-E82; PAE: 1.0,8 interactions,E86-E82; PAE: 1.0,8 interactions,,,146,,-58.5,,"Pocket 2: Mean pLDDT: 93.7, Volume: 392.46 Å³, Druggability score: 0",-44.9,,dbSNP: rs150763621; Variant type: LP/P; AA change: Glu86Val; PTM type: Acetylation; PTM morphology: EHALE*kNEVDL; Var class: II,H (helix),H (α-helix),Helix,,,0.797,1 mutation(s) (Glu86Tyr: 1.545),0.817,1 mutation(s) (Glu86Tyr: 1.545),0.817,1 mutation(s) (Glu86Tyr: 1.545),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var217220,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119089263.0,119089263.0,,257,A,T,86.0,E,V,c.257A>T,p.Glu86Val,missense_variant,missense_variant,0.7367667170000001,,No,0.0004436777164725,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Feb 01, 2024",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.899,0.4027,ambiguous,,,,,,,,,,,,,,,,,,,HMBS_Glu86Val,true,Glu86Val
HMBS_Glu86Val,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200926,CCSBVarC005160,ALE00005160,NC_000011.10:119089263:A:T,257A>T,Glu86Val,CEGS2,CegsMutGDEh1037,D01,GDEhDisVCh_40054,D03,2.0,CegsMutGDDh1037,D01,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119089263,A,T,11,Y,Y,N,N,N,11-119089263-A-T,171128.0,single nucleotide variant,NM_000190.4(HMBS):c.257A>T (p.Glu86Val),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Jan 24, 2025",150763621.0,-,RCV000148510|RCV001514054|RCV003927449,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|",Acute intermittent porphyria|not provided|HMBS-related disorder,germline,germline,GRCh38,NC_000011.10,11,119089263.0,119089263.0,11q23.3,"criteria provided, conflicting classifications",7.0,-,N,"ClinGen:CA272879,UniProtKB:P08397#VAR_025564",2.0,161252.0,119089263.0,A,T,-,-,-,-,-,-,SCV001167212|SCV001261488|SCV001721801|SCV001822907|SCV002541174,-,-,257A>T ,Glu86Val,NM_000190.4,1.0,3_Conflicting,0.000441296,161252.0,11,119089263.0,A,T,E,V,rs150763621,11,118959973,11,118465183,86.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.257A>T,p.Glu86Val,c.257A>T,p.Glu86Val,principal2,Y,.,YES,Select,+,GAG,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.21176,.,.,0.35789,.,0.996,0.77914,D,0.952,0.69100,D,.,0.13669,.,.,.,.,1.09,0.27188,L,.,0.62887,.,.,0.79136,1.0972,0.99541,D,0.9735,0.99169,D,10,.,0.00319,.,0.419506,0.93751,D,.,0.97167,.,.,.,.,.,.,0.93792,0.6347533317158794,0.63238,.,.,0.638639688492,0.58306,T,0.783028,0.94240,D,0.305539,0.83282,D,0.493258,0.94422,D,0.0607448145747185,0.07204,T,0.978852,0.92661,D,0.54433566,0.69341,0.3582298,0.61063,0.45547208,0.64071,0.31428748,0.57197,-6.406,0.51861,T,0.4027,0.59683,A,0.97727566799837,0.84692,0.19951561,0.73062,0.868,0.92825,.,.,.,.,.,.,4.992618,0.8281,27.9,0.99206915280202579,0.55544,0.945445,0.95360,D,0.607929687953653,0.73534,6.005115,0.678876757756973,0.80671,7.37513,5.96,5.96,0.96689,5.21,0.92006,8.683,0.90982,6.865000,0.56840,0.756,0.943,1.0,0.71675,1.000000,0.68239,0.992,0.67791,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,125,264690,4.7225057E-4,.,49,109408,4.478650e-04,0,141,208136,6.774420e-04,1,198,236958,8.355910e-04,1,0,7164,0.000000e+00,0,1,17112,5.843850e-05,0,39,2320,1.681030e-02,0,0,9046,0.000000e+00,0,0,13394,0.000000e+00,0,7,42768,1.636740e-04,0,0,15690,0.000000e+00,0,7,42768,1.636740e-04,0,2,16218,1.233200e-04,0,1,30524,3.276110e-05,0,109,6212,1.754670e-02,1,0,13416,0.000000e+00,0,0,16734,0.000000e+00,0,22,89558,2.456510e-04,0,0,30608,0.000000e+00,0,22,89558,2.456510e-04,0,2,14902,1.342100e-04,0,1,34260,2.918860e-05,0,164,9572,1.713330e-02,1,0,17692,0.000000e+00,0,0,21632,0.000000e+00,0,23,102754,2.238360e-04,0,0,30526,0.000000e+00,0,23,102754,2.238360e-04,0,.,716,1613784,4.436780e-04,4,499,29608,1.685360e-02,4,5,74906,6.675030e-05,0,0,912,0.000000e+00,0,2,60000,3.333330e-05,0,499,29608,1.685360e-02,4,0,44890,0.000000e+00,0,0,64026,0.000000e+00,0,0,5920,0.000000e+00,0,128,1179982,1.084760e-04,0,0,91074,0.000000e+00,0,143,96962,0.0014748045626121573,0,174,0,0,2670,0,4,4198,9.528346831824678E-4,0,790,0,0,946,0,0,656,0,0,274,0,27,8054,0.0033523714924261236,4,4372,9.149130832570906E-4,0,3326,0,174,114724,0.0015166835187057635,Conflicting_classifications_of_pathogenicity,not_provided|Acute_intermittent_porphyria|HMBS-related_disorder,"criteria_provided,_conflicting_classifications",NC_000011.10:g.119089263A>T,ClinGen:CA272879|UniProtKB:P08397#VAR_025564,C3661900|C0162565,176000,79276,"Porphobilinogen deaminase, N-terminal",Glu,Val,171128.0,single nucleotide variant,NM_000190.4(HMBS):c.257A>T (p.Glu86Val),3145.0,HMBS,HGNC:4982,Conflicting classifications of pathogenicity,0.0,"Jan 24, 2025",150763621.0,-,RCV000148510|RCV001514054|RCV003927449,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|",Acute intermittent porphyria|not provided|HMBS-related disorder,germline,germline,GRCh38,NC_000011.10,11,119089263.0,119089263.0,11q23.3,"criteria provided, conflicting classifications",7.0,-,N,"ClinGen:CA272879,UniProtKB:P08397#VAR_025564",2.0,161252.0,119089263.0,A,T,-,-,-,-,-,-,SCV001167212|SCV001261488|SCV001721801|SCV001822907|SCV002541174,-,-,257A>T ,Glu86Val,NM_000190.4,1.0,3_Conflicting,95.84,0.6649484536082474,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",E,129,95.84,Negatively-charged,Glutamic Acid,Porphobilinogen deaminase,,0.0049,-3.5,,,E86-E82; PAE: 1.0,8 interactions,E86-E82; PAE: 1.0,8 interactions,,,146,,-58.5,,"Pocket 2: Mean pLDDT: 93.7, Volume: 392.46 Å³, Druggability score: 0",-44.9,,dbSNP: rs150763621; Variant type: LP/P; AA change: Glu86Val; PTM type: Acetylation; PTM morphology: EHALE*kNEVDL; Var class: II,H (helix),H (α-helix),Helix,,,0.797,1 mutation(s) (Glu86Tyr: 1.545),0.817,1 mutation(s) (Glu86Tyr: 1.545),0.817,1 mutation(s) (Glu86Tyr: 1.545),,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var203966,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119089263.0,119089263.0,,257,A,T,86.0,E,V,c.257A>T,p.Glu86Val,missense_variant,missense_variant,0.7370006029999999,,No,0.0004436777164725,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Feb 01, 2024",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.899,0.4027,ambiguous,,,,,,,,,,,,,,,,,,,HMBS_Glu86Val,true,Glu86Val
HMBS_His256Asn,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200940,CCSBVarC005177,ALE00005177,NC_000011.10:119092518:C:A,766C>A,His256Asn,CEGS2,CegsMutGDEh1042,G06,GDEhDisVCh_40054,F07,2.0,CegsMutGDDh1042,G06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092518,C,A,11,Y,Y,N,N,N,11-119092518-C-A,16513.0,single nucleotide variant,NM_000190.4(HMBS):c.766C>A (p.His256Asn),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204115.0,-,RCV000001539,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092518.0,119092518.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034",1.0,1474.0,119092518.0,C,A,-,-,-,-,-,-,SCV000021694,-,-,766C>A ,His256Asn,NM_000190.4,,1_Pathogenic,,1474.0,11,119092518.0,C,A,H,N,rs118204115,11,118963228,11,118468438,256.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.766C>A,p.His256Asn,c.766C>A,p.His256Asn,principal2,Y,.,YES,Select,+,CAC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.08361,.,.,0.17823,.,0.546,0.38046,P,0.288,0.40614,B,.,0.97926,.,.,.,.,2.42,0.69809,M,.,0.11479,.,.,0.60035,1.0870,0.99121,D,0.8810,0.96041,D,9,.,0.72944,.,0.154635,0.83526,D,.,0.82257,0.821,0.93359,P08397,H256N,Gain of methylation at R255 (P = 0.2814)| Loss of catalytic residue at E258 (P = 0.3196)| Loss of helix (P = 0.4763)| Loss of disorder (P = 0.5616)| Gain of MoRF binding (P = 0.6045),.,0.77777,0.6382043804944534,0.63584,.,.,0.583521664143,0.50516,T,0.661814,0.89758,D,0.201684,0.73856,D,0.0519292,0.73515,D,0.723255395889282,0.41564,D,0.974203,0.90838,D,0.39711455,0.60207,0.17150109,0.39208,0.42338273,0.61995,0.2002319,0.43788,-3.527,0.19541,T,0.1596,0.35351,B,0.900888859472124,0.76114,0.03303835,0.55011,0.482,0.70274,.,.,.,.,.,.,3.216449,0.43884,21.8,0.97546153328312879,0.34708,0.617763,0.60241,D,0.310771753279657,0.56479,3.835273,0.400097499637153,0.61364,4.359105,5.24,5.24,0.72825,.,.,2.897,0.4846,5.956000,0.51809,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.994,0.71086,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,9768,0,0,114,0,0,120,0,0,3218,0,0,146,0,0,610,0,0,26,0,0,104,0,0,604,0,0,3332,0,0,146,0,0,14710,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092518C>A,ClinGen:CA251836|OMIM:609806.0034|UniProtKB:P08397#VAR_003669,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",His,Asn,16513.0,single nucleotide variant,NM_000190.4(HMBS):c.766C>A (p.His256Asn),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204115.0,-,RCV000001539,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092518.0,119092518.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034",1.0,1474.0,119092518.0,C,A,-,-,-,-,-,-,SCV000021694,-,-,766C>A ,His256Asn,NM_000190.4,,1_Pathogenic,96.92,0.391304347826087,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",H,72,96.92,Positively-charged,Histidine,Porphobilinogen deaminase,,,-3.2,,,"H256-N340, H256-A252; PAE: 1.5, 1.0",9 interactions,"H256-N340, H256-A252; PAE: 1.5, 1.0",9 interactions,,,155,,-74.3,,,-28.6,,,H (helix),H (α-helix),Helix,,,0.702,,0.785,,0.728,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var203830,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119092518.0,119092518.0,,766,C,A,256.0,H,N,c.766C>A,p.His256Asn,missense_variant,missense_variant,0.102273823,,No,,Pathogenic,no assertion criteria provided,"Dec 01, 1993",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.567,0.1596,likely_benign,,,,,,,,,,,,,,,,,,,HMBS_His256Asn,true,His256Asn
HMBS_His256Asn,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200940,CCSBVarC005177,ALE00005177,NC_000011.10:119092518:C:A,766C>A,His256Asn,CEGS2,CegsMutGDEh1042,G06,GDEhDisVCh_40054,F07,2.0,CegsMutGDDh1042,G06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092518,C,A,11,Y,Y,N,N,N,11-119092518-C-A,16513.0,single nucleotide variant,NM_000190.4(HMBS):c.766C>A (p.His256Asn),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204115.0,-,RCV000001539,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092518.0,119092518.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034",1.0,1474.0,119092518.0,C,A,-,-,-,-,-,-,SCV000021694,-,-,766C>A ,His256Asn,NM_000190.4,,1_Pathogenic,,1474.0,11,119092518.0,C,A,H,N,rs118204115,11,118963228,11,118468438,256.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.766C>A,p.His256Asn,c.766C>A,p.His256Asn,principal2,Y,.,YES,Select,+,CAC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.08361,.,.,0.17823,.,0.546,0.38046,P,0.288,0.40614,B,.,0.97926,.,.,.,.,2.42,0.69809,M,.,0.11479,.,.,0.60035,1.0870,0.99121,D,0.8810,0.96041,D,9,.,0.72944,.,0.154635,0.83526,D,.,0.82257,0.821,0.93359,P08397,H256N,Gain of methylation at R255 (P = 0.2814)| Loss of catalytic residue at E258 (P = 0.3196)| Loss of helix (P = 0.4763)| Loss of disorder (P = 0.5616)| Gain of MoRF binding (P = 0.6045),.,0.77777,0.6382043804944534,0.63584,.,.,0.583521664143,0.50516,T,0.661814,0.89758,D,0.201684,0.73856,D,0.0519292,0.73515,D,0.723255395889282,0.41564,D,0.974203,0.90838,D,0.39711455,0.60207,0.17150109,0.39208,0.42338273,0.61995,0.2002319,0.43788,-3.527,0.19541,T,0.1596,0.35351,B,0.900888859472124,0.76114,0.03303835,0.55011,0.482,0.70274,.,.,.,.,.,.,3.216449,0.43884,21.8,0.97546153328312879,0.34708,0.617763,0.60241,D,0.310771753279657,0.56479,3.835273,0.400097499637153,0.61364,4.359105,5.24,5.24,0.72825,.,.,2.897,0.4846,5.956000,0.51809,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.994,0.71086,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,9768,0,0,114,0,0,120,0,0,3218,0,0,146,0,0,610,0,0,26,0,0,104,0,0,604,0,0,3332,0,0,146,0,0,14710,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092518C>A,ClinGen:CA251836|OMIM:609806.0034|UniProtKB:P08397#VAR_003669,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",His,Asn,16513.0,single nucleotide variant,NM_000190.4(HMBS):c.766C>A (p.His256Asn),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204115.0,-,RCV000001539,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092518.0,119092518.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034",1.0,1474.0,119092518.0,C,A,-,-,-,-,-,-,SCV000021694,-,-,766C>A ,His256Asn,NM_000190.4,,1_Pathogenic,96.92,0.391304347826087,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",H,72,96.92,Positively-charged,Histidine,Porphobilinogen deaminase,,,-3.2,,,"H256-N340, H256-A252; PAE: 1.5, 1.0",9 interactions,"H256-N340, H256-A252; PAE: 1.5, 1.0",9 interactions,,,155,,-74.3,,,-28.6,,,H (helix),H (α-helix),Helix,,,0.702,,0.785,,0.728,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var216255,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119092518.0,119092518.0,,766,C,A,256.0,H,N,c.766C>A,p.His256Asn,missense_variant,missense_variant,0.27336687,,No,,Pathogenic,no assertion criteria provided,"Dec 01, 1993",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.567,0.1596,likely_benign,,,,,,,,,,,,,,,,,,,HMBS_His256Asn,true,His256Asn
HMBS_His256Asn,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200940,CCSBVarC005177,ALE00005177,NC_000011.10:119092518:C:A,766C>A,His256Asn,CEGS2,CegsMutGDEh1042,G06,GDEhDisVCh_40054,F07,2.0,CegsMutGDDh1042,G06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119092518,C,A,11,Y,Y,N,N,N,11-119092518-C-A,16513.0,single nucleotide variant,NM_000190.4(HMBS):c.766C>A (p.His256Asn),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204115.0,-,RCV000001539,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092518.0,119092518.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034",1.0,1474.0,119092518.0,C,A,-,-,-,-,-,-,SCV000021694,-,-,766C>A ,His256Asn,NM_000190.4,,1_Pathogenic,,1474.0,11,119092518.0,C,A,H,N,rs118204115,11,118963228,11,118468438,256.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.766C>A,p.His256Asn,c.766C>A,p.His256Asn,principal2,Y,.,YES,Select,+,CAC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.08361,.,.,0.17823,.,0.546,0.38046,P,0.288,0.40614,B,.,0.97926,.,.,.,.,2.42,0.69809,M,.,0.11479,.,.,0.60035,1.0870,0.99121,D,0.8810,0.96041,D,9,.,0.72944,.,0.154635,0.83526,D,.,0.82257,0.821,0.93359,P08397,H256N,Gain of methylation at R255 (P = 0.2814)| Loss of catalytic residue at E258 (P = 0.3196)| Loss of helix (P = 0.4763)| Loss of disorder (P = 0.5616)| Gain of MoRF binding (P = 0.6045),.,0.77777,0.6382043804944534,0.63584,.,.,0.583521664143,0.50516,T,0.661814,0.89758,D,0.201684,0.73856,D,0.0519292,0.73515,D,0.723255395889282,0.41564,D,0.974203,0.90838,D,0.39711455,0.60207,0.17150109,0.39208,0.42338273,0.61995,0.2002319,0.43788,-3.527,0.19541,T,0.1596,0.35351,B,0.900888859472124,0.76114,0.03303835,0.55011,0.482,0.70274,.,.,.,.,.,.,3.216449,0.43884,21.8,0.97546153328312879,0.34708,0.617763,0.60241,D,0.310771753279657,0.56479,3.835273,0.400097499637153,0.61364,4.359105,5.24,5.24,0.72825,.,.,2.897,0.4846,5.956000,0.51809,0.599,0.40292,1.0,0.71675,1.000000,0.68239,0.994,0.71086,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,9768,0,0,114,0,0,120,0,0,3218,0,0,146,0,0,610,0,0,26,0,0,104,0,0,604,0,0,3332,0,0,146,0,0,14710,0,Pathogenic,Acute_intermittent_porphyria,no_assertion_criteria_provided,NC_000011.10:g.119092518C>A,ClinGen:CA251836|OMIM:609806.0034|UniProtKB:P08397#VAR_003669,C0162565,176000,79276,"Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site",His,Asn,16513.0,single nucleotide variant,NM_000190.4(HMBS):c.766C>A (p.His256Asn),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Dec 01, 1993",118204115.0,-,RCV000001539,"MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276",Acute intermittent porphyria,germline,germline,GRCh38,NC_000011.10,11,119092518.0,119092518.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034",1.0,1474.0,119092518.0,C,A,-,-,-,-,-,-,SCV000021694,-,-,766C>A ,His256Asn,NM_000190.4,,1_Pathogenic,96.92,0.391304347826087,['176000'],autosomal dominant,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"PORPHYRIA, ACUTE INTERMITTENT",H,72,96.92,Positively-charged,Histidine,Porphobilinogen deaminase,,,-3.2,,,"H256-N340, H256-A252; PAE: 1.5, 1.0",9 interactions,"H256-N340, H256-A252; PAE: 1.5, 1.0",9 interactions,,,155,,-74.3,,,-28.6,,,H (helix),H (α-helix),Helix,,,0.702,,0.785,,0.728,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var209742,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119092518.0,119092518.0,,766,C,A,256.0,H,N,c.766C>A,p.His256Asn,missense_variant,missense_variant,0.4874070929999999,,No,,Pathogenic,no assertion criteria provided,"Dec 01, 1993",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.567,0.1596,likely_benign,,,,,,,,,,,,,,,,,,,HMBS_His256Asn,true,His256Asn
HMBS_Leu81Pro,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200927,CCSBVarC005159,ALE00005159,NC_000011.10:119089248:T:C,242T>C,Leu81Pro,CEGS2,CegsMutGDEh1039,B07,GDEhDisVCh_40054,H04,2.0,CegsMutGDDh1039,B07,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119089248,T,C,11,Y,Y,N,N,N,11-119089248-T-C,16524.0,single nucleotide variant,NM_000190.4(HMBS):c.242T>C (p.Leu81Pro),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 2004",118204119.0,-,RCV003764513,"MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119089248.0,119089248.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045",1.0,1485.0,119089248.0,T,C,-,-,-,-,-,-,SCV000021705,-,-,242T>C ,Leu81Pro,NM_000190.4,,1_Pathogenic,,1485.0,11,119089248.0,T,C,L,P,rs118204119,11,118959958,11,118465168,81.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.242T>C,p.Leu81Pro,c.242T>C,p.Leu81Pro,principal2,Y,.,YES,Select,+,CTT,2.0,0.0,T,T/T,T/T,T/T,T/T,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.99291,.,.,.,.,4.2,0.97779,H,.,0.93040,.,.,0.99026,0.9330,0.96133,D,0.9951,0.99889,D,9,.,0.99856,.,0.867657,0.98984,D,.,0.99783,0.971,0.99725,P08397,L81P,Gain of disorder (P = 0.0292)| Gain of ubiquitination at K79 (P = 0.0804)| Gain of phosphorylation at T78 (P = 0.0928)| Gain of glycosylation at L81 (P = 0.0945)| Loss of stability (P = 0.1367),.,0.99345,0.9765642607558596,0.97634,.,.,0.857390701771,0.90709,D,0.99328,0.99980,D,0.58477,0.97173,D,0.602205,0.97008,D,0.99982762336731,0.99193,D,0.99516,0.98370,D,0.9905138,0.99786,0.9536428,0.98593,0.9839415,0.99385,0.9553901,0.98697,-16.615,0.99082,D,0.9973,0.96927,P,0.999991326508259,0.99831,0.41906053,0.80050,1,0.99985,.,.,.,.,.,.,5.395449,0.90388,31.0,0.99916275516384256,0.98450,0.973601,0.99503,D,0.938515060976654,0.93478,12.09053,0.823569374365732,0.91334,10.85838,5.96,4.81,0.61353,5.13,0.91238,7.449,0.79752,7.880000,0.72494,0.665,0.62996,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,"Encephalopathy,_porphyria-related",no_assertion_criteria_provided,NC_000011.10:g.119089248T>C,ClinGen:CA251843|OMIM:609806.0045|UniProtKB:P08397#VAR_025563,CN376852,620704,.,"Porphobilinogen deaminase, N-terminal",Leu,Pro,16524.0,single nucleotide variant,NM_000190.4(HMBS):c.242T>C (p.Leu81Pro),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 2004",118204119.0,-,RCV003764513,"MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119089248.0,119089248.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045",1.0,1485.0,119089248.0,T,C,-,-,-,-,-,-,SCV000021705,-,-,242T>C ,Leu81Pro,NM_000190.4,,1_Pathogenic,90.95,0.0060975609756097,['620704'],autosomal recessive,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"ENCEPHALOPATHY, PORPHYRIA-RELATED",L,1,90.95,Aliphatic,Leucine,Porphobilinogen deaminase,,,3.8,,,L81-L85; PAE: 1.0,8 interactions,L81-L85; PAE: 1.0,9 interactions,,,131,,-76.2,,,-41.7,,dbSNP: rs118204119; Variant type: LP/P; AA change: Leu81Pro; PTM type: Ubiquitylation; PTM morphology: kSLFTkEL*EHA; Var class: II,H (helix),H (α-helix),Helix,,,0.384,,0.397,,0.415,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_ubquitous_var202590,HMBS_van_Loggerenberg_2023_ubquitous,HMBS,4982,1.0,119089248.0,119089248.0,,242,T,C,81.0,L,P,c.242T>C,p.Leu81Pro,missense_variant,missense_variant,0.543708028,,No,,Pathogenic,no assertion criteria provided,"Jan 01, 2004",aa,urn:mavedb:00000108-a-1,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.976,0.9973,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Leu81Pro,true,Leu81Pro
HMBS_Leu81Pro,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200927,CCSBVarC005159,ALE00005159,NC_000011.10:119089248:T:C,242T>C,Leu81Pro,CEGS2,CegsMutGDEh1039,B07,GDEhDisVCh_40054,H04,2.0,CegsMutGDDh1039,B07,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119089248,T,C,11,Y,Y,N,N,N,11-119089248-T-C,16524.0,single nucleotide variant,NM_000190.4(HMBS):c.242T>C (p.Leu81Pro),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 2004",118204119.0,-,RCV003764513,"MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119089248.0,119089248.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045",1.0,1485.0,119089248.0,T,C,-,-,-,-,-,-,SCV000021705,-,-,242T>C ,Leu81Pro,NM_000190.4,,1_Pathogenic,,1485.0,11,119089248.0,T,C,L,P,rs118204119,11,118959958,11,118465168,81.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.242T>C,p.Leu81Pro,c.242T>C,p.Leu81Pro,principal2,Y,.,YES,Select,+,CTT,2.0,0.0,T,T/T,T/T,T/T,T/T,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.99291,.,.,.,.,4.2,0.97779,H,.,0.93040,.,.,0.99026,0.9330,0.96133,D,0.9951,0.99889,D,9,.,0.99856,.,0.867657,0.98984,D,.,0.99783,0.971,0.99725,P08397,L81P,Gain of disorder (P = 0.0292)| Gain of ubiquitination at K79 (P = 0.0804)| Gain of phosphorylation at T78 (P = 0.0928)| Gain of glycosylation at L81 (P = 0.0945)| Loss of stability (P = 0.1367),.,0.99345,0.9765642607558596,0.97634,.,.,0.857390701771,0.90709,D,0.99328,0.99980,D,0.58477,0.97173,D,0.602205,0.97008,D,0.99982762336731,0.99193,D,0.99516,0.98370,D,0.9905138,0.99786,0.9536428,0.98593,0.9839415,0.99385,0.9553901,0.98697,-16.615,0.99082,D,0.9973,0.96927,P,0.999991326508259,0.99831,0.41906053,0.80050,1,0.99985,.,.,.,.,.,.,5.395449,0.90388,31.0,0.99916275516384256,0.98450,0.973601,0.99503,D,0.938515060976654,0.93478,12.09053,0.823569374365732,0.91334,10.85838,5.96,4.81,0.61353,5.13,0.91238,7.449,0.79752,7.880000,0.72494,0.665,0.62996,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,"Encephalopathy,_porphyria-related",no_assertion_criteria_provided,NC_000011.10:g.119089248T>C,ClinGen:CA251843|OMIM:609806.0045|UniProtKB:P08397#VAR_025563,CN376852,620704,.,"Porphobilinogen deaminase, N-terminal",Leu,Pro,16524.0,single nucleotide variant,NM_000190.4(HMBS):c.242T>C (p.Leu81Pro),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 2004",118204119.0,-,RCV003764513,"MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119089248.0,119089248.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045",1.0,1485.0,119089248.0,T,C,-,-,-,-,-,-,SCV000021705,-,-,242T>C ,Leu81Pro,NM_000190.4,,1_Pathogenic,90.95,0.0060975609756097,['620704'],autosomal recessive,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"ENCEPHALOPATHY, PORPHYRIA-RELATED",L,1,90.95,Aliphatic,Leucine,Porphobilinogen deaminase,,,3.8,,,L81-L85; PAE: 1.0,8 interactions,L81-L85; PAE: 1.0,9 interactions,,,131,,-76.2,,,-41.7,,dbSNP: rs118204119; Variant type: LP/P; AA change: Leu81Pro; PTM type: Ubiquitylation; PTM morphology: kSLFTkEL*EHA; Var class: II,H (helix),H (α-helix),Helix,,,0.384,,0.397,,0.415,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_erythroid_var208509,HMBS_van_Loggerenberg_2023_erythroid,HMBS,4982,1.0,119089248.0,119089248.0,,242,T,C,81.0,L,P,c.242T>C,p.Leu81Pro,missense_variant,missense_variant,0.457837212,,No,,Pathogenic,no assertion criteria provided,"Jan 01, 2004",aa,urn:mavedb:00000108-a-2,ENST00000652429.1,NM_000190.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.976,0.9973,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Leu81Pro,true,Leu81Pro
HMBS_Leu81Pro,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,HMBS,ENSG00000256269,2803,200927,CCSBVarC005159,ALE00005159,NC_000011.10:119089248:T:C,242T>C,Leu81Pro,CEGS2,CegsMutGDEh1039,B07,GDEhDisVCh_40054,H04,2.0,CegsMutGDDh1039,B07,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,11,119089248,T,C,11,Y,Y,N,N,N,11-119089248-T-C,16524.0,single nucleotide variant,NM_000190.4(HMBS):c.242T>C (p.Leu81Pro),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 2004",118204119.0,-,RCV003764513,"MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119089248.0,119089248.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045",1.0,1485.0,119089248.0,T,C,-,-,-,-,-,-,SCV000021705,-,-,242T>C ,Leu81Pro,NM_000190.4,,1_Pathogenic,,1485.0,11,119089248.0,T,C,L,P,rs118204119,11,118959958,11,118465168,81.0,HMBS,ENSG00000256269,ENST00000652429,ENSP00000498786,P08397,HEM3_HUMAN,c.242T>C,p.Leu81Pro,c.242T>C,p.Leu81Pro,principal2,Y,.,YES,Select,+,CTT,2.0,0.0,T,T/T,T/T,T/T,T/T,.,0.91343,.,.,0.92967,.,1.0,0.90580,D,1.0,0.97365,D,.,0.99291,.,.,.,.,4.2,0.97779,H,.,0.93040,.,.,0.99026,0.9330,0.96133,D,0.9951,0.99889,D,9,.,0.99856,.,0.867657,0.98984,D,.,0.99783,0.971,0.99725,P08397,L81P,Gain of disorder (P = 0.0292)| Gain of ubiquitination at K79 (P = 0.0804)| Gain of phosphorylation at T78 (P = 0.0928)| Gain of glycosylation at L81 (P = 0.0945)| Loss of stability (P = 0.1367),.,0.99345,0.9765642607558596,0.97634,.,.,0.857390701771,0.90709,D,0.99328,0.99980,D,0.58477,0.97173,D,0.602205,0.97008,D,0.99982762336731,0.99193,D,0.99516,0.98370,D,0.9905138,0.99786,0.9536428,0.98593,0.9839415,0.99385,0.9553901,0.98697,-16.615,0.99082,D,0.9973,0.96927,P,0.999991326508259,0.99831,0.41906053,0.80050,1,0.99985,.,.,.,.,.,.,5.395449,0.90388,31.0,0.99916275516384256,0.98450,0.973601,0.99503,D,0.938515060976654,0.93478,12.09053,0.823569374365732,0.91334,10.85838,5.96,4.81,0.61353,5.13,0.91238,7.449,0.79752,7.880000,0.72494,0.665,0.62996,1.0,0.71675,1.000000,0.68239,0.997,0.79771,228,0.91137,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,0,434,0,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,0,434,0,0,34,0,0,660,0,Pathogenic,"Encephalopathy,_porphyria-related",no_assertion_criteria_provided,NC_000011.10:g.119089248T>C,ClinGen:CA251843|OMIM:609806.0045|UniProtKB:P08397#VAR_025563,CN376852,620704,.,"Porphobilinogen deaminase, N-terminal",Leu,Pro,16524.0,single nucleotide variant,NM_000190.4(HMBS):c.242T>C (p.Leu81Pro),3145.0,HMBS,HGNC:4982,Pathogenic,1.0,"Jan 01, 2004",118204119.0,-,RCV003764513,"MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704","Encephalopathy, porphyria-related",germline,germline,GRCh38,NC_000011.10,11,119089248.0,119089248.0,11q23.3,no assertion criteria provided,1.0,-,N,"ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045",1.0,1485.0,119089248.0,T,C,-,-,-,-,-,-,SCV000021705,-,-,242T>C ,Leu81Pro,NM_000190.4,,1_Pathogenic,90.95,0.0060975609756097,['620704'],autosomal recessive,Rare genetic renal disease; Rare genetic neurological disorder; Rare inborn errors of metabolism; Rare genetic skin disease,4,"ENCEPHALOPATHY, PORPHYRIA-RELATED",L,1,90.95,Aliphatic,Leucine,Porphobilinogen deaminase,,,3.8,,,L81-L85; PAE: 1.0,8 interactions,L81-L85; PAE: 1.0,9 interactions,,,131,,-76.2,,,-41.7,,dbSNP: rs118204119; Variant type: LP/P; AA change: Leu81Pro; PTM type: Ubiquitylation; PTM morphology: kSLFTkEL*EHA; Var class: II,H (helix),H (α-helix),Helix,,,0.384,,0.397,,0.415,,,,,,,,,,false,false,HMBS_van_Loggerenberg_2023_combined_var215043,HMBS_van_Loggerenberg_2023_combined,HMBS,4982,1.0,119089248.0,119089248.0,,242,T,C,81.0,L,P,c.242T>C,p.Leu81Pro,missense_variant,missense_variant,0.519331289,,No,,Pathogenic,no assertion criteria provided,"Jan 01, 2004",aa,urn:mavedb:00000108-a-3,ENST00000652429.1,NM_000190.4,yeast,,,"catalytic activity (GO:0003824), hydroxymethylbilane synthase activity (GO:0004418)",No,,,,,,,,,,,0.976,0.9973,likely_pathogenic,,,,,,,,,,,,,,,,,,,HMBS_Leu81Pro,true,Leu81Pro
RAD51D_Ala231Ser,18,15,3,0,83.33,16.67,0.0,100.0,18,0.0,true,RAD51D,,7201,,CCSBVarC024850,,NC_000017.11:35103301:C:A,691G>T,Ala231Ser,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35103301,C,A,17,,,,,,17-35103301-C-A,478474.0,single nucleotide variant,NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Jan 14, 2025",772135704.0,-,RCV000575670|RCV001351481|RCV001764647,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided",germline;unknown,germline,GRCh38,NC_000017.11,17,35103301.0,35103301.0,17q12,"criteria provided, conflicting classifications",5.0,-,N,ClinGen:CA8499378,2.0,480531.0,35103301.0,C,A,-,-,-,-,-,-,SCV000663829|SCV000686480|SCV001545958|SCV001990804|SCV004208079,-,-,691G>T ,Ala231Ser,NM_002878.4,1.0,3_Conflicting,,480531.0,17,35103301.0,C,A,A,S,rs772135704,17,33430320,17,30454433,231.0,RAD51D,ENSG00000185379,ENST00000394589,ENSP00000378090,O75771,RA51D_HUMAN,c.691G>T,p.Ala231Ser,c.691G>T,p.Ala231Ser,principal1,Y,5,.,.,-,GCC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.39016,.,0.148,0.35663,T,0.68,0.53374,P,0.562,0.49607,P,0.18,0.50204,N,simple_aae,82.0,18.0,1.42,0.35528,L,.,0.43338,.,0.222,0.39513,-0.6345,0.63221,T,0.2791,0.64952,T,10,0.45145473,0.58389,D,0.066725,0.69852,D,0.162,0.41623,0.644,0.78027,O75771,A231S,Gain of phosphorylation at A231 (P = 0.0655)| Gain of disorder (P = 0.0844)| Gain of MoRF binding (P = 0.1284)| Loss of ubiquitination at K235 (P = 0.2243)| Loss of methylation at R232 (P = 0.3779),0.942670400808,0.94162,.,0.52746,.,0.36618,.,.,.,0.169282,0.51414,T,-0.0747325,0.40218,T,-0.00673246,0.69677,D,0.217512117147641,0.21078,T,0.864413,0.57408,D,0.5926053,0.72005,0.42019272,0.65736,0.5926053,0.72007,0.42019272,0.65736,-7.695,0.62579,D,0.116,0.32008,B,0.000766225569270482,0.08395,0.93499870,0.92618,0.232,0.50061,.,.,.,.,.,.,3.594988,0.50833,23.0,0.96226307501413078,0.29313,0.620192,0.60393,D,0.387026469158641,0.60517,4.263942,0.432911172391861,0.63430,4.600281,4.92,4.92,0.64102,3.22,0.58372,4.112,0.57674,2.653000,0.33911,0.549,0.27038,1.0,0.71675,1.0,0.68239,0.998,0.85369,908,0.22602,.,.,.,.,.,.,.,.,.,.,.,.,1,264690,3.7780044E-6,.,8,106972,7.478590e-05,0,15,203574,7.368330e-05,0,15,232448,6.453060e-05,0,0,6872,0.000000e+00,0,0,16800,0.000000e+00,0,0,2230,0.000000e+00,0,0,8846,0.000000e+00,0,0,13256,0.000000e+00,0,0,41826,0.000000e+00,0,8,15260,5.242460e-04,0,8,15260,5.242460e-04,0,0,15702,0.000000e+00,0,0,29908,0.000000e+00,0,0,6046,0.000000e+00,0,0,13302,0.000000e+00,0,0,16488,0.000000e+00,0,0,87500,0.000000e+00,0,15,29876,5.020750e-04,0,15,29876,5.020750e-04,0,0,14484,0.000000e+00,0,0,33672,0.000000e+00,0,0,9430,0.000000e+00,0,0,17458,0.000000e+00,0,0,21108,0.000000e+00,0,0,100948,0.000000e+00,0,15,29796,5.034230e-04,0,15,29796,5.034230e-04,0,.,47,1611894,2.915820e-05,0,46,90536,5.080850e-04,0,0,74890,0.000000e+00,0,0,912,0.000000e+00,0,0,59658,0.000000e+00,0,0,29510,0.000000e+00,0,0,44848,0.000000e+00,0,0,63892,0.000000e+00,0,0,6052,0.000000e+00,0,0,1179196,0.000000e+00,0,46,90536,5.080850e-04,0,0,6962,0,0,84,0,0,84,0,0,2636,0,0,146,0,0,610,0,0,24,0,0,94,0,0,518,0,0,2720,0,0,108,0,0,11158,0,Conflicting_classifications_of_pathogenicity,"Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35103301C>A,ClinGen:CA8499378,C0027672|C3661900|C3280345,614291,140162|145,"DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal",Ala,Ser,478474.0,single nucleotide variant,NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Jan 14, 2025",772135704.0,-,RCV000575670|RCV001351481|RCV001764647,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided",germline;unknown,germline,GRCh38,NC_000017.11,17,35103301.0,35103301.0,17q12,"criteria provided, conflicting classifications",5.0,-,N,ClinGen:CA8499378,2.0,480531.0,35103301.0,C,A,-,-,-,-,-,-,SCV000663829|SCV000686480|SCV001545958|SCV001990804|SCV004208079,-,-,691G>T ,Ala231Ser,NM_002878.4,1.0,3_Conflicting,97.85,0.0283018867924528,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",A,3,97.85,Aliphatic,Alanine,DNA repair protein RAD51 homolog 4,,0.0477,1.8,,,"A231-K235, A231-M227; PAE: 1.0, 1.0",5 interactions,"A231-K235, A231-M227; PAE: 1.0, 1.0",6 interactions,,,89,,-57.4,,"Pocket 3: Mean pLDDT: 97.77, Volume: 250.74 Å³, Druggability score: 0.05",-37.4,,,H (helix),H (α-helix),Helix,in Ref. 9; CAB55937,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var153186,RAD51D_unpublished,RAD51D,9823,-1.0,35103301.0,35103301.0,,691,G,T,231.0,A,S,c.691G>T,p.Ala231Ser,missense_variant,missense_variant,0.0141602,functionally_normal,Yes,0.0000291582448969,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Mar 21, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.162,0.116,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Ala231Ser,true,Ala231Ser
RAD51D_Cys9Ser,18,6,8,4,33.33,44.44,22.22,77.78,14,3.9996,true,RAD51D,,7201,,CCSBVarC024707,,NC_000017.11:35119588:C:G,26G>C,Cys9Ser,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35119588,C,G,17,,,,,,17-35119588-C-G,133343.0,single nucleotide variant,NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Mar 04, 2025",140825795.0,-,RCV000115812|RCV000231466|RCV000587404|RCV001175378|RCV001357793|RCV003492494|RCV001798342|RCV003389691,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C1333600|MedGen:CN221562|","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified|Malignant tumor of breast|Hereditary cancer|Breast and/or ovarian cancer|RAD51D-related disorder",germline;unknown,germline,GRCh38,NC_000017.11,17,35119588.0,35119588.0,17q12,"criteria provided, conflicting classifications",20.0,-,N,ClinGen:CA287968,2.0,127886.0,35119588.0,C,G,-,-,-,-,-,-,SCV000149721|SCV000185831|SCV000287702|SCV000488471|SCV000537513|SCV000602155|SCV000698094|SCV000839205|SCV000861249|SCV001434312|SCV002010056|SCV002043216|SCV002071956|SCV002534788|SCV003799801|SCV004009783|SCV004017720|SCV004242788,-,-,26G>C ,Cys9Ser,NM_002878.4,1.0,3_Conflicting,,127886.0,17,35119588.0,C,G,C,S,rs140825795,17,33446607,17,30470720,9.0,RAD51D,ENSG00000185379,ENST00000394589,ENSP00000378090,O75771,RA51D_HUMAN,c.26G>C,p.Cys9Ser,c.26G>C,p.Cys9Ser,principal1,Y,5,.,.,-,TGC,2.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.005,0.79703,D,0.948,0.77914,P,0.539,0.82066,P,0.0,0.33788,N,simple_aae,100.0,0.0,2.37,0.68084,M,-5.89,0.91889,D,0.767,0.76382,-0.5618,0.66187,T,0.3025,0.67215,T,10,0.23021111,0.39578,T,0.269442,0.89798,D,0.218,0.51046,0.75,0.88011,O75771,C9S,Gain of disorder (P = 0.0024)| Gain of phosphorylation at C9 (P = 0.0829)| Gain of methylation at R5 (P = 0.2031)| Gain of helix (P = 0.2294)| Gain of catalytic residue at G7 (P = 0.288),0.89673440463,0.89492,.,0.75662,.,0.38233,.,.,.,0.542336,0.84209,D,-0.0621782,0.42220,T,0.0874681,0.75898,D,0.123274603139513,0.14560,T,0.89681,0.63880,D,0.90909326,0.92096,0.91432685,0.95940,0.9053122,0.91745,0.9265354,0.96810,-13.828,0.92500,D,0.7562,0.75474,P,0.0197165020029777,0.29331,0.98283120,0.95814,0.694,0.83023,.,.,.,.,.,.,4.809918,0.78275,26.9,0.99055369264790372,0.51428,0.811646,0.73360,D,0.419960104252545,0.62325,4.469254,0.393835298150661,0.60976,4.315044,4.5,4.5,0.54328,.,.,3.449,0.52806,7.405000,0.58667,0.599,0.40292,1.0,0.71675,1.0,0.68239,0.842,0.39783,926,0.17784,.,.,.,.,.,.,.,.,.,.,.,.,112,264690,4.231365E-4,.,27,108026,2.499400e-04,1,83,204386,4.060940e-04,1,81,233462,3.469520e-04,1,0,7118,0.000000e+00,0,6,17088,3.511240e-04,1,0,2320,0.000000e+00,0,0,9008,0.000000e+00,0,1,12198,8.198070e-05,0,20,42712,4.682520e-04,0,0,15682,0.000000e+00,0,20,42712,4.682520e-04,0,1,16132,6.198860e-05,0,12,30494,3.935200e-04,1,0,6188,0.000000e+00,0,0,13354,0.000000e+00,0,1,15538,6.435830e-05,0,68,87248,7.793870e-04,0,0,30600,0.000000e+00,0,68,87248,7.793870e-04,0,1,14856,6.731290e-05,0,13,34236,3.797170e-04,1,0,9562,0.000000e+00,0,0,17654,0.000000e+00,0,1,20436,4.893330e-05,0,64,100606,6.361450e-04,0,0,30518,0.000000e+00,0,64,100606,6.361450e-04,0,.,1058,1612440,6.561480e-04,1,980,1179946,8.305460e-04,0,12,75044,1.599060e-04,0,0,912,0.000000e+00,0,15,60030,2.498750e-04,1,0,29602,0.000000e+00,0,0,44872,0.000000e+00,0,2,62412,3.204510e-05,0,0,6062,0.000000e+00,0,980,1179946,8.305460e-04,0,0,91086,0.000000e+00,0,56,93168,6.010647432594882E-4,0,174,0,0,2674,0,0,4182,0,1,772,0.0012953367875647669,0,946,0,0,656,0,0,274,0,3,7122,4.2122999157540015E-4,0,4356,0,0,3330,0,60,109968,5.456132693147098E-4,Conflicting_classifications_of_pathogenicity,"Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|RAD51D-related_disorder","criteria_provided,_conflicting_classifications",NC_000017.11:g.35119588C>G,ClinGen:CA287968,C0006142|CN221562|C3280345|C1333600|CN169374|C0027672|C3661900,614291,145|140162,"RAD51D, N-terminal domain",Cys,Ser,133343.0,single nucleotide variant,NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Mar 04, 2025",140825795.0,-,RCV000115812|RCV000231466|RCV000587404|RCV001175378|RCV001357793|RCV003492494|RCV001798342|RCV003389691,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C1333600|MedGen:CN221562|","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified|Malignant tumor of breast|Hereditary cancer|Breast and/or ovarian cancer|RAD51D-related disorder",germline;unknown,germline,GRCh38,NC_000017.11,17,35119588.0,35119588.0,17q12,"criteria provided, conflicting classifications",20.0,-,N,ClinGen:CA287968,2.0,127886.0,35119588.0,C,G,-,-,-,-,-,-,SCV000149721|SCV000185831|SCV000287702|SCV000488471|SCV000537513|SCV000602155|SCV000698094|SCV000839205|SCV000861249|SCV001434312|SCV002010056|SCV002043216|SCV002071956|SCV002534788|SCV003799801|SCV004009783|SCV004017720|SCV004242788,-,-,26G>C ,Cys9Ser,NM_002878.4,1.0,3_Conflicting,80.18,0.0518518518518518,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",C,7,80.18,"Special, a very reactive sulfhydryl group",Cysteine,DNA repair protein RAD51 homolog 4,,,2.5,,,,1 interaction,,4 interactions,,,121,,-149.0,,,157.1,preferentially binds ssDNA,,C (loop/coil),S (bend),,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var156198,RAD51D_unpublished,RAD51D,9823,-1.0,35119588.0,35119588.0,,26,G,C,9.0,C,S,c.26G>C,p.Cys9Ser,missense_variant,missense_variant,-0.00763888,functionally_normal,Yes,0.0006561484458336,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Nov 18, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.218,0.7562,likely_pathogenic,,,,,,,,,,,,,,,,,,,RAD51D_Cys9Ser,true,Cys9Ser
RAD51D_Glu307Lys,19,10,4,5,52.63,21.05,26.32,73.68,14,5.0008,true,RAD51D,,7201,,CCSBVarC024889,,NC_000017.11:35101021:C:T,919G>A,Glu307Lys,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35101021,C,T,17,,,,,,17-35101021-C-T,133352.0,single nucleotide variant,NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Feb 02, 2025",115031549.0,-,RCV000115821|RCV000212975|RCV000656966|RCV000989829|RCV001354385|RCV003149803|RCV003905100|RCV004700423,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562||MedGen:C1333600","Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Malignant tumor of breast|Breast and/or ovarian cancer|RAD51D-related disorder|Hereditary cancer",germline;unknown,germline,GRCh38,NC_000017.11,17,35101021.0,35101021.0,17q12,"criteria provided, conflicting classifications",12.0,-,N,ClinGen:CA287990,2.0,127895.0,35101021.0,C,T,-,-,-,-,-,-,SCV000149730|SCV000185235|SCV000287733|SCV000602170|SCV000859940|SCV000910718|SCV000918142|SCV001140404|SCV002527051|SCV003838853,-,-,919G>A ,Glu307Lys,NM_002878.4,1.0,3_Conflicting,,127895.0,17,35101021.0,C,T,E,K,rs115031549,17,33428040,17,30452153,307.0,RAD51D,ENSG00000185379,ENST00000345365,ENSP00000338790,O75771,RA51D_HUMAN,c.919G>A,p.Glu307Lys,c.919G>A,p.Glu307Lys,principal1,Y,1,YES,Select,-,GAG,1.0,0.0,C,C/C,C/C,C/C,C/C,0.178,0.22252,T,1.0,0.28071,T,0.001,0.15546,B,0.003,0.17739,B,0.04,0.16373,N,simple_aae,96.0,4.0,0.975,0.24371,L,-1.37,0.33974,N,0.183,0.40913,-1.0750,0.08363,T,0.0695,0.28228,T,10,0.005851954,0.00128,T,0.009794,0.25268,T,0.146,0.38573,.,.,.,.,.,0.607307720492,0.60114,.,0.58340,.,0.10516,.,.,.,0.12397,0.44563,T,-0.436555,0.01267,T,-0.402908,0.32684,T,0.0220424253485093,0.00910,T,.,0.44143,.,0.06279154,0.13032,0.07841017,0.17544,0.06279154,0.13031,0.07841017,0.17544,-3.296,0.19068,T,0.2196,0.48302,LB,0.00210343958860793,0.13347,0.64807075,0.84992,0.024,0.04173,.,.,.,.,.,.,2.74903,0.36098,20.1,0.95388473665255458,0.27048,0.227759,0.34944,N,-0.451516097100692,0.23421,1.273859,-0.296002730575465,0.27912,1.572344,5.16,4.19,0.48586,1.06,0.29739,2.03,0.40832,4.830000,0.45268,-0.187,0.09644,1.0,0.71675,1.0,0.68239,0.789,0.37304,913,0.21155,3,5.990415335463259E-4,3,0.0022692889561270802,0,0.0,0,0.0,0,0.0,0,0.0,238,264690,8.9916505E-4,.,20,109408,1.828020e-04,0,55,208134,2.642530e-04,0,56,236948,2.363390e-04,0,17,7164,2.372980e-03,0,2,17112,1.168770e-04,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13394,0.000000e+00,0,0,42768,0.000000e+00,0,0,15690,0.000000e+00,0,17,7164,2.372980e-03,0,46,16218,2.836350e-03,0,8,30524,2.620890e-04,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16734,0.000000e+00,0,0,89556,0.000000e+00,0,0,30608,0.000000e+00,0,46,16218,2.836350e-03,0,45,14902,3.019730e-03,0,9,34260,2.626970e-04,0,0,9572,0.000000e+00,0,0,17692,0.000000e+00,0,0,21632,0.000000e+00,0,0,102744,0.000000e+00,0,0,30526,0.000000e+00,0,45,14902,3.019730e-03,0,.,251,1613792,1.555340e-04,2,217,75054,2.891250e-03,2,217,75054,2.891250e-03,2,0,912,0.000000e+00,0,20,60010,3.332780e-04,0,0,29602,0.000000e+00,0,0,44888,0.000000e+00,0,0,64046,0.000000e+00,0,0,6062,0.000000e+00,0,3,1179658,2.543110e-06,0,0,91070,0.000000e+00,0,1,167370,5.9747864013861505E-6,3,362,0.008287292817679558,0,4488,0,28,8974,0.0031201248049922,0,460,0,0,1024,0,0,1820,0,0,296,0,0,11378,0,31,9336,0.0033204798628963155,0,6308,0,32,196172,1.6312215810615173E-4,Conflicting_classifications_of_pathogenicity,"Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|RAD51D-related_disorder","criteria_provided,_conflicting_classifications",NC_000017.11:g.35101021C>T,ClinGen:CA287990,C0027672|CN169374|C3661900|C3280345|C0006142|CN221562,614291,140162|145,.,Glu,Lys,133352.0,single nucleotide variant,NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Feb 02, 2025",115031549.0,-,RCV000115821|RCV000212975|RCV000656966|RCV000989829|RCV001354385|RCV003149803|RCV003905100|RCV004700423,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562||MedGen:C1333600","Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Malignant tumor of breast|Breast and/or ovarian cancer|RAD51D-related disorder|Hereditary cancer",germline;unknown,germline,GRCh38,NC_000017.11,17,35101021.0,35101021.0,17q12,"criteria provided, conflicting classifications",12.0,-,N,ClinGen:CA287990,2.0,127895.0,35101021.0,C,T,-,-,-,-,-,-,SCV000149730|SCV000185235|SCV000287733|SCV000602170|SCV000859940|SCV000910718|SCV000918142|SCV001140404|SCV002527051|SCV003838853,-,-,919G>A ,Glu307Lys,NM_002878.4,1.0,3_Conflicting,93.44,0.1752577319587628,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",E,34,93.44,Negatively-charged,Glutamic Acid,DNA repair protein RAD51 homolog 4,,,-3.5,,,"E307-K91, E307-A293; PAE: 2.0, 1.0",4 interactions,E307-A293; PAE: 1.0,6 interactions,,,146,,-137.1,,,145.0,,,B (undefined),E (parallel sheets),Beta strand,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var152160,RAD51D_unpublished,RAD51D,9823,-1.0,35101021.0,35101021.0,,919,G,A,307.0,E,K,c.919G>A,p.Glu307Lys,missense_variant,missense_variant,-0.0106997,functionally_normal,Yes,0.0001555342943824,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Sep 11, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.146,0.2429,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Glu307Lys,true,Glu307Lys
RAD51D_Gly289Ser,19,15,4,0,78.95,21.05,0.0,100.0,19,0.0,true,RAD51D,,7201,,CCSBVarC024877,,NC_000017.11:35101239:C:T,865G>A,Gly289Ser,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35101239,C,T,17,,,,,,17-35101239-C-T,151659.0,single nucleotide variant,NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Nov 29, 2024",587782129.0,-,RCV000130672|RCV000462688|RCV000480701|RCV001194378,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified",germline,germline,GRCh38,NC_000017.11,17,35101239.0,35101239.0,17q12,"criteria provided, conflicting classifications",5.0,-,N,ClinGen:CA166871,2.0,141945.0,35101239.0,C,T,-,-,-,-,-,-,SCV000185558|SCV000551343|SCV000569950|SCV000908946|SCV001363870,-,-,865G>A ,Gly289Ser,NM_002878.4,1.0,3_Conflicting,,141945.0,17,35101239.0,C,T,G,S,rs587782129,17,33428258,17,30452371,289.0,RAD51D,ENSG00000185379,ENST00000394589,ENSP00000378090,O75771,RA51D_HUMAN,c.865G>A,p.Gly289Ser,c.865G>A,p.Gly289Ser,principal1,Y,5,.,.,-,GGC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.00968,.,1.0,0.10481,T,0.008,0.20016,B,0.008,0.16009,B,0.06,0.18971,N,simple_aae,94.0,6.0,-0.395,0.03015,N,.,0.02351,.,0.225,0.25080,-1.0152,0.25206,T,0.1048,0.38180,T,10,0.047472775,0.04072,T,0.015582,0.36140,T,0.030,0.06938,0.393,0.41625,O75771,G289S,Gain of phosphorylation at G289 (P = 0.0191)| Gain of glycosylation at G289 (P = 0.0564)| Loss of methylation at R290 (P = 0.0588)| Gain of disorder (P = 0.0724)| Gain of MoRF binding (P = 0.1175),0.0762999501168,0.06748,.,0.22253,.,0.36811,.,.,.,0.105892,0.41382,T,-0.28641,0.09770,T,-0.55233,0.16804,T,0.0316729542490267,0.02239,T,0.675032,0.28091,T,0.018450681,0.00366,0.023860626,0.00404,0.018450681,0.00366,0.023860626,0.00404,-2.752,0.11831,T,0.0718,0.06786,B,2.70558370001736e-05,0.01340,0.14648667,0.70195,0.008,0.00393,.,.,.,.,.,.,-0.012147,0.0421,1.022,0.74482722392783784,0.10886,0.042395,0.06461,N,-1.33388171991115,0.03260,0.1469401,-1.31009436204477,0.04234,0.2024671,4.86,0.314,0.15050,-1.35,0.14151,0.155,0.16235,-0.662000,0.08011,-0.181,0.10317,0.037,0.20898,0.0,0.08389,0.001,0.02614,912,0.21478,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,2,109404,1.828090e-05,0,2,208106,9.610490e-06,0,3,236918,1.266260e-05,0,0,7164,0.000000e+00,0,0,17112,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13390,0.000000e+00,0,1,42768,2.338200e-05,0,1,15690,6.373490e-05,0,1,15690,6.373490e-05,0,0,16214,0.000000e+00,0,0,30522,0.000000e+00,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16730,0.000000e+00,0,1,89538,1.116840e-05,0,1,30608,3.267120e-05,0,1,30608,3.267120e-05,0,0,14902,0.000000e+00,0,1,34260,2.918860e-05,0,0,9572,0.000000e+00,0,0,17692,0.000000e+00,0,0,21628,0.000000e+00,0,1,102720,9.735200e-06,0,1,30526,3.275900e-05,0,1,30526,3.275900e-05,0,.,11,1614202,6.814510e-06,0,1,91088,1.097840e-05,0,0,75044,0.000000e+00,0,0,912,0.000000e+00,0,0,60024,0.000000e+00,0,0,29604,0.000000e+00,0,0,44874,0.000000e+00,0,0,64048,0.000000e+00,0,0,6062,0.000000e+00,0,9,1180036,7.626890e-06,0,1,91088,1.097840e-05,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Conflicting_classifications_of_pathogenicity,"not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_specified","criteria_provided,_conflicting_classifications",NC_000017.11:g.35101239C>T,ClinGen:CA166871,C3661900|C0027672|C3280345|CN169374,614291,140162|145,"DNA repair protein RAD51 homolog 4, C-terminal",Gly,Ser,151659.0,single nucleotide variant,NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Nov 29, 2024",587782129.0,-,RCV000130672|RCV000462688|RCV000480701|RCV001194378,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified",germline,germline,GRCh38,NC_000017.11,17,35101239.0,35101239.0,17q12,"criteria provided, conflicting classifications",5.0,-,N,ClinGen:CA166871,2.0,141945.0,35101239.0,C,T,-,-,-,-,-,-,SCV000185558|SCV000551343|SCV000569950|SCV000908946|SCV001363870,-,-,865G>A ,Gly289Ser,NM_002878.4,1.0,3_Conflicting,76.22,0.2023809523809523,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",G,17,76.22,"Special, lack of a chiral carbon, smallest amino acid, very flexible",Glycine,DNA repair protein RAD51 homolog 4,,,-0.4,,,G289-I311; PAE: 4.0,2 interactions,"G289-I311, G289-G312; PAE: 4.0, 5.5",5 interactions,,,75,,-66.1,,,-15.7,,,C (loop/coil),C (loop/coil),,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var152454,RAD51D_unpublished,RAD51D,9823,-1.0,35101239.0,35101239.0,,865,G,A,289.0,G,S,c.865G>A,p.Gly289Ser,missense_variant,missense_variant,-0.00125449,functionally_normal,Yes,6.8145126818e-6,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","May 29, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.03,0.0718,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Gly289Ser,true,Gly289Ser
RAD51D_His23Arg,19,9,9,1,47.37,47.37,5.26,94.74,18,0.9994,true,RAD51D,,7201,,CCSBVarC024711,,NC_000017.11:35119546:T:C,68A>G,His23Arg,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35119546,T,C,17,,,,,,17-35119546-T-C,409908.0,single nucleotide variant,NM_002878.4(RAD51D):c.68A>G (p.His23Arg),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Feb 03, 2024",990062370.0,-,RCV000485429|RCV000547804|RCV000566071,"MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000017.11,17,35119546.0,35119546.0,17q12,"criteria provided, conflicting classifications",3.0,-,N,ClinGen:CA16620393,2.0,418673.0,35119546.0,T,C,-,-,-,-,-,-,SCV000565901|SCV000651772|SCV000663810,-,-,68A>G ,His23Arg,NM_002878.4,1.0,3_Conflicting,,418673.0,17,35119546.0,T,C,H,R,rs990062370,17,33446565,17,30470678,23.0,RAD51D,ENSG00000185379,ENST00000394589,ENSP00000378090,O75771,RA51D_HUMAN,c.68A>G,p.His23Arg,c.68A>G,p.His23Arg,principal1,Y,5,.,.,-,CAC,2.0,0.0,T,T/T,T/T,T/T,T/T,1.0,0.00968,T,0.792,0.05378,T,0.0,0.02950,B,0.0,0.01384,B,.,.,.,.,.,.,-2.015,0.00188,N,-0.59,0.18393,N,0.064,0.10018,-0.9955,0.31058,T,0.0244,0.10333,T,10,0.032363117,0.01387,T,0.010514,0.26860,T,0.018,0.03036,0.425,0.46877,O75771,H23R,Loss of sheet (P = 0.003)| Gain of helix (P = 0.0034)| Gain of MoRF binding (P = 0.0286)| Gain of phosphorylation at S22 (P = 0.091)| Loss of ubiquitination at K26 (P = 0.1022),0.319686207203,0.31162,.,0.34452,.,0.11066,.,.,.,0.115945,0.43190,T,-0.364518,0.03721,T,-0.761382,0.02907,T,0.0475806100992363,0.05021,T,0.0435956,0.00994,T,0.040238965,0.05652,0.052508783,0.08678,0.040238965,0.05652,0.052508783,0.08677,-1.909,0.10376,T,0.0613,0.02261,B,7.77047030966497e-07,0.00398,0.22299655,0.74091,0.028,0.05473,.,.,.,.,.,.,0.56021,0.09313,6.069,0.69154575729474244,0.09022,0.046472,0.07594,N,-1.35012510449794,0.03091,0.1390257,-1.25403651457861,0.04992,0.2407925,4.5,-1.34,0.08645,-3.41,0.07546,-1.008,0.03777,-1.240000,0.05963,-0.173,0.11029,0.0,0.06393,0.0,0.08389,0.771,0.36593,926,0.17784,.,.,.,.,.,.,.,.,.,.,.,.,3,264690,1.1334013E-5,.,0,107948,0.000000e+00,0,1,204124,4.898980e-06,0,1,233180,4.288530e-06,0,0,7098,0.000000e+00,0,0,17080,0.000000e+00,0,0,2320,0.000000e+00,0,0,8998,0.000000e+00,0,0,12186,0.000000e+00,0,0,42690,0.000000e+00,0,0,15678,0.000000e+00,0,.,.,.,.,0,16112,0.000000e+00,0,0,30490,0.000000e+00,0,0,6182,0.000000e+00,0,0,13344,0.000000e+00,0,0,15526,0.000000e+00,0,1,87036,1.148950e-05,0,0,30596,0.000000e+00,0,1,87036,1.148950e-05,0,0,14834,0.000000e+00,0,0,34228,0.000000e+00,0,0,9560,0.000000e+00,0,0,17644,0.000000e+00,0,0,20424,0.000000e+00,0,1,100384,9.961750e-06,0,0,30514,0.000000e+00,0,1,100384,9.961750e-06,0,.,1,1612358,6.202100e-07,0,1,1179926,8.475110e-07,0,0,74908,0.000000e+00,0,0,912,0.000000e+00,0,0,59996,0.000000e+00,0,0,29596,0.000000e+00,0,0,44882,0.000000e+00,0,0,62504,0.000000e+00,0,0,6084,0.000000e+00,0,1,1179926,8.475110e-07,0,0,91090,0.000000e+00,0,0,7618,0,0,108,0,0,84,0,0,2708,0,0,146,0,0,610,0,0,24,0,0,94,0,0,470,0,0,2816,0,0,108,0,0,11862,0,Conflicting_classifications_of_pathogenicity,"Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_provided|Hereditary_cancer-predisposing_syndrome","criteria_provided,_conflicting_classifications",NC_000017.11:g.35119546T>C,ClinGen:CA16620393,C3280345|C3661900|C0027672,614291,145|140162,"RAD51D, N-terminal domain",His,Arg,409908.0,single nucleotide variant,NM_002878.4(RAD51D):c.68A>G (p.His23Arg),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Feb 03, 2024",990062370.0,-,RCV000485429|RCV000547804|RCV000566071,"MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000017.11,17,35119546.0,35119546.0,17q12,"criteria provided, conflicting classifications",3.0,-,N,ClinGen:CA16620393,2.0,418673.0,35119546.0,T,C,-,-,-,-,-,-,SCV000565901|SCV000651772|SCV000663810,-,-,68A>G ,His23Arg,NM_002878.4,1.0,3_Conflicting,90.21,0.4021739130434782,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",H,74,90.21,Positively-charged,Histidine,DNA repair protein RAD51 homolog 4,,,-3.2,,,"H23-L19, H23-C43; PAE: 1.0, 2.5",3 interactions,"H23-L19, H23-C43; PAE: 1.0, 2.5",4 interactions,,,155,,-95.2,,,21.4,preferentially binds ssDNA,,C (loop/coil),T (turn),,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var156072,RAD51D_unpublished,RAD51D,9823,-1.0,35119546.0,35119546.0,,68,A,G,23.0,H,R,c.68A>G,p.His23Arg,missense_variant,missense_variant,-0.0128331,functionally_normal,Yes,6.202096556720033e-7,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Oct 19, 2023",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.018,0.0613,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_His23Arg,true,His23Arg
RAD51D_Ile251Val,18,13,5,0,72.22,27.78,0.0,100.0,18,0.0,true,RAD51D,,7201,,CCSBVarC024857,,NC_000017.11:35101353:T:C,751A>G,Ile251Val,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35101353,T,C,17,,,,,,17-35101353-T-C,151014.0,single nucleotide variant,NM_002878.4(RAD51D):c.751A>G (p.Ile251Val),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Jun 23, 2024",540273429.0,-,RCV000236753|RCV000542443|RCV000129767,"MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000017.11,17,35101353.0,35101353.0,17q12,"criteria provided, conflicting classifications",4.0,-,N,ClinGen:CA165041,2.0,141300.0,35101353.0,T,C,-,-,-,-,-,-,SCV000184576|SCV000293833|SCV000651777|SCV000904087,-,-,751A>G ,Ile251Val,NM_002878.4,1.0,3_Conflicting,,141300.0,17,35101353.0,T,C,I,V,rs540273429,17,33428372,17,30452485,251.0,RAD51D,ENSG00000185379,ENST00000345365,ENSP00000338790,O75771,RA51D_HUMAN,c.751A>G,p.Ile251Val,c.751A>G,p.Ile251Val,principal1,Y,1,YES,Select,-,ATA,1.0,0.0,T,T/T,T/T,T/T,T/T,1.0,0.00968,T,1.0,0.03926,T,0.0,0.02950,B,0.001,0.04348,B,0.06,0.18971,N,simple_aae,94.0,6.0,-1.04,0.01100,N,0.1,0.05782,N,0.105,0.14965,-0.9577,0.39436,T,0.0599,0.24885,T,10,0.036506176,0.01956,T,0.010139,0.26052,T,0.070,0.20265,0.474,0.54885,O75771,I251V,Gain of phosphorylation at T248 (P = 0.0936)| Gain of disorder (P = 0.0983)| Gain of MoRF binding (P = 0.1184)| Gain of methylation at R255 (P = 0.2396)| Loss of stability (P = 0.2941),0.388174495139,0.38033,.,0.16030,.,0.31871,.,.,.,0.075571,0.34949,T,-0.130246,0.31098,T,-0.424866,0.30159,T,0.0309130971524996,0.02119,T,.,0.39652,.,0.015923232,0.00166,0.02370252,0.00388,0.015923232,0.00166,0.02370252,0.00387,-0.859,0.00857,T,0.0667,0.04993,LB,1.1537049706086e-05,0.00991,0.23355223,0.74518,0.014,0.01428,.,.,.,.,.,.,-0.048466,0.03972,0.888,0.81310861979149396,0.13840,0.042627,0.06525,N,-1.20699475414867,0.04841,0.2220042,-1.14727300713446,0.06706,0.3294306,4.86,-3.91,0.03894,-5.59,0.03621,0.337,0.19651,-2.070000,0.04280,0.665,0.62996,0.881,0.31099,0.0,0.08389,0.946,0.49004,911,0.21960,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,109058,0.000000e+00,0,1,207758,4.813290e-06,0,1,236598,4.226580e-06,0,0,7158,0.000000e+00,0,0,17110,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13062,0.000000e+00,0,0,42762,0.000000e+00,0,0,15688,0.000000e+00,0,.,.,.,.,0,16206,0.000000e+00,0,0,30522,0.000000e+00,0,0,6210,0.000000e+00,0,0,13414,0.000000e+00,0,0,16402,0.000000e+00,0,1,89534,1.116890e-05,0,0,30606,0.000000e+00,0,1,89534,1.116890e-05,0,0,14896,0.000000e+00,0,0,34258,0.000000e+00,0,0,9570,0.000000e+00,0,0,17692,0.000000e+00,0,0,21300,0.000000e+00,0,1,102740,9.733310e-06,0,0,30524,0.000000e+00,0,1,102740,9.733310e-06,0,.,7,1613900,4.337320e-06,0,1,6060,1.650170e-04,0,0,75054,0.000000e+00,0,0,912,0.000000e+00,0,0,60020,0.000000e+00,0,0,29608,0.000000e+00,0,0,44890,0.000000e+00,0,0,63756,0.000000e+00,0,1,6060,1.650170e-04,0,4,1180012,3.389800e-06,0,1,91084,1.097890e-05,0,0,6062,0,0,8,0,0,26,0,0,586,0,0,0,0,0,0,0,0,30,0,0,0,0,1,2276,4.393673110720562E-4,0,594,0,0,56,0,1,8988,1.1125945705384957E-4,Conflicting_classifications_of_pathogenicity,"Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35101353T>C,ClinGen:CA165041,C0027672|C3661900|C3280345,614291,140162|145,"DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal",Ile,Val,151014.0,single nucleotide variant,NM_002878.4(RAD51D):c.751A>G (p.Ile251Val),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Jun 23, 2024",540273429.0,-,RCV000236753|RCV000542443|RCV000129767,"MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000017.11,17,35101353.0,35101353.0,17q12,"criteria provided, conflicting classifications",4.0,-,N,ClinGen:CA165041,2.0,141300.0,35101353.0,T,C,-,-,-,-,-,-,SCV000184576|SCV000293833|SCV000651777|SCV000904087,-,-,751A>G ,Ile251Val,NM_002878.4,1.0,3_Conflicting,93.94,0.2544378698224852,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",I,43,93.94,Aliphatic,Isoleucine,DNA repair protein RAD51 homolog 4,,0.4068,4.5,,,,,I251-G107; PAE: 1.5,7 interactions,,,131,,-95.2,,"Pocket 1: Mean pLDDT: 91.59, Volume: 402.91 Å³, Druggability score: 0.41",143.2,,,B (undefined),E (parallel sheets),Beta strand,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var152783,RAD51D_unpublished,RAD51D,9823,-1.0,35101353.0,35101353.0,,751,A,G,251.0,I,V,c.751A>G,p.Ile251Val,missense_variant,missense_variant,-0.00741379,functionally_normal,Yes,4.3373195365e-6,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Feb 27, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.07,0.0661,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Ile251Val,true,Ile251Val
RAD51D_Met308Val,19,15,4,0,78.95,21.05,0.0,100.0,19,0.0,true,RAD51D,,7201,,CCSBVarC024892,,NC_000017.11:35101018:T:C,922A>G,Met308Val,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35101018,T,C,17,,,,,,17-35101018-T-C,184803.0,single nucleotide variant,NM_002878.4(RAD51D):c.922A>G (p.Met308Val),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Sep 23, 2024",786201961.0,-,RCV000164512|RCV004782268|RCV000649679,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145","Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4",germline,germline,GRCh38,NC_000017.11,17,35101018.0,35101018.0,17q12,"criteria provided, conflicting classifications",4.0,-,N,ClinGen:CA191144,2.0,185144.0,35101018.0,T,C,-,-,-,-,-,-,SCV000215164|SCV000771511|SCV000911462|SCV005394802,-,-,922A>G ,Met308Val,NM_002878.4,1.0,3_Conflicting,,185144.0,17,35101018.0,T,C,M,V,rs786201961,17,33428037,17,30452150,308.0,RAD51D,ENSG00000185379,ENST00000345365,ENSP00000338790,O75771,RA51D_HUMAN,c.922A>G,p.Met308Val,c.922A>G,p.Met308Val,principal1,Y,1,YES,Select,-,ATG,1.0,0.0,T,T/T,T/T,T/T,T/T,0.274,0.15912,T,0.326,0.19266,T,0.0,0.09864,B,0.0,0.06938,B,0.04,0.13669,N,simple_aae,96.0,4.0,0.72,0.18616,N,-0.61,0.17975,N,0.017,0.04065,-0.9351,0.43192,T,0.0836,0.32564,T,10,0.091109514,0.15785,T,0.00703,0.18349,T,0.046,0.12499,0.368,0.37543,O75771,M308V,Loss of disorder (P = 0.066)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T303 (P = 0.2109)| Loss of MoRF binding (P = 0.2269)| Gain of glycosylation at T313 (P = 0.247),0.445711490874,0.43808,.,0.24814,.,0.09186,.,.,.,0.090794,0.38381,T,-0.22766,0.16671,T,-0.564795,0.15640,T,0.04466512799263,0.04499,T,.,0.22727,.,0.09098598,0.21114,0.08494699,0.19556,0.09098598,0.21113,0.08494699,0.19555,-2.125,0.04505,T,0.0668,0.03206,LB,0.000116984907820501,0.03146,0.33311860,0.77819,0.031,0.06489,.,.,.,.,.,.,0.745387,0.11172,7.79,0.84883383379766109,0.15792,0.063394,0.12075,N,-1.10219193532207,0.06526,0.304481,-1.00842900774596,0.09439,0.4784977,5.16,-1.59,0.07985,0.883,0.28197,-0.196,0.09562,-0.511000,0.08784,0.665,0.62996,0.007,0.17722,0.0,0.08389,0.941,0.48226,913,0.21155,.,.,.,.,.,.,.,.,.,.,.,.,4,264690,1.51120175E-5,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,8,1613598,4.957860e-06,0,3,74880,4.006410e-05,0,3,74880,4.006410e-05,0,0,910,0.000000e+00,0,0,59998,0.000000e+00,0,0,29602,0.000000e+00,0,0,44890,0.000000e+00,0,0,64022,0.000000e+00,0,0,6084,0.000000e+00,0,5,1179678,4.238440e-06,0,0,91062,0.000000e+00,0,1,26588,3.761095230931247E-5,0,114,0,0,86,0,0,2804,0,0,500,0,0,628,0,0,26,0,0,98,0,0,4588,0,0,2918,0,0,112,0,1,35432,2.8223075186272295E-5,Conflicting_classifications_of_pathogenicity,"Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35101018T>C,ClinGen:CA191144,C0027672|C3280345,614291,140162|145,.,Met,Val,184803.0,single nucleotide variant,NM_002878.4(RAD51D):c.922A>G (p.Met308Val),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Sep 23, 2024",786201961.0,-,RCV000164512|RCV004782268|RCV000649679,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145","Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4",germline,germline,GRCh38,NC_000017.11,17,35101018.0,35101018.0,17q12,"criteria provided, conflicting classifications",4.0,-,N,ClinGen:CA191144,2.0,185144.0,35101018.0,T,C,-,-,-,-,-,-,SCV000215164|SCV000771511|SCV000911462|SCV005394802,-,-,922A>G ,Met308Val,NM_002878.4,1.0,3_Conflicting,91.85,0.4361702127659574,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",M,82,91.85,Aliphatic,Methionine,DNA repair protein RAD51 homolog 4,,,1.9,,,M308-S88; PAE: 1.0,3 interactions,,6 interactions,,,149,,-82.5,,,127.8,,,B (undefined),E (parallel sheets),Beta strand,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var152153,RAD51D_unpublished,RAD51D,9823,-1.0,35101018.0,35101018.0,,922,A,G,308.0,M,V,c.922A>G,p.Met308Val,missense_variant,missense_variant,0.0243469,functionally_normal,Yes,4.9578643503e-6,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Sep 23, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.046,0.0623,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Met308Val,true,Met308Val
RAD51D_Phe305Leu,19,13,6,0,68.42,31.58,0.0,100.0,19,0.0,true,RAD51D,,7201,,CCSBVarC024886,,NC_000017.11:35101025:G:C,915C>G,Phe305Leu,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35101025,G,C,17,,,,,,17-35101025-G-C,478443.0,single nucleotide variant,NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Apr 20, 2024",1316114457.0,-,RCV001040689|RCV000568982|RCV004760603,"MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided",germline,germline,GRCh38,NC_000017.11,17,35101025.0,35101025.0,17q12,"criteria provided, conflicting classifications",4.0,-,N,ClinGen:CA399086171,2.0,480950.0,35101025.0,G,C,-,-,-,-,-,-,SCV000664927|SCV000911553|SCV001204278|SCV005369137,-,-,915C>G ,Phe305Leu,NM_002878.4,1.0,3_Conflicting,,480950.0,17,35101025.0,G,C,F,L,rs1316114457,17,33428044,17,30452157,305.0,RAD51D,ENSG00000185379,ENST00000345365,ENSP00000338790,O75771,RA51D_HUMAN,c.915C>G,p.Phe305Leu,c.915C>G,p.Phe305Leu,principal1,Y,1,YES,Select,-,TTC,3.0,2.0,G,G/G,G/G,G/G,G/G,1.0,0.00968,T,1.0,0.05249,T,0.0,0.02950,B,0.0,0.01384,B,.,.,.,.,.,.,0.83,0.20850,L,0.13,0.05476,N,0.053,0.11150,-1.0215,0.23176,T,0.1042,0.38033,T,10,0.040840566,0.02691,T,0.009973,0.25673,T,0.024,0.04912,0.301,0.26717,O75771,F305L,Gain of disorder (P = 0.0917)| Gain of MoRF binding (P = 0.1056)| Loss of phosphorylation at T303 (P = 0.1899)| Gain of relative solvent accessibility (P = 0.2629)| Loss of sheet (P = 0.302),0.444807159249,0.43722,.,0.23376,.,0.10592,.,.,.,0.051884,0.28757,T,-0.259589,0.12690,T,-0.610658,0.11674,T,0.0400510121688084,0.03670,T,.,0.18007,.,0.045180835,0.07283,0.032197934,0.01928,0.045180835,0.07282,0.032197934,0.01928,-2.604,0.08768,T,0.3499,0.57023,A,4.50213563311964e-06,0.00398,0.25410953,0.75297,0.005,0.00124,.,.,.,.,.,.,1.205182,0.15999,12.23,0.83537688913623076,0.15012,0.108385,0.21352,N,-1.04489556684859,0.07596,0.357995,-0.957731270841975,0.10562,0.543092,5.16,1.6,0.22627,1.17,0.30762,-0.02,0.12505,1.312000,0.25630,-0.105,0.15707,0.788,0.29661,1.0,0.68239,0.621,0.31965,913,0.21155,.,.,.,.,.,.,.,.,.,.,.,.,1,264690,3.7780044E-6,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,2,1613800,1.239310e-06,0,2,1179680,1.695380e-06,0,0,75040,0.000000e+00,0,0,912,0.000000e+00,0,0,60016,0.000000e+00,0,0,29606,0.000000e+00,0,0,44886,0.000000e+00,0,0,64040,0.000000e+00,0,0,6062,0.000000e+00,0,2,1179680,1.695380e-06,0,0,91072,0.000000e+00,0,0,7618,0,0,108,0,0,84,0,0,2708,0,0,146,0,0,610,0,0,24,0,0,94,0,0,470,0,0,2816,0,0,108,0,0,11862,0,Conflicting_classifications_of_pathogenicity,"Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35101025G>C,ClinGen:CA399086171,C0027672|C3280345,614291,140162|145,.,Phe,Leu,478443.0,single nucleotide variant,NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Apr 20, 2024",1316114457.0,-,RCV001040689|RCV000568982|RCV004760603,"MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided",germline,germline,GRCh38,NC_000017.11,17,35101025.0,35101025.0,17q12,"criteria provided, conflicting classifications",4.0,-,N,ClinGen:CA399086171,2.0,480950.0,35101025.0,G,C,-,-,-,-,-,-,SCV000664927|SCV000911553|SCV001204278|SCV005369137,-,-,915C>G ,Phe305Leu,NM_002878.4,1.0,3_Conflicting,91.25,0.3553299492385787,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",F,70,91.25,Aromatic,Phenylalanine,DNA repair protein RAD51 homolog 4,,,2.8,,,F305-L295; PAE: 2.0,1 interaction,,6 interactions,,,165,,-60.2,,,136.3,,,C (loop/coil),C (loop/coil),,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var152168,RAD51D_unpublished,RAD51D,9823,-1.0,35101025.0,35101025.0,,915,C,G,305.0,F,L,c.915C>G,p.Phe305Leu,missense_variant,missense_variant,0.00648996,functionally_normal,Yes,1.2393109431e-6,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Apr 01, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.024,0.337,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Phe305Leu,true,Phe305Leu
RAD51D_Thr27Lys,18,6,3,9,33.33,16.67,50.0,50.0,9,9.0,true,RAD51D,,,,CCSBVarC024723,ALE00021534,NC_000017.11:35119534:G:T,80C>A,Thr27Lys,CAVA,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35119534,G,T,17,,,,,,17-35119534-G-T,402606.0,single nucleotide variant,NM_002878.4(RAD51D):c.80C>A (p.Thr27Lys),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Jan 29, 2025",139642328.0,-,RCV000473688|RCV000781799|RCV000568530|RCV000709459|RCV004999472,"MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900","Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided",germline;unknown,germline,GRCh38,NC_000017.11,17,35119534.0,35119534.0,17q12,"criteria provided, conflicting classifications",9.0,-,N,ClinGen:CA16615737,2.0,410557.0,35119534.0,G,T,-,-,-,-,-,-,SCV000551353|SCV000663813|SCV000691366|SCV000839203|SCV000895091|SCV000920128|SCV001193732|SCV004200433|SCV005623971,-,-,80C>A ,Thr27Lys,NM_002878.4,1.0,3_Conflicting,,410557.0,17,35119534.0,G,T,T,K,rs139642328,17,33446553,17,30470666,27.0,RAD51D,ENSG00000185379,ENST00000345365,ENSP00000338790,O75771,RA51D_HUMAN,c.80C>A,p.Thr27Lys,c.80C>A,p.Thr27Lys,principal1,Y,1,YES,Select,-,ACA,2.0,0.0,G,G/G,G/G,G/G,G/G,0.006,0.61594,D,0.033,0.74454,D,0.749,0.77914,P,0.424,0.84488,B,0.44,0.67594,N,simple_aae,56.0,44.0,2.74,0.79912,M,-3.7,0.71080,D,0.884,0.88229,-0.3756,0.72668,T,0.3241,0.69152,T,10,0.4162629,0.56216,D,0.198932,0.86589,D,0.379,0.69534,.,.,.,.,.,0.82232502866,0.81924,.,0.86669,.,0.36418,.,.,.,0.677485,0.90398,D,0.0718392,0.60797,D,0.0911173,0.76144,D,0.926065504550934,0.58574,D,.,0.48889,.,0.6281821,0.73924,0.41200274,0.65163,0.6281821,0.73926,0.41200274,0.65163,-10.105,0.81029,D,0.5695,0.68101,LP,0.2666253545646,0.52917,0.96397090,0.94222,0.623,0.78961,.,.,.,.,.,.,5.246992,0.88108,29.5,0.99500718419529188,0.68072,0.819422,0.73949,D,0.522471302313994,0.68255,5.214879,0.518114750693526,0.69040,5.327917,4.5,4.5,0.54328,.,.,6.195,0.7208,11.308000,0.92409,0.676,0.76753,1.0,0.71675,1.000000,0.68239,0.971,0.54653,926,0.17784,1,1.9968051118210862E-4,0,0.0,0,0.0,0,0.0,1,9.92063492063492E-4,0,0.0,.,.,.,.,1,107424,9.308910e-06,0,2,203454,9.830230e-06,0,2,232640,8.596970e-06,0,0,7080,0.000000e+00,0,0,17072,0.000000e+00,0,0,2320,0.000000e+00,0,1,8972,1.114580e-04,0,0,11730,0.000000e+00,0,0,42676,0.000000e+00,0,0,15678,0.000000e+00,0,1,8972,1.114580e-04,0,0,16076,0.000000e+00,0,0,30478,0.000000e+00,0,0,6178,0.000000e+00,0,2,13308,1.502860e-04,0,0,15070,0.000000e+00,0,0,86912,0.000000e+00,0,0,30596,0.000000e+00,0,2,13308,1.502860e-04,0,0,14812,0.000000e+00,0,0,34220,0.000000e+00,0,0,9558,0.000000e+00,0,2,17618,1.135200e-04,0,0,19968,0.000000e+00,0,0,100360,0.000000e+00,0,0,30514,0.000000e+00,0,2,17618,1.135200e-04,0,.,88,1611852,5.459560e-05,0,86,44868,1.916730e-03,0,0,75050,0.000000e+00,0,0,912,0.000000e+00,0,0,60026,0.000000e+00,0,0,29600,0.000000e+00,0,86,44868,1.916730e-03,0,0,61856,0.000000e+00,0,0,6062,0.000000e+00,0,0,1179912,0.000000e+00,0,0,91086,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Conflicting_classifications_of_pathogenicity,"Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_breast_ovarian_cancer_syndrome|not_specified","criteria_provided,_conflicting_classifications",NC_000017.11:g.35119534G>T,ClinGen:CA16615737,C0027672|C3280345|C0677776|CN169374,614291,140162|145|145,"RAD51D, N-terminal domain",Thr,Lys,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,1,false,false,RAD51D_unpublished_var156043,RAD51D_unpublished,RAD51D,9823,-1.0,35119534.0,35119534.0,,80,C,A,27.0,T,K,c.80C>A,p.Thr27Lys,missense_variant,missense_variant,0.00160939,functionally_normal,Yes,0.0000545955832173,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Jan 22, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.379,0.5091,ambiguous,,,,,,,,,,,,,,,,,,,RAD51D_Thr27Lys,true,Thr27Lys
RAD51D_Thr328Ile,19,11,7,1,57.89,36.84,5.26,94.74,18,0.9994,true,RAD51D,,7201,,CCSBVarC024896,,NC_000017.11:35100957:G:A,983C>T,Thr328Ile,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35100957,G,A,17,,,,,,17-35100957-G-A,151057.0,single nucleotide variant,NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Feb 03, 2025",138969595.0,-,RCV000129828|RCV000254688|RCV000411668|RCV000859034|RCV003935215,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|","Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|RAD51D-related disorder",germline;unknown,germline,GRCh38,NC_000017.11,17,35100957.0,35100957.0,17q12,"criteria provided, conflicting classifications",11.0,-,N,ClinGen:CA294126,2.0,141343.0,35100957.0,G,A,-,-,-,-,-,-,SCV000184643|SCV000211662|SCV000488575|SCV000551327|SCV000902869|SCV001134809|SCV001140402|SCV001363868|SCV002527059|SCV004017733,-,-,983C>T ,Thr328Ile,NM_002878.4,1.0,3_Conflicting,,141343.0,17,35100957.0,G,A,T,I,rs138969595,17,33427976,17,30452089,328.0,RAD51D,ENSG00000185379,ENST00000345365,ENSP00000338790,O75771,RA51D_HUMAN,c.983C>T,p.Thr328Ile,c.983C>T,p.Thr328Ile,principal1,Y,1,YES,Select,-,ACA,2.0,0.0,G,G/G,G/G,G/G,G/G,0.0,0.91343,D,0.0,0.92967,D,0.0,0.02950,B,0.001,0.04348,B,0.0,0.01751,N,simple_aae,100.0,0.0,0.145,0.08752,N,-1.32,0.32965,N,0.053,0.21823,-1.0435,0.16258,T,0.0417,0.17815,T,10,0.009995133,0.00221,T,0.006771,0.17625,T,0.026,0.05575,.,.,.,.,.,0.207176502487,0.19935,.,0.26638,.,0.45724,.,.,.,0.115639,0.43135,T,-0.601611,0.00139,T,-0.677482,0.06933,T,0.075320455379959,0.09265,T,.,0.22097,.,0.08105616,0.18434,0.09681502,0.22979,0.08105616,0.18434,0.09681502,0.22979,-4.387,0.29411,T,0.1002,0.28639,LB,4.77421596645541e-05,0.01873,0.28552076,0.76376,0.032,0.06833,.,.,.,.,.,.,1.075211,0.14598,11.14,0.59940449977036514,0.06433,0.051862,0.09058,N,-1.19812197881439,0.04971,0.2282938,-1.22724989160509,0.05389,0.2610204,5.12,-1.75,0.07582,-1.09,0.15326,-0.5,0.065,-0.087000,0.12155,-0.119,0.14328,0.0,0.06393,0.0,0.08389,0.07,0.16685,914,0.21043,4,7.987220447284345E-4,4,0.0030257186081694403,0,0.0,0,0.0,0,0.0,0,0.0,76,264690,2.8712835E-4,.,6,109408,5.484060e-05,0,19,208136,9.128650e-05,0,17,236950,7.174510e-05,0,6,7164,8.375210e-04,0,0,17112,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13394,0.000000e+00,0,0,42768,0.000000e+00,0,0,15690,0.000000e+00,0,6,7164,8.375210e-04,0,17,16218,1.048220e-03,0,1,30524,3.276110e-05,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16734,0.000000e+00,0,0,89558,0.000000e+00,0,1,30608,3.267120e-05,0,17,16218,1.048220e-03,0,14,14902,9.394710e-04,0,2,34260,5.837710e-05,0,0,9572,0.000000e+00,0,0,17692,0.000000e+00,0,0,21632,0.000000e+00,0,0,102746,0.000000e+00,0,1,30526,3.275900e-05,0,14,14902,9.394710e-04,0,.,96,1611324,5.957830e-05,1,80,74978,1.066980e-03,1,80,74978,1.066980e-03,1,0,912,0.000000e+00,0,4,60018,6.664670e-05,0,0,29586,0.000000e+00,0,0,44862,0.000000e+00,0,0,64034,0.000000e+00,0,2,6032,3.315650e-04,0,0,1177472,0.000000e+00,0,2,91016,2.197420e-05,0,1,163022,6.13414140422765E-6,0,360,0,0,2712,0,9,9362,9.613330484939116E-4,0,442,0,0,950,0,0,682,0,0,280,0,0,11320,0,9,9722,9.257354453816088E-4,0,3394,0,10,189130,5.287368476709142E-5,Conflicting_classifications_of_pathogenicity,"Breast-ovarian_cancer,_familial,_susceptibility_to,_4|RAD51D-related_disorder|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided","criteria_provided,_conflicting_classifications",NC_000017.11:g.35100957G>A,ClinGen:CA294126,C3280345|C0027672|CN169374|C3661900,614291,145|140162,.,Thr,Ile,151057.0,single nucleotide variant,NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Feb 03, 2025",138969595.0,-,RCV000129828|RCV000254688|RCV000411668|RCV000859034|RCV003935215,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|","Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|RAD51D-related disorder",germline;unknown,germline,GRCh38,NC_000017.11,17,35100957.0,35100957.0,17q12,"criteria provided, conflicting classifications",11.0,-,N,ClinGen:CA294126,2.0,141343.0,35100957.0,G,A,-,-,-,-,-,-,SCV000184643|SCV000211662|SCV000488575|SCV000551327|SCV000902869|SCV001134809|SCV001140402|SCV001363868|SCV002527059|SCV004017733,-,-,983C>T ,Thr328Ile,NM_002878.4,1.0,3_Conflicting,39.66,1.0,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",T,217,39.66,Polar/Neutral,Threonine,DNA repair protein RAD51 homolog 4,,,-0.7,,,,,,,,,119,,63.9,,,360.0,,,C (loop/coil),C (loop/coil),,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var151972,RAD51D_unpublished,RAD51D,9823,-1.0,35100957.0,35100957.0,,983,C,T,328.0,T,I,c.983C>T,p.Thr328Ile,missense_variant,missense_variant,-0.0127746,functionally_normal,Yes,0.0000595783343387,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Feb 01, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.026,0.1127,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Thr328Ile,true,Thr328Ile
RAD51D_Val132Ile,18,4,3,11,22.22,16.67,61.11,38.89,7,10.9998,true,RAD51D,,7201,,CCSBVarC024822,,NC_000017.11:35107074:C:T,394G>A,Val132Ile,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35107074,C,T,17,,,,,,17-35107074-C-T,184833.0,single nucleotide variant,NM_002878.4(RAD51D):c.394G>A (p.Val132Ile),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Jan 19, 2025",201141245.0,-,RCV000458927|RCV000164547|RCV000588322|RCV004764772|RCV001356158,"MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142","Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast",germline;unknown,germline,GRCh38,NC_000017.11,17,35107074.0,35107074.0,17q12,"criteria provided, conflicting classifications",15.0,-,N,ClinGen:CA191240,2.0,185178.0,35107074.0,C,T,-,-,-,-,-,-,SCV000215203|SCV000292678|SCV000551340|SCV000698100|SCV000784995|SCV000822177|SCV000886447|SCV000910748|SCV001470090|SCV002534813|SCV004017742|SCV004208066|SCV005374642,-,-,394G>A ,Val132Ile,NM_002878.4,1.0,3_Conflicting,,185178.0,17,35107074.0,C,T,V,I,rs201141245,17,33434093,17,30458206,132.0,RAD51D,ENSG00000185379,ENST00000394589,ENSP00000378090,O75771,RA51D_HUMAN,c.394G>A,p.Val132Ile,c.394G>A,p.Val132Ile,principal1,Y,5,.,.,-,GTC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.44188,.,0.039,0.53076,D,0.424,0.35468,B,0.382,0.43907,B,0.05,0.18971,N,simple_aae,95.0,5.0,2.62,0.76477,M,.,0.22672,.,0.216,0.24096,-0.3916,0.72168,T,0.3597,0.72046,T,10,0.109271616,0.20146,T,0.071049,0.71066,D,0.229,0.52699,.,.,.,.,.,0.62430428174,0.61834,.,0.37837,.,0.25574,.,.,.,0.15308,0.49109,T,-0.122049,0.32431,T,-0.107115,0.62576,T,0.0757847073892739,0.09324,T,0.738826,0.35767,T,0.08056444,0.18299,0.09804036,0.23318,0.08056444,0.18299,0.09804036,0.23318,-7.63,0.58592,D,0.1016,0.17936,B,0.000961144535626309,0.09382,0.62951803,0.84609,0.122,0.32993,.,.,.,.,.,.,1.358257,0.17693,13.3,0.72709087620192148,0.10230,0.067676,0.13137,N,-0.614819935582183,0.18271,0.9608728,-0.673516161556329,0.17340,0.9379878,4.65,2.66,0.30590,0.89,0.28255,1.984,0.40383,-0.207000,0.10935,-0.939,0.02107,0.942,0.32811,0.0,0.08389,0.696,0.34057,921,0.19236,2,3.9936102236421724E-4,1,7.564296520423601E-4,0,0.0,1,0.001440922190201729,0,0.0,0,0.0,30,264690,1.1334013E-4,.,6,109402,5.484360e-05,0,14,208126,6.726690e-05,0,15,236922,6.331200e-05,0,2,7164,2.791740e-04,0,3,17112,1.753160e-04,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,1,13388,7.469380e-05,0,0,42768,0.000000e+00,0,0,15690,0.000000e+00,0,2,7164,2.791740e-04,0,5,16218,3.082990e-04,0,4,30524,1.310440e-04,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,1,16728,5.978000e-05,0,4,89554,4.466580e-05,0,0,30608,0.000000e+00,0,5,16218,3.082990e-04,0,4,14902,2.684200e-04,0,5,34260,1.459430e-04,0,0,9572,0.000000e+00,0,0,17692,0.000000e+00,0,1,21626,4.624060e-05,0,5,102724,4.867410e-05,0,0,30526,0.000000e+00,0,4,14902,2.684200e-04,0,.,72,1614046,4.460840e-05,0,3,6060,4.950500e-04,0,8,74988,1.066840e-04,0,0,912,0.000000e+00,0,7,60010,1.166470e-04,0,0,29606,0.000000e+00,0,4,44860,8.916630e-05,0,1,64012,1.562210e-05,0,3,6060,4.950500e-04,0,42,1180002,3.559320e-05,0,2,91086,2.195730e-05,0,12,179916,6.669779230307477E-5,0,360,0,0,2712,0,1,9384,1.0656436487638534E-4,0,796,0,0,968,0,0,682,0,0,278,0,0,15410,0,1,9744,1.0262725779967159E-4,0,3394,0,13,210506,6.175595945008693E-5,Conflicting_classifications_of_pathogenicity,"not_provided|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35107074C>T,ClinGen:CA191240,C3661900|C0027672|C0006142|C3280345,614291,140162|145,"DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal",Val,Ile,184833.0,single nucleotide variant,NM_002878.4(RAD51D):c.394G>A (p.Val132Ile),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Jan 19, 2025",201141245.0,-,RCV000458927|RCV000164547|RCV000588322|RCV004764772|RCV001356158,"MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142","Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast",germline;unknown,germline,GRCh38,NC_000017.11,17,35107074.0,35107074.0,17q12,"criteria provided, conflicting classifications",15.0,-,N,ClinGen:CA191240,2.0,185178.0,35107074.0,C,T,-,-,-,-,-,-,SCV000215203|SCV000292678|SCV000551340|SCV000698100|SCV000784995|SCV000822177|SCV000886447|SCV000910748|SCV001470090|SCV002534813|SCV004017742|SCV004208066|SCV005374642,-,-,394G>A ,Val132Ile,NM_002878.4,1.0,3_Conflicting,97.74,0.0,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",V,0,97.74,Aliphatic,Valine,DNA repair protein RAD51 homolog 4,,,4.2,,,"V132-Q168, V132-R166; PAE: 1.0, 1.0",5 interactions,V132-Q168; PAE: 1.0,9 interactions,,,117,,-123.4,,,129.5,,,B (undefined),E (parallel sheets),Beta strand,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var154337,RAD51D_unpublished,RAD51D,9823,-1.0,35107074.0,35107074.0,,394,G,A,132.0,V,I,c.394G>A,p.Val132Ile,missense_variant,missense_variant,0.00161802,functionally_normal,Yes,0.0000446083940606,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","May 13, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.229,0.1016,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Val132Ile,true,Val132Ile
RAD51D_Val28Leu,19,6,4,9,31.58,21.05,47.37,52.63,10,9.0003,true,RAD51D,,7201,,CCSBVarC024750,,NC_000017.11:35119532:C:G,82G>C,Val28Leu,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35119532,C,G,17,,,,,,17-35119532-C-G,1813922.0,single nucleotide variant,NM_002878.4(RAD51D):c.82G>C (p.Val28Leu),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,1.0,"Nov 06, 2023",-1.0,-,RCV002430340|RCV003454215,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4",germline;unknown,germline,GRCh38,NC_000017.11,17,35119532.0,35119532.0,17q12,"criteria provided, conflicting classifications",2.0,-,N,ClinGen:CA399092236,2.0,1762829.0,35119532.0,C,G,-,-,-,-,-,-,SCV002681932|SCV004189682,-,-,82G>C ,Val28Leu,NM_002878.4,1.0,3_Conflicting,,1762829.0,17,35119532.0,C,G,V,L,rs2142480064,17,33446551,17,30470664,28.0,RAD51D,ENSG00000185379,ENST00000394589,ENSP00000378090,O75771,RA51D_HUMAN,c.82G>C,p.Val28Leu,c.82G>C,p.Val28Leu,principal1,Y,5,.,.,-,GTG,1.0,0.0,C,C/C,C/C,C/C,C/C,0.0,0.91343,D,0.106,0.92967,T,1.0,0.90580,D,0.996,0.84488,D,.,.,.,.,.,.,2.71,0.79120,M,-2.45,0.56973,N,0.495,0.55314,-0.3621,0.73082,T,0.3608,0.72130,T,9,0.57687366,0.65335,D,0.226204,0.88003,D,0.229,0.52699,0.463,0.53105,O75771,V28L,Loss of sheet (P = 0.0126)| Gain of helix (P = 0.027)| Gain of loop (P = 0.0851)| Gain of ubiquitination at K26 (P = 0.1504)| Loss of phosphorylation at T27 (P = 0.2477),0.834963111294,0.83208,.,0.68920,.,0.39860,.,.,.,0.485341,0.81083,T,0.0746214,0.61132,D,-0.130588,0.60646,T,0.984222710132599,0.75431,D,0.90461,0.67517,D,0.593787,0.72069,0.3945471,0.63896,0.593787,0.72070,0.3945471,0.63896,-8.931,0.67329,D,0.7085,0.75430,P,0.00939506599652921,0.23451,0.90928640,0.91550,0.676,0.82005,.,.,.,.,.,.,7.247327,0.96318,36.0,0.99800754297607808,0.88559,0.836844,0.75365,D,0.678883385112307,0.78132,6.833586,0.616344378564284,0.75995,6.433988,4.5,4.5,0.54328,.,.,3.379,0.52266,7.344000,0.58328,0.599,0.40292,1.0,0.71675,1.0,0.68239,0.947,0.4917,926,0.17784,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Conflicting_classifications_of_pathogenicity,"Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35119532C>G,.,C0027672|C3280345,614291,140162|145,"RAD51D, N-terminal domain",Val,Leu,1813922.0,single nucleotide variant,NM_002878.4(RAD51D):c.82G>C (p.Val28Leu),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,1.0,"Nov 06, 2023",-1.0,-,RCV002430340|RCV003454215,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4",germline;unknown,germline,GRCh38,NC_000017.11,17,35119532.0,35119532.0,17q12,"criteria provided, conflicting classifications",2.0,-,N,ClinGen:CA399092236,2.0,1762829.0,35119532.0,C,G,-,-,-,-,-,-,SCV002681932|SCV004189682,-,-,82G>C ,Val28Leu,NM_002878.4,1.0,3_Conflicting,89.91,0.0704225352112676,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",V,10,89.91,Aliphatic,Valine,DNA repair protein RAD51 homolog 4,,,4.2,,,"V28-G2, V28-V32; PAE: 3.0, 1.0",5 interactions,"V28-G2, V28-V32; PAE: 3.0, 1.0",7 interactions,,,117,,-57.1,,,-39.1,preferentially binds ssDNA,,H (helix),H (α-helix),Helix,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var156036,RAD51D_unpublished,RAD51D,9823,-1.0,35119532.0,35119532.0,,82,G,C,28.0,V,L,c.82G>C,p.Val28Leu,missense_variant,missense_variant,-0.191517,functionally_abnormal,Yes,,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Nov 06, 2023",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.229,0.7085,likely_pathogenic,,,,,,,,,,,,,,,,,,,RAD51D_Val28Leu,true,Val28Leu
RAD51D_Val56Gly,19,15,4,0,78.95,21.05,0.0,100.0,19,0.0,true,RAD51D,,7201,,CCSBVarC024801,,NC_000017.11:35118597:A:C,167T>G,Val56Gly,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35118597,A,C,17,,,,,,17-35118597-A-C,1087626.0,single nucleotide variant,NM_002878.4(RAD51D):c.167T>G (p.Val56Gly),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"May 03, 2021",745307359.0,-,RCV001779181|RCV001799083,"MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN221562","Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer",germline,germline,GRCh38,NC_000017.11,17,35118597.0,35118597.0,17q12,"criteria provided, conflicting classifications",2.0,-,N,ClinGen:CA8499636,2.0,1098881.0,35118597.0,A,C,-,-,-,-,-,-,SCV001623514|SCV002043212,-,-,167T>G ,Val56Gly,NM_002878.4,1.0,3_Conflicting,,1098881.0,17,35118597.0,A,C,V,G,rs745307359,17,33445616,17,30469729,56.0,RAD51D,ENSG00000185379,ENST00000394589,ENSP00000378090,O75771,RA51D_HUMAN,c.167T>G,p.Val56Gly,c.167T>G,p.Val56Gly,principal1,Y,5,.,.,-,GTG,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.31374,.,0.002,0.79703,D,0.722,0.42404,P,0.488,0.47286,P,.,.,.,.,.,.,1.795,0.47093,L,.,0.62039,.,0.721,0.72170,-0.8783,0.49699,T,0.1726,0.51308,T,10,0.03294766,0.01460,T,0.089068,0.75174,D,.,0.75010,0.613,0.74554,O75771,V56G,Loss of stability (P = 2e-04)| Gain of helix (P = 0.0425)| Loss of loop (P = 0.0804)| Gain of relative solvent accessibility (P = 0.1066)| Loss of MoRF binding (P = 0.1311),0.776739155903,0.77291,.,.,.,.,.,.,.,0.488934,0.81292,T,0.239419,0.77440,D,0.106132,0.77147,D,0.0787749525895067,0.09708,T,0.559044,0.19237,T,0.33676666,0.55690,0.3519664,0.60545,0.33676666,0.55690,0.3519664,0.60544,-8.078,0.61675,D,0.5902,0.68420,P,0.0493707858960898,0.37072,0.99278045,0.97206,0.385,0.63571,.,.,.,.,.,.,5.133939,0.85944,28.7,0.99732360981923829,0.82849,0.946436,0.95573,D,0.430607372517603,0.62920,4.538864,0.465062733801357,0.65503,4.855777,4.79,4.79,0.60860,.,.,7.519,0.80763,11.047000,0.85271,0.756,0.943,1.0,0.71675,1.0,0.68239,0.989,0.64309,926,0.17784,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,7,108972,6.423670e-05,0,8,207056,3.863690e-05,0,82,235244,3.485740e-04,0,0,7146,0.000000e+00,0,0,17078,0.000000e+00,0,0,2320,0.000000e+00,0,3,9000,3.333330e-04,0,1,13178,7.588400e-05,0,2,42660,4.688230e-05,0,1,15678,6.378360e-05,0,3,9000,3.333330e-04,0,1,16102,6.210410e-05,0,0,30476,0.000000e+00,0,0,6194,0.000000e+00,0,3,13346,2.247860e-04,0,1,16510,6.056940e-05,0,2,88982,2.247650e-05,0,1,30596,3.268400e-05,0,3,13346,2.247860e-04,0,1,14812,6.751280e-05,0,0,34214,0.000000e+00,0,0,9556,0.000000e+00,0,3,17638,1.700870e-04,0,39,20808,1.874280e-03,0,36,102102,3.525890e-04,0,1,30514,3.277180e-05,0,36,102102,3.525890e-04,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Conflicting_classifications_of_pathogenicity,"Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35118597A>C,.,CN221562|C3280345,614291,145,"RAD51D, N-terminal domain",Val,Gly,1087626.0,single nucleotide variant,NM_002878.4(RAD51D):c.167T>G (p.Val56Gly),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"May 03, 2021",745307359.0,-,RCV001779181|RCV001799083,"MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN221562","Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer",germline,germline,GRCh38,NC_000017.11,17,35118597.0,35118597.0,17q12,"criteria provided, conflicting classifications",2.0,-,N,ClinGen:CA8499636,2.0,1098881.0,35118597.0,A,C,-,-,-,-,-,-,SCV001623514|SCV002043212,-,-,167T>G ,Val56Gly,NM_002878.4,1.0,3_Conflicting,90.63,0.3380281690140845,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",V,48,90.63,Aliphatic,Valine,DNA repair protein RAD51 homolog 4,,,4.2,,,"V56-Q60, V56-A52; PAE: 1.0, 1.0",5 interactions,"V56-Q60, V56-A52; PAE: 1.0, 1.0",5 interactions,,,117,,-65.6,,,-42.9,preferentially binds ssDNA,,H (helix),H (α-helix),Helix,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var155319,RAD51D_unpublished,RAD51D,9823,-1.0,35118597.0,35118597.0,,167,T,G,56.0,V,G,c.167T>G,p.Val56Gly,missense_variant,missense_variant,-0.0642389,functionally_normal,Yes,,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","May 03, 2021",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.451,0.5902,likely_pathogenic,,,,,,,,,,,,,,,,,,,RAD51D_Val56Gly,true,Val56Gly
RAD51D_Val66Leu,19,16,2,1,84.21,10.53,5.26,94.74,18,0.9994,true,RAD51D,,7201,,CCSBVarC024807,,NC_000017.11:35118568:C:A,196G>T,Val66Leu,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35118568,C,A,17,,,,,,17-35118568-C-A,409903.0,single nucleotide variant,NM_002878.4(RAD51D):c.196G>T (p.Val66Leu),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Oct 24, 2024",56026142.0,-,RCV000484401|RCV001373871|RCV001524373,"MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000017.11,17,35118568.0,35118568.0,17q12,"criteria provided, conflicting classifications",5.0,-,N,ClinGen:CA16620388,2.0,419663.0,35118568.0,C,A,-,-,-,-,-,-,SCV000567624|SCV001570603|SCV001734195|SCV002721596|SCV005641837,-,-,196G>T ,Val66Leu,NM_002878.4,1.0,3_Conflicting,,419663.0,17,35118568.0,C,A,V,L,rs56026142,17,33445587,17,30469700,66.0,RAD51D,ENSG00000185379,ENST00000345365,ENSP00000338790,O75771,RA51D_HUMAN,c.196G>T,p.Val66Leu,c.196G>T,p.Val66Leu,principal1,Y,1,YES,Select,-,GTG,1.0,0.0,C,C/C,C/C,C/C,C/C,0.831,0.13644,T,0.486,0.11871,T,0.0,0.02950,B,0.004,0.10086,B,0.06,0.18971,N,simple_aae,94.0,6.0,-0.185,0.04240,N,0.04,0.06455,N,0.164,0.17177,-1.0483,0.14873,T,0.0520,0.21919,T,10,0.057495058,0.06602,T,0.008992,0.23404,T,0.048,0.13183,0.513,0.61027,O75771,V66L,Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Loss of catalytic residue at V66 (P = 0.2378)| Gain of disorder (P = 0.3398)| Gain of loop (P = 0.3485),0.394990421082,0.38713,.,.,.,.,.,.,.,0.112411,0.42566,T,-0.25802,0.12873,T,-0.608404,0.11857,T,0.170912176370621,0.18410,T,.,0.24645,.,0.08530245,0.19601,0.0358917,0.02939,0.08530245,0.19601,0.0358917,0.02939,-4.193,0.26677,T,0.1367,0.29891,LB,1.88384050960672e-05,0.00991,0.78514117,0.87977,0.009,0.00522,.,.,.,.,.,.,0.314705,0.06924,3.434,0.81722106588712895,0.14047,0.088102,0.17661,N,-1.34751807488594,0.03118,0.1402777,-1.22328831331821,0.05450,0.2641167,4.79,-0.163,0.12675,-5.85,0.03264,0.004,0.13047,0.681000,0.20762,-1.926,0.00504,0.001,0.13799,0.444,0.24998,0.443,0.27788,926,0.17784,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,2,1614178,1.239020e-06,0,1,75058,1.332300e-05,0,1,75058,1.332300e-05,0,0,912,0.000000e+00,0,0,60016,0.000000e+00,0,0,29608,0.000000e+00,0,0,44872,0.000000e+00,0,0,64024,0.000000e+00,0,0,6062,0.000000e+00,0,0,1180038,0.000000e+00,0,0,91078,0.000000e+00,0,0,153016,0,0,176,0,0,4498,0,0,4724,0,0,442,0,0,950,0,0,1848,0,0,280,0,0,11718,0,0,4900,0,0,6346,0,0,177652,0,Conflicting_classifications_of_pathogenicity,"not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35118568C>A,ClinGen:CA16620388,C3661900|C0027672|C3280345,614291,140162|145,.,Val,Leu,409903.0,single nucleotide variant,NM_002878.4(RAD51D):c.196G>T (p.Val66Leu),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Oct 24, 2024",56026142.0,-,RCV000484401|RCV001373871|RCV001524373,"MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162","not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome",germline,germline,GRCh38,NC_000017.11,17,35118568.0,35118568.0,17q12,"criteria provided, conflicting classifications",5.0,-,N,ClinGen:CA16620388,2.0,419663.0,35118568.0,C,A,-,-,-,-,-,-,SCV000567624|SCV001570603|SCV001734195|SCV002721596|SCV005641837,-,-,196G>T ,Val66Leu,NM_002878.4,1.0,3_Conflicting,87.61,0.647887323943662,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",V,92,87.61,Aliphatic,Valine,DNA repair protein RAD51 homolog 4,,,4.2,4 interactions,5 interactions,,,,,,,117,,-109.1,,,144.7,preferentially binds ssDNA,,C (loop/coil),C (loop/coil),,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var155234,RAD51D_unpublished,RAD51D,9823,-1.0,35118568.0,35118568.0,,196,G,T,66.0,V,L,c.196G>T,p.Val66Leu,missense_variant,missense_variant,0.0187496,functionally_normal,Yes,1.2390207275e-6,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Aug 10, 2023",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.048,0.133,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Val66Leu,true,Val66Leu
RAD51D_Val66Met,19,17,1,1,89.47,5.26,5.26,94.74,18,0.9994,true,RAD51D,,7201,,CCSBVarC024804,,NC_000017.11:35118568:C:T,196G>A,Val66Met,,,,,,,,,,,,,,,,,,,,,,,,,,,,17,35118568,C,T,17,,,,,,17-35118568-C-T,151292.0,single nucleotide variant,NM_002878.4(RAD51D):c.196G>A (p.Val66Met),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Mar 04, 2025",56026142.0,-,RCV000130161|RCV000238834|RCV000225779|RCV001030594|RCV001284344|RCV001798441|RCV003952682,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562|","Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|RAD51D-related disorder",germline;unknown,germline,GRCh38,NC_000017.11,17,35118568.0,35118568.0,17q12,"criteria provided, conflicting classifications",16.0,-,N,ClinGen:CA165840,2.0,141578.0,35118568.0,C,T,-,-,-,-,-,-,SCV000184996|SCV000287700|SCV000297127|SCV000489108|SCV000515953|SCV000686426|SCV000920125|SCV001193731|SCV001470086|SCV002043215|SCV002534780|SCV004017746|SCV004024299,-,-,196G>A ,Val66Met,NM_002878.4,1.0,3_Conflicting,,141578.0,17,35118568.0,C,T,V,M,rs56026142,17,33445587,17,30469700,66.0,RAD51D,ENSG00000185379,ENST00000345365,ENSP00000338790,O75771,RA51D_HUMAN,c.196G>A,p.Val66Met,c.196G>A,p.Val66Met,principal1,Y,1,YES,Select,-,GTG,1.0,0.0,C,C/C,C/C,C/C,C/C,0.095,0.34240,T,0.066,0.44850,T,0.476,0.36683,P,0.365,0.43339,B,0.05,0.16373,N,simple_aae,95.0,5.0,1.2,0.30152,L,-0.54,0.16529,N,0.358,0.39815,-0.9936,0.31561,T,0.1126,0.40048,T,10,0.010412663,0.00228,T,0.024861,0.47635,T,0.088,0.25383,0.532,0.63879,O75771,V66M,Loss of catalytic residue at V66 (P = 0.1757)| Gain of disorder (P = 0.2016)| Gain of relative solvent accessibility (P = 0.2816)| Loss of glycosylation at S62 (P = 0.3483)| Gain of loop (P = 0.3485),0.485420873983,0.47807,.,.,.,.,.,.,.,0.159822,0.50082,T,-0.540521,0.00322,T,-0.547555,0.17258,T,0.0349691153311283,0.02783,T,.,0.67135,.,0.085984245,0.19788,0.05022742,0.07854,0.085984245,0.19787,0.05022742,0.07854,-4.122,0.28513,T,0.1196,0.24734,LB,0.000394112558413836,0.06034,0.88900130,0.90830,0.035,0.07875,.,.,.,.,.,.,1.488353,0.19181,14.12,0.85296696707845254,0.16045,0.093680,0.18747,N,-0.868469024722056,0.11459,0.5605822,-0.881724750457004,0.12311,0.6448988,4.79,-0.163,0.12675,-5.85,0.03264,0.004,0.13047,0.681000,0.20762,-1.926,0.00504,0.001,0.13799,0.444,0.24998,0.443,0.27788,926,0.17784,3,5.990415335463259E-4,1,7.564296520423601E-4,0,0.0,0,0.0,2,0.001984126984126984,0,0.0,53,264690,2.0023424E-4,.,30,109376,2.742830e-04,0,60,208066,2.883700e-04,0,76,236884,3.208320e-04,0,1,7164,1.395870e-04,0,1,17112,5.843850e-05,0,0,2320,0.000000e+00,0,24,9044,2.653690e-03,0,0,13366,0.000000e+00,0,2,42766,4.676610e-05,0,1,15690,6.373490e-05,0,24,9044,2.653690e-03,0,1,16218,6.165990e-05,0,2,30524,6.552220e-05,0,0,6212,0.000000e+00,0,48,13414,3.578350e-03,0,0,16706,0.000000e+00,0,4,89522,4.468180e-05,0,1,30608,3.267120e-05,0,48,13414,3.578350e-03,0,1,14902,6.710510e-05,0,4,34260,1.167540e-04,0,0,9572,0.000000e+00,0,65,17690,3.674390e-03,0,0,21604,0.000000e+00,0,2,102710,1.947230e-05,0,1,30526,3.275900e-05,0,65,17690,3.674390e-03,0,.,420,1614178,2.601940e-04,1,374,44872,8.334820e-03,1,1,75058,1.332300e-05,0,0,912,0.000000e+00,0,5,60016,8.331110e-05,0,1,29608,3.377470e-05,0,374,44872,8.334820e-03,1,0,64024,0.000000e+00,0,1,6062,1.649620e-04,0,9,1180038,7.626870e-06,0,17,91078,1.866530e-04,0,1,153016,6.535264286087729E-6,0,176,0,18,4498,0.004001778568252557,0,4724,0,0,442,0,0,950,0,6,1848,0.003246753246753247,0,280,0,9,11718,7.680491551459293E-4,0,4900,0,24,6346,0.003781909864481563,34,177652,1.9138540517416071E-4,Conflicting_classifications_of_pathogenicity,"Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|RAD51D-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_4","criteria_provided,_conflicting_classifications",NC_000017.11:g.35118568C>T,ClinGen:CA165840,C0027672|CN221562|C3661900|C0677776|CN169374|C3280345,614291,140162|145|145,.,Val,Met,151292.0,single nucleotide variant,NM_002878.4(RAD51D):c.196G>A (p.Val66Met),5892.0,RAD51D,HGNC:9823,Conflicting classifications of pathogenicity,0.0,"Mar 04, 2025",56026142.0,-,RCV000130161|RCV000238834|RCV000225779|RCV001030594|RCV001284344|RCV001798441|RCV003952682,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562|","Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|RAD51D-related disorder",germline;unknown,germline,GRCh38,NC_000017.11,17,35118568.0,35118568.0,17q12,"criteria provided, conflicting classifications",16.0,-,N,ClinGen:CA165840,2.0,141578.0,35118568.0,C,T,-,-,-,-,-,-,SCV000184996|SCV000287700|SCV000297127|SCV000489108|SCV000515953|SCV000686426|SCV000920125|SCV001193731|SCV001470086|SCV002043215|SCV002534780|SCV004017746|SCV004024299,-,-,196G>A ,Val66Met,NM_002878.4,1.0,3_Conflicting,87.61,0.647887323943662,['614291'],,Rare genetic tumor,1,"BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4",V,92,87.61,Aliphatic,Valine,DNA repair protein RAD51 homolog 4,,,4.2,4 interactions,5 interactions,,,,,,,117,,-109.1,,,144.7,preferentially binds ssDNA,,C (loop/coil),C (loop/coil),,,,,,,,,,,,,,,,,,false,false,RAD51D_unpublished_var155236,RAD51D_unpublished,RAD51D,9823,-1.0,35118568.0,35118568.0,,196,G,A,66.0,V,M,c.196G>A,p.Val66Met,missense_variant,missense_variant,0.00606963,functionally_normal,Yes,0.0002601943527913,Conflicting classifications of pathogenicity,"criteria provided, conflicting classifications","Jan 28, 2024",nucleotide,,ENST00000345365.11,NM_002878.4,immortalized human cells,,,,Yes,,,,,,,,,,,0.088,0.1158,likely_benign,,,,,,,,,,,,,,,,,,,RAD51D_Val66Met,true,Val66Met
TPK1_Asn50His,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,TPK1,ENSG00000196511,14468,218332,CCSBVarC005853,ALE00005853,NC_000007.14:144682946:T:G,148A>C,Asn50His,CEGS2,CegsMutGDEh1033,C08,GDEhDisVCh_40090,D06,2.0,CegsMutGDDh1033,C08,VUSN2Hmut_GDN2h_06,B05,VUSMutpDEST2_11,A09,VUSmut_GDEh06,B05,1.0,1.0,1.0,1.0,1.0,1.0,99.0,1.0,1.0,1.0,1.0,1.0,99.0,7,144682946,T,G,7,Y,Y,Y,Y,Y,7-144682946-T-G,39525.0,single nucleotide variant,NM_022445.4(TPK1):c.148A>C (p.Asn50His),27010.0,TPK1,HGNC:17358,Pathogenic,1.0,"Dec 09, 2011",387906935.0,-,RCV000023531,"MONDO:MONDO:0013761,MedGen:C3280866,OMIM:614458,Orphanet:293955",Childhood encephalopathy due to thiamine pyrophosphokinase deficiency,germline,germline,GRCh38,NC_000007.14,7,144682946.0,144682946.0,7q35,no assertion criteria provided,1.0,-,N,"ClinGen:CA129339,UniProtKB:Q9H3S4#VAR_067392,OMIM:606370.0001",1.0,30568.0,144682946.0,T,G,-,-,-,-,-,-,SCV000044822,-,-,148A>C ,Asn50His,NM_022445.4,,1_Pathogenic,,30568.0,7,144682946.0,T,G,N,H,rs387906935,7,144380039.0,7,144010972.0,50.0,TPK1,ENSG00000196511,ENST00000360057,ENSP00000353165,Q9H3S4,TPK1_HUMAN,c.148A>C,p.Asn50His,c.148A>C,p.Asn50His,principal1,Y,1,YES,Select,-,AAC,1.0,0.0,T,T/T,T/T,T/T,T/T,0.002,0.72322,D,0.028,0.55281,D,1.0,0.90580,D,0.998,0.88579,D,0.82,0.89397,A,simple_aae,18.0,82.0,3.165,0.88471,M,-3.15,0.72390,D,0.803,0.87459,0.6356,0.92333,D,0.7563,0.91673,D,10,0.9722638,0.96830,D,0.129243,0.81072,D,0.706,0.89423,0.927,0.98799,Q9H3S4,N50H,Gain of disorder (P = 0.0849)| Gain of loop (P = 0.1069)| Loss of helix (P = 0.2022)| Gain of catalytic residue at L52 (P = 0.2669)| Gain of phosphorylation at Y53 (P = 0.2887),0.844119709855,0.84140,0.8469067075486448,0.84558,0.670258421466,0.59130,0.471933841705,0.34900,T,0.832489,0.95983,D,0.121089,0.6624,D,-0.063841,0.6582,T,0.985888185988907,0.76580,D,0.963804,0.86602,D,0.92997354,0.94147,0.8282496,0.89942,0.9366974,0.94834,0.8183861,0.89299,-12.885,0.88908,D,0.8159,0.77989,P,0.983044329435162,0.86093,0.67232020,0.85496,0.473,0.69678,.,.,.,.,.,.,4.68795,0.75138,26.3,0.9967558155891376,0.78934,0.469733,0.51431,N,0.776684384396305,0.84543,8.341359,0.75073761053793,0.86135,8.817646,6.02,6.02,0.97555,.,.,4.036,0.57104,7.831000,0.70162,0.665,0.62996,1.0,0.71675,1.0,0.68239,0.999,0.91597,936,0.14735,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,0,0,0,0,0,0,0,0,0,426,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52,0,0,426,0,0,0,0,0,478,0,Pathogenic,Childhood_encephalopathy_due_to_thiamine_pyrophosphokinase_deficiency,no_assertion_criteria_provided,NC_000007.14:g.144682946T>G,ClinGen:CA129339|OMIM:606370.0001|UniProtKB:Q9H3S4#VAR_067392,C3280866,614458,293955,"Thiamin pyrophosphokinase, catalytic domain",Asn,His,39525.0,single nucleotide variant,NM_022445.4(TPK1):c.148A>C (p.Asn50His),27010.0,TPK1,HGNC:17358,Pathogenic,1.0,"Dec 09, 2011",387906935.0,-,RCV000023531,"MONDO:MONDO:0013761,MedGen:C3280866,OMIM:614458,Orphanet:293955",Childhood encephalopathy due to thiamine pyrophosphokinase deficiency,germline,germline,GRCh38,NC_000007.14,7,144682946.0,144682946.0,7q35,no assertion criteria provided,1.0,-,N,"ClinGen:CA129339,UniProtKB:Q9H3S4#VAR_067392,OMIM:606370.0001",1.0,30568.0,144682946.0,T,G,-,-,-,-,-,-,SCV000044822,-,-,148A>C ,Asn50His,NM_022445.4,,1_Pathogenic,98.87,0.0700636942675159,['614458'],autosomal recessive,Rare inborn errors of metabolism,1,THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE),N,11,98.87,Polar/Neutral,Asparagine,Thiamine pyrophosphokinase 1,,,-3.5,,,"N50-D54, N50-R76, N50-S74; PAE: 1.0, 1.0, 1.0",3 interactions,"N50-D54, N50-R76; PAE: 1.0, 1.0",2 interactions,,,132,,-62.0,,,-43.2,,,H (helix),H (α-helix),Helix,,,,,,,,,,,,,0.729,,,,false,false,TPK1_Weile_2017_var184778,TPK1_Weile_2017,TPK1,17358,-1.0,144682946.0,144682946.0,,148,A,C,50.0,N,H,c.148A>C,p.Asn50His,missense_variant,missense_variant,1.47683904300009,,No,,Pathogenic,no assertion criteria provided,"Dec 09, 2011",aa,urn:mavedb:00000001-d-1,ENST00000360057.7,NM_022445.4,yeast,"cell viability assay (BAO_0003009), genetic complementation (BAO_0002488)",survival rate (OBI_0000789),"catalytic activity (GO:0003824), thiamine diphosphokinase activity (GO:0004788)",No,,,,,,,,,,updated,0.706,0.8159,likely_pathogenic,,,,,,,,,,,,,,,,,,,TPK1_Asn50His,true,Asn50His
VHL_Arg126Gly,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,204012,CCSBVarC006546,ALE00006545,NC_000003.12:10149822:C:G,376C>G,Arg126Gly,CEGS2,CegsMutGDEh1045,D09,GDEhDisVCh_40037,E05,1.0,CegsMutGDDh1045,D09,,,,,,,1.0,6.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10149822,C,G,3,N,Y,N,N,N,3-10149822-C-G,17258.0,single nucleotide variant,NM_000551.4(VHL):c.499C>G (p.Arg167Gly),7428.0,VHL,HGNC:12687,Pathogenic,1.0,"Jun 26, 2022",5030820.0,-,RCV002336073|RCV000002304|RCV000466046,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557",Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia,germline,germline,GRCh38,NC_000003.12,3,10149822.0,10149822.0,3p25.3,"criteria provided, multiple submitters, no conflicts",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020446,UniProtKB:P40337#VAR_005760,OMIM:608537.0004",3.0,2219.0,10149822.0,C,G,-,-,-,-,-,-,SCV000553389|SCV000897839|SCV002640461,-,-,499C>G ,Arg167Gly,NM_000551.4,2.0,1_Pathogenic,,2219.0,3,10149822.0,C,G,R,G,rs5030820,3,10191506,3,10166506,167.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.499C>G,p.Arg167Gly,c.499C>G,p.Arg167Gly,principal1,Y,1,YES,Select,+,CGG,1.0,2.0,C,C/C,C/C,C/C,C/C,.,0.91343,.,0.0,0.92967,D,1.0,0.90580,D,0.999,0.92348,D,0.99,0.97926,A,simple_aae,1.0,99.0,2.495,0.72481,M,-5.67,0.87174,D,0.927,0.93141,1.0240,0.97601,D,0.9875,0.99632,D,10,0.9932893,0.99860,D,0.871588,0.99016,D,0.813,0.93950,0.965,0.99652,P40337,R167G,Gain of relative solvent accessibility (P = 0.0289)| Loss of MoRF binding (P = 0.0331)| Gain of ubiquitination at K171 (P = 0.0359)| Loss of helix (P = 0.0626)| Gain of glycosylation at S168 (P = 0.1126),0.997778129293,0.99771,0.9382113927052022,0.93763,1.22262797902,0.81023,0.652706027031,0.60307,T,0.960332,0.99482,D,0.524963,0.94985,D,0.516297,0.94911,D,0.997754871845245,0.92273,D,0.916108,0.69984,D,0.9841898,0.99402,0.8936179,0.94448,0.9851917,0.99470,0.8893855,0.94145,-5.566,0.42532,T,0.9813,0.91384,P,0.989336191084761,0.88134,0.99988353,0.99849,0.997,0.99892,.,.,.,.,.,.,4.867609,0.79747,27.2,0.99870003467077606,0.94818,0.361827,0.44945,N,0.509329016886708,0.67469,5.108638,0.437869938818146,0.63746,4.638358,4.86,3.97,0.45177,2.77,0.50688,3.372,0.52209,5.814000,0.50105,0.599,0.40292,0.998,0.41403,1.0,0.68239,0.891,0.42933,379,0.83782,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,Chuvash_polycythemia|Von_Hippel-Lindau_syndrome|Hereditary_cancer-predisposing_syndrome,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10149822C>G,ClinGen:CA020446|OMIM:608537.0004|UniProtKB:P40337#VAR_005760,C1837915|C0019562|C0027672,263400|193300,238557|892|140162,"von Hippel-Lindau disease tumour suppressor, alpha domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Arg,Gly,17258.0,single nucleotide variant,NM_000551.4(VHL):c.499C>G (p.Arg167Gly),7428.0,VHL,HGNC:12687,Pathogenic,1.0,"Jun 26, 2022",5030820.0,-,RCV002336073|RCV000002304|RCV000466046,"MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557",Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia,germline,germline,GRCh38,NC_000003.12,3,10149822.0,10149822.0,3p25.3,"criteria provided, multiple submitters, no conflicts",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020446,UniProtKB:P40337#VAR_005760,OMIM:608537.0004",3.0,2219.0,10149822.0,C,G,-,-,-,-,-,-,SCV000553389|SCV000897839|SCV002640461,-,-,499C>G ,Arg167Gly,NM_000551.4,2.0,1_Pathogenic,98.38,0.1209677419354838,"['193300', '193300', '263400']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var102292,VHL_Buckley_2024,VHL,12687,1.0,10149822.0,10149822.0,ENST00000256474.3,499,C,G,167.0,R,G,c.499C>G,p.Arg167Gly,missense_variant,missense_variant,-2.49807675848378,LOF1,Yes,,Pathogenic,"criteria provided, multiple submitters, no conflicts","Jun 26, 2022",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.813,0.9813,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_Arg167Gly,true,Arg167Gly
VHL_Cys121Phe,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,VHL,ENSG00000134086,13320,204015,CCSBVarC006548,ALE00006547,NC_000003.12:10149808:G:T,362G>T,Cys121Phe,CEGS2,CegsMutGDEh1044,A04,GDEhDisVCh_40037,F02,1.0,CegsMutGDDh1044,A04,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10149808,G,T,3,Y,Y,N,N,N,3-10149808-G-T,52773.0,single nucleotide variant,NM_000551.4(VHL):c.485G>T (p.Cys162Phe),7428.0,VHL,HGNC:12687,Pathogenic,1.0,"Oct 18, 2023",397516444.0,-,RCV000036548|RCV002513389,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome|Chuvash polycythemia;Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10149808.0,10149808.0,3p25.3,"criteria provided, multiple submitters, no conflicts",5.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020418,UniProtKB:P40337#VAR_005754",2.0,43604.0,10149808.0,G,T,-,-,-,-,-,-,SCV000697522|SCV003525020|SCV004171480,-,-,485G>T ,Cys162Phe,NM_000551.4,2.0,1_Pathogenic,,43604.0,3,10149808.0,G,T,C,F,rs397516444,3,10191492,3,10166492,162.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.485G>T,p.Cys162Phe,c.485G>T,p.Cys162Phe,principal1,Y,1,YES,Select,+,TGC,2.0,0.0,G,G/G,G/G,G/G,G/G,.,0.78662,.,0.003,0.79703,D,1.0,0.90580,D,0.991,0.79680,D,0.99,0.97926,A,simple_aae,1.0,99.0,2.33,0.66629,M,-7.8,0.95940,D,0.908,0.90930,0.9714,0.96714,D,0.9893,0.99700,D,10,0.99186033,0.99717,D,0.742232,0.97932,D,0.908,0.97508,0.979,0.99802,P40337,C162F,Loss of helix (P = 0.0138)| Gain of loop (P = 0.0312)| Gain of sheet (P = 0.0507)| Gain of MoRF binding (P = 0.0683)| Loss of ubiquitination at K159 (P = 0.1055),0.994288837492,0.99414,0.9517624211219246,0.95130,1.34561835585,0.83898,0.809871733189,0.83443,D,0.988653,0.99942,D,0.53016,0.95125,D,0.523761,0.95053,D,0.998773515224457,0.95085,D,0.865113,0.58615,D,0.97748387,0.98893,0.946917,0.98183,0.97685766,0.98841,0.9435371,0.97967,-2.595,0.17124,T,0.9903,0.93677,P,0.998634039728608,0.94782,0.99992967,0.99924,0.991,0.99694,.,.,.,.,.,.,5.426341,0.90774,31.0,0.99290024555685363,0.58282,0.683250,0.64472,D,0.725106972213724,0.81178,7.484913,0.68796574001593,0.81360,7.532881,4.86,4.86,0.62577,3.74,0.68722,5.641,0.67629,11.556000,0.93214,0.676,0.76753,1.0,0.71675,1.0,0.68239,0.996,0.76032,379,0.83782,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,109380,0.000000e+00,0,1,208084,4.805750e-06,0,0,236916,0.000000e+00,0,0,7164,0.000000e+00,0,0,17108,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13374,0.000000e+00,0,0,42766,0.000000e+00,0,0,15688,0.000000e+00,0,.,.,.,.,1,16218,6.165990e-05,0,0,30518,0.000000e+00,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16714,0.000000e+00,0,0,89540,0.000000e+00,0,0,30604,0.000000e+00,0,1,16218,6.165990e-05,0,0,14902,0.000000e+00,0,0,34254,0.000000e+00,0,0,9572,0.000000e+00,0,0,17692,0.000000e+00,0,0,21612,0.000000e+00,0,0,102742,0.000000e+00,0,0,30522,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,Chuvash_polycythemia|Von_Hippel-Lindau_syndrome,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10149808G>T,ClinGen:CA020418|UniProtKB:P40337#VAR_005754,C1837915|C0019562,263400|193300,238557|892,"von Hippel-Lindau disease tumour suppressor, alpha domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Cys,Phe,52773.0,single nucleotide variant,NM_000551.4(VHL):c.485G>T (p.Cys162Phe),7428.0,VHL,HGNC:12687,Pathogenic,1.0,"Oct 18, 2023",397516444.0,-,RCV000036548|RCV002513389,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome|Chuvash polycythemia;Von Hippel-Lindau syndrome,germline,germline,GRCh38,NC_000003.12,3,10149808.0,10149808.0,3p25.3,"criteria provided, multiple submitters, no conflicts",5.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020418,UniProtKB:P40337#VAR_005754",2.0,43604.0,10149808.0,G,T,-,-,-,-,-,-,SCV000697522|SCV003525020|SCV004171480,-,-,485G>T ,Cys162Phe,NM_000551.4,2.0,1_Pathogenic,98.4,0.4962962962962963,"['193300', '263400', '193300']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2; VON HIPPEL-LINDAU SYNDROME",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,true,true,VHL_Buckley_2024_var102250,VHL_Buckley_2024,VHL,12687,1.0,10149808.0,10149808.0,ENST00000256474.3,485,G,T,162.0,C,F,c.485G>T,p.Cys162Phe,missense_variant,missense_variant,-1.99966283732352,LOF1,Yes,,Pathogenic,"criteria provided, multiple submitters, no conflicts","Oct 18, 2023",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.908,0.9903,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_Cys162Phe,true,Cys162Phe
VHL_Gln123Arg,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,204016,CCSBVarC006549,ALE00006548,NC_000003.12:10149814:A:G,368A>G,Gln123Arg,CEGS2,CegsMutGDEh1044,C06,GDEhDisVCh_40037,A03,1.0,CegsMutGDDh1044,C06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10149814,A,G,3,Y,Y,N,N,N,3-10149814-A-G,17277.0,single nucleotide variant,NM_000551.4(VHL):c.491A>G (p.Gln164Arg),7428.0,VHL,HGNC:12687,Pathogenic,1.0,"Dec 02, 2024",267607170.0,-,RCV000002326|RCV001052383|RCV001023261,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10149814.0,10149814.0,3p25.3,"criteria provided, multiple submitters, no conflicts",5.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020429,UniProtKB:P40337#VAR_005758,OMIM:608537.0027",3.0,2238.0,10149814.0,A,G,-,-,-,-,-,-,SCV000697523|SCV000897835|SCV001185112|SCV001216592,-,-,491A>G ,Gln164Arg,NM_000551.4,2.0,1_Pathogenic,,2238.0,3,10149814.0,A,G,Q,R,rs267607170,3,10191498,3,10166498,164.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.491A>G,p.Gln164Arg,c.491A>G,p.Gln164Arg,principal1,Y,1,YES,Select,+,CAG,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.91343,.,0.156,0.92967,T,0.998,0.73231,D,0.975,0.73364,D,0.9,0.92786,A,simple_aae,10.0,90.0,1.555,0.39212,L,-2.37,0.52310,N,0.564,0.59524,1.0983,0.99589,D,0.9783,0.99327,D,10,0.96196854,0.95569,D,0.488326,0.94948,D,0.827,0.94487,0.933,0.98984,P40337,Q164R,Gain of MoRF binding (P = 0.0098)| Gain of solvent accessibility (P = 0.1071)| Gain of glycosylation at S168 (P = 0.1126)| Loss of ubiquitination at K159 (P = 0.1351)| Gain of relative solvent accessibility (P = 0.1894),0.99983920897,0.99983,0.9042220559476919,0.90334,1.05742674549,0.76204,0.737874209881,0.72612,T,0.823631,0.95680,D,0.521207,0.94874,D,0.510902,0.94799,D,0.967182397842407,0.67615,D,0.835616,0.52140,T,0.948475,0.96050,0.77509785,0.86564,0.94496924,0.95688,0.8065975,0.88540,-2.848,0.08643,T,0.9482,0.86689,P,0.976476343061274,0.84520,0.99988639,0.99864,0.956,0.98079,.,.,.,.,.,.,3.958704,0.58126,23.9,0.99829969999459456,0.91205,0.707875,0.66124,D,0.496831673590075,0.66728,5.010994,0.514163016172036,0.68773,5.290214,4.86,4.86,0.62577,3.74,0.68722,7.261,0.7786,10.956000,0.84455,0.756,0.943,1.0,0.71675,1.0,0.68239,0.997,0.79771,379,0.83782,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,78,0,0,0,0,0,34,0,1,434,0.002304147465437788,0,0,0,0,0,0,0,0,0,0,6,0,0,108,0,1,434,0.002304147465437788,0,34,0,1,660,0.0015151515151515152,Pathogenic,Chuvash_polycythemia|Von_Hippel-Lindau_syndrome|Hereditary_cancer-predisposing_syndrome,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10149814A>G,ClinGen:CA020429|OMIM:608537.0027|UniProtKB:P40337#VAR_005758,C1837915|C0019562|C0027672,263400|193300,238557|892|140162,"von Hippel-Lindau disease tumour suppressor, alpha domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Gln,Arg,17277.0,single nucleotide variant,NM_000551.4(VHL):c.491A>G (p.Gln164Arg),7428.0,VHL,HGNC:12687,Pathogenic,1.0,"Dec 02, 2024",267607170.0,-,RCV000002326|RCV001052383|RCV001023261,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10149814.0,10149814.0,3p25.3,"criteria provided, multiple submitters, no conflicts",5.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020429,UniProtKB:P40337#VAR_005758,OMIM:608537.0027",3.0,2238.0,10149814.0,A,G,-,-,-,-,-,-,SCV000697523|SCV000897835|SCV001185112|SCV001216592,-,-,491A>G ,Gln164Arg,NM_000551.4,2.0,1_Pathogenic,98.51,0.0555555555555555,"['193300', '193300', '263400']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var102270,VHL_Buckley_2024,VHL,12687,1.0,10149814.0,10149814.0,ENST00000256474.3,491,A,G,164.0,Q,R,c.491A>G,p.Gln164Arg,missense_variant,missense_variant,-0.977528506076001,LOF2,Yes,,Pathogenic,"criteria provided, multiple submitters, no conflicts","Mar 26, 2023",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.827,0.9482,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_Gln164Arg,true,Gln164Arg
VHL_Glu145Lys,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,204017,CCSBVarC006550,ALE00006549,NC_000003.12:10149879:G:A,433G>A,Glu145Lys,CEGS2,CegsMutGDEh1044,G08,GDEhDisVCh_40037,C03,1.0,CegsMutGDDh1044,G08,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10149879,G,A,3,Y,Y,N,N,N,3-10149879-G-A,171081.0,single nucleotide variant,NM_000551.4(VHL):c.556G>A (p.Glu186Lys),7428.0,VHL,HGNC:12687,Uncertain significance,0.0,"Jul 29, 2024",367545984.0,-,RCV000148924|RCV000698671|RCV000589801|RCV003467207|RCV001024290|RCV005025228,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MedGen:C3661900|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0007763,MedGen:CN074294,OMIM:144700,Orphanet:422526",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided|Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Von Hippel-Lindau syndrome;Chuvash polycythemia;Nonpapillary renal cell carcinoma,germline;unknown,germline,GRCh38,NC_000003.12,3,10149879.0,10149879.0,3p25.3,"criteria provided, multiple submitters, no conflicts",10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020480,UniProtKB:P40337#VAR_005773",2.0,161403.0,10149879.0,G,A,-,-,-,-,-,-,SCV000292944|SCV000697526|SCV000805357|SCV000827351|SCV001136314|SCV001186275|SCV003820401|SCV004206459|SCV005658815,-,-,556G>A ,Glu186Lys,NM_000551.4,2.0,4_VUS,0.0000218897,161403.0,3,10149879.0,G,A,E,K,rs367545984,3,10191563,3,10166563,186.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.556G>A,p.Glu186Lys,c.556G>A,p.Glu186Lys,principal1,Y,1,YES,Select,+,GAA,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.63383,.,0.036,0.65108,D,0.992,0.77914,D,0.691,0.65630,P,0.75,0.84994,A,simple_aae,25.0,75.0,2.005,0.54374,M,-2.49,0.54240,N,0.763,0.76009,1.0034,0.97238,D,0.9860,0.99579,D,10,0.73425806,0.74269,D,0.76082,0.98097,D,0.815,0.94028,.,.,.,.,.,0.999903236356,0.99990,0.8233968388259885,0.82191,0.953426343205,0.72563,0.623266875744,0.56124,T,0.862523,0.96936,D,0.472707,0.93386,D,0.504881,0.94682,D,0.861815929412842,0.50950,D,0.942106,0.78302,D,0.95998716,0.97235,0.79238266,0.87639,0.95026773,0.96235,0.7707008,0.86295,-3.669,0.22067,T,0.4226,0.66271,A,0.908466820276463,0.76654,0.99990976,0.99894,0.691,0.82854,.,.,.,.,.,.,4.345781,0.66772,25.0,0.99916665916894087,0.98450,0.813097,0.73469,D,0.616691785089867,0.74091,6.097448,0.60206359949268,0.74951,6.249337,4.97,4.97,0.65374,.,.,7.779,0.84321,11.572000,0.93301,0.676,0.76753,1.0,0.71675,1.0,0.68239,0.603,0.31506,379,0.83782,.,.,.,.,.,.,.,.,.,.,.,.,9,264690,3.400204E-5,.,0,109382,0.000000e+00,0,2,208068,9.612240e-06,0,3,236908,1.266310e-05,0,0,7164,0.000000e+00,0,0,17102,0.000000e+00,0,0,2320,0.000000e+00,0,0,9046,0.000000e+00,0,0,13382,0.000000e+00,0,0,42764,0.000000e+00,0,0,15690,0.000000e+00,0,.,.,.,.,0,16216,0.000000e+00,0,0,30504,0.000000e+00,0,0,6212,0.000000e+00,0,0,13416,0.000000e+00,0,0,16722,0.000000e+00,0,1,89528,1.116970e-05,0,0,30608,0.000000e+00,0,1,89528,1.116970e-05,0,0,14902,0.000000e+00,0,0,34240,0.000000e+00,0,1,9572,1.044710e-04,0,0,17692,0.000000e+00,0,0,21620,0.000000e+00,0,2,102738,1.946700e-05,0,0,30526,0.000000e+00,0,2,102738,1.946700e-05,0,.,38,1614050,2.354330e-05,0,1,6084,1.643660e-04,0,6,74926,8.007900e-05,0,0,912,0.000000e+00,0,0,59992,0.000000e+00,0,4,29608,1.350990e-04,0,1,44894,2.227470e-05,0,0,64032,0.000000e+00,0,1,6084,1.643660e-04,0,23,1180034,1.949100e-05,0,0,91084,0.000000e+00,0,5,109736,4.556389881169352E-5,0,168,0,0,2682,0,0,4040,0,0,790,0,0,946,0,0,626,0,0,280,0,0,6154,0,0,4208,0,0,3308,0,5,125422,3.986541436111687E-5,Uncertain_significance,Von_Hippel-Lindau_syndrome|Hereditary_cancer-predisposing_syndrome|Chuvash_polycythemia|not_provided,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10149879G>A,ClinGen:CA020480|UniProtKB:P40337#VAR_005773,C0019562|C0027672|C1837915|C3661900,193300|263400,892|140162|238557,"von Hippel-Lindau disease tumour suppressor, alpha domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Glu,Lys,171081.0,single nucleotide variant,NM_000551.4(VHL):c.556G>A (p.Glu186Lys),7428.0,VHL,HGNC:12687,Uncertain significance,0.0,"Jul 29, 2024",367545984.0,-,RCV000148924|RCV000698671|RCV000589801|RCV003467207|RCV001024290|RCV005025228,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MedGen:C3661900|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0007763,MedGen:CN074294,OMIM:144700,Orphanet:422526",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided|Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Von Hippel-Lindau syndrome;Chuvash polycythemia;Nonpapillary renal cell carcinoma,germline;unknown,germline,GRCh38,NC_000003.12,3,10149879.0,10149879.0,3p25.3,"criteria provided, multiple submitters, no conflicts",10.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020480,UniProtKB:P40337#VAR_005773",2.0,161403.0,10149879.0,G,A,-,-,-,-,-,-,SCV000292944|SCV000697526|SCV000805357|SCV000827351|SCV001136314|SCV001186275|SCV003820401|SCV004206459|SCV005658815,-,-,556G>A ,Glu186Lys,NM_000551.4,2.0,4_VUS,97.52,0.6752577319587629,"['193300', '193300', '263400', '263400', '171300', '193300', '263400', '144700']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2; ERYTHROCYTOSIS, FAMILIAL, 2; PHEOCHROMOCYTOMA; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2; RENAL CELL CARCINOMA, NONPAPILLARY",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var102460,VHL_Buckley_2024,VHL,12687,1.0,10149879.0,10149879.0,ENST00000256474.3,556,G,A,186.0,E,K,c.556G>A,p.Glu186Lys,missense_variant,missense_variant,-0.0031487562229396,Neutral,Yes,0.0000235432607416,Uncertain significance,"criteria provided, multiple submitters, no conflicts","Jul 29, 2024",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.815,0.4226,ambiguous,,,,,,,,,,,,,,,,,,,VHL_Glu186Lys,true,Glu186Lys
VHL_Glu52Lys,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,203986,CCSBVarC006536,ALE00006535,NC_000003.12:10142001:G:A,154G>A,Glu52Lys,CEGS2,CegsMutGDEh1045,H11,GDEhDisVCh_40037,A06,1.0,CegsMutGDDh1045,H11,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10142001,G,A,3,Y,Y,N,N,N,3-10142001-G-A,171078.0,single nucleotide variant,NM_000551.4(VHL):c.154G>A (p.Glu52Lys),7428.0,VHL,HGNC:12687,Benign,1.0,"Jun 25, 2024",373068386.0,-,RCV000148923|RCV000227809|RCV000575111|RCV001843484|RCV001704076|RCV002465537|RCV003415985|RCV002467589,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002884,MONDO:MONDO:0018666,MedGen:C0206624,Orphanet:449|MedGen:C3661900|MedGen:CN169374||Human Phenotype Ontology:HP:0005701,MONDO:MONDO:0008145,MedGen:C0014084,OMIM:166000,Orphanet:296",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Hepatoblastoma|not provided|not specified|VHL-related disorder|Enchondromatosis,germline;unknown,germline,GRCh38,NC_000003.12,3,10142001.0,10142001.0,3p25.3,reviewed by expert panel,17.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"UniProtKB:P40337#VAR_005671,ClinGen:CA020056",2.0,161402.0,10142001.0,G,A,-,-,-,-,-,-,SCV005187296,-,-,154G>A ,Glu52Lys,NM_000551.4,3.0,2_Benign,0.0000538153,161402.0,3,10142001.0,G,A,E,K,rs373068386,3,10183685,3,10158685,52.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.154G>A,p.Glu52Lys,c.154G>A,p.Glu52Lys,principal1,Y,1,YES,Select,+,GAG,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.49276,.,0.211,0.44651,T,0.001,0.07480,B,0.001,0.06938,B,0.7,0.82410,D,simple_aae,30.0,70.0,0.55,0.14367,N,-0.76,0.21370,N,0.679,0.68449,-0.6918,0.60656,T,0.4079,0.75619,T,10,0.013942212,0.00290,T,0.103206,0.77641,D,0.559,0.81796,.,.,.,.,.,0.930016542147,0.92876,0.7437269150985154,0.74180,0.550323672437,0.51607,0.700024366379,0.67092,T,0.372247,0.73473,T,-0.141624,0.29276,T,-0.0592421,0.66145,T,0.0116703172070972,0.00177,T,0.672333,0.27841,T,0.19717397,0.41255,0.10751787,0.25830,0.29801673,0.52394,0.16334277,0.37776,-7.39,0.57102,T,0.0808,0.17554,B,0.0281799768288736,0.32290,0.99780770,0.98515,0.063,0.17447,.,.,.,.,.,.,1.298029,0.17018,12.89,0.97189040177714048,0.32940,0.050035,0.08566,N,-0.913181555285335,0.10406,0.5037837,-0.94288088445461,0.10899,0.5627841,4.79,0.645,0.16911,1.14,0.30476,0.417,0.2101,0.974000,0.23162,-0.217,0.0818,0.001,0.13799,0.002,0.18256,0.014,0.10256,364,0.84712,2,3.9936102236421724E-4,2,0.0015128593040847202,0,0.0,0,0.0,0,0.0,0,0.0,88,264690,3.324644E-4,.,5,84768,5.898450e-05,0,10,160232,6.240950e-05,0,12,185752,6.460230e-05,0,4,4288,9.328360e-04,0,1,14490,6.901310e-05,0,0,1724,0.000000e+00,0,0,6270,0.000000e+00,0,0,11272,0.000000e+00,0,0,31982,0.000000e+00,0,0,13158,0.000000e+00,0,4,4288,9.328360e-04,0,7,9932,7.047930e-04,0,1,25044,3.992970e-05,0,0,5022,0.000000e+00,0,1,10606,9.428630e-05,0,0,13546,0.000000e+00,0,0,65974,0.000000e+00,0,1,26194,3.817670e-05,0,7,9932,7.047930e-04,0,7,9416,7.434150e-04,0,2,28966,6.904650e-05,0,0,8568,0.000000e+00,0,1,13894,7.197350e-05,0,0,16766,0.000000e+00,0,0,77212,0.000000e+00,0,1,26166,3.821750e-05,0,7,9416,7.434150e-04,0,.,107,1583178,6.758560e-05,1,78,74388,1.048560e-03,1,78,74388,1.048560e-03,1,0,912,0.000000e+00,0,4,55306,7.232490e-05,0,0,28942,0.000000e+00,0,2,43106,4.639730e-05,0,0,59792,0.000000e+00,0,5,5852,8.544090e-04,0,4,1166190,3.429970e-06,0,3,87394,3.432730e-05,0,0,32474,0,0,114,0,0,86,0,0,3222,0,0,496,0,0,626,0,0,26,0,0,98,0,0,4842,0,0,3336,0,0,112,0,0,41984,0,Benign,Von_Hippel-Lindau_syndrome|Enchondromatosis|not_specified|Chuvash_polycythemia|not_provided|VHL-related_disorder|Hereditary_cancer-predisposing_syndrome|Hepatoblastoma,reviewed_by_expert_panel,NC_000003.12:g.10142001G>A,ClinGen:CA020056|UniProtKB:P40337#VAR_005671,C0019562|C0014084|CN169374|C1837915|C3661900|C0027672|C0206624,193300|166000|263400,892|296|238557|140162|449,.,Glu,Lys,171078.0,single nucleotide variant,NM_000551.4(VHL):c.154G>A (p.Glu52Lys),7428.0,VHL,HGNC:12687,Benign,1.0,"Jun 25, 2024",373068386.0,-,RCV000148923|RCV000227809|RCV000575111|RCV001843484|RCV001704076|RCV002465537|RCV003415985|RCV002467589,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002884,MONDO:MONDO:0018666,MedGen:C0206624,Orphanet:449|MedGen:C3661900|MedGen:CN169374||Human Phenotype Ontology:HP:0005701,MONDO:MONDO:0008145,MedGen:C0014084,OMIM:166000,Orphanet:296",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|Hepatoblastoma|not provided|not specified|VHL-related disorder|Enchondromatosis,germline;unknown,germline,GRCh38,NC_000003.12,3,10142001.0,10142001.0,3p25.3,reviewed by expert panel,17.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"UniProtKB:P40337#VAR_005671,ClinGen:CA020056",2.0,161402.0,10142001.0,G,A,-,-,-,-,-,-,SCV005187296,-,-,154G>A ,Glu52Lys,NM_000551.4,3.0,2_Benign,47.54,0.6804123711340206,"['193300', '193300', '263400', '166000']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2; ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var100714,VHL_Buckley_2024,VHL,12687,1.0,10142001.0,10142001.0,ENST00000256474.3,154,G,A,52.0,E,K,c.154G>A,p.Glu52Lys,missense_variant,missense_variant,-0.0532046723704077,Neutral,Yes,0.0000675855778693,Benign,reviewed by expert panel,"Jun 25, 2024",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.559,0.0808,likely_benign,161402.0,CA020056,von Hippel-Lindau disease,MONDO:0008667,Autosomal dominant inheritance,Benign,BA1,PP3,"The variant NM_000551.3(VHL):c.154G>A (p.Glu52Lys) is a missense variant in the first exon of the VHL gene. The GroupMax Filtering Allele Frequency (95% CI) in gnomAD v4.1.0 is 0.0008611 (78/74388 from African/African American Population). This is higher than the ClinGen VHL VCEP threshold of >=0.000156 (0.0156%) threshold expected for VHL disease (BA1) and is classified as Benign for autosomal-dominant von Hippel-Lindau disease (VHL disease) based on the ACMG/AMP criteria applied, as specified by the ClinGen VHL VCEP Version 1.0 (Specifications approval date: 02/26/2024. Variant Approval Date 06/25/2024).",VHL VCEP,https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50036,6/25/24,6/25/24,false,https://erepo.genome.network/evrepo/ui/classification/9f120c06-bb61-4115-9c9c-187ef481f769,9f120c06-bb61-4115-9c9c-187ef481f769,VUS,BA1,VHL_Glu52Lys,true,Glu52Lys
VHL_Glu70Lys,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,204003,CCSBVarC006540,ALE00006539,NC_000003.12:10142055:G:A,208G>A,Glu70Lys,CEGS2,CegsMutGDEh1046,F11,GDEhDisVCh_40037,C08,1.0,CegsMutGDDh1046,F11,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10142055,G,A,3,Y,Y,N,N,N,3-10142055-G-A,52767.0,single nucleotide variant,NM_000551.4(VHL):c.208G>A (p.Glu70Lys),7428.0,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1.0,"Nov 08, 2023",5030802.0,-,RCV000036540|RCV000492137|RCV001379599,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Chuvash polycythemia;Von Hippel-Lindau syndrome,germline;unknown,germline,GRCh38,NC_000003.12,3,10142055.0,10142055.0,3p25.3,"criteria provided, multiple submitters, no conflicts",8.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020108,UniProtKB:P40337#VAR_005676",3.0,43598.0,10142055.0,G,A,-,-,-,-,-,-,SCV000580979|SCV000697485|SCV000782417|SCV001192829|SCV001577426|SCV004185990,-,-,208G>A ,Glu70Lys,NM_000551.4,2.0,1_Pathogenic,6.87765e-7,43598.0,3,10142055.0,G,A,E,K,rs5030802,3,10183739,3,10158739,70.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.208G>A,p.Glu70Lys,c.208G>A,p.Glu70Lys,principal1,Y,1,YES,Select,+,GAG,1.0,0.0,G,G/G,G/G,G/G,G/G,.,0.31374,.,0.328,0.39683,T,0.111,0.34094,B,0.018,0.24975,B,0.76,0.85999,A,simple_aae,24.0,76.0,1.67,0.42718,L,-1.8,0.49699,N,0.733,0.73254,1.0311,0.97733,D,0.9528,0.98463,D,10,0.8858986,0.87785,D,0.992968,0.99978,D,0.668,0.87618,0.815,0.92954,P40337,E70K,Gain of methylation at E70 (P = 0.0074)| Gain of MoRF binding (P = 0.0186)| Gain of glycosylation at S72 (P = 0.0212)| Gain of solvent accessibility (P = 0.0314)| Gain of ubiquitination at E70 (P = 0.0337),0.999058375935,0.99903,0.916466887974535,0.91569,0.57978778604,0.53551,0.926633834839,0.98785,D,0.839174,0.96204,D,0.399414,0.89809,D,0.335954,0.89682,D,0.568558871746063,0.34868,D,0.859914,0.55106,D,0.79190904,0.83183,0.6445971,0.78995,0.8378863,0.86279,0.69882935,0.82055,-6.382,0.51921,T,0.6772,0.74073,P,0.958988211154975,0.81581,0.99979228,0.99726,0.791,0.88436,.,.,.,.,.,.,3.193688,0.43484,21.7,0.99867925714130923,0.94551,0.181124,0.30631,N,-0.21662331281629,0.32173,1.830282,-0.0668793690608979,0.36465,2.14404,5.43,4.56,0.55591,2.47,0.45624,2.171,0.42184,6.610000,0.56152,0.586,0.30628,1.0,0.71675,1.0,0.68239,0.731,0.35169,364,0.84712,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0,100756,0.000000e+00,0,1,189206,5.285240e-06,0,1,219798,4.549630e-06,0,0,6262,0.000000e+00,0,0,16534,0.000000e+00,0,0,2186,0.000000e+00,0,0,8282,0.000000e+00,0,0,9978,0.000000e+00,0,0,40630,0.000000e+00,0,0,15096,0.000000e+00,0,.,.,.,.,0,13426,0.000000e+00,0,0,29468,0.000000e+00,0,0,5726,0.000000e+00,0,0,12414,0.000000e+00,0,0,13066,0.000000e+00,0,0,80984,0.000000e+00,0,1,29688,3.368360e-05,0,1,29688,3.368360e-05,0,0,12632,0.000000e+00,0,0,33324,0.000000e+00,0,0,9242,0.000000e+00,0,0,16852,0.000000e+00,0,0,17380,0.000000e+00,0,0,95426,0.000000e+00,0,1,29634,3.374500e-05,0,1,29634,3.374500e-05,0,.,1,1606316,6.225430e-07,0,1,90484,1.105170e-05,0,0,74982,0.000000e+00,0,0,912,0.000000e+00,0,0,59538,0.000000e+00,0,0,29464,0.000000e+00,0,0,44704,0.000000e+00,0,0,59412,0.000000e+00,0,0,6048,0.000000e+00,0,0,1178494,0.000000e+00,0,1,90484,1.105170e-05,0,0,0,0,0,0,0,0,0,0,0,412,0,0,0,0,0,0,0,0,0,0,0,0,0,0,52,0,0,412,0,0,0,0,0,464,0,Pathogenic/Likely_pathogenic,Von_Hippel-Lindau_syndrome|Chuvash_polycythemia|Hereditary_cancer-predisposing_syndrome,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10142055G>A,ClinGen:CA020108|UniProtKB:P40337#VAR_005676,C0019562|C1837915|C0027672,193300|263400,892|238557|140162,"von Hippel-Lindau disease tumour suppressor, beta domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Glu,Lys,52767.0,single nucleotide variant,NM_000551.4(VHL):c.208G>A (p.Glu70Lys),7428.0,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1.0,"Nov 08, 2023",5030802.0,-,RCV000036540|RCV000492137|RCV001379599,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557;MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892",Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Chuvash polycythemia;Von Hippel-Lindau syndrome,germline;unknown,germline,GRCh38,NC_000003.12,3,10142055.0,10142055.0,3p25.3,"criteria provided, multiple submitters, no conflicts",8.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020108,UniProtKB:P40337#VAR_005676",3.0,43598.0,10142055.0,G,A,-,-,-,-,-,-,SCV000580979|SCV000697485|SCV000782417|SCV001192829|SCV001577426|SCV004185990,-,-,208G>A ,Glu70Lys,NM_000551.4,2.0,1_Pathogenic,97.23,0.3505154639175257,"['193300', '263400', '193300']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2; VON HIPPEL-LINDAU SYNDROME",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var100874,VHL_Buckley_2024,VHL,12687,1.0,10142055.0,10142055.0,ENST00000256474.3,208,G,A,70.0,E,K,c.208G>A,p.Glu70Lys,missense_variant,missense_variant,-0.350052772546135,Intermediate,Yes,6.22542513428242e-7,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Nov 08, 2023",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.668,0.6772,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_Glu70Lys,true,Glu70Lys
VHL_His150Asp,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,204006,CCSBVarC006542,ALE00006541,NC_000003.12:10149894:C:G,448C>G,His150Asp,CEGS2,CegsMutGDEh1044,F11,GDEhDisVCh_40037,E03,1.0,CegsMutGDDh1044,F11,,,,,,,1.0,6.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10149894,C,G,3,N,Y,N,N,N,3-10149894-C-G,17274.0,single nucleotide variant,NM_000551.4(VHL):c.571C>G (p.His191Asp),7428.0,VHL,HGNC:12687,Likely pathogenic,1.0,"Jun 21, 2020",28940301.0,-,RCV000002323|RCV001219111,"MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557",Chuvash polycythemia|Von Hippel-Lindau syndrome;Chuvash polycythemia,germline,germline,GRCh38,NC_000003.12,3,10149894.0,10149894.0,3p25.3,"criteria provided, single submitter",2.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020495,UniProtKB:P40337#VAR_034999,OMIM:608537.0024",3.0,2235.0,10149894.0,C,G,-,-,-,-,-,-,SCV001391032,-,-,571C>G ,His191Asp,NM_000551.4,1.0,1_Pathogenic,6.84049e-7,2235.0,3,10149894.0,C,G,H,D,rs28940301,3,10191578,3,10166578,191.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.571C>G,p.His191Asp,c.571C>G,p.His191Asp,principal1,Y,1,YES,Select,+,CAC,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.63383,.,0.027,0.65108,D,0.449,0.42301,B,0.517,0.48103,P,0.71,0.88920,A,simple_aae,29.0,71.0,1.61,0.40979,L,-3.33,0.72508,D,0.757,0.75453,1.2045,0.99971,D,0.9616,0.98763,D,9,0.8454554,0.83538,D,0.17119,0.84813,D,0.712,0.89698,0.8,0.91903,P40337,H191D,Loss of helix (P = 0.0444)| Gain of loop (P = 0.0502)| Gain of disorder (P = 0.0886)| Gain of relative solvent accessibility (P = 0.1066)| Loss of catalytic residue at H191 (P = 0.1134),0.999897315328,0.99989,0.804492499785103,0.80290,0.754815705559,0.63725,0.41149610281,0.26632,T,0.919397,0.98528,D,0.465706,0.93112,D,0.431178,0.93027,D,0.950683116912842,0.63165,D,0.828317,0.49081,T,0.94104165,0.95282,0.8770645,0.93267,0.92158544,0.93303,0.7800543,0.86871,-2.666,0.07029,T,0.5685,0.67517,P,0.976780560229719,0.84585,0.99989688,0.99879,0.807,0.89331,.,.,.,.,.,.,4.197383,0.63387,24.6,0.99266814711533613,0.57489,0.389786,0.46706,N,0.121783472657936,0.47230,2.973159,0.197493280665678,0.49451,3.170953,4.97,4.09,0.46976,3.76,0.69107,1.493,0.3532,2.583000,0.33509,0.599,0.40292,1.0,0.71675,1.0,0.68239,0.997,0.79771,379,0.83782,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1614166,6.195150e-07,0,1,1180028,8.474380e-07,0,0,75040,0.000000e+00,0,0,912,0.000000e+00,0,0,60010,0.000000e+00,0,0,29608,0.000000e+00,0,0,44880,0.000000e+00,0,0,64034,0.000000e+00,0,0,6062,0.000000e+00,0,1,1180028,8.474380e-07,0,0,91082,0.000000e+00,0,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic,Von_Hippel-Lindau_syndrome|Chuvash_polycythemia,"criteria_provided,_single_submitter",NC_000003.12:g.10149894C>G,ClinGen:CA020495|OMIM:608537.0024|UniProtKB:P40337#VAR_034999,C0019562|C1837915,193300|263400,892|238557,"von Hippel-Lindau disease tumour suppressor, alpha domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",His,Asp,17274.0,single nucleotide variant,NM_000551.4(VHL):c.571C>G (p.His191Asp),7428.0,VHL,HGNC:12687,Likely pathogenic,1.0,"Jun 21, 2020",28940301.0,-,RCV000002323|RCV001219111,"MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557",Chuvash polycythemia|Von Hippel-Lindau syndrome;Chuvash polycythemia,germline,germline,GRCh38,NC_000003.12,3,10149894.0,10149894.0,3p25.3,"criteria provided, single submitter",2.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020495,UniProtKB:P40337#VAR_034999,OMIM:608537.0024",3.0,2235.0,10149894.0,C,G,-,-,-,-,-,-,SCV001391032,-,-,571C>G ,His191Asp,NM_000551.4,1.0,1_Pathogenic,97.62,0.4021739130434782,"['263400', '193300', '263400']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"ERYTHROCYTOSIS, FAMILIAL, 2; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var102503,VHL_Buckley_2024,VHL,12687,1.0,10149894.0,10149894.0,ENST00000256474.3,571,C,G,191.0,H,D,c.571C>G,p.His191Asp,missense_variant,missense_variant,-0.121089474362779,Neutral,Yes,6.195149693402042e-7,Likely pathogenic,"criteria provided, single submitter","Jun 21, 2020",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.712,0.5685,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_His191Asp,true,His191Asp
VHL_Leu122Pro,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,204010,CCSBVarC006545,ALE00006544,NC_000003.12:10149811:T:C,365T>C,Leu122Pro,CEGS2,CegsMutGDEh1045,A07,GDEhDisVCh_40037,A05,1.0,CegsMutGDDh1045,A07,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10149811,T,C,3,Y,Y,N,N,N,3-10149811-T-C,17270.0,single nucleotide variant,NM_000551.4(VHL):c.488T>C (p.Leu163Pro),7428.0,VHL,HGNC:12687,Likely pathogenic,1.0,"Mar 05, 2024",28940297.0,-,RCV000002319|RCV001231697|RCV004018540|RCV003298026,"MedGen:C4017161|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162",RENAL CELL CARCINOMA WITH PARANEOPLASTIC ERYTHROCYTOSIS|Von Hippel-Lindau syndrome;Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome,germline;unknown,germline,GRCh38,NC_000003.12,3,10149811.0,10149811.0,3p25.3,"criteria provided, multiple submitters, no conflicts",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020423,UniProtKB:P40337#VAR_034998,OMIM:608537.0018",3.0,2231.0,10149811.0,T,C,-,-,-,-,-,-,SCV001404228|SCV004006359|SCV004930953,-,-,488T>C ,Leu163Pro,NM_000551.4,2.0,1_Pathogenic,,2231.0,3,10149811.0,T,C,L,P,rs28940297,3,10191495,3,10166495,163.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.488T>C,p.Leu163Pro,c.488T>C,p.Leu163Pro,principal1,Y,1,YES,Select,+,CTC,2.0,0.0,T,T/T,T/T,T/T,T/T,.,0.56615,.,0.0,0.92967,D,1.0,0.90580,D,1.0,0.97365,D,0.99,0.97926,A,simple_aae,1.0,99.0,2.545,0.74100,M,-4.73,0.80118,D,0.995,0.99931,0.9804,0.96857,D,0.9890,0.99688,D,9,0.9931407,0.99847,D,0.876693,0.99057,D,0.922,0.98039,0.963,0.99626,P40337,L163P,Loss of helix (P = 0.0138)| Loss of catalytic residue at L163 (P = 0.0395)| Loss of stability (P = 0.0418)| Gain of relative solvent accessibility (P = 0.0479)| Gain of sheet (P = 0.0507),0.995879406206,0.99578,0.9815934838549631,0.98143,1.38241626667,0.84736,0.785631835461,0.79742,T,0.99222,0.99973,D,0.530341,0.95128,D,0.524022,0.95056,D,0.998030960559845,0.93000,D,0.855114,0.54106,D,0.99333304,0.99910,0.9519358,0.98492,0.9924481,0.99876,0.96566373,0.99253,-7.725,0.59253,D,0.9964,0.96271,P,0.988526704047355,0.87828,0.99992000,0.99909,0.968,0.98734,.,.,.,.,.,.,4.830708,0.78814,27.0,0.99899725923291072,0.97201,0.827906,0.74617,D,0.706336184216031,0.79941,7.208681,0.662968406388336,0.79467,7.112436,4.86,4.86,0.62577,3.74,0.68722,6.258,0.72514,7.711000,0.66857,0.665,0.62996,1.0,0.71675,1.0,0.68239,0.998,0.85369,379,0.83782,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Likely_pathogenic,Von_Hippel-Lindau_syndrome|Chuvash_polycythemia|Renal_cell_carcinoma_with_paraneoplastic_erythrocytosis|Hereditary_cancer-predisposing_syndrome,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10149811T>C,ClinGen:CA020423|OMIM:608537.0018|UniProtKB:P40337#VAR_034998,C0019562|C1837915|C4017161|C0027672,193300|263400,892|238557|140162,"von Hippel-Lindau disease tumour suppressor, alpha domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Leu,Pro,17270.0,single nucleotide variant,NM_000551.4(VHL):c.488T>C (p.Leu163Pro),7428.0,VHL,HGNC:12687,Likely pathogenic,1.0,"Mar 05, 2024",28940297.0,-,RCV000002319|RCV001231697|RCV004018540|RCV003298026,"MedGen:C4017161|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162",RENAL CELL CARCINOMA WITH PARANEOPLASTIC ERYTHROCYTOSIS|Von Hippel-Lindau syndrome;Chuvash polycythemia|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome,germline;unknown,germline,GRCh38,NC_000003.12,3,10149811.0,10149811.0,3p25.3,"criteria provided, multiple submitters, no conflicts",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020423,UniProtKB:P40337#VAR_034998,OMIM:608537.0018",3.0,2231.0,10149811.0,T,C,-,-,-,-,-,-,SCV001404228|SCV004006359|SCV004930953,-,-,488T>C ,Leu163Pro,NM_000551.4,2.0,1_Pathogenic,98.59,0.0792682926829268,"['193300', '263400', '193300']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2; VON HIPPEL-LINDAU SYNDROME",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var102259,VHL_Buckley_2024,VHL,12687,1.0,10149811.0,10149811.0,ENST00000256474.3,488,T,C,163.0,L,P,c.488T>C,p.Leu163Pro,missense_variant,missense_variant,-2.25641301429423,LOF1,Yes,,Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Mar 05, 2024",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.922,0.9964,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_Leu163Pro,true,Leu163Pro
VHL_Pro81Ser,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,VHL,ENSG00000134086,13320,203992,CCSBVarC006537,ALE00006536,NC_000003.12:10142088:C:T,241C>T,Pro81Ser,CEGS2,CegsMutGDEh1046,C04,GDEhDisVCh_40037,F06,1.0,CegsMutGDDh1046,C04,,,,,,,1.0,1.0,1.0,99.0,0.0,,,0.0,,,0.0,,,3,10142088,C,T,3,Y,Y,N,N,N,3-10142088-C-T,17272.0,single nucleotide variant,NM_000551.4(VHL):c.241C>T (p.Pro81Ser),7428.0,VHL,HGNC:12687,Benign,1.0,"Jun 25, 2024",104893829.0,-,RCV000002321|RCV000656990|RCV001843451|RCV001080004|RCV000115744|RCV000213077|RCV002467489|RCV003225718,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:C3661900|Human Phenotype Ontology:HP:0002884,MONDO:MONDO:0018666,MedGen:C0206624,Orphanet:449|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|Human Phenotype Ontology:HP:0005701,MONDO:MONDO:0008145,MedGen:C0014084,OMIM:166000,Orphanet:296|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557",Von Hippel-Lindau syndrome|not provided|Hepatoblastoma|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not specified|Enchondromatosis|Chuvash polycythemia,germline;paternal;unknown,germline,GRCh38,NC_000003.12,3,10142088.0,10142088.0,3p25.3,reviewed by expert panel,27.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020148,UniProtKB:P40337#VAR_005689,OMIM:608537.0020",3.0,2233.0,10142088.0,C,T,-,-,-,-,-,-,SCV005187310,-,-,241C>T ,Pro81Ser,NM_000551.4,3.0,2_Benign,0.000353058,2233.0,3,10142088.0,C,T,P,S,rs104893829,3,10183772,3,10158772,81.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.241C>T,p.Pro81Ser,c.241C>T,p.Pro81Ser,principal1,Y,1,YES,Select,+,CCG,1.0,0.0,C,C/C,C/C,C/C,C/C,.,0.42941,.,0.386,0.30459,T,0.945,0.56027,P,0.322,0.54817,B,0.9,0.93829,D,simple_aae,10.0,90.0,1.67,0.42718,L,-3.18,0.66927,D,0.347,0.50447,0.9894,0.97004,D,0.9682,0.98990,D,10,0.5509856,0.63951,D,0.988088,0.99950,D,0.678,0.88104,.,.,.,.,.,0.999935069407,0.99993,0.9210141937225951,0.92027,0.824530614107,0.67115,0.880600571632,0.94033,D,0.912083,0.98334,D,0.0497428,0.58019,T,0.207126,0.83396,D,0.326699584722519,0.25798,T,0.870213,0.57408,D,0.80532545,0.84046,0.64801645,0.79187,0.849518,0.87130,0.6533981,0.79488,-5.765,0.44323,T,0.5826,0.68105,P,0.717661026483067,0.67636,0.99986613,0.99835,0.607,0.78025,.,.,.,.,.,.,3.075395,0.41438,21.3,0.99874836341629913,0.95164,0.109912,0.21603,N,0.232290541523548,0.52532,3.449104,0.281110289359972,0.54198,3.608699,5.32,3.24,0.36180,3.52,0.63825,1.474,0.35112,3.511000,0.38920,0.521,0.23918,0.998,0.41403,0.999,0.35501,0.845,0.39945,364,0.84712,.,.,.,.,.,.,.,.,.,.,.,.,92,264690,3.4757642E-4,.,15,100052,1.499220e-04,0,37,189950,1.947880e-04,0,43,220144,1.953270e-04,0,0,6590,0.000000e+00,0,1,16736,5.975140e-05,0,0,2282,0.000000e+00,0,0,8392,0.000000e+00,0,0,7004,0.000000e+00,0,13,41852,3.106180e-04,0,0,15388,0.000000e+00,0,13,41852,3.106180e-04,0,1,13942,7.172570e-05,0,1,29972,3.336450e-05,0,0,5862,0.000000e+00,0,0,12524,0.000000e+00,0,0,10286,0.000000e+00,0,34,82570,4.117720e-04,0,0,30248,0.000000e+00,0,34,82570,4.117720e-04,0,1,13100,7.633590e-05,0,1,33790,2.959460e-05,0,0,9352,0.000000e+00,0,0,17030,0.000000e+00,0,0,14928,0.000000e+00,0,40,96378,4.150320e-04,0,0,30184,0.000000e+00,0,40,96378,4.150320e-04,0,.,566,1605226,3.525980e-04,1,543,1179690,4.602900e-04,1,7,74924,9.342800e-05,0,0,912,0.000000e+00,0,4,59932,6.674230e-05,0,0,29554,0.000000e+00,0,0,44862,0.000000e+00,0,2,55888,3.578590e-05,0,0,6080,0.000000e+00,0,543,1179690,4.602900e-04,1,1,91022,1.098640e-05,0,18,24620,7.311129163281885E-4,0,122,0,0,146,0,0,3848,0,0,146,0,0,610,0,0,56,0,0,104,0,1,3852,2.5960539979231567E-4,0,3970,0,0,202,0,19,33504,5.670964660936008E-4,Benign,Hepatoblastoma|Von_Hippel-Lindau_syndrome|Chuvash_polycythemia|Enchondromatosis|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome|Neoplasm,reviewed_by_expert_panel,NC_000003.12:g.10142088C>T,ClinGen:CA020148|OMIM:608537.0020|UniProtKB:P40337#VAR_005689,C0206624|C0019562|C1837915|C0014084|C3661900|CN169374|C0027672|C0027651,193300|263400|166000,449|892|238557|296|140162,"von Hippel-Lindau disease tumour suppressor, beta domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Pro,Ser,17272.0,single nucleotide variant,NM_000551.4(VHL):c.241C>T (p.Pro81Ser),7428.0,VHL,HGNC:12687,Benign,1.0,"Jun 25, 2024",104893829.0,-,RCV000002321|RCV000656990|RCV001843451|RCV001080004|RCV000115744|RCV000213077|RCV002467489|RCV003225718,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MedGen:C3661900|Human Phenotype Ontology:HP:0002884,MONDO:MONDO:0018666,MedGen:C0206624,Orphanet:449|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|Human Phenotype Ontology:HP:0005701,MONDO:MONDO:0008145,MedGen:C0014084,OMIM:166000,Orphanet:296|MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557",Von Hippel-Lindau syndrome|not provided|Hepatoblastoma|Von Hippel-Lindau syndrome;Chuvash polycythemia|Hereditary cancer-predisposing syndrome|not specified|Enchondromatosis|Chuvash polycythemia,germline;paternal;unknown,germline,GRCh38,NC_000003.12,3,10142088.0,10142088.0,3p25.3,reviewed by expert panel,27.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020148,UniProtKB:P40337#VAR_005689,OMIM:608537.0020",3.0,2233.0,10142088.0,C,T,-,-,-,-,-,-,SCV005187310,-,-,241C>T ,Pro81Ser,NM_000551.4,3.0,2_Benign,98.51,0.6691176470588235,"['193300', '193300', '263400', '166000', '263400']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2; ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE; ERYTHROCYTOSIS, FAMILIAL, 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,true,true,VHL_Buckley_2024_var100969,VHL_Buckley_2024,VHL,12687,1.0,10142088.0,10142088.0,ENST00000256474.3,241,C,T,81.0,P,S,c.241C>T,p.Pro81Ser,missense_variant,missense_variant,-0.0025152908280948,Neutral,Yes,0.0003525983257186,Benign,reviewed by expert panel,"Jun 25, 2024",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.678,0.5826,likely_pathogenic,2233.0,CA020148,von Hippel-Lindau disease,MONDO:0008667,Autosomal dominant inheritance,Benign,BA1,,"The variant NM_000551.4(VHL):c.241C>T (p.Pro81Ser) is a missense variant in the first exon of the VHL gene. The GroupMax Filtering Allele Frequency (95% CI) in gnomAD v4.1.0 is 0.0004281 (543/1179690 from European, Non-Finnish Population). This is higher than the ClinGen VHL VCEP threshold of >=0.000156 (0.0156%) threshold expected for VHL disease (BA1). Therefore this variant meets the criterion for (BA1) and is classified as Benign for autosomal-dominant von Hippel-Lindau disease (VHL disease) based on the ACMG/AMP criteria applied, as specified by the ClinGen VHL VCEP Version 1.0 (Specifications approval date: 02/26/2024. Variant Approval Date 06/25/2024).",VHL VCEP,https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50036,6/25/24,6/25/24,false,https://erepo.genome.network/evrepo/ui/classification/416afbe6-3dd6-40d9-9e61-d3c54b017b5e,416afbe6-3dd6-40d9-9e61-d3c54b017b5e,VUS,BA1,VHL_Pro81Ser,true,Pro81Ser
VHL_Tyr112His,1,0,0,1,0.0,0.0,100.0,0.0,0,1.0,true,VHL,ENSG00000134086,13320,203995,CCSBVarC006538,ALE00006537,NC_000003.12:10142181:T:C,334T>C,Tyr112His,CEGS2,CegsMutGDEh1046,E06,GDEhDisVCh_40037,C07,1.0,CegsMutGDDh1046,E06,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10142181,T,C,3,Y,Y,N,N,N,3-10142181-T-C,17261.0,single nucleotide variant,NM_000551.4(VHL):c.334T>C (p.Tyr112His),7428.0,VHL,HGNC:12687,Pathogenic,1.0,"Jan 09, 2024",104893824.0,-,RCV000002308|RCV000698407|RCV003407257|RCV002321468,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557||MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|VHL-related disorder|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10142181.0,10142181.0,3p25.3,"criteria provided, multiple submitters, no conflicts",6.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020277,UniProtKB:P40337#VAR_005717,OMIM:608537.0012",3.0,2222.0,10142181.0,T,C,-,-,-,-,-,-,SCV000827068|SCV000897805|SCV000918341|SCV002606729|SCV004109013,-,-,334T>C ,Tyr112His,NM_000551.4,2.0,1_Pathogenic,,2222.0,3,10142181.0,T,C,Y,H,rs104893824,3,10183865,3,10158865,112.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.334T>C,p.Tyr112His,c.334T>C,p.Tyr112His,principal1,Y,1,YES,Select,+,TAC,1.0,0.0,T,T/T,T/T,T/T,T/T,.,0.43552,.,0.003,0.92967,D,1.0,0.90580,D,1.0,0.97365,D,0.87,0.90832,A,simple_aae,13.0,87.0,2.25,0.63621,M,-3.59,0.69272,D,0.89,0.88895,1.0879,0.99155,D,0.9915,0.99784,D,10,0.9902532,0.99517,D,0.990227,0.99964,D,0.851,0.95384,0.953,0.99464,P40337,Y112H,Gain of disorder (P = 0.0205)| Loss of sheet (P = 0.0315)| Gain of glycosylation at S111 (P = 0.0582)| Gain of loop (P = 0.069)| Loss of stability (P = 0.0798),0.998710219499,0.99867,0.9635893573369442,0.96324,0.536705096442,0.50709,0.894185781479,0.95765,D,0.989041,0.99946,D,0.502384,0.94312,D,0.483863,0.94233,D,0.987660109996796,0.77954,D,0.824018,0.48374,T,0.9346393,0.94623,0.86507696,0.92426,0.95743597,0.96973,0.82802266,0.89928,-4.256,0.47942,T,0.9843,0.92045,P,0.992585450960762,0.89588,0.99988997,0.99864,0.946,0.97496,.,.,.,.,.,.,4.582344,0.72457,25.8,0.99742869030627268,0.83644,0.695784,0.65308,D,0.673365051741103,0.77769,6.762185,0.633304177169064,0.77249,6.666779,5.17,5.17,0.70808,.,.,5.006,0.63812,5.732000,0.49601,0.515,0.23513,1.0,0.71675,1.0,0.68239,0.966,0.53174,364,0.84712,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic,VHL-related_disorder|Von_Hippel-Lindau_syndrome|Chuvash_polycythemia|Hereditary_cancer-predisposing_syndrome,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10142181T>C,ClinGen:CA020277|OMIM:608537.0012|UniProtKB:P40337#VAR_005717,C0019562|C1837915|C0027672,193300|263400,892|238557|140162,"von Hippel-Lindau disease tumour suppressor, beta domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Tyr,His,17261.0,single nucleotide variant,NM_000551.4(VHL):c.334T>C (p.Tyr112His),7428.0,VHL,HGNC:12687,Pathogenic,1.0,"Jan 09, 2024",104893824.0,-,RCV000002308|RCV000698407|RCV003407257|RCV002321468,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557||MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|VHL-related disorder|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10142181.0,10142181.0,3p25.3,"criteria provided, multiple submitters, no conflicts",6.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,"ClinGen:CA020277,UniProtKB:P40337#VAR_005717,OMIM:608537.0012",3.0,2222.0,10142181.0,T,C,-,-,-,-,-,-,SCV000827068|SCV000897805|SCV000918341|SCV002606729|SCV004109013,-,-,334T>C ,Tyr112His,NM_000551.4,2.0,1_Pathogenic,98.07,0.4549549549549549,"['193300', '193300', '263400']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,true,true,VHL_Buckley_2024_var101240,VHL_Buckley_2024,VHL,12687,1.0,10142181.0,10142181.0,ENST00000256474.3,334,T,C,112.0,Y,H,c.334T>C,p.Tyr112His,missense_variant,missense_variant,-0.789074004711427,LOF2,Yes,,Pathogenic,"criteria provided, multiple submitters, no conflicts","Jan 09, 2024",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.851,0.9843,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_Tyr112His,true,Tyr112His
VHL_Tyr134Cys,1,0,1,0,0.0,100.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,204008,CCSBVarC006543,ALE00006542,NC_000003.12:10149847:A:G,401A>G,Tyr134Cys,CEGS2,CegsMutGDEh1045,H01,GDEhDisVCh_40037,B04,1.0,CegsMutGDDh1045,H01,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10149847,A,G,3,Y,Y,N,N,N,3-10149847-A-G,45566.0,single nucleotide variant,NM_000551.4(VHL):c.524A>G (p.Tyr175Cys),7428.0,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1.0,"Nov 22, 2024",193922613.0,-,RCV000030589|RCV000533687|RCV004700288|RCV000492408,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10149847.0,10149847.0,3p25.3,"criteria provided, multiple submitters, no conflicts",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA020462,2.0,36905.0,10149847.0,A,G,-,-,-,-,-,-,SCV000053266|SCV000580980|SCV000626909|SCV005202017,-,-,524A>G ,Tyr175Cys,NM_000551.4,2.0,1_Pathogenic,,36905.0,3,10149847.0,A,G,Y,C,rs193922613,3,10191531,3,10166531,175.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.524A>G,p.Tyr175Cys,c.524A>G,p.Tyr175Cys,principal1,Y,1,YES,Select,+,TAC,2.0,0.0,A,A/A,A/A,A/A,A/A,.,0.78662,.,0.013,0.79703,D,1.0,0.90580,D,1.0,0.97365,D,0.87,0.90832,A,simple_aae,13.0,87.0,2.255,0.63995,M,-4.97,0.82092,D,0.912,0.91390,0.9883,0.96986,D,0.9871,0.99618,D,10,0.96428144,0.95836,D,0.793067,0.98373,D,0.892,0.96904,0.823,0.93491,P40337,Y175C,Gain of glycosylation at Y175 (P = 0.0214)| Loss of loop (P = 0.0512)| Gain of helix (P = 0.0696)| Loss of MoRF binding (P = 0.1006)| Gain of sheet (P = 0.1451),0.999412493541,0.99939,0.8977081225389613,0.89677,1.20330381642,0.80501,0.663946151733,0.61912,T,0.971241,0.99688,D,0.527392,0.95024,D,0.519785,0.94951,D,0.998838841915131,0.95270,D,0.926307,0.72838,D,0.95785505,0.97017,0.8224695,0.89564,0.9462098,0.95816,0.78108066,0.86934,-3.13,0.19778,T,0.8952,0.82387,P,0.997504936199203,0.93212,0.99991380,0.99894,0.973,0.98982,.,.,.,.,.,.,4.750907,0.76761,26.6,0.99798013040991584,0.88293,0.692590,0.65094,D,0.631162246048001,0.75020,6.256173,0.608858946979728,0.75446,6.336101,4.97,4.97,0.65374,3.76,0.69107,5.342,0.65818,9.089000,0.78771,0.756,0.943,1.0,0.71675,1.0,0.68239,0.988,0.63383,379,0.83782,.,.,.,.,.,.,.,.,.,.,.,.,1,264690,3.7780044E-6,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,1,1614106,6.195380e-07,0,1,1180052,8.474200e-07,0,0,74944,0.000000e+00,0,0,912,0.000000e+00,0,0,59992,0.000000e+00,0,0,29604,0.000000e+00,0,0,44894,0.000000e+00,0,0,64044,0.000000e+00,0,0,6084,0.000000e+00,0,1,1180052,8.474200e-07,0,0,91092,0.000000e+00,0,0,9690,0,0,114,0,0,86,0,0,2782,0,0,146,0,0,610,0,0,26,0,0,98,0,0,496,0,0,2896,0,0,112,0,0,14048,0,Pathogenic/Likely_pathogenic,Hereditary_cancer-predisposing_syndrome|Von_Hippel-Lindau_syndrome|Chuvash_polycythemia,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10149847A>G,ClinGen:CA020462,C0027672|C0019562|C1837915,193300|263400,140162|892|238557,"von Hippel-Lindau disease tumour suppressor, alpha domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Tyr,Cys,45566.0,single nucleotide variant,NM_000551.4(VHL):c.524A>G (p.Tyr175Cys),7428.0,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1.0,"Nov 22, 2024",193922613.0,-,RCV000030589|RCV000533687|RCV004700288|RCV000492408,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892;MONDO:MONDO:0009892,MedGen:C1837915,OMIM:263400,Orphanet:238557|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162",Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome;Chuvash polycythemia|not provided|Hereditary cancer-predisposing syndrome,germline,germline,GRCh38,NC_000003.12,3,10149847.0,10149847.0,3p25.3,"criteria provided, multiple submitters, no conflicts",4.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA020462,2.0,36905.0,10149847.0,A,G,-,-,-,-,-,-,SCV000053266|SCV000580980|SCV000626909|SCV005202017,-,-,524A>G ,Tyr175Cys,NM_000551.4,2.0,1_Pathogenic,98.23,0.0225225225225225,"['193300', '193300', '263400']",multiple,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,"VON HIPPEL-LINDAU SYNDROME; VON HIPPEL-LINDAU SYNDROME; ERYTHROCYTOSIS, FAMILIAL, 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var102364,VHL_Buckley_2024,VHL,12687,1.0,10149847.0,10149847.0,ENST00000256474.3,524,A,G,175.0,Y,C,c.524A>G,p.Tyr175Cys,missense_variant,missense_variant,-0.422939455853937,LOF2,Yes,6.195379981240389e-7,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Apr 19, 2024",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.892,0.8952,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_Tyr175Cys,true,Tyr175Cys
VHL_Val125Ala,1,1,0,0,100.0,0.0,0.0,100.0,1,0.0,true,VHL,ENSG00000134086,13320,204009,CCSBVarC006544,ALE00006543,NC_000003.12:10149820:T:C,374T>C,Val125Ala,CEGS2,CegsMutGDEh1045,D04,GDEhDisVCh_40037,F04,1.0,CegsMutGDDh1045,D04,,,,,,,1.0,1.0,1.0,1.0,0.0,,,0.0,,,0.0,,,3,10149820,T,C,3,Y,Y,N,N,N,3-10149820-T-C,52774.0,single nucleotide variant,NM_000551.4(VHL):c.497T>C (p.Val166Ala),7428.0,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1.0,"Aug 01, 2018",397516445.0,-,RCV000036549|RCV001023359|RCV001701727,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900",Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided,germline,germline,GRCh38,NC_000003.12,3,10149820.0,10149820.0,3p25.3,"criteria provided, multiple submitters, no conflicts",5.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA020442,2.0,43605.0,10149820.0,T,C,-,-,-,-,-,-,SCV000060204|SCV000897837|SCV001185223,-,-,497T>C ,Val166Ala,NM_000551.4,2.0,1_Pathogenic,,43605.0,3,10149820.0,T,C,V,A,rs397516445,3,10191504,3,10166504,166.0,VHL,ENSG00000134086,ENST00000256474,ENSP00000256474,P40337,VHL_HUMAN,c.497T>C,p.Val166Ala,c.497T>C,p.Val166Ala,principal1,Y,1,YES,Select,+,GTC,2.0,0.0,T,T/T,T/T,T/T,T/T,.,0.58783,.,0.005,0.72530,D,0.934,0.52216,P,0.764,0.56585,P,0.94,0.94378,A,simple_aae,6.0,94.0,1.825,0.47724,L,-2.93,0.61315,D,0.793,0.78847,1.0090,0.97333,D,0.9837,0.99503,D,10,0.98198533,0.98235,D,0.694288,0.97483,D,0.868,0.96013,0.951,0.99425,P40337,V166A,Loss of helix (P = 0.0626)| Gain of glycosylation at S168 (P = 0.1126)| Loss of MoRF binding (P = 0.1457)| Loss of stability (P = 0.2083)| Gain of disorder (P = 0.255),0.998050396216,0.99800,0.8610207784804341,0.85981,0.909016350626,0.70800,0.692285478115,0.65977,T,0.908489,0.98239,D,0.500207,0.94241,D,0.480736,0.94162,D,0.952891409397125,0.63675,D,0.816918,0.47162,T,0.897139,0.91002,0.668959,0.80361,0.9028341,0.91518,0.7449305,0.84741,-4.766,0.34232,T,0.9238,0.84465,P,0.996382947552379,0.92095,0.99985349,0.99806,0.929,0.96474,.,.,.,.,.,.,4.71373,0.75802,26.4,0.99793109994728735,0.87849,0.577505,0.57758,D,0.547382090304779,0.69762,5.426499,0.541065407386246,0.70617,5.555456,4.86,4.86,0.62577,3.74,0.68722,6.258,0.72514,7.711000,0.66857,0.665,0.62996,0.998,0.41403,1.0,0.68239,0.947,0.4917,379,0.83782,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,Pathogenic/Likely_pathogenic,Von_Hippel-Lindau_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided,"criteria_provided,_multiple_submitters,_no_conflicts",NC_000003.12:g.10149820T>C,ClinGen:CA020442,C0019562|C0027672|C3661900,193300,892|140162,"von Hippel-Lindau disease tumour suppressor, alpha domain|von Hippel-Lindau disease tumour suppressor, beta/alpha domain",Val,Ala,52774.0,single nucleotide variant,NM_000551.4(VHL):c.497T>C (p.Val166Ala),7428.0,VHL,HGNC:12687,Pathogenic/Likely pathogenic,1.0,"Aug 01, 2018",397516445.0,-,RCV000036549|RCV001023359|RCV001701727,"MONDO:MONDO:0008667,MedGen:C0019562,OMIM:193300,Orphanet:892|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900",Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|not provided,germline,germline,GRCh38,NC_000003.12,3,10149820.0,10149820.0,3p25.3,"criteria provided, multiple submitters, no conflicts",5.0,"ACMG2013,ACMG2016,ACMG2021,ACMG2022",N,ClinGen:CA020442,2.0,43605.0,10149820.0,T,C,-,-,-,-,-,-,SCV000060204|SCV000897837|SCV001185223,-,-,497T>C ,Val166Ala,NM_000551.4,2.0,1_Pathogenic,98.44,0.323943661971831,['193300'],autosomal dominant,Rare genetic eye disease; Rare genetic renal disease; Rare genetic developmental defect during embryogenesis; Rare genetic hematologic disease; Rare genetic endocrine disease; Rare genetic neurological disorder; Rare genetic tumor; Inherited cancer-predisposing syndrome,8,VON HIPPEL-LINDAU SYNDROME,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,false,false,VHL_Buckley_2024_var102288,VHL_Buckley_2024,VHL,12687,1.0,10149820.0,10149820.0,ENST00000256474.3,497,T,C,166.0,V,A,c.497T>C,p.Val166Ala,missense_variant,missense_variant,-0.496434927022058,LOF2,Yes,,Pathogenic/Likely pathogenic,"criteria provided, multiple submitters, no conflicts","Aug 01, 2018",nucleotide,urn:mavedb:00000675-a-1,ENST00000256474.3,NM_000551.4,immortalized human cells,cell viability assay (BAO_0003009),survival rate (OBI_0000789),"molecular function (GO:0003674)
",No,,,,,,,,,,,0.868,0.9238,likely_pathogenic,,,,,,,,,,,,,,,,,,,VHL_Val166Ala,true,Val166Ala
